data_2roe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2roe _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.849 0.357 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -116.18 131.15 57.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.713 1.605 . . . . 0.0 109.866 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -132.63 144.38 50.32 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.549 1.539 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -110.94 115.73 30.0 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.88 142.64 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.53 115.97 13.65 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.581 0.753 . . . . 0.0 109.888 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.62 -17.03 5.31 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.446 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.5 mtm -73.4 107.99 6.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.742 1.771 . . . . 0.0 107.612 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -121.23 16.9 11.51 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.908 -0.495 . . . . 0.0 111.209 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.0 t -151.94 152.46 32.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.63 1.172 . . . . 0.0 108.039 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -61.0 -30.95 70.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.002 0.521 . . . . 0.0 110.014 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.15 -39.24 81.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 110.765 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.4 m -63.68 -53.66 47.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.241 1.016 . . . . 0.0 108.968 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.92 -50.45 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 125.561 1.545 . . . . 0.0 110.839 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.9 ptm -63.49 -40.97 98.49 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.706 1.139 . . . . 0.0 112.355 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.94 79.65 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.29 -39.15 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.758 2.023 . . . . 0.0 110.471 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -55.48 -58.86 6.01 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.49 -41.07 96.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.653 -0.654 . . . . 0.0 111.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -43.13 77.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.029 0.532 . . . . 0.0 111.295 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.87 -36.12 77.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -65.68 -13.13 58.6 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.883 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -75.44 -8.01 55.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.9 1.227 . . . . 0.0 111.368 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.03 134.64 59.51 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 124.143 0.977 . . . . 0.0 111.048 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.14 112.9 2.65 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.719 2.279 . . . . 0.0 107.558 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.93 -3.98 14.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.848 1.69 . . . . 0.0 113.806 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -87.42 139.99 16.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 120.288 2.044 . . . . 0.0 109.486 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -118.75 -59.76 1.83 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.856 1.662 . . . . 0.0 108.815 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -135.76 158.99 43.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 162.75 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -144.5 107.83 4.58 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.24 122.65 68.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.795 0.838 . . . . 0.0 109.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.7 t -84.73 -177.74 6.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.22 1.008 . . . . 0.0 108.804 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.6 tp -132.44 -14.24 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.907 2.083 . . . . 0.0 109.214 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.68 -27.35 7.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.616 1.167 . . . . 0.0 112.281 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -89.97 -15.12 32.62 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 117.641 -1.171 . . . . 0.0 113.625 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.9 35.39 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 119.785 1.175 . . . . 0.0 110.557 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -122.08 154.39 37.39 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.763 1.225 . . . . 0.0 110.64 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.81 79.43 1.62 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.345 1.458 . . . . 0.0 110.255 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.68 145.83 55.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.664 0.786 . . . . 0.0 109.821 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.5 t -128.37 127.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.259 1.423 . . . . 0.0 107.67 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -93.57 -23.15 18.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.522 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.13 176.41 30.39 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.934 0.778 . . . . 0.0 111.601 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -95.5 10.39 36.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.519 1.528 . . . . 0.0 111.939 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.7 4.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.914 -0.491 . . . . 0.0 112.002 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.68 149.39 46.09 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.62 -33.23 46.09 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.202 1.935 . . . . 0.0 113.861 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -61.58 -47.97 83.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.98 69.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.061 0.545 . . . . 0.0 111.544 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.75 -59.0 2.98 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.564 0.746 . . . . 0.0 109.986 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.47 -39.98 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.091 0.957 . . . . 0.0 110.819 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -53.19 -51.33 62.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.26 1.424 . . . . 0.0 109.312 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.49 -26.18 65.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -83.73 -43.15 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 119.651 1.114 . . . . 0.0 108.604 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -60.67 -32.69 71.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.577 1.151 . . . . 0.0 108.663 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.84 -29.14 70.08 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.108 1.363 . . . . 0.0 110.841 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -79.6 -0.68 34.72 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.536 -0.727 . . . . 0.0 110.374 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 11.64 67.6 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.763 1.173 . . . . 0.0 114.563 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -102.98 -178.71 3.75 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.24 1.52 . . . . 0.0 108.104 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -116.42 130.95 57.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 118.167 -0.92 . . . . 0.0 108.627 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.18 159.05 43.03 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.822 0.737 . . . . 0.0 110.25 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.53 144.04 20.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.636 1.174 . . . . 0.0 108.631 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.99 158.83 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -119.27 21.17 12.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 109.733 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 126.17 1.788 . . . . 0.0 106.374 178.929 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.476 0.655 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -121.52 128.68 52.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.29 145.89 51.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.938 1.695 . . . . 0.0 108.98 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.404 ' HE2' HD22 ' A' ' 65' ' ' LEU . 24.6 ttmm -109.32 119.06 38.34 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.4 t -109.09 146.46 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -141.57 126.26 17.98 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 126.54 -23.31 5.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.958 1.266 . . . . 0.0 113.015 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.1 mtm -68.03 118.4 11.16 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.261 1.531 . . . . 0.0 108.684 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -119.58 -8.7 9.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.732 0.813 . . . . 0.0 111.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.68 158.16 43.93 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.846 1.258 . . . . 0.0 108.399 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.27 -32.31 62.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 112.204 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -60.42 -34.75 74.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.531 0.605 . . . . 0.0 110.76 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m -69.13 -48.53 62.18 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -54.59 -54.09 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 125.103 1.361 . . . . 0.0 110.526 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ptm -60.86 -29.56 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.767 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.14 48.27 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.9 t -55.42 -46.2 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.854 1.261 . . . . 0.0 108.418 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.3 m -55.38 -53.56 54.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.894 0.878 . . . . 0.0 109.719 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -64.82 -40.52 95.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.073 -1.017 . . . . 0.0 112.613 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.52 98.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.004 0.521 . . . . 0.0 111.191 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.21 -44.02 92.26 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -65.87 -9.46 29.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.404 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -74.96 -24.78 58.51 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 121.428 1.922 . . . . 0.0 110.015 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.07 128.22 91.97 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 123.508 0.723 . . . . 0.0 110.72 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.06 108.25 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.152 2.568 . . . . 0.0 108.377 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.84 -4.48 7.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 124.559 1.076 . . . . 0.0 111.829 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.2 t -91.28 100.58 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 119.601 1.701 . . . . 0.0 110.946 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.25 -56.09 5.06 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.427 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -146.28 160.23 42.29 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -150.0 175.46 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 126.966 2.106 . . . . 0.0 108.918 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -152.46 143.75 23.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.77 126.01 6.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 t -84.2 176.42 8.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.9 tp -117.76 -13.99 10.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.68 1.592 . . . . 0.0 109.903 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -125.63 -39.06 2.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 112.814 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.37 -17.56 64.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.56 42.14 97.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -141.67 129.17 21.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.212 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.13 144.98 48.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 106.185 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.57 156.19 48.91 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.12 142.26 44.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.559 1.144 . . . . 0.0 108.406 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -125.01 42.34 3.3 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.296 1.838 . . . . 0.0 110.142 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.4 -167.23 12.07 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.464 1.506 . . . . 0.0 112.796 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -104.53 3.37 31.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.457 1.903 . . . . 0.0 111.993 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.94 169.06 1.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.947 -1.095 . . . . 0.0 113.518 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.33 148.73 35.56 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.834 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -58.21 -34.49 98.61 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.472 2.115 . . . . 0.0 113.78 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.68 -52.65 23.73 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.165 0.986 . . . . 0.0 111.429 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.05 66.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.3 mt -67.86 -60.65 2.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.365 1.466 . . . . 0.0 111.302 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -55.52 -44.93 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -57.62 -39.9 77.97 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.552 0.741 . . . . 0.0 111.366 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.71 -28.15 68.85 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.208 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.33 -37.18 15.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 108.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.0 -33.29 75.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.58 -12.47 61.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.878 1.271 . . . . 0.0 111.816 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -90.4 -9.79 46.27 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.31 1.414 . . . . 0.0 109.031 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.96 15.09 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.728 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -114.99 -179.37 3.61 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.618 1.709 . . . . 0.0 108.683 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -118.68 127.84 53.95 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.34 157.91 45.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.746 0.703 . . . . 0.0 111.37 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.03 135.16 13.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.535 1.534 . . . . 0.0 108.592 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.97 147.81 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.885 0.766 . . . . 0.0 110.759 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.404 HD22 ' HE2' ' A' ' 5' ' ' LYS . 84.8 mt -123.77 20.21 9.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.678 2.391 . . . . 0.0 111.009 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.814 0 C-N-CA 124.565 1.146 . . . . 0.0 108.283 -179.633 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.234 0.278 0 CA-C-O 119.51 -0.281 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -115.54 134.88 54.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.781 1.232 . . . . 0.0 108.499 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mt -128.3 132.04 48.66 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.493 1.517 . . . . 0.0 108.373 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -92.0 117.55 29.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.56 159.73 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -143.65 148.92 36.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.42 63.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.488 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.0 mtm -73.82 109.4 7.29 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.582 2.191 . . . . 0.0 106.23 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.2 p -123.31 -6.13 8.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -150.02 162.62 40.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.108 -0.995 . . . . 0.0 108.792 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.38 -37.43 67.55 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.692 1.597 . . . . 0.0 111.262 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -64.89 -38.8 92.19 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 m -60.5 -46.52 89.82 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.22 -58.57 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptm -59.16 -37.52 77.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.59 69.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.513 0.597 . . . . 0.0 109.562 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.43 -44.04 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -52.64 -58.96 5.12 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 120.954 -1.091 . . . . 0.0 109.626 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.45 -36.96 81.85 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 112.702 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.61 67.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.0 0.92 . . . . 0.0 109.881 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.26 -46.18 15.16 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -24.01 39.75 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.095 1.358 . . . . 0.0 114.434 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -64.77 -24.1 67.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.75 1.159 . . . . 0.0 111.036 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.03 127.73 88.23 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 118.944 0.793 . . . . 0.0 110.585 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.62 110.75 2.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.594 2.196 . . . . 0.0 107.764 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 -9.86 6.91 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.993 1.759 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.0 t -88.75 104.01 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 118.4 1.1 . . . . 0.0 109.823 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.76 -64.69 0.82 Allowed 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -146.62 166.96 24.98 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.15 156.51 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.71 110.96 8.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.4 t -113.28 134.02 57.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.073 0.949 . . . . 0.0 109.01 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 t -114.78 125.77 54.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.792 1.237 . . . . 0.0 109.812 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.22 -37.56 80.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.49 0.716 . . . . 0.0 110.7 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.35 -54.43 9.46 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.03 0.532 . . . . 0.0 110.251 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.87 -28.17 68.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.205 0.912 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.94 26.59 74.56 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.61 164.59 16.27 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.965 1.306 . . . . 0.0 109.68 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.12 31.03 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.999 1.72 . . . . 0.0 108.14 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.13 136.16 48.28 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -121.55 125.53 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.0 -9.6 52.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.252 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.15 -166.07 4.49 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.901 1.238 . . . . 0.0 114.154 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -124.31 8.42 8.47 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.806 1.642 . . . . 0.0 111.176 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.25 158.71 16.53 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.273 1.029 . . . . 0.0 109.768 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 148.87 90.36 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 125.557 1.543 . . . . 0.0 110.06 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.51 -30.43 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.228 1.286 . . . . 0.0 111.585 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.455 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -63.76 -56.49 15.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.818 1.247 . . . . 0.0 108.251 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.22 67.35 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.29 -55.32 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.855 1.262 . . . . 0.0 111.211 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.13 -43.94 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.399 1.0 . . . . 0.0 111.39 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -46.46 82.89 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.831 1.252 . . . . 0.0 108.264 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -23.01 60.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.241 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.06 -42.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.345 1.43 . . . . 0.0 109.71 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.59 -26.91 68.84 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.52 -15.94 63.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.428 1.891 . . . . 0.0 113.156 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -97.7 -6.09 33.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.665 1.12 . . . . 0.0 109.055 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.87 6.86 53.9 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.317 0.96 . . . . 0.0 112.624 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -95.48 -170.47 2.17 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -132.19 134.04 44.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.37 167.55 21.65 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 118.329 0.513 . . . . 0.0 111.422 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -159.57 130.86 6.05 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 124.811 1.244 . . . . 0.0 108.687 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.428 HG21 ' H ' ' A' ' 66' ' ' ALA . 1.8 p -74.9 130.98 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.09 16.25 18.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.082 0.953 . . . . 0.0 112.638 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' H ' HG21 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.537 1.535 . . . . 0.0 110.61 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 C--O 1.236 0.368 0 CA-C-O 122.558 1.171 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -159.13 131.58 6.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mt -138.23 160.06 40.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.15 1.38 . . . . 0.0 109.309 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -126.98 145.91 50.53 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.5 141.04 44.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 127.391 2.277 . . . . 0.0 109.5 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.84 114.2 10.24 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.116 1.366 . . . . 0.0 108.237 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.62 -6.62 5.23 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.911 1.72 . . . . 0.0 115.0 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -68.28 155.02 40.58 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.88 2.34 . . . . 0.0 109.816 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -137.15 -41.43 0.58 Allowed 'General case' 0 C--N 1.339 0.12 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 m -136.73 169.15 18.2 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 124.581 1.152 . . . . 0.0 109.699 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -49.55 -43.09 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.514 1.525 . . . . 0.0 111.698 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -58.75 -37.76 76.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.106 0.563 . . . . 0.0 111.67 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.99 -39.81 94.03 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.01 -58.81 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 109.449 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -53.33 -37.06 61.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.94 -55.15 38.65 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.911 0.862 . . . . 0.0 108.797 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.09 -40.84 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.396 1.078 . . . . 0.0 110.021 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.4 m -55.69 -46.0 77.72 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.986 1.267 . . . . 0.0 108.12 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -67.81 -36.36 80.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.206 -0.934 . . . . 0.0 111.315 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.01 73.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.774 0.715 . . . . 0.0 111.385 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mt -61.24 -39.45 90.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.657 1.117 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -67.42 -9.65 43.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.882 0.873 . . . . 0.0 112.834 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.31 -29.09 66.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.021 1.282 . . . . 0.0 109.544 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -58.89 129.52 85.57 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.231 1.413 . . . . 0.0 112.796 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.83 117.34 4.82 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 122.445 2.097 . . . . 0.0 107.66 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.82 -14.43 12.79 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 126.423 1.963 . . . . 0.0 112.613 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.3 140.89 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-N 119.335 1.567 . . . . 0.0 107.757 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -121.49 -54.88 1.96 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.248 1.019 . . . . 0.0 108.49 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -137.27 153.97 50.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -140.92 168.76 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.199 0.937 . . . . 0.0 111.033 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.92 138.66 34.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.652 2.381 . . . . 0.0 104.631 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -151.65 136.53 10.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -137.19 129.55 29.74 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.682 0.674 . . . . 0.0 110.369 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -66.47 -48.82 68.65 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.663 1.185 . . . . 0.0 109.81 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -61.3 -35.18 76.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -84.27 -29.92 26.05 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.283 0.633 . . . . 0.0 111.941 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.56 33.39 71.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.85 169.52 17.62 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.042 1.421 . . . . 0.0 112.787 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.33 140.25 33.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.931 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.8 149.6 47.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.416 1.886 . . . . 0.0 106.899 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -131.18 133.66 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.79 2.036 . . . . 0.0 108.243 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -100.22 -3.97 30.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.742 0.817 . . . . 0.0 111.669 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.19 -170.67 46.49 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.294 0.949 . . . . 0.0 113.296 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 t -101.08 3.82 41.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.957 1.703 . . . . 0.0 111.483 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.55 153.84 9.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.004 0.922 . . . . 0.0 112.849 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 150.64 61.02 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.102 0.561 . . . . 0.0 110.578 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.58 -40.85 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.483 2.122 . . . . 0.0 113.009 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -55.68 -47.22 77.14 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.625 0.77 . . . . 0.0 110.714 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.57 79.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.262 0.625 . . . . 0.0 111.623 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.6 mt -67.24 -52.52 40.02 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 123.839 0.856 . . . . 0.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 p -60.52 -40.51 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.12 -45.66 86.93 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.051 0.941 . . . . 0.0 109.929 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -85.96 -33.21 7.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.92 -32.74 74.59 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.34 -29.23 69.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.715 1.206 . . . . 0.0 109.782 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -78.33 -7.4 57.22 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.85 25.33 41.85 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.681 1.61 . . . . 0.0 113.475 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.45 177.88 4.66 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -115.22 98.33 6.71 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.717 0.807 . . . . 0.0 109.685 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.0 161.53 13.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.688 -0.632 . . . . 0.0 110.747 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -151.36 138.76 19.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.155 0.982 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.9 t -78.06 138.72 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.38 9.65 18.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.054 0.942 . . . . 0.0 111.561 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.661 1.585 . . . . 0.0 108.722 179.319 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.0 mt . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.87 130.37 56.8 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 108.713 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.06 151.68 51.62 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 125.37 1.468 . . . . 0.0 107.315 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -118.52 120.86 38.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.42 138.89 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -137.05 102.95 4.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.86 -8.56 1.76 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.801 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.5 mtm -75.38 130.35 38.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.5 t -136.15 14.33 3.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.263 0.483 . . . . 0.0 111.753 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 t -160.93 165.27 30.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.938 -1.101 . . . . 0.0 109.646 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -61.28 -33.22 73.2 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.365 1.066 . . . . 0.0 110.973 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.27 -25.57 63.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.983 0.513 . . . . 0.0 111.656 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -71.67 -47.01 57.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -55.46 -56.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.66 0.784 . . . . 0.0 109.54 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.2 ptm -58.54 -34.13 70.66 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.66 -51.1 66.6 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.37 -39.06 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.616 1.167 . . . . 0.0 109.4 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.1 m -57.05 -50.26 73.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.292 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -69.87 -37.78 76.18 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.656 -1.278 . . . . 0.0 111.468 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.37 78.83 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.439 1.095 . . . . 0.0 108.669 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.76 -41.17 60.58 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.927 -1.108 . . . . 0.0 109.276 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -64.78 -16.54 63.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -13.76 60.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.74 1.609 . . . . 0.0 110.987 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.54 130.14 89.34 Favored Pre-proline 0 N--CA 1.452 -0.351 0 C-N-CA 124.581 1.153 . . . . 0.0 110.623 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.56 111.51 2.13 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 106.073 -2.318 . . . . 0.0 106.073 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.95 -3.9 9.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.758 1.647 . . . . 0.0 112.318 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.05 138.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.587 2.193 . . . . 0.0 109.076 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.52 -51.9 1.72 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.565 1.546 . . . . 0.0 111.451 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -139.47 153.58 47.56 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 m -147.4 166.28 5.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.24 94.17 2.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.342 1.057 . . . . 0.0 109.993 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.17 134.01 38.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.639 1.176 . . . . 0.0 108.609 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -131.6 134.53 46.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.073 0.949 . . . . 0.0 109.902 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.3 tp -76.99 -42.07 40.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.81 -53.03 62.8 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.844 0.857 . . . . 0.0 110.183 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -14.92 55.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.839 -1.076 . . . . 0.0 113.395 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 55.16 29.71 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.4 170.06 18.15 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.849 -0.795 . . . . 0.0 110.577 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.9 95.26 2.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.668 1.187 . . . . 0.0 113.312 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.46 152.82 40.61 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.891 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.19 135.89 60.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.269 1.428 . . . . 0.0 108.249 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -103.65 -19.26 14.4 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.738 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.73 -172.1 28.6 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.3 p -103.53 8.78 37.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.649 1.179 . . . . 0.0 112.425 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.18 155.1 7.01 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.479 0.711 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 151.25 65.5 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 122.859 0.464 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.14 -40.16 34.93 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.989 1.792 . . . . 0.0 114.91 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -59.05 -45.33 91.04 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.411 0.684 . . . . 0.0 110.095 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.39 -32.02 72.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.275 -0.265 . . . . 0.0 111.47 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.1 mt -69.42 -57.68 4.96 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.261 1.024 . . . . 0.0 109.981 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.49 -40.49 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.48 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -53.37 -51.97 60.79 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.925 0.89 . . . . 0.0 110.127 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -28.26 65.03 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.6 -39.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -60.77 -39.47 88.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.84 -21.84 66.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 0.0 112.279 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -86.27 -9.41 56.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.223 0.919 . . . . 0.0 110.468 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.97 21.45 18.27 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.657 -1.079 . . . . 0.0 114.229 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.93 179.55 4.08 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.415 1.608 . . . . 0.0 108.048 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -120.57 109.48 15.31 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.24 165.64 12.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 118.902 0.774 . . . . 0.0 110.353 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -157.91 132.63 8.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.877 -0.514 . . . . 0.0 111.339 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.78 147.86 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.46 33.83 4.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.29 1.036 . . . . 0.0 110.177 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.569 2.348 . . . . 0.0 107.028 179.26 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mt . . . . . 0 C--O 1.233 0.196 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -132.26 123.66 27.38 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.57 133.11 51.16 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.711 0.804 . . . . 0.0 109.436 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -88.19 121.27 30.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.28 150.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -142.48 120.49 12.08 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.77 -10.71 9.61 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.05 1.31 . . . . 0.0 115.141 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.2 mtm -74.92 111.88 10.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 120.052 1.926 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.67 11.42 9.14 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.533 0.733 . . . . 0.0 111.797 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.0 t -151.24 151.86 32.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -60.76 -27.96 68.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.902 0.481 . . . . 0.0 110.599 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -63.26 -32.5 73.93 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.844 0.747 . . . . 0.0 110.4 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -64.89 -47.74 76.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -57.17 -57.03 11.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.296 1.038 . . . . 0.0 110.057 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ptm -63.78 -36.46 83.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.95 -49.51 65.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.491 1.041 . . . . 0.0 108.582 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.46 -32.11 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.905 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -57.12 -43.74 82.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -67.52 -47.26 70.46 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.163 -0.96 . . . . 0.0 109.954 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.38 -46.66 69.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.525 0.73 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.88 -38.09 86.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.786 1.234 . . . . 0.0 109.511 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -76.77 -6.99 54.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 117.322 -1.323 . . . . 0.0 111.167 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.73 -27.66 63.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.207 1.821 . . . . 0.0 107.669 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.67 120.69 47.7 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 125.018 1.327 . . . . 0.0 107.75 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.3 101.49 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.48 2.787 . . . . 0.0 109.456 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.88 -7.4 1.91 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.858 1.694 . . . . 0.0 111.801 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.56 141.12 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 120.495 -1.591 . . . . 0.0 111.074 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.79 -59.44 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.011 1.324 . . . . 0.0 107.743 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -135.68 157.27 47.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.849 1.259 . . . . 0.0 108.711 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 t -142.33 145.43 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.37 77.02 1.45 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.611 1.964 . . . . 0.0 109.742 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 t -85.89 143.05 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -141.61 133.47 27.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.24 1.016 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.59 -64.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.788 1.635 . . . . 0.0 112.373 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.03 -30.2 71.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.202 2.201 . . . . 0.0 114.924 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -81.91 -15.25 54.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.775 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.82 35.77 83.9 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -139.44 166.78 23.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 122.406 1.098 . . . . 0.0 112.273 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.82 129.3 16.94 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.281 2.633 . . . . 0.0 105.67 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mt -121.16 154.45 36.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.3 t -129.39 152.77 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.653 1.216 . . . . 0.0 111.326 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -135.2 111.38 9.63 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 100.909 -3.737 . . . . 0.0 100.909 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.71 -177.49 37.95 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 p -94.61 -0.65 54.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 111.535 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 144.94 54.05 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 111.909 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -80.82 149.27 67.01 Favored Pre-proline 0 N--CA 1.465 0.309 0 C-N-CA 125.454 1.501 . . . . 0.0 110.218 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.57 -38.57 81.58 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.519 2.146 . . . . 0.0 116.145 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -46.77 85.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 110.477 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.23 65.68 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.74 -56.45 6.36 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.764 0.826 . . . . 0.0 110.094 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -57.02 -45.11 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.736 0.698 . . . . 0.0 109.579 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.84 -47.79 60.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 111.288 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.18 66.49 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -88.99 -35.64 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -63.85 -33.89 76.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.45 -25.7 68.12 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.68 0.792 . . . . 0.0 111.019 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.04 -4.19 56.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.038 0.836 . . . . 0.0 110.603 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.58 19.11 35.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.806 1.185 . . . . 0.0 114.137 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -113.32 177.24 4.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.961 1.381 . . . . 0.0 108.944 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -116.01 116.46 27.94 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.23 154.49 38.7 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -153.72 138.28 16.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.587 1.155 . . . . 0.0 108.966 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.87 140.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.446 -0.784 . . . . 0.0 111.13 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -98.94 19.36 15.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.735 1.214 . . . . 0.0 110.82 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.893 2.077 . . . . 0.0 105.473 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.236 0.356 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -123.74 159.41 29.5 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 108.019 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mt -157.05 131.8 8.78 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -99.57 122.5 42.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.68 144.4 22.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -135.59 125.28 25.35 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.43 -15.95 8.05 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.298 -1.279 . . . . 0.0 114.221 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 69.6 mtm -65.2 131.97 47.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.401 2.1 . . . . 0.0 106.944 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -134.45 -21.85 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.3 m -135.45 167.62 20.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.47 1.032 . . . . 0.0 109.137 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.4 -36.66 64.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.411 1.485 . . . . 0.0 109.11 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -59.32 -44.3 92.58 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.853 1.661 . . . . 0.0 110.195 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 m -59.77 -43.98 94.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.32 -53.85 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.021 0.529 . . . . 0.0 110.101 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ptm -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.104 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.29 -59.92 4.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.967 0.803 . . . . 0.0 108.879 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.16 -38.74 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.534 0.734 . . . . 0.0 109.994 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -58.66 -52.87 63.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.076 -1.64 . . . . 0.0 109.161 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -61.6 -43.84 98.12 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 121.623 -0.673 . . . . 0.0 112.33 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.27 86.07 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.681 0.613 . . . . 0.0 110.793 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.57 -39.46 93.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 0.0 109.497 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -67.05 -11.79 58.1 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.14 -17.93 60.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.883 1.219 . . . . 0.0 110.082 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.64 133.95 95.27 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 124.575 1.15 . . . . 0.0 111.616 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.66 115.99 4.2 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.218 1.945 . . . . 0.0 107.553 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.56 26.8 Favored Glycine 0 C--N 1.318 -0.457 0 C-N-CA 126.537 2.018 . . . . 0.0 113.627 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -80.98 131.13 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 120.755 2.278 . . . . 0.0 107.428 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -104.35 -62.41 1.32 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -136.06 158.18 45.04 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.986 0.915 . . . . 0.0 108.546 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.23 154.46 20.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 126.035 1.734 . . . . 0.0 107.525 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -145.29 112.15 5.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.18 149.8 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.821 0.849 . . . . 0.0 110.349 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -126.96 135.41 50.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.104 1.362 . . . . 0.0 109.033 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 tp -84.45 -21.09 30.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.362 0.665 . . . . 0.0 110.65 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -84.3 -38.29 20.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.313 1.045 . . . . 0.0 111.967 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -98.86 -13.06 20.24 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.6 33.33 81.55 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 120.043 1.292 . . . . 0.0 111.382 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -119.31 148.84 42.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.233 1.013 . . . . 0.0 108.568 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.19 98.73 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 109.214 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.99 147.41 27.46 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.46 151.01 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 125.011 1.324 . . . . 0.0 107.456 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.75 -9.73 7.28 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.26 -168.1 41.19 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.07 0.85 . . . . 0.0 114.458 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.1 p -100.2 9.48 42.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.206 1.403 . . . . 0.0 111.203 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.5 155.5 18.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.54 0.736 . . . . 0.0 111.749 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.83 149.41 50.8 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.513 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.4 -37.46 17.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 112.291 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.79 -36.56 67.53 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.26 0.624 . . . . 0.0 111.676 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.88 26.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.115 0.966 . . . . 0.0 112.175 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 mt -63.91 -53.35 51.76 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.296 1.038 . . . . 0.0 109.77 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.38 -39.96 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.538 0.608 . . . . 0.0 110.156 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -47.35 77.74 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.174 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.19 -18.8 50.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.81 -39.57 10.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 119.809 1.186 . . . . 0.0 108.838 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -66.78 -32.39 73.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.27 -13.16 62.06 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.982 0.81 . . . . 0.0 109.838 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.66 -6.6 45.99 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.445 -1.409 . . . . 0.0 108.926 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.15 2.42 71.16 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 128.215 2.817 . . . . 0.0 114.952 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -88.39 159.95 17.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 118.92 1.36 . . . . 0.0 107.651 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -98.07 118.26 34.26 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.23 162.98 24.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.524 0.602 . . . . 0.0 110.626 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -163.35 145.93 10.07 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.167 1.387 . . . . 0.0 109.105 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.49 150.94 5.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.5 mt -110.68 9.68 22.83 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.243 1.017 . . . . 0.0 110.995 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.644 1.578 . . . . 0.0 107.247 179.476 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.9 mt . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.187 0.517 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -137.03 143.98 42.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.38 157.93 44.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.328 2.651 . . . . 0.0 108.026 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -123.87 122.45 38.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 127.499 2.32 . . . . 0.0 105.485 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.26 145.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 125.766 1.626 . . . . 0.0 108.368 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.66 130.11 33.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.55 -11.08 12.52 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.248 -1.307 . . . . 0.0 112.343 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.7 mtm -71.75 138.01 48.14 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.345 2.073 . . . . 0.0 108.269 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.8 p -135.17 -15.27 1.97 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.91 177.14 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 109.556 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -62.08 -31.58 72.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.831 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -60.18 -35.71 75.99 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.472 1.033 . . . . 0.0 109.062 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.8 m -65.61 -47.76 74.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -55.9 -54.49 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.604 0.762 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -37.94 88.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.729 1.149 . . . . 0.0 111.58 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.61 -51.15 64.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.794 0.725 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.2 t -61.22 -40.76 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.677 1.191 . . . . 0.0 108.608 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.2 m -58.01 -61.11 2.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.58 -33.4 69.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.331 0.968 . . . . 0.0 112.951 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.71 95.97 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.93 -36.74 70.03 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.91 -1.119 . . . . 0.0 108.361 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -64.75 -33.52 76.16 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.759 -1.213 . . . . 0.0 114.166 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.27 -20.37 64.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.839 1.2 . . . . 0.0 113.15 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 128.41 89.81 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.51 102.74 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.217 2.612 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.12 -10.2 4.16 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.45 1.024 . . . . 0.0 111.574 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.41 132.1 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 118.464 1.132 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -104.54 -56.48 2.18 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.877 1.671 . . . . 0.0 108.556 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -138.74 159.87 41.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.569 1.148 . . . . 0.0 108.2 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -140.44 159.57 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -135.68 122.75 21.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.68 159.77 41.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 119.429 1.013 . . . . 0.0 109.539 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -141.24 126.93 19.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.15 1.38 . . . . 0.0 109.086 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.21 -52.41 41.42 Favored 'General case' 0 N--CA 1.46 0.061 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -60.01 -56.61 19.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.237 1.015 . . . . 0.0 112.303 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -72.44 -28.07 62.72 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.203 0.456 . . . . 0.0 111.896 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.66 80.87 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -89.55 150.99 22.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.947 1.373 . . . . 0.0 108.242 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.09 139.16 39.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.95 156.17 49.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.27 144.22 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.438 1.095 . . . . 0.0 109.3 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -110.19 -4.02 15.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.33 -172.52 47.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.426 -0.796 . . . . 0.0 112.121 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -97.57 6.16 48.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.145 1.778 . . . . 0.0 110.892 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.57 167.98 4.01 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.74 1.216 . . . . 0.0 111.165 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -99.21 153.1 37.95 Favored Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 124.28 1.032 . . . . 0.0 112.877 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.25 -48.08 15.04 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.218 2.612 . . . . 0.0 113.91 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -44.07 97.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -31.81 72.43 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.873 -0.517 . . . . 0.0 111.888 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.11 -50.43 22.83 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.092 0.957 . . . . 0.0 110.76 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -60.19 -41.36 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.11 -56.1 16.58 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.415 1.486 . . . . 0.0 110.367 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.59 64.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.0 t -81.08 -34.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 119.275 0.943 . . . . 0.0 110.267 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.95 -26.97 68.53 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -66.33 -15.85 63.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.167 -0.958 . . . . 0.0 111.166 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -98.26 3.16 48.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.356 1.463 . . . . 0.0 111.338 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.53 85.66 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.996 0.816 . . . . 0.0 113.889 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.59 161.52 14.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -109.4 114.46 28.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.42 154.65 33.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.282 0.563 . . . . 0.0 111.523 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.86 133.93 17.1 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.3 150.74 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.245 1.418 . . . . 0.0 109.704 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.61 61.46 1.56 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.185 1.394 . . . . 0.0 109.676 -179.035 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.235 0.3 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -108.35 146.88 32.34 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.729 0.695 . . . . 0.0 110.71 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.0 156.18 47.42 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.443 1.497 . . . . 0.0 107.782 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -120.14 136.58 54.56 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -127.11 151.61 34.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 124.744 1.218 . . . . 0.0 107.955 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -141.69 145.91 35.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.86 -21.06 41.63 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.863 1.221 . . . . 0.0 112.781 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.5 mtm -66.7 122.56 17.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -125.79 -12.68 6.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.47 165.23 28.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.286 -0.884 . . . . 0.0 110.826 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -60.46 -34.25 73.74 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -62.73 -27.71 69.46 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.229 0.612 . . . . 0.0 110.716 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.93 -48.15 22.4 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.8 t -54.1 -57.3 6.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 123.784 0.834 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.2 ptm -55.36 -32.24 62.4 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.76 -54.42 31.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -63.49 -39.53 85.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.368 0.667 . . . . 0.0 109.794 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -56.17 -46.91 79.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.892 1.224 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -66.84 -43.69 83.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.127 -0.358 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.5 81.07 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.533 0.733 . . . . 0.0 110.1 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.59 -38.1 70.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.977 -1.077 . . . . 0.0 109.048 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -67.22 -30.63 70.61 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.696 -1.253 . . . . 0.0 114.299 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -65.66 -22.94 66.69 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.997 1.271 . . . . 0.0 110.186 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.2 t -56.87 130.3 78.57 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.52 110.48 1.63 Allowed 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.221 1.947 . . . . 0.0 110.532 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.55 19.56 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.224 1.392 . . . . 0.0 113.684 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -88.28 106.94 17.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 119.661 1.73 . . . . 0.0 111.912 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -81.51 -45.0 16.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.503 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -149.29 163.27 38.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.28 138.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -122.46 79.51 1.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 t -85.71 145.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.95 1.3 . . . . 0.0 109.184 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -134.97 131.81 37.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.845 1.258 . . . . 0.0 108.699 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.8 tp -68.94 -59.93 2.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.569 1.147 . . . . 0.0 109.318 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.17 -43.32 78.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.512 1.125 . . . . 0.0 111.969 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -81.97 -18.03 44.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 117.946 -1.026 . . . . 0.0 113.575 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.81 70.32 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -135.66 154.17 51.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.341 -1.093 . . . . 0.0 109.499 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.92 149.68 47.74 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.001 1.32 . . . . 0.0 109.96 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.84 129.62 40.66 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.28 118.82 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.705 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -82.14 -16.88 48.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.833 0.853 . . . . 0.0 111.026 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.76 177.28 31.03 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.341 0.972 . . . . 0.0 112.466 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 p -95.61 0.2 52.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.949 0.9 . . . . 0.0 113.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.06 148.66 0.8 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.596 1.958 . . . . 0.0 114.642 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -71.87 137.15 82.47 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -59.36 -41.07 61.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.248 1.966 . . . . 0.0 112.554 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -59.81 -32.8 70.98 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.633 1.173 . . . . 0.0 112.198 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -34.71 41.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.084 0.553 . . . . 0.0 110.15 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.14 -56.52 16.08 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.802 0.841 . . . . 0.0 109.252 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.03 -41.62 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.635 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -58.14 -45.13 87.91 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.721 0.691 . . . . 0.0 110.265 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.66 66.2 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.8 -38.6 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.373 -1.455 . . . . 0.0 108.163 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.73 -34.31 77.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.911 0.884 . . . . 0.0 110.576 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.74 -22.5 65.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.182 0.901 . . . . 0.0 110.733 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -85.01 0.75 50.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.33 1.052 . . . . 0.0 110.049 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.29 7.82 75.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.226 1.393 . . . . 0.0 115.014 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.56 166.68 11.91 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.871 1.335 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -106.23 110.17 22.33 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.15 165.06 16.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.747 0.654 . . . . 0.0 112.327 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -162.32 141.56 9.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.552 1.941 . . . . 0.0 107.572 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 81.1 t -76.82 152.72 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.3 mt -126.58 59.15 1.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.438 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 C-N-CA 124.454 1.102 . . . . 0.0 108.812 177.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 CA--C 1.521 -0.173 0 CA-C-O 119.179 -0.438 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.09 151.08 21.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.374 1.469 . . . . 0.0 111.331 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.18 144.49 24.01 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.244 1.818 . . . . 0.0 107.5 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.49 125.75 52.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.47 140.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.74 125.11 42.46 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.73 -9.68 8.59 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.984 1.278 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.1 mtm -74.1 90.17 2.01 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 107.252 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -98.36 -12.46 21.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.509 1.124 . . . . 0.0 112.416 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.8 m -136.19 162.08 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.398 -0.814 . . . . 0.0 110.247 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.89 -37.17 75.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.924 0.49 . . . . 0.0 110.207 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.72 -37.52 76.33 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.29 -46.95 88.05 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.18 0.9 . . . . 0.0 109.493 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.79 -55.12 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.202 1.001 . . . . 0.0 110.065 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptm -62.31 -28.93 70.08 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.674 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.11 -53.07 13.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.6 t -52.75 -47.14 51.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.946 1.298 . . . . 0.0 107.696 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 m -53.86 -55.07 30.09 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.418 1.087 . . . . 0.0 109.032 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -62.56 -36.78 83.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 117.92 -1.038 . . . . 0.0 113.292 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.65 71.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.158 0.89 . . . . 0.0 109.343 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.03 -41.01 99.42 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -61.97 -11.64 14.44 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.324 -0.846 . . . . 0.0 113.208 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -77.29 -20.28 55.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.028 1.286 . . . . 0.0 110.576 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.06 128.79 93.46 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.28 100.24 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.759 2.306 . . . . 0.0 111.542 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.3 -7.71 4.35 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.821 1.201 . . . . 0.0 112.463 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.52 104.6 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.213 -1.169 . . . . 0.0 111.005 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.15 -56.52 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -148.07 160.61 42.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.467 1.107 . . . . 0.0 108.671 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.14 153.62 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -137.14 90.62 2.54 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.1 t -99.16 139.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.401 1.48 . . . . 0.0 107.854 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -126.4 136.94 53.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.64 -60.59 3.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 125.029 1.332 . . . . 0.0 110.615 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.23 -46.1 89.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.815 1.246 . . . . 0.0 112.303 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -74.92 -31.45 61.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.494 -0.765 . . . . 0.0 113.057 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.09 40.93 55.54 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.61 167.41 21.72 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.238 -1.154 . . . . 0.0 109.206 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.4 123.73 20.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.397 1.879 . . . . 0.0 106.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.0 mt -111.51 143.63 42.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.04 126.53 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 119.893 1.224 . . . . 0.0 110.473 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -93.45 2.64 56.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.862 2.065 . . . . 0.0 110.387 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.94 -179.34 38.81 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.86 1.695 . . . . 0.0 112.932 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.5 p -96.18 4.75 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.483 1.913 . . . . 0.0 111.706 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.83 165.87 3.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.134 0.974 . . . . 0.0 112.73 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.07 147.56 33.16 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.965 2.106 . . . . 0.0 109.41 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.94 -42.17 8.83 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.933 1.755 . . . . 0.0 112.757 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -59.03 -30.23 67.87 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.329 0.968 . . . . 0.0 111.741 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -23.66 32.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 111.624 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.9 mt -82.18 -56.46 3.91 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.022 2.129 . . . . 0.0 109.489 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.1 p -50.57 -40.57 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.016 1.326 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -58.66 -43.84 89.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.604 0.362 . . . . 0.0 110.99 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.36 -14.64 57.53 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.7 t -93.75 -43.32 13.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.528 1.131 . . . . 0.0 108.01 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.32 -30.82 71.85 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.306 1.042 . . . . 0.0 111.31 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.62 -9.57 59.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.829 0.852 . . . . 0.0 111.031 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.94 41.79 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 119.181 -0.789 . . . . 0.0 113.524 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -85.93 177.8 7.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.682 1.241 . . . . 0.0 107.817 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -114.69 134.07 55.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.81 158.34 44.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.477 0.581 . . . . 0.0 112.041 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.77 136.29 11.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.611 1.565 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.76 131.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.056 -1.028 . . . . 0.0 110.331 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -101.9 22.68 12.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.438 -0.789 . . . . 0.0 110.343 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.419 1.887 . . . . 0.0 111.203 179.759 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -111.77 136.46 51.01 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.678 1.591 . . . . 0.0 110.888 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.77 159.94 40.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.413 1.085 . . . . 0.0 109.7 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' HE2' ' OE1' ' A' ' 7' ' ' GLU . 3.2 ttpm? -127.82 123.18 34.53 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.97 137.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' OE1' ' HE2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -120.05 148.77 43.17 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.88 -12.48 65.77 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 117.783 -1.565 . . . . 0.0 113.54 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.8 mtm -66.11 146.15 55.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.729 2.264 . . . . 0.0 108.24 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.0 p -136.11 -38.04 0.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.2 m -141.68 179.83 6.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.11 1.364 . . . . 0.0 109.401 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -52.99 -36.0 59.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.258 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -52.34 -35.16 50.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.944 0.793 . . . . 0.0 111.068 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -74.57 -55.62 5.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.2 t -49.59 -51.85 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.952 1.301 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.8 ptm -65.64 -37.57 86.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.705 0.802 . . . . 0.0 112.743 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.12 -53.65 50.11 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.4 -48.54 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.58 1.952 . . . . 0.0 108.832 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.4 m -54.01 -61.76 2.09 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.565 1.146 . . . . 0.0 110.389 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.16 -26.69 68.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.99 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.03 -45.13 67.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.476 1.035 . . . . 0.0 109.092 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.87 -32.12 69.17 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -70.12 -13.47 62.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -78.49 -7.45 57.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.898 1.226 . . . . 0.0 111.638 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.6 t -78.74 127.49 80.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.294 1.438 . . . . 0.0 112.11 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.98 107.05 1.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.856 2.371 . . . . 0.0 111.927 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 -9.71 7.11 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 126.498 1.999 . . . . 0.0 113.342 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.57 146.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.46 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -124.96 -53.6 1.64 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.182 1.793 . . . . 0.0 108.122 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -132.6 147.46 52.35 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.811 0.844 . . . . 0.0 109.426 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.99 155.34 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.644 1.978 . . . . 0.0 106.05 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -145.17 138.2 26.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -135.41 140.8 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -130.77 116.81 18.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.203 1.001 . . . . 0.0 110.657 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 tp -60.2 -54.61 43.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.158 0.583 . . . . 0.0 109.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.95 -38.42 72.92 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -85.36 -17.74 35.86 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.45 25.52 67.04 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -126.86 155.05 43.56 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 118.265 1.032 . . . . 0.0 110.672 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.43 125.74 29.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.091 1.756 . . . . 0.0 106.503 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.67 138.87 49.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.83 146.75 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.82 -12.05 10.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.279 1.032 . . . . 0.0 111.453 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.36 37.48 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.0 p -98.07 8.1 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.448 1.499 . . . . 0.0 111.547 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.72 143.92 11.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.275 1.03 . . . . 0.0 111.594 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.52 149.41 95.56 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.36 -51.46 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.819 1.679 . . . . 0.0 112.597 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -53.98 -34.94 61.17 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.633 1.173 . . . . 0.0 112.792 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.21 -31.46 60.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.791 0.837 . . . . 0.0 112.805 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -68.89 -50.3 50.81 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.53 -44.61 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -48.99 -49.74 39.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.819 0.848 . . . . 0.0 111.524 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.62 -27.99 69.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.041 -0.981 . . . . 0.0 113.632 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.8 t -88.71 -31.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 120.074 1.307 . . . . 0.0 110.711 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' CD ' ' HZ1' ' A' ' 61' ' ' LYS . 5.1 mm-40 -61.52 -32.8 72.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.08 -0.99 23.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.735 2.414 . . . . 0.0 112.973 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.1 -10.44 17.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.782 1.174 . . . . 0.0 110.569 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.41 24.79 11.78 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.066 -0.852 . . . . 0.0 112.04 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -126.13 161.4 27.73 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.888 1.275 . . . . 0.0 108.019 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HZ1' ' CD ' ' A' ' 56' ' ' GLU . 11.3 tppt? -98.74 106.38 18.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.38 155.48 18.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.343 0.519 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -154.15 133.3 12.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.28 1.432 . . . . 0.0 108.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.46 129.95 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.2 mt -109.89 32.1 5.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.764 1.226 . . . . 0.0 110.945 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.833 0 C-N-CA 125.087 1.355 . . . . 0.0 107.368 179.554 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -113.67 113.5 25.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.103 1.361 . . . . 0.0 109.364 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -112.79 124.22 52.08 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.281 1.032 . . . . 0.0 109.255 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -90.13 122.11 32.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.86 151.63 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.005 0.922 . . . . 0.0 110.919 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.83 144.88 47.85 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.141 1.776 . . . . 0.0 106.214 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.0 -12.99 49.49 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.793 2.14 . . . . 0.0 111.999 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.0 mtm -74.62 75.28 2.01 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.132 1.466 . . . . 0.0 111.1 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.5 p -80.63 -33.79 35.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.555 -0.716 . . . . 0.0 111.676 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.6 m -118.1 161.43 19.85 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.238 1.415 . . . . 0.0 113.154 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.271 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -64.59 -32.51 74.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.271 1.028 . . . . 0.0 108.773 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 m -72.95 -49.79 27.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -52.02 -48.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.774 1.23 . . . . 0.0 110.765 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.5 ptm -63.72 -36.63 84.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.734 0.697 . . . . 0.0 112.125 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.17 -50.82 59.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.95 -39.65 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.553 1.141 . . . . 0.0 108.761 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.1 m -60.5 -59.24 5.71 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.258 -0.901 . . . . 0.0 108.866 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.18 -35.85 78.25 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.889 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.93 95.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.424 1.09 . . . . 0.0 109.877 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.0 mt -65.13 -33.62 76.45 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -74.12 6.53 3.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -90.8 -13.02 34.68 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.277 -1.514 . . . . 0.0 108.996 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.49 132.12 79.06 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.626 1.57 . . . . 0.0 112.629 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.55 109.09 1.98 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.085 1.857 . . . . 0.0 110.879 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.23 -7.64 7.58 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.786 1.66 . . . . 0.0 114.706 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' A' ' 23' ' ' LYS . 13.9 p -80.17 136.0 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 1.36 . . . . 0.0 112.253 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -97.29 -61.38 1.41 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -145.72 165.82 27.66 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.058 1.343 . . . . 0.0 107.447 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.1 t -145.86 143.36 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -125.05 101.1 6.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 t -100.61 136.92 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 m -119.63 132.62 55.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.745 1.218 . . . . 0.0 109.385 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.2 -68.72 0.27 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.656 1.583 . . . . 0.0 111.431 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.21 -53.42 35.24 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.918 1.687 . . . . 0.0 112.858 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.15 -21.89 64.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.987 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.36 39.54 92.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -132.02 157.84 43.08 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.656 1.182 . . . . 0.0 109.401 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.76 129.57 40.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.262 2.225 . . . . 0.0 107.263 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.24 102.3 10.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -82.27 126.06 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -96.31 -10.24 28.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.308 1.443 . . . . 0.0 113.784 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.88 -173.17 39.32 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -99.8 14.26 30.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.958 1.303 . . . . 0.0 112.248 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 150.83 3.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.212 0.605 . . . . 0.0 110.531 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.77 140.64 58.91 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 123.283 0.633 . . . . 0.0 111.617 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.93 -41.98 56.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.467 2.111 . . . . 0.0 113.219 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -57.66 -36.03 71.35 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.833 1.253 . . . . 0.0 112.529 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.82 -30.78 22.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.788 . . . . 0.0 111.616 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.7 mt -67.79 -55.04 14.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.223 1.009 . . . . 0.0 109.252 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.86 -43.42 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -55.94 -52.61 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.369 1.067 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 -25.94 36.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.76 -40.9 16.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 119.207 0.912 . . . . 0.0 108.648 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.68 -37.15 86.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.384 0.538 . . . . 0.0 109.559 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.51 -19.83 64.0 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.015 0.526 . . . . 0.0 111.369 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -86.52 -5.21 59.21 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.509 -1.369 . . . . 0.0 110.982 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.82 13.15 51.28 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.386 0.993 . . . . 0.0 112.961 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -105.71 -177.74 3.45 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -126.52 137.55 53.38 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.4 35.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 123.684 0.615 . . . . 0.0 110.292 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.5 138.76 14.7 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.188 1.395 . . . . 0.0 108.034 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.05 119.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -81.1 23.28 0.58 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.16 1.784 . . . . 0.0 109.232 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--O 1.234 0.241 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -117.02 130.11 56.46 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.144 1.378 . . . . 0.0 111.714 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.52 164.42 26.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.433 1.493 . . . . 0.0 110.331 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.56 128.31 44.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.57 2.748 . . . . 0.0 105.527 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.77 145.03 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -137.94 109.93 7.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.33 -11.1 2.5 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.476 1.513 . . . . 0.0 115.875 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.5 mtm -72.34 127.44 32.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 121.029 2.414 . . . . 0.0 112.708 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -133.27 -5.85 3.0 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.141 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.1 m -145.63 164.89 30.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.904 1.281 . . . . 0.0 109.912 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.33 -40.9 71.74 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.956 1.303 . . . . 0.0 110.672 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -56.84 -38.3 72.47 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.108 0.563 . . . . 0.0 111.546 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 m -59.92 -47.44 85.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 t -57.09 -49.04 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 109.375 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.3 ptm -65.83 -39.53 90.91 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.536 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.33 -53.19 60.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.57 1.077 . . . . 0.0 109.283 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -49.57 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 109.382 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.9 m -55.11 -50.1 70.06 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.277 1.031 . . . . 0.0 109.583 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -60.43 -46.76 88.88 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.949 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.32 81.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 123.704 0.628 . . . . 0.0 110.133 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.28 -33.44 75.52 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.254 0.621 . . . . 0.0 110.358 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -76.24 -11.81 59.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.402 -0.808 . . . . 0.0 112.221 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.5 -7.72 56.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.307 1.412 . . . . 0.0 111.488 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.25 142.38 81.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 112.526 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.74 112.64 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.015 1.81 . . . . 0.0 109.875 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.69 26.92 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.374 1.464 . . . . 0.0 115.67 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.2 p -77.19 145.42 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 119.6 1.7 . . . . 0.0 109.822 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -120.14 -57.9 1.9 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.557 1.143 . . . . 0.0 109.063 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -133.32 152.59 51.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.57 144.69 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -124.31 99.61 6.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 t -107.47 117.51 53.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -80.15 174.92 11.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.5 tp -122.55 -33.96 3.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -99.2 -32.8 11.04 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.057 0.844 . . . . 0.0 111.228 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -74.36 -17.53 60.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.39 32.97 84.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.647 1.112 . . . . 0.0 112.593 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -133.65 153.31 51.78 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.799 -1.412 . . . . 0.0 107.342 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.35 148.74 50.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.9 mt -140.53 158.46 43.96 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.2 t -134.51 143.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.567 1.147 . . . . 0.0 111.565 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -100.69 -33.8 10.12 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.961 0.904 . . . . 0.0 110.022 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.46 177.28 1.87 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.851 0.738 . . . . 0.0 113.816 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 t -89.06 6.54 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.173 1.389 . . . . 0.0 110.951 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.37 151.99 3.73 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.369 0.668 . . . . 0.0 112.405 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.59 146.17 52.73 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.7 -37.96 53.19 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.409 2.073 . . . . 0.0 113.069 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.34 -48.55 80.19 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.698 0.799 . . . . 0.0 111.262 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.41 -24.89 63.91 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.874 -0.516 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.8 mt -74.21 -55.37 6.13 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.701 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 -44.43 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.708 0.685 . . . . 0.0 109.43 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.24 -51.59 61.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.196 1.798 . . . . 0.0 111.25 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.15 -35.72 71.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.81 -40.7 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 121.198 -0.939 . . . . 0.0 108.929 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -61.51 -33.59 74.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.923 0.889 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.73 -23.43 66.74 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.231 1.012 . . . . 0.0 111.72 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -86.62 3.76 43.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.399 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.54 80.94 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.669 1.604 . . . . 0.0 114.474 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.84 177.32 6.22 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.52 1.66 . . . . 0.0 107.188 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -114.14 133.31 55.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.19 167.82 19.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.079 0.943 . . . . 0.0 111.631 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.49 146.57 16.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.873 1.269 . . . . 0.0 109.787 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.57 141.66 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.07 34.94 3.45 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.521 0.728 . . . . 0.0 111.038 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.423 0 C-N-CA 127.907 2.483 . . . . 0.0 107.219 179.1 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 121.435 0.636 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -127.57 118.3 23.67 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 128.215 2.606 . . . . 0.0 109.489 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.77 152.26 36.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -119.59 122.67 42.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -107.32 150.98 9.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -135.46 160.25 39.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.43 -22.81 25.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.211 -1.327 . . . . 0.0 111.729 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 32.0 mtm -64.19 146.65 53.93 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.626 1.713 . . . . 0.0 107.262 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.2 p -136.91 -22.08 1.22 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.5 p -145.29 177.08 9.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.086 0.946 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -62.49 -31.73 72.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.402 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.49 -39.45 91.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -62.37 -49.93 73.59 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 t -54.44 -56.28 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.506 1.523 . . . . 0.0 110.651 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -34.49 69.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.957 0.799 . . . . 0.0 112.607 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.88 45.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.234 0.925 . . . . 0.0 109.715 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.92 -38.16 78.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.109 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.723 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -56.31 -48.93 75.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -65.2 -34.6 78.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.507 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.83 -41.1 75.41 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 108.454 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.37 -39.1 86.02 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.801 -1.187 . . . . 0.0 110.081 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -65.31 -14.24 60.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -69.24 -27.51 65.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.98 0.809 . . . . 0.0 110.715 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.25 134.21 93.15 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.68 1.192 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.24 108.27 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.255 2.637 . . . . 0.0 110.425 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.03 -2.51 19.32 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-O 119.204 -0.775 . . . . 0.0 113.012 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -86.99 98.23 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 119.254 1.527 . . . . 0.0 110.583 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.17 -44.16 39.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.541 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.38 158.61 41.74 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.56 143.76 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.72 87.42 2.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.993 1.317 . . . . 0.0 107.658 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.74 145.94 6.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -139.83 122.04 15.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.477 1.111 . . . . 0.0 111.239 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.83 -39.75 79.83 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -60.02 -29.5 68.53 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.383 1.473 . . . . 0.0 112.546 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -102.65 -30.5 10.89 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.55 1.14 . . . . 0.0 113.565 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.18 21.75 66.92 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.49 161.91 19.77 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -1.156 . . . . 0.0 111.772 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.97 108.52 7.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.153 2.181 . . . . 0.0 106.548 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.28 151.13 19.8 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.06 124.7 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 119.894 1.224 . . . . 0.0 108.975 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -88.07 -13.61 41.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.49 -176.95 16.13 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.626 1.584 . . . . 0.0 114.198 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.0 t -103.62 -6.67 21.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.634 1.973 . . . . 0.0 113.912 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.33 157.93 0.91 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.745 2.018 . . . . 0.0 115.556 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.26 146.39 58.06 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 123.422 0.689 . . . . 0.0 110.254 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.3 -34.31 55.97 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.75 1.633 . . . . 0.0 113.477 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -61.46 -39.72 91.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.178 1.354 . . . . 0.0 112.114 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.2 78.56 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -66.6 -47.13 73.67 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 124.905 1.282 . . . . 0.0 108.842 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.07 -48.27 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.506 HE21 ' HA ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -59.8 -27.73 66.83 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.45 87.5 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.073 0.852 . . . . 0.0 110.52 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.4 t -84.02 -44.2 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 125.254 1.422 . . . . 0.0 110.455 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -65.19 -6.57 9.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.309 1.044 . . . . 0.0 111.777 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -107.07 -13.6 15.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.807 1.185 . . . . 0.0 109.482 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -83.89 -10.77 57.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.346 1.459 . . . . 0.0 110.251 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.9 29.11 7.03 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.604 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -136.3 172.36 13.12 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.18 1.49 . . . . 0.0 109.949 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -102.74 142.74 33.39 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.11 141.24 44.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -131.13 116.7 18.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.628 1.571 . . . . 0.0 108.266 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 p -77.09 139.54 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -120.53 45.38 2.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.216 0 C-N-CA 125.244 1.418 . . . . 0.0 107.555 178.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.489 0.185 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -136.55 133.62 36.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.696 1.599 . . . . 0.0 109.372 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mt -138.26 149.61 45.89 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 126.213 1.805 . . . . 0.0 107.5 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -110.45 129.14 55.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.07 147.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -137.42 114.48 10.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.553 1.141 . . . . 0.0 108.156 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.29 -10.75 4.11 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.745 1.641 . . . . 0.0 113.887 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.4 mtm -73.42 97.09 2.47 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.689 1.744 . . . . 0.0 107.809 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -115.19 3.36 14.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.682 1.193 . . . . 0.0 111.139 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 m -146.57 152.9 39.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.433 1.493 . . . . 0.0 107.441 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -60.56 -36.19 77.88 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -59.18 -32.64 70.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.397 1.079 . . . . 0.0 110.478 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.4 m -66.46 -39.66 88.94 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -59.73 -59.26 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.2 ptm -57.49 -33.71 68.3 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.943 0.792 . . . . 0.0 112.991 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.24 -53.53 53.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.54 1.064 . . . . 0.0 109.604 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.81 -39.8 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.109 1.363 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m -59.97 -46.02 90.78 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.928 -1.108 . . . . 0.0 108.846 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -44.84 95.94 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 121.819 -0.55 . . . . 0.0 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.43 95.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.4 -33.36 74.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.588 1.085 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -76.33 -16.85 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.052 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -76.28 -17.28 59.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.536 1.971 . . . . 0.0 111.733 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.07 140.0 95.94 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 126.805 2.042 . . . . 0.0 112.711 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.06 108.71 2.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 109.923 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.92 -6.83 9.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.171 1.843 . . . . 0.0 114.728 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -80.97 159.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.118 1.459 . . . . 0.0 108.013 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -130.71 -64.62 0.82 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -132.56 159.92 38.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 108.302 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.6 139.09 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -128.45 106.92 9.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.06 154.58 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.747 1.219 . . . . 0.0 111.501 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.6 t -129.61 129.34 44.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.303 1.841 . . . . 0.0 109.563 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.01 -43.22 88.31 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.744 0.817 . . . . 0.0 109.996 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.31 -47.9 46.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -76.98 -20.62 55.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 35.54 92.17 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -128.96 137.47 51.4 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.02 136.78 54.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.283 2.233 . . . . 0.0 108.822 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.45 155.46 38.85 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.0 t -129.29 122.12 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -81.36 -18.67 44.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.605 1.162 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.32 -168.74 27.62 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.623 1.106 . . . . 0.0 113.189 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -105.96 5.75 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.245 1.418 . . . . 0.0 113.067 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.3 147.79 9.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.647 0.658 . . . . 0.0 110.902 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.74 146.93 83.85 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.01 -39.33 71.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.297 1.998 . . . . 0.0 114.615 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -60.12 -41.99 93.79 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.605 0.639 . . . . 0.0 109.625 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.64 76.53 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.832 -0.542 . . . . 0.0 109.849 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.91 -49.37 58.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.041 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.04 -49.13 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -49.69 -54.39 19.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.466 1.106 . . . . 0.0 109.439 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.18 -34.86 47.07 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -79.35 -42.48 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.21 -40.06 88.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.104 1.762 . . . . 0.0 109.191 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.4 -4.19 17.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.167 2.187 . . . . 0.0 111.892 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -110.64 2.21 18.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.723 1.209 . . . . 0.0 109.832 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.98 22.4 57.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.12 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -106.89 170.05 8.18 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -109.92 121.16 44.61 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.64 151.73 48.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.707 0.685 . . . . 0.0 109.92 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.91 125.91 15.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.24 153.16 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -111.34 18.83 18.86 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.061 0.945 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.465 1.106 . . . . 0.0 108.76 179.3 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.229 0.538 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -138.93 129.13 25.45 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.739 1.616 . . . . 0.0 108.581 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.76 156.3 39.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 127.53 2.332 . . . . 0.0 108.211 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -113.73 136.03 53.29 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.23 137.55 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 125.581 1.553 . . . . 0.0 108.093 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -132.98 128.77 37.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.69 -14.8 7.59 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.133 -1.37 . . . . 0.0 112.377 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 67.1 mtm -73.69 133.45 43.38 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.934 1.867 . . . . 0.0 106.828 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -126.72 -22.88 3.81 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.954 0.343 . . . . 0.0 111.658 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.2 m -139.32 167.69 21.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.749 1.62 . . . . 0.0 108.598 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -57.12 -37.57 72.18 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.093 0.957 . . . . 0.0 113.253 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -58.62 -33.06 69.61 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.2 m -62.97 -35.33 79.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.476 0.58 . . . . 0.0 110.503 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.85 -51.29 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.523 1.529 . . . . 0.0 109.568 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -63.84 -31.94 73.28 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.307 -0.871 . . . . 0.0 111.315 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.97 4.84 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.06 -35.13 51.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 111.764 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 m -56.58 -43.36 79.97 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -66.96 -44.71 79.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.192 -0.942 . . . . 0.0 111.262 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.87 97.53 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.446 0.641 . . . . 0.0 110.701 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -32.68 73.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.437 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -79.86 -4.85 53.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.658 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.37 -23.3 40.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.52 1.509 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.12 126.16 72.69 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 125.475 1.51 . . . . 0.0 111.503 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 110.59 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.705 2.27 . . . . 0.0 106.433 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.04 -1.43 7.81 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.315 1.912 . . . . 0.0 112.07 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.8 t -100.49 138.38 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 119.756 1.778 . . . . 0.0 110.886 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -123.17 -52.47 1.86 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.615 1.566 . . . . 0.0 110.308 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -128.01 149.1 50.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.3 165.81 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 125.275 1.609 . . . . 0.0 108.045 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -152.96 97.44 2.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.374 0.669 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.2 156.4 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.951 -1.093 . . . . 0.0 108.853 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -144.63 135.62 25.01 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.87 0.868 . . . . 0.0 110.291 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.0 tp -66.56 -52.04 49.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.557 0.743 . . . . 0.0 109.838 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -53.99 -65.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.092 2.157 . . . . 0.0 112.187 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -69.35 -17.9 63.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.194 -0.908 . . . . 0.0 112.722 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.89 31.59 68.51 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.263 0.938 . . . . 0.0 111.097 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -122.1 156.98 32.47 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.922 0.889 . . . . 0.0 110.212 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.45 130.88 28.93 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.44 1.896 . . . . 0.0 109.64 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.04 158.05 34.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.67 142.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.484 1.114 . . . . 0.0 108.866 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -104.17 -17.61 14.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.655 0.782 . . . . 0.0 111.45 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.16 -177.83 21.95 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 t -90.37 2.49 55.53 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.231 -1.158 . . . . 0.0 111.746 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 149.94 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -82.02 148.23 59.93 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 124.684 1.194 . . . . 0.0 111.318 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.27 -41.08 44.7 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.078 1.852 . . . . 0.0 113.202 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -58.46 -40.82 83.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.02 0.528 . . . . 0.0 110.821 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.77 -32.38 67.62 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.024 0.829 . . . . 0.0 110.672 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.46 -56.19 10.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.485 1.114 . . . . 0.0 110.004 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.35 -42.81 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.877 0.762 . . . . 0.0 109.461 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -57.99 -41.61 83.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.679 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.75 -19.0 47.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.386 0.993 . . . . 0.0 112.57 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.5 t -94.04 -36.88 7.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 108.566 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -67.6 -31.11 70.93 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.71 -17.73 62.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.122 1.769 . . . . 0.0 110.602 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.19 -3.98 49.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.612 1.565 . . . . 0.0 110.258 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.8 10.42 63.06 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 125.185 1.374 . . . . 0.0 114.731 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -98.56 -176.76 3.47 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.498 1.649 . . . . 0.0 108.415 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -122.27 119.37 30.96 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.51 161.26 31.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.89 0.768 . . . . 0.0 110.355 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -156.86 138.48 14.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.211 1.404 . . . . 0.0 109.196 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.48 133.76 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.9 mt -88.86 24.11 2.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.023 0.929 . . . . 0.0 112.804 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.757 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.011 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.235 0.312 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.25 150.04 52.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.775 0.83 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mt -144.1 155.82 44.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.215 2.206 . . . . 0.0 105.918 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -121.44 118.48 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.15 134.88 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.99 115.13 14.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.39 -6.29 4.25 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.533 2.016 . . . . 0.0 113.173 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 72.2 mtm -77.09 129.37 35.95 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.379 2.09 . . . . 0.0 107.132 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -141.04 16.08 2.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.0 0.818 . . . . 0.0 111.901 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t -156.17 156.92 35.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.616 1.566 . . . . 0.0 108.525 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.34 -35.72 74.38 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.989 0.916 . . . . 0.0 109.543 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -60.49 -36.04 77.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.45 0.7 . . . . 0.0 110.213 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 m -62.08 -47.01 86.56 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.35 -56.02 13.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.754 0.822 . . . . 0.0 110.436 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . 0.261 5.3 ppp? -62.57 -27.48 69.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.619 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.33 -51.29 15.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 108.278 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.21 -40.19 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.4 m -60.02 -45.22 93.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.981 0.913 . . . . 0.0 108.849 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -62.46 -47.0 85.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 121.009 -1.057 . . . . 0.0 111.01 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.83 84.09 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.4 mt -64.7 -39.05 93.0 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.899 -1.126 . . . . 0.0 110.055 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HE2' ' CG2' ' A' ' 31' ' ' VAL . 47.0 mttm -72.82 -14.36 61.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.952 -1.092 . . . . 0.0 113.057 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -13.17 59.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.098 1.317 . . . . 0.0 110.722 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.01 130.6 89.7 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.749 1.619 . . . . 0.0 111.978 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.4 106.4 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.101 2.534 . . . . 0.0 110.638 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.95 -8.09 6.4 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.316 0.96 . . . . 0.0 115.03 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.2 p -75.36 150.17 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.207 1.503 . . . . 0.0 111.242 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.2 -58.48 1.99 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.828 1.651 . . . . 0.0 107.287 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -144.63 155.4 43.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.857 1.263 . . . . 0.0 108.144 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.433 ' CG2' ' HE2' ' A' ' 23' ' ' LYS . 2.1 m -138.93 152.65 24.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.949 1.699 . . . . 0.0 109.919 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -138.28 88.97 2.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.722 2.009 . . . . 0.0 109.247 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.87 148.11 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -135.01 116.43 14.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.565 1.146 . . . . 0.0 113.056 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.46 -39.72 92.35 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.636 1.174 . . . . 0.0 110.193 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.98 -54.34 8.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.518 0.727 . . . . 0.0 110.759 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 -21.81 62.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.169 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.2 31.93 82.42 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.32 159.4 40.38 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.454 1.502 . . . . 0.0 107.147 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.63 122.66 12.83 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.57 148.08 28.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.67 123.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.658 0.783 . . . . 0.0 110.062 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 -19.92 27.29 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.58 -172.74 5.05 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.402 1.477 . . . . 0.0 114.44 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.34 8.81 18.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 158.03 15.2 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.908 0.776 . . . . 0.0 109.84 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 145.88 79.03 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 124.259 1.023 . . . . 0.0 111.97 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.23 -35.77 61.31 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.627 1.551 . . . . 0.0 112.941 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -38.5 89.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.056 0.389 . . . . 0.0 110.882 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.36 -38.08 56.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.857 0.463 . . . . 0.0 110.31 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.67 -53.44 58.04 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 125.151 1.38 . . . . 0.0 110.731 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.27 -44.63 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -54.65 -50.28 68.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.731 1.213 . . . . 0.0 113.162 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.82 68.86 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.76 -43.51 86.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.393 0.677 . . . . 0.0 109.353 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.82 -28.85 70.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.103 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -63.8 -35.29 80.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.823 0.738 . . . . 0.0 110.511 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -70.88 -17.29 62.72 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.695 -0.628 . . . . 0.0 109.862 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.34 -6.45 26.69 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 126.062 1.792 . . . . 0.0 114.692 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -77.27 166.41 23.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.943 1.872 . . . . 0.0 110.13 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -97.75 128.62 44.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.22 147.23 50.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.26 142.69 18.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.058 1.343 . . . . 0.0 107.637 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.99 149.91 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.452 1.101 . . . . 0.0 111.424 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -117.87 25.68 10.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.147 1.379 . . . . 0.0 110.213 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.761 2.024 . . . . 0.0 108.961 -179.06 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.071 0.463 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.64 151.58 25.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 mt -147.9 143.55 27.46 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.061 1.345 . . . . 0.0 107.387 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -117.89 111.6 19.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.853 1.261 . . . . 0.0 108.327 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 158.87 3.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.3 134.97 13.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.35 -12.22 36.55 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.01 -1.439 . . . . 0.0 115.312 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.9 mtm -75.64 130.64 39.08 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.64 2.22 . . . . 0.0 108.612 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.29 0.6 OUTLIER -126.31 -1.2 6.98 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -149.77 157.91 43.66 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.1 1.36 . . . . 0.0 108.631 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.93 -28.72 58.12 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -63.94 -23.15 67.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.488 1.04 . . . . 0.0 111.209 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.63 -48.48 59.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.5 t -49.67 -58.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 125.935 1.694 . . . . 0.0 109.892 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.8 ptm -58.84 -26.67 64.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.69 -51.05 20.96 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.38 -41.42 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.888 1.675 . . . . 0.0 108.528 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.0 m -57.86 -59.05 5.84 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.231 0.923 . . . . 0.0 109.366 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -56.32 -39.11 72.25 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.314 0.645 . . . . 0.0 112.588 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.2 78.47 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.096 0.958 . . . . 0.0 108.783 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.03 -26.57 68.62 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.876 -1.765 . . . . 0.0 109.188 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -82.44 -9.6 59.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.789 0.836 . . . . 0.0 112.141 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.32 -12.26 60.23 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.41 1.005 . . . . 0.0 110.386 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.8 t -78.16 123.42 86.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 126.755 2.022 . . . . 0.0 111.819 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.31 107.41 2.26 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.677 2.251 . . . . 0.0 110.766 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.16 -18.0 3.78 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.469 1.509 . . . . 0.0 112.166 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.2 161.76 4.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 120.873 -1.369 . . . . 0.0 109.675 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.78 -66.13 0.73 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -125.42 158.35 34.59 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.675 0.79 . . . . 0.0 110.189 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -150.73 164.11 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.908 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 144.75 26.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 t -144.2 136.77 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -134.01 114.84 13.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 118.362 0.528 . . . . 0.0 112.255 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 tp -56.98 -63.12 1.31 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 112.049 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.47 -28.86 47.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.076 1.35 . . . . 0.0 114.53 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -82.32 -57.66 3.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.074 0.95 . . . . 0.0 109.08 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.43 26.16 7.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.944 1.735 . . . . 0.0 110.209 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -136.29 169.47 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.341 1.571 . . . . 0.0 111.49 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.61 152.58 44.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.439 1.896 . . . . 0.0 108.767 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.43 156.32 43.37 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.964 2.106 . . . . 0.0 108.853 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.1 t -137.63 147.59 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -125.0 -7.99 7.18 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.58 -155.52 23.07 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.385 0.993 . . . . 0.0 113.112 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -106.38 6.36 30.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.515 1.926 . . . . 0.0 111.773 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 148.04 23.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.929 . . . . 0.0 111.121 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.48 146.61 70.24 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.904 1.281 . . . . 0.0 109.131 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.74 -42.3 26.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.206 1.937 . . . . 0.0 112.395 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -57.5 -38.52 74.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.469 0.708 . . . . 0.0 111.341 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.04 52.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.707 0.685 . . . . 0.0 110.846 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.61 -49.13 69.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.87 0.868 . . . . 0.0 109.743 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.27 -49.97 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.151 -0.452 . . . . 0.0 109.963 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -28.28 67.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.606 0.639 . . . . 0.0 112.65 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.45 -34.42 75.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.543 -0.723 . . . . 0.0 110.232 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -78.63 -39.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.94 -31.25 71.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.97 -22.46 67.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.731 0.812 . . . . 0.0 112.222 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -86.05 -4.12 59.1 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.281 1.032 . . . . 0.0 112.574 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.94 38.44 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.781 -1.011 . . . . 0.0 113.702 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.37 166.42 12.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.662 1.231 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -103.52 138.84 39.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.14 49.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.19 137.26 19.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.17 141.35 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.978 0.911 . . . . 0.0 108.726 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.41 39.87 3.02 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.567 1.147 . . . . 0.0 108.405 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 C-N-CA 125.958 1.703 . . . . 0.0 108.897 -179.52 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--O 1.235 0.322 0 CA-C-O 119.469 -0.3 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -120.77 136.94 54.75 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 mt -133.75 157.12 46.66 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.731 2.012 . . . . 0.0 109.217 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.0 122.41 44.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.645 1.578 . . . . 0.0 106.968 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -105.38 142.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -136.89 147.43 46.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.13 -19.85 47.42 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.457 1.504 . . . . 0.0 113.126 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.8 mtm -70.44 125.7 27.55 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.863 1.831 . . . . 0.0 111.2 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -129.8 6.1 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.163 0.985 . . . . 0.0 111.608 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.6 t -144.39 146.55 32.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.119 0.968 . . . . 0.0 108.862 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.93 -32.37 71.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.744 0.418 . . . . 0.0 110.727 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -58.59 -30.38 67.16 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.525 -0.734 . . . . 0.0 111.038 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 m -69.5 -40.15 77.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.41 0.684 . . . . 0.0 109.382 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.52 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.246 1.018 . . . . 0.0 108.658 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 ptm -58.84 -35.87 73.62 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.68 -55.36 20.57 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.099 0.863 . . . . 0.0 109.505 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.79 -27.29 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.913 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 m -62.12 -42.76 99.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -65.87 -34.54 78.38 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 120.798 -1.189 . . . . 0.0 110.169 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.45 81.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.36 -29.26 68.8 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 110.11 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -74.13 -10.58 59.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.834 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -81.56 -15.52 54.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.16 1.345 . . . . 0.0 111.024 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.25 128.08 90.58 Favored Pre-proline 0 N--CA 1.44 -0.94 0 C-N-CA 125.204 1.402 . . . . 0.0 112.022 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.6 109.18 1.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.415 2.076 . . . . 0.0 111.631 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.54 15.98 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.523 1.535 . . . . 0.0 113.178 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.62 154.24 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 119.367 1.583 . . . . 0.0 108.471 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -130.92 -57.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -135.28 145.34 47.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.1 m -124.56 153.58 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 127.115 2.166 . . . . 0.0 107.817 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 115.89 5.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.96 156.77 43.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 118.922 0.783 . . . . 0.0 109.777 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -145.04 137.89 26.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.4 -47.76 54.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.193 0.997 . . . . 0.0 110.049 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.72 -34.11 72.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.412 0.685 . . . . 0.0 112.699 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -92.56 -30.76 15.49 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.565 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.0 94.71 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 106.236 -2.746 . . . . 0.0 106.236 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.61 147.27 48.6 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.97 1.308 . . . . 0.0 108.626 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.89 128.65 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.01 2.124 . . . . 0.0 108.117 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.93 150.83 39.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.409 1.484 . . . . 0.0 108.684 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.7 t -127.51 139.18 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 123.469 0.708 . . . . 0.0 109.555 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -106.42 1.49 25.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.591 1.156 . . . . 0.0 111.537 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.11 -151.37 28.26 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.706 1.622 . . . . 0.0 109.581 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 11.54 8.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.802 1.641 . . . . 0.0 112.578 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.28 149.99 2.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.682 1.193 . . . . 0.0 113.065 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.18 140.22 87.94 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.227 1.011 . . . . 0.0 109.659 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.59 -45.19 11.88 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.439 1.426 . . . . 0.0 110.164 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -57.05 -37.61 72.05 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.449 1.499 . . . . 0.0 112.018 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.86 31.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.386 0.539 . . . . 0.0 110.796 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.84 -51.22 50.93 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.286 -0.884 . . . . 0.0 108.75 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 p -60.08 -37.32 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.99 -50.26 71.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.134 0.974 . . . . 0.0 111.659 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.17 35.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.334 0.97 . . . . 0.0 113.423 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.2 t -74.14 -46.75 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.34 1.456 . . . . 0.0 108.618 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.57 -31.06 71.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.338 0.655 . . . . 0.0 110.378 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.56 -33.34 75.69 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -78.5 -17.51 56.15 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.4 -0.813 . . . . 0.0 108.866 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.89 5.95 35.15 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 117.241 -1.866 . . . . 0.0 117.074 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -96.32 160.42 14.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.067 1.933 . . . . 0.0 109.072 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -85.89 137.74 32.53 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.21 140.95 37.92 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.87 134.29 14.37 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.965 1.306 . . . . 0.0 108.608 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.42 131.29 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 127.062 2.145 . . . . 0.0 111.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt -98.82 37.6 1.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.856 1.262 . . . . 0.0 111.148 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.997 1.719 . . . . 0.0 107.957 178.769 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.24 145.8 42.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.475 1.11 . . . . 0.0 109.518 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.19 139.15 28.57 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 108.947 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -105.14 111.16 23.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -88.41 162.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -152.47 122.51 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.24 -10.59 9.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.614 1.578 . . . . 0.0 113.547 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.5 mtm -73.99 122.39 22.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.586 2.193 . . . . 0.0 109.544 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.7 p -121.12 -12.17 8.74 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 m -137.11 165.49 25.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.925 0.89 . . . . 0.0 110.674 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -60.54 -27.74 67.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.449 1.099 . . . . 0.0 109.604 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -42.27 98.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.8 -40.76 96.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.055 0.388 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.68 -53.02 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.5 ptm -64.65 -43.58 93.16 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.893 0.77 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.0 -57.62 10.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.772 0.829 . . . . 0.0 110.177 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.42 -38.28 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.0 m -57.97 -42.27 84.71 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.186 -0.947 . . . . 0.0 110.271 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.54 -43.9 79.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.969 . . . . 0.0 110.593 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.91 85.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 122.807 0.443 . . . . 0.0 110.131 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -62.49 -36.08 81.4 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.242 -1.536 . . . . 0.0 108.376 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -69.24 -7.28 35.36 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.742 -1.224 . . . . 0.0 112.381 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -73.15 -17.78 61.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.719 1.6 . . . . 0.0 110.723 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.4 t -76.13 133.6 71.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.42 108.09 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.871 2.38 . . . . 0.0 112.846 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.46 -17.91 6.48 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.84 1.686 . . . . 0.0 113.174 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.9 p -62.33 144.34 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.475 1.637 . . . . 0.0 110.873 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -122.77 -54.49 1.84 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.097 0.959 . . . . 0.0 108.502 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -140.41 150.49 43.93 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 t -133.25 142.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.47 96.72 4.5 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 t -108.27 152.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.977 0.911 . . . . 0.0 109.321 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -146.67 138.2 24.44 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.467 0.576 . . . . 0.0 111.013 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.63 -52.21 41.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.466 1.106 . . . . 0.0 110.403 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -58.9 -38.12 78.15 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.699 1.6 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -86.39 -26.4 24.8 Favored 'General case' 0 N--CA 1.458 -0.067 0 O-C-N 121.988 -0.445 . . . . 0.0 110.623 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.43 35.23 88.22 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.47 158.42 43.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.69 135.3 48.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.801 2.04 . . . . 0.0 107.532 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -122.23 146.76 46.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.1 t -132.62 136.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 118.813 0.733 . . . . 0.0 109.444 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.6 -14.54 16.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.8 1.24 . . . . 0.0 111.432 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.83 -175.07 40.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.19 -0.944 . . . . 0.0 113.47 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.0 p -91.63 12.05 22.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.0 2.12 . . . . 0.0 110.236 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.75 149.17 14.95 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.549 -0.72 . . . . 0.0 111.134 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.03 142.97 60.54 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.304 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.0 -47.98 15.97 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.474 2.783 . . . . 0.0 112.799 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -58.73 -38.83 79.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.331 0.514 . . . . 0.0 110.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.22 -29.6 68.47 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.401 -0.812 . . . . 0.0 110.643 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.22 -55.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -58.77 -42.81 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.67 -52.73 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.688 1.195 . . . . 0.0 110.257 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -22.91 60.11 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.4 t -87.11 -38.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 120.806 -1.184 . . . . 0.0 108.245 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.47 -31.44 68.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.48 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.22 -22.79 67.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.179 0.9 . . . . 0.0 110.559 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.89 -12.49 47.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.978 1.311 . . . . 0.0 110.235 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.44 -3.93 40.18 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.218 1.389 . . . . 0.0 116.04 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -81.73 165.2 21.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.192 1.996 . . . . 0.0 109.641 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.18 114.01 25.67 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.62 156.83 33.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.75 139.36 15.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.959 0.904 . . . . 0.0 109.118 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.7 t -78.91 140.53 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.93 50.87 0.76 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.914 0.885 . . . . 0.0 108.719 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.443 0 C-N-CA 127.168 2.187 . . . . 0.0 108.607 179.239 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptm . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mt -70.6 150.54 45.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.849 0.357 . . . . 0.0 111.262 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -116.18 131.15 57.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.713 1.605 . . . . 0.0 109.866 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -132.63 144.38 50.32 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.549 1.539 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -110.94 115.73 30.0 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.88 142.64 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.53 115.97 13.65 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.581 0.753 . . . . 0.0 109.888 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.62 -17.03 5.31 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.446 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.5 mtm -73.4 107.99 6.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.742 1.771 . . . . 0.0 107.612 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -121.23 16.9 11.51 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.908 -0.495 . . . . 0.0 111.209 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.0 t -151.94 152.46 32.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.63 1.172 . . . . 0.0 108.039 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -61.0 -30.95 70.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.002 0.521 . . . . 0.0 110.014 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.15 -39.24 81.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 110.765 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.4 m -63.68 -53.66 47.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.241 1.016 . . . . 0.0 108.968 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.92 -50.45 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 125.561 1.545 . . . . 0.0 110.839 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.9 ptm -63.49 -40.97 98.49 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.706 1.139 . . . . 0.0 112.355 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.94 79.65 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.29 -39.15 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.758 2.023 . . . . 0.0 110.471 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -55.48 -58.86 6.01 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.49 -41.07 96.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.653 -0.654 . . . . 0.0 111.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -43.13 77.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.029 0.532 . . . . 0.0 111.295 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.87 -36.12 77.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -65.68 -13.13 58.6 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.883 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -75.44 -8.01 55.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.9 1.227 . . . . 0.0 111.368 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.03 134.64 59.51 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 124.143 0.977 . . . . 0.0 111.048 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.14 112.9 2.65 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.719 2.279 . . . . 0.0 107.558 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.93 -3.98 14.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.848 1.69 . . . . 0.0 113.806 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -87.42 139.99 16.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 120.288 2.044 . . . . 0.0 109.486 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -118.75 -59.76 1.83 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.856 1.662 . . . . 0.0 108.815 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -135.76 158.99 43.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 162.75 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -144.5 107.83 4.58 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.24 122.65 68.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.795 0.838 . . . . 0.0 109.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.7 t -84.73 -177.74 6.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.22 1.008 . . . . 0.0 108.804 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.6 tp -132.44 -14.24 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.907 2.083 . . . . 0.0 109.214 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.68 -27.35 7.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.616 1.167 . . . . 0.0 112.281 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -89.97 -15.12 32.62 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 117.641 -1.171 . . . . 0.0 113.625 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.9 35.39 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 119.785 1.175 . . . . 0.0 110.557 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -122.08 154.39 37.39 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.763 1.225 . . . . 0.0 110.64 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.81 79.43 1.62 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.345 1.458 . . . . 0.0 110.255 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.68 145.83 55.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.664 0.786 . . . . 0.0 109.821 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.5 t -128.37 127.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.259 1.423 . . . . 0.0 107.67 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -93.57 -23.15 18.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.522 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.13 176.41 30.39 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.934 0.778 . . . . 0.0 111.601 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -95.5 10.39 36.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.519 1.528 . . . . 0.0 111.939 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.7 4.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.914 -0.491 . . . . 0.0 112.002 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.68 149.39 46.09 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.62 -33.23 46.09 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.202 1.935 . . . . 0.0 113.861 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -61.58 -47.97 83.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.98 69.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.061 0.545 . . . . 0.0 111.544 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.75 -59.0 2.98 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.564 0.746 . . . . 0.0 109.986 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.47 -39.98 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.091 0.957 . . . . 0.0 110.819 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -53.19 -51.33 62.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.26 1.424 . . . . 0.0 109.312 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.49 -26.18 65.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -83.73 -43.15 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 119.651 1.114 . . . . 0.0 108.604 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -60.67 -32.69 71.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.577 1.151 . . . . 0.0 108.663 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.84 -29.14 70.08 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.108 1.363 . . . . 0.0 110.841 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -79.6 -0.68 34.72 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.536 -0.727 . . . . 0.0 110.374 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 11.64 67.6 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.763 1.173 . . . . 0.0 114.563 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -102.98 -178.71 3.75 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.24 1.52 . . . . 0.0 108.104 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -116.42 130.95 57.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 118.167 -0.92 . . . . 0.0 108.627 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.18 159.05 43.03 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.822 0.737 . . . . 0.0 110.25 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.53 144.04 20.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.636 1.174 . . . . 0.0 108.631 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.99 158.83 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -119.27 21.17 12.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 109.733 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 126.17 1.788 . . . . 0.0 106.374 178.929 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ttt . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.46 156.57 22.42 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.503 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -121.52 128.68 52.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.29 145.89 51.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.938 1.695 . . . . 0.0 108.98 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.404 ' HE2' HD22 ' A' ' 65' ' ' LEU . 24.6 ttmm -109.32 119.06 38.34 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.4 t -109.09 146.46 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -141.57 126.26 17.98 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 126.54 -23.31 5.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.958 1.266 . . . . 0.0 113.015 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.1 mtm -68.03 118.4 11.16 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.261 1.531 . . . . 0.0 108.684 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -119.58 -8.7 9.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.732 0.813 . . . . 0.0 111.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.68 158.16 43.93 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.846 1.258 . . . . 0.0 108.399 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.27 -32.31 62.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 112.204 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -60.42 -34.75 74.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.531 0.605 . . . . 0.0 110.76 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m -69.13 -48.53 62.18 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -54.59 -54.09 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 125.103 1.361 . . . . 0.0 110.526 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ptm -60.86 -29.56 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.767 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.14 48.27 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.9 t -55.42 -46.2 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.854 1.261 . . . . 0.0 108.418 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.3 m -55.38 -53.56 54.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.894 0.878 . . . . 0.0 109.719 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -64.82 -40.52 95.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.073 -1.017 . . . . 0.0 112.613 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.52 98.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.004 0.521 . . . . 0.0 111.191 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.21 -44.02 92.26 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -65.87 -9.46 29.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.404 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -74.96 -24.78 58.51 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 121.428 1.922 . . . . 0.0 110.015 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.07 128.22 91.97 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 123.508 0.723 . . . . 0.0 110.72 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.06 108.25 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.152 2.568 . . . . 0.0 108.377 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.84 -4.48 7.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 124.559 1.076 . . . . 0.0 111.829 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.2 t -91.28 100.58 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 119.601 1.701 . . . . 0.0 110.946 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.25 -56.09 5.06 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.427 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -146.28 160.23 42.29 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -150.0 175.46 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 126.966 2.106 . . . . 0.0 108.918 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -152.46 143.75 23.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.77 126.01 6.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 t -84.2 176.42 8.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.9 tp -117.76 -13.99 10.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.68 1.592 . . . . 0.0 109.903 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -125.63 -39.06 2.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 112.814 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.37 -17.56 64.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.56 42.14 97.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -141.67 129.17 21.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.212 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.13 144.98 48.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 106.185 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.57 156.19 48.91 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.12 142.26 44.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.559 1.144 . . . . 0.0 108.406 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -125.01 42.34 3.3 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.296 1.838 . . . . 0.0 110.142 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.4 -167.23 12.07 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.464 1.506 . . . . 0.0 112.796 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -104.53 3.37 31.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.457 1.903 . . . . 0.0 111.993 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.94 169.06 1.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.947 -1.095 . . . . 0.0 113.518 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.33 148.73 35.56 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.834 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -58.21 -34.49 98.61 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.472 2.115 . . . . 0.0 113.78 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.68 -52.65 23.73 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.165 0.986 . . . . 0.0 111.429 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.05 66.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.3 mt -67.86 -60.65 2.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.365 1.466 . . . . 0.0 111.302 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -55.52 -44.93 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -57.62 -39.9 77.97 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.552 0.741 . . . . 0.0 111.366 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.71 -28.15 68.85 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.208 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.33 -37.18 15.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 108.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.0 -33.29 75.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.58 -12.47 61.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.878 1.271 . . . . 0.0 111.816 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -90.4 -9.79 46.27 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.31 1.414 . . . . 0.0 109.031 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.96 15.09 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.728 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -114.99 -179.37 3.61 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.618 1.709 . . . . 0.0 108.683 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -118.68 127.84 53.95 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.34 157.91 45.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.746 0.703 . . . . 0.0 111.37 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.03 135.16 13.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.535 1.534 . . . . 0.0 108.592 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.97 147.81 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.885 0.766 . . . . 0.0 110.759 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.404 HD22 ' HE2' ' A' ' 5' ' ' LYS . 84.8 mt -123.77 20.21 9.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.678 2.391 . . . . 0.0 111.009 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.814 0 C-N-CA 124.565 1.146 . . . . 0.0 108.283 -179.633 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 119.122 -0.466 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mt -88.92 151.14 22.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.186 0.448 . . . . 0.0 110.987 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -115.54 134.88 54.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.781 1.232 . . . . 0.0 108.499 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mt -128.3 132.04 48.66 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.493 1.517 . . . . 0.0 108.373 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -92.0 117.55 29.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.56 159.73 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -143.65 148.92 36.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.42 63.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.488 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.0 mtm -73.82 109.4 7.29 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.582 2.191 . . . . 0.0 106.23 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.2 p -123.31 -6.13 8.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -150.02 162.62 40.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.108 -0.995 . . . . 0.0 108.792 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.38 -37.43 67.55 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.692 1.597 . . . . 0.0 111.262 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -64.89 -38.8 92.19 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 m -60.5 -46.52 89.82 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.22 -58.57 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptm -59.16 -37.52 77.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.59 69.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.513 0.597 . . . . 0.0 109.562 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.43 -44.04 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -52.64 -58.96 5.12 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 120.954 -1.091 . . . . 0.0 109.626 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.45 -36.96 81.85 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 112.702 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.61 67.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.0 0.92 . . . . 0.0 109.881 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.26 -46.18 15.16 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -24.01 39.75 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.095 1.358 . . . . 0.0 114.434 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -64.77 -24.1 67.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.75 1.159 . . . . 0.0 111.036 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.03 127.73 88.23 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 118.944 0.793 . . . . 0.0 110.585 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.62 110.75 2.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.594 2.196 . . . . 0.0 107.764 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 -9.86 6.91 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.993 1.759 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.0 t -88.75 104.01 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 118.4 1.1 . . . . 0.0 109.823 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.76 -64.69 0.82 Allowed 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -146.62 166.96 24.98 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.15 156.51 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.71 110.96 8.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.4 t -113.28 134.02 57.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.073 0.949 . . . . 0.0 109.01 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 t -114.78 125.77 54.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.792 1.237 . . . . 0.0 109.812 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.22 -37.56 80.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.49 0.716 . . . . 0.0 110.7 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.35 -54.43 9.46 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.03 0.532 . . . . 0.0 110.251 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.87 -28.17 68.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.205 0.912 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.94 26.59 74.56 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.61 164.59 16.27 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.965 1.306 . . . . 0.0 109.68 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.12 31.03 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.999 1.72 . . . . 0.0 108.14 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.13 136.16 48.28 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 1' ' ' MET . 95.0 t -121.55 125.53 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.0 -9.6 52.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.252 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.15 -166.07 4.49 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.901 1.238 . . . . 0.0 114.154 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -124.31 8.42 8.47 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.806 1.642 . . . . 0.0 111.176 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.25 158.71 16.53 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.273 1.029 . . . . 0.0 109.768 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 148.87 90.36 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 125.557 1.543 . . . . 0.0 110.06 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.51 -30.43 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.228 1.286 . . . . 0.0 111.585 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.455 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -63.76 -56.49 15.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.818 1.247 . . . . 0.0 108.251 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.22 67.35 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.29 -55.32 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.855 1.262 . . . . 0.0 111.211 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.13 -43.94 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.399 1.0 . . . . 0.0 111.39 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -46.46 82.89 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.831 1.252 . . . . 0.0 108.264 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -23.01 60.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.241 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.06 -42.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.345 1.43 . . . . 0.0 109.71 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.59 -26.91 68.84 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.52 -15.94 63.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.428 1.891 . . . . 0.0 113.156 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -97.7 -6.09 33.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.665 1.12 . . . . 0.0 109.055 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.87 6.86 53.9 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.317 0.96 . . . . 0.0 112.624 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -95.48 -170.47 2.17 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -132.19 134.04 44.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.37 167.55 21.65 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 118.329 0.513 . . . . 0.0 111.422 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -159.57 130.86 6.05 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 124.811 1.244 . . . . 0.0 108.687 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG21 ' H ' ' A' ' 66' ' ' ALA . 1.8 p -74.9 130.98 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.09 16.25 18.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.082 0.953 . . . . 0.0 112.638 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' H ' HG21 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.537 1.535 . . . . 0.0 110.61 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttp . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mt -103.74 -159.53 0.72 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 128.524 2.73 . . . . 0.0 110.14 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -159.13 131.58 6.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mt -138.23 160.06 40.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.15 1.38 . . . . 0.0 109.309 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -126.98 145.91 50.53 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.5 141.04 44.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 127.391 2.277 . . . . 0.0 109.5 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.84 114.2 10.24 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.116 1.366 . . . . 0.0 108.237 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.62 -6.62 5.23 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.911 1.72 . . . . 0.0 115.0 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -68.28 155.02 40.58 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.88 2.34 . . . . 0.0 109.816 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -137.15 -41.43 0.58 Allowed 'General case' 0 C--N 1.339 0.12 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 m -136.73 169.15 18.2 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 124.581 1.152 . . . . 0.0 109.699 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -49.55 -43.09 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.514 1.525 . . . . 0.0 111.698 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -58.75 -37.76 76.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.106 0.563 . . . . 0.0 111.67 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.99 -39.81 94.03 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.01 -58.81 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 109.449 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -53.33 -37.06 61.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.94 -55.15 38.65 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.911 0.862 . . . . 0.0 108.797 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.09 -40.84 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.396 1.078 . . . . 0.0 110.021 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.4 m -55.69 -46.0 77.72 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.986 1.267 . . . . 0.0 108.12 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -67.81 -36.36 80.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.206 -0.934 . . . . 0.0 111.315 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.01 73.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.774 0.715 . . . . 0.0 111.385 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mt -61.24 -39.45 90.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.657 1.117 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -67.42 -9.65 43.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.882 0.873 . . . . 0.0 112.834 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.31 -29.09 66.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.021 1.282 . . . . 0.0 109.544 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -58.89 129.52 85.57 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.231 1.413 . . . . 0.0 112.796 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.83 117.34 4.82 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 122.445 2.097 . . . . 0.0 107.66 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.82 -14.43 12.79 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 126.423 1.963 . . . . 0.0 112.613 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.3 140.89 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-N 119.335 1.567 . . . . 0.0 107.757 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -121.49 -54.88 1.96 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.248 1.019 . . . . 0.0 108.49 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -137.27 153.97 50.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -140.92 168.76 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.199 0.937 . . . . 0.0 111.033 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.92 138.66 34.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.652 2.381 . . . . 0.0 104.631 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -151.65 136.53 10.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -137.19 129.55 29.74 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.682 0.674 . . . . 0.0 110.369 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -66.47 -48.82 68.65 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.663 1.185 . . . . 0.0 109.81 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -61.3 -35.18 76.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -84.27 -29.92 26.05 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.283 0.633 . . . . 0.0 111.941 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.56 33.39 71.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.85 169.52 17.62 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.042 1.421 . . . . 0.0 112.787 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.33 140.25 33.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.931 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.8 149.6 47.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.416 1.886 . . . . 0.0 106.899 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -131.18 133.66 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.79 2.036 . . . . 0.0 108.243 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -100.22 -3.97 30.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.742 0.817 . . . . 0.0 111.669 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.19 -170.67 46.49 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.294 0.949 . . . . 0.0 113.296 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 t -101.08 3.82 41.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.957 1.703 . . . . 0.0 111.483 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.55 153.84 9.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.004 0.922 . . . . 0.0 112.849 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 150.64 61.02 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.102 0.561 . . . . 0.0 110.578 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.58 -40.85 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.483 2.122 . . . . 0.0 113.009 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -55.68 -47.22 77.14 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.625 0.77 . . . . 0.0 110.714 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.57 79.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.262 0.625 . . . . 0.0 111.623 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.6 mt -67.24 -52.52 40.02 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 123.839 0.856 . . . . 0.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 p -60.52 -40.51 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.12 -45.66 86.93 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.051 0.941 . . . . 0.0 109.929 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -85.96 -33.21 7.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.92 -32.74 74.59 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.34 -29.23 69.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.715 1.206 . . . . 0.0 109.782 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -78.33 -7.4 57.22 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.85 25.33 41.85 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.681 1.61 . . . . 0.0 113.475 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.45 177.88 4.66 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -115.22 98.33 6.71 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.717 0.807 . . . . 0.0 109.685 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.0 161.53 13.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.688 -0.632 . . . . 0.0 110.747 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -151.36 138.76 19.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.155 0.982 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.9 t -78.06 138.72 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.38 9.65 18.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.054 0.942 . . . . 0.0 111.561 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.661 1.585 . . . . 0.0 108.722 179.319 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 ttm . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.0 mt -132.33 149.69 52.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.87 130.37 56.8 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 108.713 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.06 151.68 51.62 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 125.37 1.468 . . . . 0.0 107.315 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -118.52 120.86 38.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.42 138.89 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -137.05 102.95 4.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.86 -8.56 1.76 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.801 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.5 mtm -75.38 130.35 38.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.5 t -136.15 14.33 3.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.263 0.483 . . . . 0.0 111.753 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 t -160.93 165.27 30.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.938 -1.101 . . . . 0.0 109.646 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -61.28 -33.22 73.2 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.365 1.066 . . . . 0.0 110.973 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.27 -25.57 63.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.983 0.513 . . . . 0.0 111.656 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -71.67 -47.01 57.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -55.46 -56.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.66 0.784 . . . . 0.0 109.54 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.2 ptm -58.54 -34.13 70.66 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.66 -51.1 66.6 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.37 -39.06 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.616 1.167 . . . . 0.0 109.4 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.1 m -57.05 -50.26 73.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.292 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -69.87 -37.78 76.18 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.656 -1.278 . . . . 0.0 111.468 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.37 78.83 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.439 1.095 . . . . 0.0 108.669 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.76 -41.17 60.58 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.927 -1.108 . . . . 0.0 109.276 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -64.78 -16.54 63.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -13.76 60.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.74 1.609 . . . . 0.0 110.987 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.54 130.14 89.34 Favored Pre-proline 0 N--CA 1.452 -0.351 0 C-N-CA 124.581 1.153 . . . . 0.0 110.623 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.56 111.51 2.13 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 106.073 -2.318 . . . . 0.0 106.073 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.95 -3.9 9.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.758 1.647 . . . . 0.0 112.318 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.05 138.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.587 2.193 . . . . 0.0 109.076 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.52 -51.9 1.72 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.565 1.546 . . . . 0.0 111.451 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -139.47 153.58 47.56 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 m -147.4 166.28 5.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.24 94.17 2.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.342 1.057 . . . . 0.0 109.993 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.17 134.01 38.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.639 1.176 . . . . 0.0 108.609 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -131.6 134.53 46.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.073 0.949 . . . . 0.0 109.902 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.3 tp -76.99 -42.07 40.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.81 -53.03 62.8 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.844 0.857 . . . . 0.0 110.183 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -14.92 55.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.839 -1.076 . . . . 0.0 113.395 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 55.16 29.71 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.4 170.06 18.15 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.849 -0.795 . . . . 0.0 110.577 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.9 95.26 2.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.668 1.187 . . . . 0.0 113.312 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.46 152.82 40.61 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.891 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.19 135.89 60.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.269 1.428 . . . . 0.0 108.249 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -103.65 -19.26 14.4 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.738 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.73 -172.1 28.6 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.3 p -103.53 8.78 37.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.649 1.179 . . . . 0.0 112.425 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.18 155.1 7.01 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.479 0.711 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 151.25 65.5 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 122.859 0.464 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.14 -40.16 34.93 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.989 1.792 . . . . 0.0 114.91 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -59.05 -45.33 91.04 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.411 0.684 . . . . 0.0 110.095 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.39 -32.02 72.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.275 -0.265 . . . . 0.0 111.47 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.1 mt -69.42 -57.68 4.96 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.261 1.024 . . . . 0.0 109.981 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.49 -40.49 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.48 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -53.37 -51.97 60.79 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.925 0.89 . . . . 0.0 110.127 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -28.26 65.03 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.6 -39.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -60.77 -39.47 88.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.84 -21.84 66.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 0.0 112.279 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -86.27 -9.41 56.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.223 0.919 . . . . 0.0 110.468 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.97 21.45 18.27 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.657 -1.079 . . . . 0.0 114.229 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.93 179.55 4.08 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.415 1.608 . . . . 0.0 108.048 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -120.57 109.48 15.31 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.24 165.64 12.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 118.902 0.774 . . . . 0.0 110.353 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -157.91 132.63 8.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.877 -0.514 . . . . 0.0 111.339 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.78 147.86 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.46 33.83 4.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.29 1.036 . . . . 0.0 110.177 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.569 2.348 . . . . 0.0 107.028 179.26 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tmt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mt -120.35 164.45 16.31 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.535 1.134 . . . . 0.0 109.218 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -132.26 123.66 27.38 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.57 133.11 51.16 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.711 0.804 . . . . 0.0 109.436 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -88.19 121.27 30.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.28 150.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -142.48 120.49 12.08 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.77 -10.71 9.61 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.05 1.31 . . . . 0.0 115.141 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.2 mtm -74.92 111.88 10.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 120.052 1.926 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.67 11.42 9.14 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.533 0.733 . . . . 0.0 111.797 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.0 t -151.24 151.86 32.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -60.76 -27.96 68.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.902 0.481 . . . . 0.0 110.599 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -63.26 -32.5 73.93 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.844 0.747 . . . . 0.0 110.4 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -64.89 -47.74 76.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -57.17 -57.03 11.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.296 1.038 . . . . 0.0 110.057 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ptm -63.78 -36.46 83.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.95 -49.51 65.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.491 1.041 . . . . 0.0 108.582 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.46 -32.11 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.905 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -57.12 -43.74 82.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -67.52 -47.26 70.46 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.163 -0.96 . . . . 0.0 109.954 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.38 -46.66 69.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.525 0.73 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.88 -38.09 86.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.786 1.234 . . . . 0.0 109.511 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -76.77 -6.99 54.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 117.322 -1.323 . . . . 0.0 111.167 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.73 -27.66 63.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.207 1.821 . . . . 0.0 107.669 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.67 120.69 47.7 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 125.018 1.327 . . . . 0.0 107.75 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.3 101.49 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.48 2.787 . . . . 0.0 109.456 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.88 -7.4 1.91 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.858 1.694 . . . . 0.0 111.801 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.56 141.12 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 120.495 -1.591 . . . . 0.0 111.074 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.79 -59.44 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.011 1.324 . . . . 0.0 107.743 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -135.68 157.27 47.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.849 1.259 . . . . 0.0 108.711 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 t -142.33 145.43 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.37 77.02 1.45 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.611 1.964 . . . . 0.0 109.742 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 t -85.89 143.05 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -141.61 133.47 27.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.24 1.016 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.59 -64.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.788 1.635 . . . . 0.0 112.373 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.03 -30.2 71.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.202 2.201 . . . . 0.0 114.924 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -81.91 -15.25 54.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.775 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.82 35.77 83.9 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -139.44 166.78 23.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 122.406 1.098 . . . . 0.0 112.273 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.82 129.3 16.94 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.281 2.633 . . . . 0.0 105.67 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mt -121.16 154.45 36.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.3 t -129.39 152.77 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.653 1.216 . . . . 0.0 111.326 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -135.2 111.38 9.63 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 100.909 -3.737 . . . . 0.0 100.909 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.71 -177.49 37.95 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 p -94.61 -0.65 54.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 111.535 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 144.94 54.05 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 111.909 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -80.82 149.27 67.01 Favored Pre-proline 0 N--CA 1.465 0.309 0 C-N-CA 125.454 1.501 . . . . 0.0 110.218 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.57 -38.57 81.58 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.519 2.146 . . . . 0.0 116.145 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -46.77 85.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 110.477 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.23 65.68 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.74 -56.45 6.36 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.764 0.826 . . . . 0.0 110.094 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -57.02 -45.11 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.736 0.698 . . . . 0.0 109.579 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.84 -47.79 60.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 111.288 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.18 66.49 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -88.99 -35.64 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -63.85 -33.89 76.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.45 -25.7 68.12 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.68 0.792 . . . . 0.0 111.019 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.04 -4.19 56.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.038 0.836 . . . . 0.0 110.603 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.58 19.11 35.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.806 1.185 . . . . 0.0 114.137 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -113.32 177.24 4.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.961 1.381 . . . . 0.0 108.944 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -116.01 116.46 27.94 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.23 154.49 38.7 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -153.72 138.28 16.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.587 1.155 . . . . 0.0 108.966 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.87 140.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.446 -0.784 . . . . 0.0 111.13 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -98.94 19.36 15.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.735 1.214 . . . . 0.0 110.82 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.893 2.077 . . . . 0.0 105.473 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.01 167.73 20.68 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.944 1.297 . . . . 0.0 108.418 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -123.74 159.41 29.5 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 108.019 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mt -157.05 131.8 8.78 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -99.57 122.5 42.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.68 144.4 22.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -135.59 125.28 25.35 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.43 -15.95 8.05 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.298 -1.279 . . . . 0.0 114.221 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 69.6 mtm -65.2 131.97 47.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.401 2.1 . . . . 0.0 106.944 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -134.45 -21.85 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.3 m -135.45 167.62 20.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.47 1.032 . . . . 0.0 109.137 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.4 -36.66 64.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.411 1.485 . . . . 0.0 109.11 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -59.32 -44.3 92.58 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.853 1.661 . . . . 0.0 110.195 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 m -59.77 -43.98 94.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.32 -53.85 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.021 0.529 . . . . 0.0 110.101 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ptm -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.104 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.29 -59.92 4.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.967 0.803 . . . . 0.0 108.879 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.16 -38.74 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.534 0.734 . . . . 0.0 109.994 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -58.66 -52.87 63.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.076 -1.64 . . . . 0.0 109.161 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -61.6 -43.84 98.12 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 121.623 -0.673 . . . . 0.0 112.33 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.27 86.07 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.681 0.613 . . . . 0.0 110.793 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.57 -39.46 93.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 0.0 109.497 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -67.05 -11.79 58.1 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.14 -17.93 60.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.883 1.219 . . . . 0.0 110.082 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.64 133.95 95.27 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 124.575 1.15 . . . . 0.0 111.616 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.66 115.99 4.2 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.218 1.945 . . . . 0.0 107.553 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.56 26.8 Favored Glycine 0 C--N 1.318 -0.457 0 C-N-CA 126.537 2.018 . . . . 0.0 113.627 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -80.98 131.13 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 120.755 2.278 . . . . 0.0 107.428 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -104.35 -62.41 1.32 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -136.06 158.18 45.04 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.986 0.915 . . . . 0.0 108.546 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.23 154.46 20.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 126.035 1.734 . . . . 0.0 107.525 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -145.29 112.15 5.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.18 149.8 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.821 0.849 . . . . 0.0 110.349 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -126.96 135.41 50.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.104 1.362 . . . . 0.0 109.033 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 tp -84.45 -21.09 30.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.362 0.665 . . . . 0.0 110.65 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -84.3 -38.29 20.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.313 1.045 . . . . 0.0 111.967 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -98.86 -13.06 20.24 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.6 33.33 81.55 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 120.043 1.292 . . . . 0.0 111.382 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -119.31 148.84 42.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.233 1.013 . . . . 0.0 108.568 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.19 98.73 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 109.214 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.99 147.41 27.46 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.46 151.01 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 125.011 1.324 . . . . 0.0 107.456 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.75 -9.73 7.28 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.26 -168.1 41.19 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.07 0.85 . . . . 0.0 114.458 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.1 p -100.2 9.48 42.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.206 1.403 . . . . 0.0 111.203 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.5 155.5 18.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.54 0.736 . . . . 0.0 111.749 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.83 149.41 50.8 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.513 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.4 -37.46 17.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 112.291 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.79 -36.56 67.53 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.26 0.624 . . . . 0.0 111.676 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.88 26.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.115 0.966 . . . . 0.0 112.175 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 mt -63.91 -53.35 51.76 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.296 1.038 . . . . 0.0 109.77 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.38 -39.96 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.538 0.608 . . . . 0.0 110.156 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -47.35 77.74 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.174 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.19 -18.8 50.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.81 -39.57 10.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 119.809 1.186 . . . . 0.0 108.838 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -66.78 -32.39 73.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.27 -13.16 62.06 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.982 0.81 . . . . 0.0 109.838 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.66 -6.6 45.99 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.445 -1.409 . . . . 0.0 108.926 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.15 2.42 71.16 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 128.215 2.817 . . . . 0.0 114.952 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -88.39 159.95 17.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 118.92 1.36 . . . . 0.0 107.651 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -98.07 118.26 34.26 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.23 162.98 24.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.524 0.602 . . . . 0.0 110.626 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -163.35 145.93 10.07 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.167 1.387 . . . . 0.0 109.105 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.49 150.94 5.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.5 mt -110.68 9.68 22.83 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.243 1.017 . . . . 0.0 110.995 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.644 1.578 . . . . 0.0 107.247 179.476 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.32 165.68 11.32 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.151 0.98 . . . . 0.0 110.547 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -137.03 143.98 42.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.38 157.93 44.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.328 2.651 . . . . 0.0 108.026 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -123.87 122.45 38.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 127.499 2.32 . . . . 0.0 105.485 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.26 145.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 125.766 1.626 . . . . 0.0 108.368 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.66 130.11 33.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.55 -11.08 12.52 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.248 -1.307 . . . . 0.0 112.343 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.7 mtm -71.75 138.01 48.14 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.345 2.073 . . . . 0.0 108.269 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.8 p -135.17 -15.27 1.97 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.91 177.14 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 109.556 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -62.08 -31.58 72.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.831 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -60.18 -35.71 75.99 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.472 1.033 . . . . 0.0 109.062 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.8 m -65.61 -47.76 74.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -55.9 -54.49 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.604 0.762 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -37.94 88.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.729 1.149 . . . . 0.0 111.58 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.61 -51.15 64.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.794 0.725 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.2 t -61.22 -40.76 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.677 1.191 . . . . 0.0 108.608 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.2 m -58.01 -61.11 2.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.58 -33.4 69.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.331 0.968 . . . . 0.0 112.951 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.71 95.97 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.93 -36.74 70.03 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.91 -1.119 . . . . 0.0 108.361 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -64.75 -33.52 76.16 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.759 -1.213 . . . . 0.0 114.166 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.27 -20.37 64.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.839 1.2 . . . . 0.0 113.15 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 128.41 89.81 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.51 102.74 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.217 2.612 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.12 -10.2 4.16 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.45 1.024 . . . . 0.0 111.574 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.41 132.1 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 118.464 1.132 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -104.54 -56.48 2.18 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.877 1.671 . . . . 0.0 108.556 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -138.74 159.87 41.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.569 1.148 . . . . 0.0 108.2 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -140.44 159.57 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -135.68 122.75 21.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.68 159.77 41.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 119.429 1.013 . . . . 0.0 109.539 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -141.24 126.93 19.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.15 1.38 . . . . 0.0 109.086 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.21 -52.41 41.42 Favored 'General case' 0 N--CA 1.46 0.061 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -60.01 -56.61 19.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.237 1.015 . . . . 0.0 112.303 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -72.44 -28.07 62.72 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.203 0.456 . . . . 0.0 111.896 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.66 80.87 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -89.55 150.99 22.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.947 1.373 . . . . 0.0 108.242 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.09 139.16 39.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.95 156.17 49.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.27 144.22 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.438 1.095 . . . . 0.0 109.3 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -110.19 -4.02 15.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.33 -172.52 47.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.426 -0.796 . . . . 0.0 112.121 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -97.57 6.16 48.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.145 1.778 . . . . 0.0 110.892 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.57 167.98 4.01 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.74 1.216 . . . . 0.0 111.165 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -99.21 153.1 37.95 Favored Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 124.28 1.032 . . . . 0.0 112.877 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.25 -48.08 15.04 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.218 2.612 . . . . 0.0 113.91 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -44.07 97.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -31.81 72.43 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.873 -0.517 . . . . 0.0 111.888 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.11 -50.43 22.83 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.092 0.957 . . . . 0.0 110.76 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -60.19 -41.36 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.11 -56.1 16.58 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.415 1.486 . . . . 0.0 110.367 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.59 64.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.0 t -81.08 -34.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 119.275 0.943 . . . . 0.0 110.267 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.95 -26.97 68.53 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -66.33 -15.85 63.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.167 -0.958 . . . . 0.0 111.166 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -98.26 3.16 48.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.356 1.463 . . . . 0.0 111.338 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.53 85.66 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.996 0.816 . . . . 0.0 113.889 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.59 161.52 14.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -109.4 114.46 28.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.42 154.65 33.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.282 0.563 . . . . 0.0 111.523 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.86 133.93 17.1 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.3 150.74 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.245 1.418 . . . . 0.0 109.704 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.61 61.46 1.56 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.185 1.394 . . . . 0.0 109.676 -179.035 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HE1' ' HE3' ' A' ' 3' ' ' LYS . 14.3 tmm? . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt -115.13 142.22 46.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.405 1.482 . . . . 0.0 109.645 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HE3' ' HE1' ' A' ' 1' ' ' MET . 34.6 mttp -108.35 146.88 32.34 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.729 0.695 . . . . 0.0 110.71 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.0 156.18 47.42 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.443 1.497 . . . . 0.0 107.782 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -120.14 136.58 54.56 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -127.11 151.61 34.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 124.744 1.218 . . . . 0.0 107.955 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -141.69 145.91 35.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.86 -21.06 41.63 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.863 1.221 . . . . 0.0 112.781 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.5 mtm -66.7 122.56 17.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -125.79 -12.68 6.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.47 165.23 28.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.286 -0.884 . . . . 0.0 110.826 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -60.46 -34.25 73.74 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -62.73 -27.71 69.46 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.229 0.612 . . . . 0.0 110.716 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.93 -48.15 22.4 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.8 t -54.1 -57.3 6.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 123.784 0.834 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.2 ptm -55.36 -32.24 62.4 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.76 -54.42 31.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -63.49 -39.53 85.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.368 0.667 . . . . 0.0 109.794 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -56.17 -46.91 79.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.892 1.224 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -66.84 -43.69 83.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.127 -0.358 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.5 81.07 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.533 0.733 . . . . 0.0 110.1 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.59 -38.1 70.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.977 -1.077 . . . . 0.0 109.048 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -67.22 -30.63 70.61 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.696 -1.253 . . . . 0.0 114.299 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -65.66 -22.94 66.69 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.997 1.271 . . . . 0.0 110.186 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.2 t -56.87 130.3 78.57 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.52 110.48 1.63 Allowed 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.221 1.947 . . . . 0.0 110.532 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.55 19.56 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.224 1.392 . . . . 0.0 113.684 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -88.28 106.94 17.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 119.661 1.73 . . . . 0.0 111.912 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -81.51 -45.0 16.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.503 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -149.29 163.27 38.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.28 138.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -122.46 79.51 1.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 t -85.71 145.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.95 1.3 . . . . 0.0 109.184 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -134.97 131.81 37.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.845 1.258 . . . . 0.0 108.699 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.8 tp -68.94 -59.93 2.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.569 1.147 . . . . 0.0 109.318 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.17 -43.32 78.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.512 1.125 . . . . 0.0 111.969 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -81.97 -18.03 44.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 117.946 -1.026 . . . . 0.0 113.575 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.81 70.32 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -135.66 154.17 51.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.341 -1.093 . . . . 0.0 109.499 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.92 149.68 47.74 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.001 1.32 . . . . 0.0 109.96 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.84 129.62 40.66 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.28 118.82 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.705 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -82.14 -16.88 48.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.833 0.853 . . . . 0.0 111.026 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.76 177.28 31.03 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.341 0.972 . . . . 0.0 112.466 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 p -95.61 0.2 52.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.949 0.9 . . . . 0.0 113.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.06 148.66 0.8 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.596 1.958 . . . . 0.0 114.642 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -71.87 137.15 82.47 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -59.36 -41.07 61.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.248 1.966 . . . . 0.0 112.554 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -59.81 -32.8 70.98 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.633 1.173 . . . . 0.0 112.198 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -34.71 41.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.084 0.553 . . . . 0.0 110.15 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.14 -56.52 16.08 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.802 0.841 . . . . 0.0 109.252 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.03 -41.62 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.635 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -58.14 -45.13 87.91 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.721 0.691 . . . . 0.0 110.265 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.66 66.2 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.8 -38.6 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.373 -1.455 . . . . 0.0 108.163 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.73 -34.31 77.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.911 0.884 . . . . 0.0 110.576 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.74 -22.5 65.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.182 0.901 . . . . 0.0 110.733 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -85.01 0.75 50.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.33 1.052 . . . . 0.0 110.049 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.29 7.82 75.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.226 1.393 . . . . 0.0 115.014 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.56 166.68 11.91 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.871 1.335 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -106.23 110.17 22.33 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.15 165.06 16.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.747 0.654 . . . . 0.0 112.327 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -162.32 141.56 9.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.552 1.941 . . . . 0.0 107.572 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 81.1 t -76.82 152.72 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.3 mt -126.58 59.15 1.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.438 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 C-N-CA 124.454 1.102 . . . . 0.0 108.812 177.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttt . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 mt -48.17 131.49 16.13 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 126.032 1.733 . . . . 0.0 111.855 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.09 151.08 21.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.374 1.469 . . . . 0.0 111.331 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.18 144.49 24.01 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.244 1.818 . . . . 0.0 107.5 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.49 125.75 52.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.47 140.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.74 125.11 42.46 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.73 -9.68 8.59 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.984 1.278 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.1 mtm -74.1 90.17 2.01 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 107.252 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -98.36 -12.46 21.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.509 1.124 . . . . 0.0 112.416 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.8 m -136.19 162.08 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.398 -0.814 . . . . 0.0 110.247 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.89 -37.17 75.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.924 0.49 . . . . 0.0 110.207 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.72 -37.52 76.33 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.29 -46.95 88.05 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.18 0.9 . . . . 0.0 109.493 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.79 -55.12 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.202 1.001 . . . . 0.0 110.065 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptm -62.31 -28.93 70.08 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.674 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.11 -53.07 13.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.6 t -52.75 -47.14 51.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.946 1.298 . . . . 0.0 107.696 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 m -53.86 -55.07 30.09 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.418 1.087 . . . . 0.0 109.032 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -62.56 -36.78 83.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 117.92 -1.038 . . . . 0.0 113.292 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.65 71.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.158 0.89 . . . . 0.0 109.343 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.03 -41.01 99.42 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -61.97 -11.64 14.44 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.324 -0.846 . . . . 0.0 113.208 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -77.29 -20.28 55.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.028 1.286 . . . . 0.0 110.576 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.06 128.79 93.46 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.28 100.24 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.759 2.306 . . . . 0.0 111.542 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.3 -7.71 4.35 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.821 1.201 . . . . 0.0 112.463 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.52 104.6 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.213 -1.169 . . . . 0.0 111.005 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.15 -56.52 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -148.07 160.61 42.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.467 1.107 . . . . 0.0 108.671 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.14 153.62 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -137.14 90.62 2.54 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.1 t -99.16 139.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.401 1.48 . . . . 0.0 107.854 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -126.4 136.94 53.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.64 -60.59 3.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 125.029 1.332 . . . . 0.0 110.615 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.23 -46.1 89.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.815 1.246 . . . . 0.0 112.303 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -74.92 -31.45 61.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.494 -0.765 . . . . 0.0 113.057 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.09 40.93 55.54 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.61 167.41 21.72 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.238 -1.154 . . . . 0.0 109.206 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.4 123.73 20.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.397 1.879 . . . . 0.0 106.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.0 mt -111.51 143.63 42.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.04 126.53 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 119.893 1.224 . . . . 0.0 110.473 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -93.45 2.64 56.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.862 2.065 . . . . 0.0 110.387 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.94 -179.34 38.81 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.86 1.695 . . . . 0.0 112.932 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.5 p -96.18 4.75 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.483 1.913 . . . . 0.0 111.706 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.83 165.87 3.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.134 0.974 . . . . 0.0 112.73 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.07 147.56 33.16 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.965 2.106 . . . . 0.0 109.41 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.94 -42.17 8.83 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.933 1.755 . . . . 0.0 112.757 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -59.03 -30.23 67.87 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.329 0.968 . . . . 0.0 111.741 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -23.66 32.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 111.624 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.9 mt -82.18 -56.46 3.91 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.022 2.129 . . . . 0.0 109.489 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.1 p -50.57 -40.57 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.016 1.326 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -58.66 -43.84 89.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.604 0.362 . . . . 0.0 110.99 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.36 -14.64 57.53 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.7 t -93.75 -43.32 13.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.528 1.131 . . . . 0.0 108.01 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.32 -30.82 71.85 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.306 1.042 . . . . 0.0 111.31 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.62 -9.57 59.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.829 0.852 . . . . 0.0 111.031 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.94 41.79 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 119.181 -0.789 . . . . 0.0 113.524 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -85.93 177.8 7.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.682 1.241 . . . . 0.0 107.817 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -114.69 134.07 55.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.81 158.34 44.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.477 0.581 . . . . 0.0 112.041 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.77 136.29 11.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.611 1.565 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.76 131.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.056 -1.028 . . . . 0.0 110.331 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -101.9 22.68 12.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.438 -0.789 . . . . 0.0 110.343 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.419 1.887 . . . . 0.0 111.203 179.759 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 11.8 ttt . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.33 139.47 58.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.923 0.889 . . . . 0.0 111.654 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -111.77 136.46 51.01 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.678 1.591 . . . . 0.0 110.888 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.77 159.94 40.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.413 1.085 . . . . 0.0 109.7 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' HE2' ' OE1' ' A' ' 7' ' ' GLU . 3.2 ttpm? -127.82 123.18 34.53 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.97 137.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' OE1' ' HE2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -120.05 148.77 43.17 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.88 -12.48 65.77 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 117.783 -1.565 . . . . 0.0 113.54 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.8 mtm -66.11 146.15 55.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.729 2.264 . . . . 0.0 108.24 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.0 p -136.11 -38.04 0.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.2 m -141.68 179.83 6.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.11 1.364 . . . . 0.0 109.401 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -52.99 -36.0 59.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.258 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -52.34 -35.16 50.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.944 0.793 . . . . 0.0 111.068 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -74.57 -55.62 5.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.2 t -49.59 -51.85 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.952 1.301 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.8 ptm -65.64 -37.57 86.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.705 0.802 . . . . 0.0 112.743 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.12 -53.65 50.11 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.4 -48.54 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.58 1.952 . . . . 0.0 108.832 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.4 m -54.01 -61.76 2.09 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.565 1.146 . . . . 0.0 110.389 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.16 -26.69 68.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.99 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.03 -45.13 67.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.476 1.035 . . . . 0.0 109.092 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.87 -32.12 69.17 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -70.12 -13.47 62.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -78.49 -7.45 57.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.898 1.226 . . . . 0.0 111.638 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.6 t -78.74 127.49 80.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.294 1.438 . . . . 0.0 112.11 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.98 107.05 1.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.856 2.371 . . . . 0.0 111.927 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 -9.71 7.11 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 126.498 1.999 . . . . 0.0 113.342 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.57 146.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.46 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -124.96 -53.6 1.64 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.182 1.793 . . . . 0.0 108.122 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -132.6 147.46 52.35 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.811 0.844 . . . . 0.0 109.426 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.99 155.34 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.644 1.978 . . . . 0.0 106.05 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -145.17 138.2 26.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -135.41 140.8 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -130.77 116.81 18.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.203 1.001 . . . . 0.0 110.657 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 tp -60.2 -54.61 43.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.158 0.583 . . . . 0.0 109.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.95 -38.42 72.92 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -85.36 -17.74 35.86 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.45 25.52 67.04 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -126.86 155.05 43.56 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 118.265 1.032 . . . . 0.0 110.672 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.43 125.74 29.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.091 1.756 . . . . 0.0 106.503 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.67 138.87 49.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.8 t -118.83 146.75 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.82 -12.05 10.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.279 1.032 . . . . 0.0 111.453 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.36 37.48 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.0 p -98.07 8.1 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.448 1.499 . . . . 0.0 111.547 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.72 143.92 11.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.275 1.03 . . . . 0.0 111.594 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.52 149.41 95.56 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.36 -51.46 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.819 1.679 . . . . 0.0 112.597 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -53.98 -34.94 61.17 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.633 1.173 . . . . 0.0 112.792 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.21 -31.46 60.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.791 0.837 . . . . 0.0 112.805 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -68.89 -50.3 50.81 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.53 -44.61 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -48.99 -49.74 39.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.819 0.848 . . . . 0.0 111.524 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.62 -27.99 69.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.041 -0.981 . . . . 0.0 113.632 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.8 t -88.71 -31.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 120.074 1.307 . . . . 0.0 110.711 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' CD ' ' HZ1' ' A' ' 61' ' ' LYS . 5.1 mm-40 -61.52 -32.8 72.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.08 -0.99 23.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.735 2.414 . . . . 0.0 112.973 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.1 -10.44 17.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.782 1.174 . . . . 0.0 110.569 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.41 24.79 11.78 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.066 -0.852 . . . . 0.0 112.04 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -126.13 161.4 27.73 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.888 1.275 . . . . 0.0 108.019 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HZ1' ' CD ' ' A' ' 56' ' ' GLU . 11.3 tppt? -98.74 106.38 18.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.38 155.48 18.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.343 0.519 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -154.15 133.3 12.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.28 1.432 . . . . 0.0 108.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.46 129.95 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.2 mt -109.89 32.1 5.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.764 1.226 . . . . 0.0 110.945 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.833 0 C-N-CA 125.087 1.355 . . . . 0.0 107.368 179.554 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.55 150.67 43.74 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.356 0.98 . . . . 0.0 109.424 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -113.67 113.5 25.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.103 1.361 . . . . 0.0 109.364 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -112.79 124.22 52.08 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.281 1.032 . . . . 0.0 109.255 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -90.13 122.11 32.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.86 151.63 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.005 0.922 . . . . 0.0 110.919 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.83 144.88 47.85 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.141 1.776 . . . . 0.0 106.214 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.0 -12.99 49.49 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.793 2.14 . . . . 0.0 111.999 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.0 mtm -74.62 75.28 2.01 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.132 1.466 . . . . 0.0 111.1 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.5 p -80.63 -33.79 35.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.555 -0.716 . . . . 0.0 111.676 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.6 m -118.1 161.43 19.85 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.238 1.415 . . . . 0.0 113.154 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.271 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -64.59 -32.51 74.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.271 1.028 . . . . 0.0 108.773 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 m -72.95 -49.79 27.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -52.02 -48.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.774 1.23 . . . . 0.0 110.765 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.5 ptm -63.72 -36.63 84.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.734 0.697 . . . . 0.0 112.125 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.17 -50.82 59.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.95 -39.65 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.553 1.141 . . . . 0.0 108.761 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.1 m -60.5 -59.24 5.71 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.258 -0.901 . . . . 0.0 108.866 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.18 -35.85 78.25 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.889 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.93 95.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.424 1.09 . . . . 0.0 109.877 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.0 mt -65.13 -33.62 76.45 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -74.12 6.53 3.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -90.8 -13.02 34.68 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.277 -1.514 . . . . 0.0 108.996 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.49 132.12 79.06 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.626 1.57 . . . . 0.0 112.629 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.55 109.09 1.98 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.085 1.857 . . . . 0.0 110.879 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.23 -7.64 7.58 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.786 1.66 . . . . 0.0 114.706 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' A' ' 23' ' ' LYS . 13.9 p -80.17 136.0 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 1.36 . . . . 0.0 112.253 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -97.29 -61.38 1.41 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -145.72 165.82 27.66 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.058 1.343 . . . . 0.0 107.447 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.1 t -145.86 143.36 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -125.05 101.1 6.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 t -100.61 136.92 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 m -119.63 132.62 55.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.745 1.218 . . . . 0.0 109.385 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.2 -68.72 0.27 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.656 1.583 . . . . 0.0 111.431 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.21 -53.42 35.24 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.918 1.687 . . . . 0.0 112.858 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.15 -21.89 64.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.987 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.36 39.54 92.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -132.02 157.84 43.08 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.656 1.182 . . . . 0.0 109.401 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.76 129.57 40.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.262 2.225 . . . . 0.0 107.263 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.24 102.3 10.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -82.27 126.06 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -96.31 -10.24 28.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.308 1.443 . . . . 0.0 113.784 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.88 -173.17 39.32 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -99.8 14.26 30.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.958 1.303 . . . . 0.0 112.248 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 150.83 3.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.212 0.605 . . . . 0.0 110.531 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.77 140.64 58.91 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 123.283 0.633 . . . . 0.0 111.617 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.93 -41.98 56.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.467 2.111 . . . . 0.0 113.219 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -57.66 -36.03 71.35 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.833 1.253 . . . . 0.0 112.529 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.82 -30.78 22.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.788 . . . . 0.0 111.616 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.7 mt -67.79 -55.04 14.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.223 1.009 . . . . 0.0 109.252 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.86 -43.42 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -55.94 -52.61 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.369 1.067 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 -25.94 36.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.76 -40.9 16.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 119.207 0.912 . . . . 0.0 108.648 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.68 -37.15 86.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.384 0.538 . . . . 0.0 109.559 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.51 -19.83 64.0 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.015 0.526 . . . . 0.0 111.369 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -86.52 -5.21 59.21 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.509 -1.369 . . . . 0.0 110.982 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.82 13.15 51.28 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.386 0.993 . . . . 0.0 112.961 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -105.71 -177.74 3.45 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -126.52 137.55 53.38 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.4 35.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 123.684 0.615 . . . . 0.0 110.292 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.5 138.76 14.7 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.188 1.395 . . . . 0.0 108.034 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.05 119.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -81.1 23.28 0.58 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.16 1.784 . . . . 0.0 109.232 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttp . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.98 144.75 54.04 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 122.875 0.47 . . . . 0.0 109.993 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -117.02 130.11 56.46 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.144 1.378 . . . . 0.0 111.714 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.52 164.42 26.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.433 1.493 . . . . 0.0 110.331 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.56 128.31 44.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.57 2.748 . . . . 0.0 105.527 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.77 145.03 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -137.94 109.93 7.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.33 -11.1 2.5 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.476 1.513 . . . . 0.0 115.875 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.5 mtm -72.34 127.44 32.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 121.029 2.414 . . . . 0.0 112.708 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -133.27 -5.85 3.0 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.141 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.1 m -145.63 164.89 30.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.904 1.281 . . . . 0.0 109.912 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.33 -40.9 71.74 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.956 1.303 . . . . 0.0 110.672 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -56.84 -38.3 72.47 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.108 0.563 . . . . 0.0 111.546 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 m -59.92 -47.44 85.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 t -57.09 -49.04 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 109.375 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.3 ptm -65.83 -39.53 90.91 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.536 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.33 -53.19 60.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.57 1.077 . . . . 0.0 109.283 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -49.57 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 109.382 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.9 m -55.11 -50.1 70.06 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.277 1.031 . . . . 0.0 109.583 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -60.43 -46.76 88.88 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.949 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.32 81.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 123.704 0.628 . . . . 0.0 110.133 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.28 -33.44 75.52 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.254 0.621 . . . . 0.0 110.358 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -76.24 -11.81 59.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.402 -0.808 . . . . 0.0 112.221 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.5 -7.72 56.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.307 1.412 . . . . 0.0 111.488 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.25 142.38 81.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 112.526 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.74 112.64 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.015 1.81 . . . . 0.0 109.875 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.69 26.92 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.374 1.464 . . . . 0.0 115.67 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.2 p -77.19 145.42 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 119.6 1.7 . . . . 0.0 109.822 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -120.14 -57.9 1.9 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.557 1.143 . . . . 0.0 109.063 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -133.32 152.59 51.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.57 144.69 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -124.31 99.61 6.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 t -107.47 117.51 53.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -80.15 174.92 11.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.5 tp -122.55 -33.96 3.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -99.2 -32.8 11.04 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.057 0.844 . . . . 0.0 111.228 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -74.36 -17.53 60.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.39 32.97 84.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.647 1.112 . . . . 0.0 112.593 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -133.65 153.31 51.78 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.799 -1.412 . . . . 0.0 107.342 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.35 148.74 50.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.9 mt -140.53 158.46 43.96 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.2 t -134.51 143.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.567 1.147 . . . . 0.0 111.565 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -100.69 -33.8 10.12 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.961 0.904 . . . . 0.0 110.022 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.46 177.28 1.87 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.851 0.738 . . . . 0.0 113.816 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 t -89.06 6.54 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.173 1.389 . . . . 0.0 110.951 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.37 151.99 3.73 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.369 0.668 . . . . 0.0 112.405 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.59 146.17 52.73 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.7 -37.96 53.19 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.409 2.073 . . . . 0.0 113.069 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.34 -48.55 80.19 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.698 0.799 . . . . 0.0 111.262 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.41 -24.89 63.91 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.874 -0.516 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.8 mt -74.21 -55.37 6.13 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.701 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 -44.43 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.708 0.685 . . . . 0.0 109.43 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.24 -51.59 61.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.196 1.798 . . . . 0.0 111.25 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.15 -35.72 71.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.81 -40.7 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 121.198 -0.939 . . . . 0.0 108.929 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -61.51 -33.59 74.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.923 0.889 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.73 -23.43 66.74 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.231 1.012 . . . . 0.0 111.72 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -86.62 3.76 43.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.399 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.54 80.94 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.669 1.604 . . . . 0.0 114.474 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.84 177.32 6.22 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.52 1.66 . . . . 0.0 107.188 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -114.14 133.31 55.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.19 167.82 19.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.079 0.943 . . . . 0.0 111.631 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.49 146.57 16.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.873 1.269 . . . . 0.0 109.787 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.57 141.66 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.07 34.94 3.45 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.521 0.728 . . . . 0.0 111.038 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.423 0 C-N-CA 127.907 2.483 . . . . 0.0 107.219 179.1 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 24.2 ttt . . . . . 0 C--O 1.235 0.333 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.7 mt -66.24 156.81 33.18 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.184 0.994 . . . . 0.0 112.011 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -127.57 118.3 23.67 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 128.215 2.606 . . . . 0.0 109.489 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.77 152.26 36.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -119.59 122.67 42.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -107.32 150.98 9.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -135.46 160.25 39.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.43 -22.81 25.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.211 -1.327 . . . . 0.0 111.729 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 32.0 mtm -64.19 146.65 53.93 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.626 1.713 . . . . 0.0 107.262 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.2 p -136.91 -22.08 1.22 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.5 p -145.29 177.08 9.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.086 0.946 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -62.49 -31.73 72.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.402 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.49 -39.45 91.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -62.37 -49.93 73.59 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 t -54.44 -56.28 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.506 1.523 . . . . 0.0 110.651 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -34.49 69.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.957 0.799 . . . . 0.0 112.607 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.88 45.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.234 0.925 . . . . 0.0 109.715 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.92 -38.16 78.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.109 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.723 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -56.31 -48.93 75.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -65.2 -34.6 78.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.507 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.83 -41.1 75.41 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 108.454 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.37 -39.1 86.02 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.801 -1.187 . . . . 0.0 110.081 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -65.31 -14.24 60.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -69.24 -27.51 65.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.98 0.809 . . . . 0.0 110.715 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.25 134.21 93.15 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.68 1.192 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.24 108.27 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.255 2.637 . . . . 0.0 110.425 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.03 -2.51 19.32 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-O 119.204 -0.775 . . . . 0.0 113.012 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -86.99 98.23 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 119.254 1.527 . . . . 0.0 110.583 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.17 -44.16 39.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.541 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.38 158.61 41.74 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.56 143.76 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.72 87.42 2.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.993 1.317 . . . . 0.0 107.658 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.74 145.94 6.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -139.83 122.04 15.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.477 1.111 . . . . 0.0 111.239 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.83 -39.75 79.83 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -60.02 -29.5 68.53 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.383 1.473 . . . . 0.0 112.546 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -102.65 -30.5 10.89 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.55 1.14 . . . . 0.0 113.565 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.18 21.75 66.92 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.49 161.91 19.77 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -1.156 . . . . 0.0 111.772 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.97 108.52 7.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.153 2.181 . . . . 0.0 106.548 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.28 151.13 19.8 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 1' ' ' MET . 46.5 t -128.06 124.7 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 119.894 1.224 . . . . 0.0 108.975 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -88.07 -13.61 41.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.49 -176.95 16.13 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.626 1.584 . . . . 0.0 114.198 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.0 t -103.62 -6.67 21.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.634 1.973 . . . . 0.0 113.912 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.33 157.93 0.91 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.745 2.018 . . . . 0.0 115.556 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.26 146.39 58.06 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 123.422 0.689 . . . . 0.0 110.254 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.3 -34.31 55.97 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.75 1.633 . . . . 0.0 113.477 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -61.46 -39.72 91.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.178 1.354 . . . . 0.0 112.114 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.2 78.56 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -66.6 -47.13 73.67 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 124.905 1.282 . . . . 0.0 108.842 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.07 -48.27 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.506 HE21 ' HA ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -59.8 -27.73 66.83 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.45 87.5 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.073 0.852 . . . . 0.0 110.52 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.4 t -84.02 -44.2 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 125.254 1.422 . . . . 0.0 110.455 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -65.19 -6.57 9.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.309 1.044 . . . . 0.0 111.777 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -107.07 -13.6 15.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.807 1.185 . . . . 0.0 109.482 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -83.89 -10.77 57.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.346 1.459 . . . . 0.0 110.251 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.9 29.11 7.03 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.604 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -136.3 172.36 13.12 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.18 1.49 . . . . 0.0 109.949 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -102.74 142.74 33.39 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.11 141.24 44.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -131.13 116.7 18.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.628 1.571 . . . . 0.0 108.266 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 p -77.09 139.54 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -120.53 45.38 2.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.216 0 C-N-CA 125.244 1.418 . . . . 0.0 107.555 178.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptm . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.07 169.28 16.07 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.746 0.819 . . . . 0.0 110.525 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -136.55 133.62 36.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.696 1.599 . . . . 0.0 109.372 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mt -138.26 149.61 45.89 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 126.213 1.805 . . . . 0.0 107.5 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -110.45 129.14 55.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.07 147.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -137.42 114.48 10.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.553 1.141 . . . . 0.0 108.156 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.29 -10.75 4.11 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.745 1.641 . . . . 0.0 113.887 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.4 mtm -73.42 97.09 2.47 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.689 1.744 . . . . 0.0 107.809 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -115.19 3.36 14.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.682 1.193 . . . . 0.0 111.139 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 m -146.57 152.9 39.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.433 1.493 . . . . 0.0 107.441 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -60.56 -36.19 77.88 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -59.18 -32.64 70.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.397 1.079 . . . . 0.0 110.478 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.4 m -66.46 -39.66 88.94 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -59.73 -59.26 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.2 ptm -57.49 -33.71 68.3 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.943 0.792 . . . . 0.0 112.991 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.24 -53.53 53.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.54 1.064 . . . . 0.0 109.604 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.81 -39.8 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.109 1.363 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m -59.97 -46.02 90.78 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.928 -1.108 . . . . 0.0 108.846 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -44.84 95.94 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 121.819 -0.55 . . . . 0.0 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.43 95.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.4 -33.36 74.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.588 1.085 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -76.33 -16.85 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.052 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -76.28 -17.28 59.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.536 1.971 . . . . 0.0 111.733 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.07 140.0 95.94 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 126.805 2.042 . . . . 0.0 112.711 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.06 108.71 2.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 109.923 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.92 -6.83 9.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.171 1.843 . . . . 0.0 114.728 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -80.97 159.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.118 1.459 . . . . 0.0 108.013 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -130.71 -64.62 0.82 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -132.56 159.92 38.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 108.302 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.6 139.09 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -128.45 106.92 9.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.06 154.58 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.747 1.219 . . . . 0.0 111.501 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.6 t -129.61 129.34 44.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.303 1.841 . . . . 0.0 109.563 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.01 -43.22 88.31 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.744 0.817 . . . . 0.0 109.996 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.31 -47.9 46.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -76.98 -20.62 55.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 35.54 92.17 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -128.96 137.47 51.4 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.02 136.78 54.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.283 2.233 . . . . 0.0 108.822 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.45 155.46 38.85 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.0 t -129.29 122.12 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -81.36 -18.67 44.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.605 1.162 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.32 -168.74 27.62 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.623 1.106 . . . . 0.0 113.189 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -105.96 5.75 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.245 1.418 . . . . 0.0 113.067 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.3 147.79 9.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.647 0.658 . . . . 0.0 110.902 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.74 146.93 83.85 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.01 -39.33 71.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.297 1.998 . . . . 0.0 114.615 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -60.12 -41.99 93.79 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.605 0.639 . . . . 0.0 109.625 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.64 76.53 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.832 -0.542 . . . . 0.0 109.849 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.91 -49.37 58.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.041 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.04 -49.13 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -49.69 -54.39 19.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.466 1.106 . . . . 0.0 109.439 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.18 -34.86 47.07 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 t -79.35 -42.48 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.21 -40.06 88.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.104 1.762 . . . . 0.0 109.191 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.4 -4.19 17.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.167 2.187 . . . . 0.0 111.892 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -110.64 2.21 18.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.723 1.209 . . . . 0.0 109.832 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.98 22.4 57.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.12 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -106.89 170.05 8.18 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -109.92 121.16 44.61 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.64 151.73 48.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.707 0.685 . . . . 0.0 109.92 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.91 125.91 15.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.24 153.16 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -111.34 18.83 18.86 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.061 0.945 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.465 1.106 . . . . 0.0 108.76 179.3 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.7 ttm . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mt -95.94 170.09 9.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.248 1.019 . . . . 0.0 110.241 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -138.93 129.13 25.45 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.739 1.616 . . . . 0.0 108.581 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.76 156.3 39.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 127.53 2.332 . . . . 0.0 108.211 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -113.73 136.03 53.29 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.23 137.55 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 125.581 1.553 . . . . 0.0 108.093 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -132.98 128.77 37.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.69 -14.8 7.59 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.133 -1.37 . . . . 0.0 112.377 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 67.1 mtm -73.69 133.45 43.38 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.934 1.867 . . . . 0.0 106.828 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -126.72 -22.88 3.81 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.954 0.343 . . . . 0.0 111.658 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.2 m -139.32 167.69 21.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.749 1.62 . . . . 0.0 108.598 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -57.12 -37.57 72.18 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.093 0.957 . . . . 0.0 113.253 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -58.62 -33.06 69.61 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.2 m -62.97 -35.33 79.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.476 0.58 . . . . 0.0 110.503 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.85 -51.29 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.523 1.529 . . . . 0.0 109.568 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -63.84 -31.94 73.28 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.307 -0.871 . . . . 0.0 111.315 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.97 4.84 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.06 -35.13 51.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 111.764 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 m -56.58 -43.36 79.97 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -66.96 -44.71 79.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.192 -0.942 . . . . 0.0 111.262 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.87 97.53 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.446 0.641 . . . . 0.0 110.701 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -32.68 73.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.437 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -79.86 -4.85 53.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.658 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.37 -23.3 40.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.52 1.509 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.12 126.16 72.69 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 125.475 1.51 . . . . 0.0 111.503 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 110.59 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.705 2.27 . . . . 0.0 106.433 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.04 -1.43 7.81 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.315 1.912 . . . . 0.0 112.07 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.8 t -100.49 138.38 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 119.756 1.778 . . . . 0.0 110.886 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -123.17 -52.47 1.86 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.615 1.566 . . . . 0.0 110.308 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -128.01 149.1 50.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.3 165.81 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 125.275 1.609 . . . . 0.0 108.045 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -152.96 97.44 2.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.374 0.669 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.2 156.4 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.951 -1.093 . . . . 0.0 108.853 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -144.63 135.62 25.01 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.87 0.868 . . . . 0.0 110.291 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.0 tp -66.56 -52.04 49.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.557 0.743 . . . . 0.0 109.838 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -53.99 -65.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.092 2.157 . . . . 0.0 112.187 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -69.35 -17.9 63.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.194 -0.908 . . . . 0.0 112.722 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.89 31.59 68.51 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.263 0.938 . . . . 0.0 111.097 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -122.1 156.98 32.47 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.922 0.889 . . . . 0.0 110.212 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.45 130.88 28.93 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.44 1.896 . . . . 0.0 109.64 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.04 158.05 34.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.67 142.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.484 1.114 . . . . 0.0 108.866 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -104.17 -17.61 14.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.655 0.782 . . . . 0.0 111.45 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.16 -177.83 21.95 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 t -90.37 2.49 55.53 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.231 -1.158 . . . . 0.0 111.746 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 149.94 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -82.02 148.23 59.93 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 124.684 1.194 . . . . 0.0 111.318 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.27 -41.08 44.7 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.078 1.852 . . . . 0.0 113.202 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -58.46 -40.82 83.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.02 0.528 . . . . 0.0 110.821 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.77 -32.38 67.62 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.024 0.829 . . . . 0.0 110.672 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.46 -56.19 10.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.485 1.114 . . . . 0.0 110.004 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.35 -42.81 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.877 0.762 . . . . 0.0 109.461 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -57.99 -41.61 83.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.679 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.75 -19.0 47.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.386 0.993 . . . . 0.0 112.57 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.5 t -94.04 -36.88 7.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 108.566 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -67.6 -31.11 70.93 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.71 -17.73 62.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.122 1.769 . . . . 0.0 110.602 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.19 -3.98 49.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.612 1.565 . . . . 0.0 110.258 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.8 10.42 63.06 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 125.185 1.374 . . . . 0.0 114.731 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -98.56 -176.76 3.47 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.498 1.649 . . . . 0.0 108.415 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -122.27 119.37 30.96 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.51 161.26 31.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.89 0.768 . . . . 0.0 110.355 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -156.86 138.48 14.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.211 1.404 . . . . 0.0 109.196 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.48 133.76 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.9 mt -88.86 24.11 2.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.023 0.929 . . . . 0.0 112.804 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.757 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.011 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ptm . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mt -77.06 162.34 27.58 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.25 150.04 52.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.775 0.83 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mt -144.1 155.82 44.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.215 2.206 . . . . 0.0 105.918 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -121.44 118.48 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.15 134.88 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.99 115.13 14.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.39 -6.29 4.25 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.533 2.016 . . . . 0.0 113.173 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 72.2 mtm -77.09 129.37 35.95 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.379 2.09 . . . . 0.0 107.132 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -141.04 16.08 2.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.0 0.818 . . . . 0.0 111.901 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t -156.17 156.92 35.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.616 1.566 . . . . 0.0 108.525 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.34 -35.72 74.38 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.989 0.916 . . . . 0.0 109.543 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -60.49 -36.04 77.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.45 0.7 . . . . 0.0 110.213 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 m -62.08 -47.01 86.56 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.35 -56.02 13.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.754 0.822 . . . . 0.0 110.436 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . 0.261 5.3 ppp? -62.57 -27.48 69.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.619 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.33 -51.29 15.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 108.278 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.21 -40.19 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.4 m -60.02 -45.22 93.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.981 0.913 . . . . 0.0 108.849 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -62.46 -47.0 85.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 121.009 -1.057 . . . . 0.0 111.01 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.83 84.09 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.4 mt -64.7 -39.05 93.0 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.899 -1.126 . . . . 0.0 110.055 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HE2' ' CG2' ' A' ' 31' ' ' VAL . 47.0 mttm -72.82 -14.36 61.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.952 -1.092 . . . . 0.0 113.057 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -13.17 59.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.098 1.317 . . . . 0.0 110.722 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.01 130.6 89.7 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.749 1.619 . . . . 0.0 111.978 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.4 106.4 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.101 2.534 . . . . 0.0 110.638 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.95 -8.09 6.4 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.316 0.96 . . . . 0.0 115.03 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.2 p -75.36 150.17 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.207 1.503 . . . . 0.0 111.242 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.2 -58.48 1.99 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.828 1.651 . . . . 0.0 107.287 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -144.63 155.4 43.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.857 1.263 . . . . 0.0 108.144 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.433 ' CG2' ' HE2' ' A' ' 23' ' ' LYS . 2.1 m -138.93 152.65 24.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.949 1.699 . . . . 0.0 109.919 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -138.28 88.97 2.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.722 2.009 . . . . 0.0 109.247 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.87 148.11 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -135.01 116.43 14.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.565 1.146 . . . . 0.0 113.056 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.46 -39.72 92.35 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.636 1.174 . . . . 0.0 110.193 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.98 -54.34 8.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.518 0.727 . . . . 0.0 110.759 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 -21.81 62.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.169 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.2 31.93 82.42 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.32 159.4 40.38 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.454 1.502 . . . . 0.0 107.147 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.63 122.66 12.83 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.57 148.08 28.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.67 123.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.658 0.783 . . . . 0.0 110.062 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 -19.92 27.29 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.58 -172.74 5.05 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.402 1.477 . . . . 0.0 114.44 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.34 8.81 18.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 158.03 15.2 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.908 0.776 . . . . 0.0 109.84 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 145.88 79.03 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 124.259 1.023 . . . . 0.0 111.97 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.23 -35.77 61.31 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.627 1.551 . . . . 0.0 112.941 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -38.5 89.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.056 0.389 . . . . 0.0 110.882 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.36 -38.08 56.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.857 0.463 . . . . 0.0 110.31 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.67 -53.44 58.04 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 125.151 1.38 . . . . 0.0 110.731 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.27 -44.63 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -54.65 -50.28 68.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.731 1.213 . . . . 0.0 113.162 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.82 68.86 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.76 -43.51 86.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.393 0.677 . . . . 0.0 109.353 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.82 -28.85 70.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.103 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -63.8 -35.29 80.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.823 0.738 . . . . 0.0 110.511 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -70.88 -17.29 62.72 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.695 -0.628 . . . . 0.0 109.862 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.34 -6.45 26.69 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 126.062 1.792 . . . . 0.0 114.692 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -77.27 166.41 23.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.943 1.872 . . . . 0.0 110.13 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -97.75 128.62 44.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.22 147.23 50.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.26 142.69 18.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.058 1.343 . . . . 0.0 107.637 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.99 149.91 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.452 1.101 . . . . 0.0 111.424 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -117.87 25.68 10.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.147 1.379 . . . . 0.0 110.213 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.761 2.024 . . . . 0.0 108.961 -179.06 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mt -77.92 148.06 34.72 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.071 0.463 . . . . 0.0 111.131 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.64 151.58 25.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 mt -147.9 143.55 27.46 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.061 1.345 . . . . 0.0 107.387 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -117.89 111.6 19.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.853 1.261 . . . . 0.0 108.327 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 158.87 3.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.3 134.97 13.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.35 -12.22 36.55 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.01 -1.439 . . . . 0.0 115.312 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.9 mtm -75.64 130.64 39.08 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.64 2.22 . . . . 0.0 108.612 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.29 0.6 OUTLIER -126.31 -1.2 6.98 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -149.77 157.91 43.66 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.1 1.36 . . . . 0.0 108.631 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.93 -28.72 58.12 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -63.94 -23.15 67.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.488 1.04 . . . . 0.0 111.209 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.63 -48.48 59.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.5 t -49.67 -58.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 125.935 1.694 . . . . 0.0 109.892 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.8 ptm -58.84 -26.67 64.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.69 -51.05 20.96 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.38 -41.42 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.888 1.675 . . . . 0.0 108.528 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.0 m -57.86 -59.05 5.84 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.231 0.923 . . . . 0.0 109.366 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -56.32 -39.11 72.25 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.314 0.645 . . . . 0.0 112.588 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.2 78.47 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.096 0.958 . . . . 0.0 108.783 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.03 -26.57 68.62 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.876 -1.765 . . . . 0.0 109.188 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -82.44 -9.6 59.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.789 0.836 . . . . 0.0 112.141 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.32 -12.26 60.23 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.41 1.005 . . . . 0.0 110.386 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.8 t -78.16 123.42 86.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 126.755 2.022 . . . . 0.0 111.819 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.31 107.41 2.26 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.677 2.251 . . . . 0.0 110.766 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.16 -18.0 3.78 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.469 1.509 . . . . 0.0 112.166 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.2 161.76 4.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 120.873 -1.369 . . . . 0.0 109.675 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.78 -66.13 0.73 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -125.42 158.35 34.59 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.675 0.79 . . . . 0.0 110.189 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -150.73 164.11 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.908 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 144.75 26.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 t -144.2 136.77 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -134.01 114.84 13.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 118.362 0.528 . . . . 0.0 112.255 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 tp -56.98 -63.12 1.31 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 112.049 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.47 -28.86 47.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.076 1.35 . . . . 0.0 114.53 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -82.32 -57.66 3.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.074 0.95 . . . . 0.0 109.08 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.43 26.16 7.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.944 1.735 . . . . 0.0 110.209 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -136.29 169.47 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.341 1.571 . . . . 0.0 111.49 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.61 152.58 44.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.439 1.896 . . . . 0.0 108.767 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.43 156.32 43.37 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.964 2.106 . . . . 0.0 108.853 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.1 t -137.63 147.59 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -125.0 -7.99 7.18 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.58 -155.52 23.07 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.385 0.993 . . . . 0.0 113.112 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -106.38 6.36 30.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.515 1.926 . . . . 0.0 111.773 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 148.04 23.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.929 . . . . 0.0 111.121 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.48 146.61 70.24 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.904 1.281 . . . . 0.0 109.131 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.74 -42.3 26.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.206 1.937 . . . . 0.0 112.395 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -57.5 -38.52 74.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.469 0.708 . . . . 0.0 111.341 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.04 52.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.707 0.685 . . . . 0.0 110.846 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.61 -49.13 69.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.87 0.868 . . . . 0.0 109.743 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.27 -49.97 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.151 -0.452 . . . . 0.0 109.963 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -28.28 67.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.606 0.639 . . . . 0.0 112.65 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.45 -34.42 75.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.543 -0.723 . . . . 0.0 110.232 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -78.63 -39.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.94 -31.25 71.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.97 -22.46 67.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.731 0.812 . . . . 0.0 112.222 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -86.05 -4.12 59.1 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.281 1.032 . . . . 0.0 112.574 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.94 38.44 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.781 -1.011 . . . . 0.0 113.702 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.37 166.42 12.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.662 1.231 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -103.52 138.84 39.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.14 49.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.19 137.26 19.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.17 141.35 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.978 0.911 . . . . 0.0 108.726 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.41 39.87 3.02 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.567 1.147 . . . . 0.0 108.405 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 C-N-CA 125.958 1.703 . . . . 0.0 108.897 -179.52 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ttt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mt -69.96 147.7 49.85 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.77 0.428 . . . . 0.0 111.113 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -120.77 136.94 54.75 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 mt -133.75 157.12 46.66 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.731 2.012 . . . . 0.0 109.217 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.0 122.41 44.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.645 1.578 . . . . 0.0 106.968 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -105.38 142.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -136.89 147.43 46.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.13 -19.85 47.42 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.457 1.504 . . . . 0.0 113.126 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.8 mtm -70.44 125.7 27.55 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.863 1.831 . . . . 0.0 111.2 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -129.8 6.1 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.163 0.985 . . . . 0.0 111.608 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.6 t -144.39 146.55 32.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.119 0.968 . . . . 0.0 108.862 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.93 -32.37 71.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.744 0.418 . . . . 0.0 110.727 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -58.59 -30.38 67.16 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.525 -0.734 . . . . 0.0 111.038 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 m -69.5 -40.15 77.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.41 0.684 . . . . 0.0 109.382 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.52 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.246 1.018 . . . . 0.0 108.658 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 ptm -58.84 -35.87 73.62 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.68 -55.36 20.57 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.099 0.863 . . . . 0.0 109.505 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.79 -27.29 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.913 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 m -62.12 -42.76 99.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -65.87 -34.54 78.38 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 120.798 -1.189 . . . . 0.0 110.169 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.45 81.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.36 -29.26 68.8 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 110.11 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -74.13 -10.58 59.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.834 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -81.56 -15.52 54.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.16 1.345 . . . . 0.0 111.024 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.25 128.08 90.58 Favored Pre-proline 0 N--CA 1.44 -0.94 0 C-N-CA 125.204 1.402 . . . . 0.0 112.022 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.6 109.18 1.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.415 2.076 . . . . 0.0 111.631 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.54 15.98 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.523 1.535 . . . . 0.0 113.178 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.62 154.24 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 119.367 1.583 . . . . 0.0 108.471 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -130.92 -57.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -135.28 145.34 47.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.1 m -124.56 153.58 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 127.115 2.166 . . . . 0.0 107.817 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 115.89 5.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.96 156.77 43.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 118.922 0.783 . . . . 0.0 109.777 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -145.04 137.89 26.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.4 -47.76 54.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.193 0.997 . . . . 0.0 110.049 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.72 -34.11 72.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.412 0.685 . . . . 0.0 112.699 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -92.56 -30.76 15.49 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.565 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.0 94.71 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 106.236 -2.746 . . . . 0.0 106.236 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.61 147.27 48.6 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.97 1.308 . . . . 0.0 108.626 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.89 128.65 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.01 2.124 . . . . 0.0 108.117 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.93 150.83 39.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.409 1.484 . . . . 0.0 108.684 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.7 t -127.51 139.18 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 123.469 0.708 . . . . 0.0 109.555 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -106.42 1.49 25.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.591 1.156 . . . . 0.0 111.537 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.11 -151.37 28.26 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.706 1.622 . . . . 0.0 109.581 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 11.54 8.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.802 1.641 . . . . 0.0 112.578 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.28 149.99 2.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.682 1.193 . . . . 0.0 113.065 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.18 140.22 87.94 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.227 1.011 . . . . 0.0 109.659 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.59 -45.19 11.88 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.439 1.426 . . . . 0.0 110.164 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -57.05 -37.61 72.05 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.449 1.499 . . . . 0.0 112.018 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.86 31.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.386 0.539 . . . . 0.0 110.796 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.84 -51.22 50.93 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.286 -0.884 . . . . 0.0 108.75 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 p -60.08 -37.32 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.99 -50.26 71.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.134 0.974 . . . . 0.0 111.659 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.17 35.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.334 0.97 . . . . 0.0 113.423 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.2 t -74.14 -46.75 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.34 1.456 . . . . 0.0 108.618 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.57 -31.06 71.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.338 0.655 . . . . 0.0 110.378 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.56 -33.34 75.69 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -78.5 -17.51 56.15 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.4 -0.813 . . . . 0.0 108.866 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.89 5.95 35.15 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 117.241 -1.866 . . . . 0.0 117.074 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -96.32 160.42 14.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.067 1.933 . . . . 0.0 109.072 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -85.89 137.74 32.53 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.21 140.95 37.92 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.87 134.29 14.37 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.965 1.306 . . . . 0.0 108.608 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.42 131.29 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 127.062 2.145 . . . . 0.0 111.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt -98.82 37.6 1.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.856 1.262 . . . . 0.0 111.148 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.997 1.719 . . . . 0.0 107.957 178.769 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttt . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mt -67.79 149.49 49.85 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.249 0.477 . . . . 0.0 110.38 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.24 145.8 42.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.475 1.11 . . . . 0.0 109.518 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.19 139.15 28.57 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 108.947 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -105.14 111.16 23.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -88.41 162.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -152.47 122.51 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.24 -10.59 9.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.614 1.578 . . . . 0.0 113.547 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.5 mtm -73.99 122.39 22.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.586 2.193 . . . . 0.0 109.544 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.7 p -121.12 -12.17 8.74 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 m -137.11 165.49 25.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.925 0.89 . . . . 0.0 110.674 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -60.54 -27.74 67.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.449 1.099 . . . . 0.0 109.604 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -42.27 98.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.8 -40.76 96.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.055 0.388 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.68 -53.02 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.5 ptm -64.65 -43.58 93.16 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.893 0.77 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.0 -57.62 10.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.772 0.829 . . . . 0.0 110.177 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.42 -38.28 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.0 m -57.97 -42.27 84.71 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.186 -0.947 . . . . 0.0 110.271 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.54 -43.9 79.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.969 . . . . 0.0 110.593 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.91 85.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 122.807 0.443 . . . . 0.0 110.131 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -62.49 -36.08 81.4 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.242 -1.536 . . . . 0.0 108.376 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -69.24 -7.28 35.36 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.742 -1.224 . . . . 0.0 112.381 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -73.15 -17.78 61.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.719 1.6 . . . . 0.0 110.723 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.4 t -76.13 133.6 71.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.42 108.09 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.871 2.38 . . . . 0.0 112.846 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.46 -17.91 6.48 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.84 1.686 . . . . 0.0 113.174 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.9 p -62.33 144.34 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.475 1.637 . . . . 0.0 110.873 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -122.77 -54.49 1.84 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.097 0.959 . . . . 0.0 108.502 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -140.41 150.49 43.93 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 t -133.25 142.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.47 96.72 4.5 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 t -108.27 152.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.977 0.911 . . . . 0.0 109.321 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -146.67 138.2 24.44 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.467 0.576 . . . . 0.0 111.013 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.63 -52.21 41.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.466 1.106 . . . . 0.0 110.403 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -58.9 -38.12 78.15 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.699 1.6 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -86.39 -26.4 24.8 Favored 'General case' 0 N--CA 1.458 -0.067 0 O-C-N 121.988 -0.445 . . . . 0.0 110.623 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.43 35.23 88.22 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.47 158.42 43.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.69 135.3 48.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.801 2.04 . . . . 0.0 107.532 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -122.23 146.76 46.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.1 t -132.62 136.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 118.813 0.733 . . . . 0.0 109.444 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.6 -14.54 16.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.8 1.24 . . . . 0.0 111.432 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.83 -175.07 40.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.19 -0.944 . . . . 0.0 113.47 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.0 p -91.63 12.05 22.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.0 2.12 . . . . 0.0 110.236 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.75 149.17 14.95 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.549 -0.72 . . . . 0.0 111.134 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.03 142.97 60.54 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.304 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.0 -47.98 15.97 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.474 2.783 . . . . 0.0 112.799 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -58.73 -38.83 79.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.331 0.514 . . . . 0.0 110.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.22 -29.6 68.47 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.401 -0.812 . . . . 0.0 110.643 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.22 -55.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -58.77 -42.81 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.67 -52.73 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.688 1.195 . . . . 0.0 110.257 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -22.91 60.11 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.4 t -87.11 -38.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 120.806 -1.184 . . . . 0.0 108.245 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.47 -31.44 68.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.48 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.22 -22.79 67.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.179 0.9 . . . . 0.0 110.559 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.89 -12.49 47.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.978 1.311 . . . . 0.0 110.235 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.44 -3.93 40.18 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.218 1.389 . . . . 0.0 116.04 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -81.73 165.2 21.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.192 1.996 . . . . 0.0 109.641 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.18 114.01 25.67 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.62 156.83 33.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.75 139.36 15.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.959 0.904 . . . . 0.0 109.118 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.7 t -78.91 140.53 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.93 50.87 0.76 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.914 0.885 . . . . 0.0 108.719 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.443 0 C-N-CA 127.168 2.187 . . . . 0.0 108.607 179.239 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.849 0.357 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -116.18 131.15 57.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.713 1.605 . . . . 0.0 109.866 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -132.63 144.38 50.32 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.549 1.539 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -110.94 115.73 30.0 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.88 142.64 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.53 115.97 13.65 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.581 0.753 . . . . 0.0 109.888 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.62 -17.03 5.31 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.446 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.5 mtm -73.4 107.99 6.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.742 1.771 . . . . 0.0 107.612 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -121.23 16.9 11.51 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.908 -0.495 . . . . 0.0 111.209 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.0 t -151.94 152.46 32.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.63 1.172 . . . . 0.0 108.039 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -61.0 -30.95 70.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.002 0.521 . . . . 0.0 110.014 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.15 -39.24 81.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 110.765 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.4 m -63.68 -53.66 47.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.241 1.016 . . . . 0.0 108.968 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.92 -50.45 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 125.561 1.545 . . . . 0.0 110.839 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.9 ptm -63.49 -40.97 98.49 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.706 1.139 . . . . 0.0 112.355 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.94 79.65 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.29 -39.15 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.758 2.023 . . . . 0.0 110.471 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -55.48 -58.86 6.01 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.49 -41.07 96.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.653 -0.654 . . . . 0.0 111.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -43.13 77.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.029 0.532 . . . . 0.0 111.295 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.87 -36.12 77.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -65.68 -13.13 58.6 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.883 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -75.44 -8.01 55.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.9 1.227 . . . . 0.0 111.368 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.03 134.64 59.51 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 124.143 0.977 . . . . 0.0 111.048 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.14 112.9 2.65 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.719 2.279 . . . . 0.0 107.558 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.93 -3.98 14.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.848 1.69 . . . . 0.0 113.806 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -87.42 139.99 16.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 120.288 2.044 . . . . 0.0 109.486 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -118.75 -59.76 1.83 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.856 1.662 . . . . 0.0 108.815 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -135.76 158.99 43.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 162.75 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -144.5 107.83 4.58 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.24 122.65 68.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.795 0.838 . . . . 0.0 109.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.7 t -84.73 -177.74 6.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.22 1.008 . . . . 0.0 108.804 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.6 tp -132.44 -14.24 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.907 2.083 . . . . 0.0 109.214 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.68 -27.35 7.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.616 1.167 . . . . 0.0 112.281 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -89.97 -15.12 32.62 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 117.641 -1.171 . . . . 0.0 113.625 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.9 35.39 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 119.785 1.175 . . . . 0.0 110.557 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -122.08 154.39 37.39 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.763 1.225 . . . . 0.0 110.64 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.81 79.43 1.62 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.345 1.458 . . . . 0.0 110.255 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.68 145.83 55.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.664 0.786 . . . . 0.0 109.821 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.5 t -128.37 127.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.259 1.423 . . . . 0.0 107.67 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -93.57 -23.15 18.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.522 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.13 176.41 30.39 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.934 0.778 . . . . 0.0 111.601 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -95.5 10.39 36.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.519 1.528 . . . . 0.0 111.939 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.7 4.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.914 -0.491 . . . . 0.0 112.002 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.68 149.39 46.09 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.62 -33.23 46.09 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.202 1.935 . . . . 0.0 113.861 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -61.58 -47.97 83.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.98 69.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.061 0.545 . . . . 0.0 111.544 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.75 -59.0 2.98 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.564 0.746 . . . . 0.0 109.986 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.47 -39.98 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.091 0.957 . . . . 0.0 110.819 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -53.19 -51.33 62.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.26 1.424 . . . . 0.0 109.312 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.49 -26.18 65.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -83.73 -43.15 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 119.651 1.114 . . . . 0.0 108.604 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -60.67 -32.69 71.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.577 1.151 . . . . 0.0 108.663 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.84 -29.14 70.08 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.108 1.363 . . . . 0.0 110.841 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -79.6 -0.68 34.72 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.536 -0.727 . . . . 0.0 110.374 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 11.64 67.6 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.763 1.173 . . . . 0.0 114.563 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -102.98 -178.71 3.75 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.24 1.52 . . . . 0.0 108.104 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -116.42 130.95 57.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 118.167 -0.92 . . . . 0.0 108.627 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.18 159.05 43.03 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.822 0.737 . . . . 0.0 110.25 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.53 144.04 20.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.636 1.174 . . . . 0.0 108.631 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' ALA . 9.9 p -77.99 158.83 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -119.27 21.17 12.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 109.733 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 126.17 1.788 . . . . 0.0 106.374 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.476 0.655 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -121.52 128.68 52.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.29 145.89 51.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.938 1.695 . . . . 0.0 108.98 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' HD21 ' A' ' 65' ' ' LEU . 24.6 ttmm -109.32 119.06 38.34 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.4 t -109.09 146.46 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -141.57 126.26 17.98 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 126.54 -23.31 5.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.958 1.266 . . . . 0.0 113.015 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.1 mtm -68.03 118.4 11.16 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.261 1.531 . . . . 0.0 108.684 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -119.58 -8.7 9.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.732 0.813 . . . . 0.0 111.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.68 158.16 43.93 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.846 1.258 . . . . 0.0 108.399 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.27 -32.31 62.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 112.204 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -60.42 -34.75 74.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.531 0.605 . . . . 0.0 110.76 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m -69.13 -48.53 62.18 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -54.59 -54.09 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 125.103 1.361 . . . . 0.0 110.526 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ptm -60.86 -29.56 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.767 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.14 48.27 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.9 t -55.42 -46.2 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.854 1.261 . . . . 0.0 108.418 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.3 m -55.38 -53.56 54.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.894 0.878 . . . . 0.0 109.719 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -64.82 -40.52 95.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.073 -1.017 . . . . 0.0 112.613 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.52 98.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.004 0.521 . . . . 0.0 111.191 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.21 -44.02 92.26 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -65.87 -9.46 29.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.404 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -74.96 -24.78 58.51 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 121.428 1.922 . . . . 0.0 110.015 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.07 128.22 91.97 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 123.508 0.723 . . . . 0.0 110.72 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.06 108.25 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.152 2.568 . . . . 0.0 108.377 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.84 -4.48 7.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 124.559 1.076 . . . . 0.0 111.829 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.2 t -91.28 100.58 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 119.601 1.701 . . . . 0.0 110.946 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.25 -56.09 5.06 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.427 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -146.28 160.23 42.29 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -150.0 175.46 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 126.966 2.106 . . . . 0.0 108.918 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -152.46 143.75 23.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.77 126.01 6.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 t -84.2 176.42 8.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.9 tp -117.76 -13.99 10.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.68 1.592 . . . . 0.0 109.903 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -125.63 -39.06 2.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 112.814 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.37 -17.56 64.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.56 42.14 97.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -141.67 129.17 21.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.212 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.13 144.98 48.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 106.185 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.57 156.19 48.91 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 51' ' ' LEU . 16.5 t -128.12 142.26 44.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.559 1.144 . . . . 0.0 108.406 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -125.01 42.34 3.3 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.296 1.838 . . . . 0.0 110.142 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.4 -167.23 12.07 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.464 1.506 . . . . 0.0 112.796 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -104.53 3.37 31.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.457 1.903 . . . . 0.0 111.993 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.94 169.06 1.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.947 -1.095 . . . . 0.0 113.518 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.33 148.73 35.56 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.834 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -58.21 -34.49 98.61 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.472 2.115 . . . . 0.0 113.78 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -69.68 -52.65 23.73 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.165 0.986 . . . . 0.0 111.429 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.05 66.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 42' ' ' VAL . 67.3 mt -67.86 -60.65 2.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.365 1.466 . . . . 0.0 111.302 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -55.52 -44.93 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -57.62 -39.9 77.97 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.552 0.741 . . . . 0.0 111.366 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.71 -28.15 68.85 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.208 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.33 -37.18 15.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 108.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.0 -33.29 75.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.58 -12.47 61.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.878 1.271 . . . . 0.0 111.816 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -90.4 -9.79 46.27 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.31 1.414 . . . . 0.0 109.031 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.96 15.09 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.728 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -114.99 -179.37 3.61 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.618 1.709 . . . . 0.0 108.683 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -118.68 127.84 53.95 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.34 157.91 45.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.746 0.703 . . . . 0.0 111.37 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.03 135.16 13.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.535 1.534 . . . . 0.0 108.592 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 66' ' ' ALA . 7.1 p -77.97 147.81 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.885 0.766 . . . . 0.0 110.759 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.414 HD21 ' HE2' ' A' ' 5' ' ' LYS . 84.8 mt -123.77 20.21 9.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.678 2.391 . . . . 0.0 111.009 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.459 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.244 0.814 0 C-N-CA 124.565 1.146 . . . . 0.0 108.283 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.234 0.278 0 CA-C-O 119.51 -0.281 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.57 ' HE3' HD21 ' A' ' 41' ' ' LEU . 25.1 mtpt -115.54 134.88 54.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.781 1.232 . . . . 0.0 108.499 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mt -128.3 132.04 48.66 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.493 1.517 . . . . 0.0 108.373 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -92.0 117.55 29.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.56 159.73 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -143.65 148.92 36.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.42 63.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.488 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.0 mtm -73.82 109.4 7.29 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.582 2.191 . . . . 0.0 106.23 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.2 p -123.31 -6.13 8.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -150.02 162.62 40.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.108 -0.995 . . . . 0.0 108.792 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.38 -37.43 67.55 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.692 1.597 . . . . 0.0 111.262 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -64.89 -38.8 92.19 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 m -60.5 -46.52 89.82 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.22 -58.57 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptm -59.16 -37.52 77.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.59 69.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.513 0.597 . . . . 0.0 109.562 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.43 -44.04 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -52.64 -58.96 5.12 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 120.954 -1.091 . . . . 0.0 109.626 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.45 -36.96 81.85 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 112.702 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.61 67.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.0 0.92 . . . . 0.0 109.881 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.26 -46.18 15.16 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -24.01 39.75 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.095 1.358 . . . . 0.0 114.434 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -64.77 -24.1 67.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.75 1.159 . . . . 0.0 111.036 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.03 127.73 88.23 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 118.944 0.793 . . . . 0.0 110.585 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.62 110.75 2.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.594 2.196 . . . . 0.0 107.764 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 -9.86 6.91 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.993 1.759 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.0 t -88.75 104.01 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 118.4 1.1 . . . . 0.0 109.823 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.76 -64.69 0.82 Allowed 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -146.62 166.96 24.98 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.15 156.51 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.71 110.96 8.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.4 t -113.28 134.02 57.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.073 0.949 . . . . 0.0 109.01 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 t -114.78 125.77 54.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.792 1.237 . . . . 0.0 109.812 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.22 -37.56 80.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.49 0.716 . . . . 0.0 110.7 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.35 -54.43 9.46 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.03 0.532 . . . . 0.0 110.251 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.87 -28.17 68.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.205 0.912 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.94 26.59 74.56 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.61 164.59 16.27 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.965 1.306 . . . . 0.0 109.68 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.12 31.03 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.999 1.72 . . . . 0.0 108.14 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.57 HD21 ' HE3' ' A' ' 3' ' ' LYS . 3.3 mm? -108.13 136.16 48.28 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -121.55 125.53 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.0 -9.6 52.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.252 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.15 -166.07 4.49 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.901 1.238 . . . . 0.0 114.154 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -124.31 8.42 8.47 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.806 1.642 . . . . 0.0 111.176 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.25 158.71 16.53 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.273 1.029 . . . . 0.0 109.768 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 148.87 90.36 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 125.557 1.543 . . . . 0.0 110.06 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.51 -30.43 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.228 1.286 . . . . 0.0 111.585 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -63.76 -56.49 15.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.818 1.247 . . . . 0.0 108.251 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.22 67.35 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.29 -55.32 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.855 1.262 . . . . 0.0 111.211 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.13 -43.94 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.399 1.0 . . . . 0.0 111.39 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -46.46 82.89 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.831 1.252 . . . . 0.0 108.264 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -23.01 60.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.241 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.06 -42.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.345 1.43 . . . . 0.0 109.71 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.59 -26.91 68.84 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.52 -15.94 63.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.428 1.891 . . . . 0.0 113.156 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -97.7 -6.09 33.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.665 1.12 . . . . 0.0 109.055 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.87 6.86 53.9 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.317 0.96 . . . . 0.0 112.624 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -95.48 -170.47 2.17 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -132.19 134.04 44.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.37 167.55 21.65 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 118.329 0.513 . . . . 0.0 111.422 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -159.57 130.86 6.05 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 124.811 1.244 . . . . 0.0 108.687 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 66' ' ' ALA . 1.8 p -74.9 130.98 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.09 16.25 18.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.082 0.953 . . . . 0.0 112.638 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.588 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.537 1.535 . . . . 0.0 110.61 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 C--O 1.236 0.368 0 CA-C-O 122.558 1.171 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -159.13 131.58 6.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mt -138.23 160.06 40.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.15 1.38 . . . . 0.0 109.309 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -126.98 145.91 50.53 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.5 141.04 44.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 127.391 2.277 . . . . 0.0 109.5 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.84 114.2 10.24 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.116 1.366 . . . . 0.0 108.237 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.62 -6.62 5.23 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.911 1.72 . . . . 0.0 115.0 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -68.28 155.02 40.58 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.88 2.34 . . . . 0.0 109.816 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -137.15 -41.43 0.58 Allowed 'General case' 0 C--N 1.339 0.12 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 m -136.73 169.15 18.2 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 124.581 1.152 . . . . 0.0 109.699 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -49.55 -43.09 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.514 1.525 . . . . 0.0 111.698 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -58.75 -37.76 76.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.106 0.563 . . . . 0.0 111.67 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.99 -39.81 94.03 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.01 -58.81 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 109.449 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -53.33 -37.06 61.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.94 -55.15 38.65 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.911 0.862 . . . . 0.0 108.797 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.09 -40.84 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.396 1.078 . . . . 0.0 110.021 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.4 m -55.69 -46.0 77.72 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.986 1.267 . . . . 0.0 108.12 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -67.81 -36.36 80.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.206 -0.934 . . . . 0.0 111.315 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.01 73.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.774 0.715 . . . . 0.0 111.385 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mt -61.24 -39.45 90.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.657 1.117 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -67.42 -9.65 43.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.882 0.873 . . . . 0.0 112.834 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.31 -29.09 66.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.021 1.282 . . . . 0.0 109.544 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -58.89 129.52 85.57 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.231 1.413 . . . . 0.0 112.796 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.83 117.34 4.82 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 122.445 2.097 . . . . 0.0 107.66 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.82 -14.43 12.79 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 126.423 1.963 . . . . 0.0 112.613 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.3 140.89 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-N 119.335 1.567 . . . . 0.0 107.757 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -121.49 -54.88 1.96 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.248 1.019 . . . . 0.0 108.49 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -137.27 153.97 50.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -140.92 168.76 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.199 0.937 . . . . 0.0 111.033 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.92 138.66 34.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.652 2.381 . . . . 0.0 104.631 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -151.65 136.53 10.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -137.19 129.55 29.74 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.682 0.674 . . . . 0.0 110.369 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -66.47 -48.82 68.65 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.663 1.185 . . . . 0.0 109.81 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -61.3 -35.18 76.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -84.27 -29.92 26.05 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.283 0.633 . . . . 0.0 111.941 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.56 33.39 71.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.85 169.52 17.62 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.042 1.421 . . . . 0.0 112.787 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.33 140.25 33.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.931 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.8 149.6 47.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.416 1.886 . . . . 0.0 106.899 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -131.18 133.66 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.79 2.036 . . . . 0.0 108.243 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -100.22 -3.97 30.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.742 0.817 . . . . 0.0 111.669 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.19 -170.67 46.49 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.294 0.949 . . . . 0.0 113.296 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 t -101.08 3.82 41.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.957 1.703 . . . . 0.0 111.483 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.55 153.84 9.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.004 0.922 . . . . 0.0 112.849 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 150.64 61.02 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.102 0.561 . . . . 0.0 110.578 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.58 -40.85 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.483 2.122 . . . . 0.0 113.009 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -55.68 -47.22 77.14 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.625 0.77 . . . . 0.0 110.714 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.57 79.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.262 0.625 . . . . 0.0 111.623 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.6 mt -67.24 -52.52 40.02 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 123.839 0.856 . . . . 0.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 p -60.52 -40.51 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.12 -45.66 86.93 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.051 0.941 . . . . 0.0 109.929 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -85.96 -33.21 7.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.92 -32.74 74.59 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.34 -29.23 69.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.715 1.206 . . . . 0.0 109.782 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -78.33 -7.4 57.22 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.85 25.33 41.85 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.681 1.61 . . . . 0.0 113.475 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.45 177.88 4.66 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -115.22 98.33 6.71 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.717 0.807 . . . . 0.0 109.685 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.0 161.53 13.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.688 -0.632 . . . . 0.0 110.747 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -151.36 138.76 19.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.155 0.982 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.9 t -78.06 138.72 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.38 9.65 18.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.054 0.942 . . . . 0.0 111.561 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.661 1.585 . . . . 0.0 108.722 179.319 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.418 HD11 ' HD3' ' A' ' 48' ' ' PRO . 6.0 mt . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.87 130.37 56.8 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 108.713 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.06 151.68 51.62 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 125.37 1.468 . . . . 0.0 107.315 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -118.52 120.86 38.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.42 138.89 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -137.05 102.95 4.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.86 -8.56 1.76 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.801 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.5 mtm -75.38 130.35 38.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.5 t -136.15 14.33 3.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.263 0.483 . . . . 0.0 111.753 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 t -160.93 165.27 30.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.938 -1.101 . . . . 0.0 109.646 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -61.28 -33.22 73.2 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.365 1.066 . . . . 0.0 110.973 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.27 -25.57 63.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.983 0.513 . . . . 0.0 111.656 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -71.67 -47.01 57.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -55.46 -56.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.66 0.784 . . . . 0.0 109.54 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.2 ptm -58.54 -34.13 70.66 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.66 -51.1 66.6 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.37 -39.06 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.616 1.167 . . . . 0.0 109.4 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.1 m -57.05 -50.26 73.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.292 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -69.87 -37.78 76.18 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.656 -1.278 . . . . 0.0 111.468 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.37 78.83 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.439 1.095 . . . . 0.0 108.669 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.76 -41.17 60.58 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.927 -1.108 . . . . 0.0 109.276 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -64.78 -16.54 63.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -13.76 60.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.74 1.609 . . . . 0.0 110.987 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.54 130.14 89.34 Favored Pre-proline 0 N--CA 1.452 -0.351 0 C-N-CA 124.581 1.153 . . . . 0.0 110.623 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.56 111.51 2.13 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 106.073 -2.318 . . . . 0.0 106.073 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.95 -3.9 9.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.758 1.647 . . . . 0.0 112.318 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.05 138.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.587 2.193 . . . . 0.0 109.076 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.52 -51.9 1.72 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.565 1.546 . . . . 0.0 111.451 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -139.47 153.58 47.56 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 m -147.4 166.28 5.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.24 94.17 2.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.342 1.057 . . . . 0.0 109.993 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.17 134.01 38.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.639 1.176 . . . . 0.0 108.609 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -131.6 134.53 46.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.073 0.949 . . . . 0.0 109.902 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.3 tp -76.99 -42.07 40.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.81 -53.03 62.8 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.844 0.857 . . . . 0.0 110.183 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -14.92 55.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.839 -1.076 . . . . 0.0 113.395 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 55.16 29.71 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.4 170.06 18.15 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.849 -0.795 . . . . 0.0 110.577 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.9 95.26 2.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.668 1.187 . . . . 0.0 113.312 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.46 152.82 40.61 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.891 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.19 135.89 60.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.269 1.428 . . . . 0.0 108.249 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -103.65 -19.26 14.4 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.738 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.73 -172.1 28.6 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.3 p -103.53 8.78 37.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.649 1.179 . . . . 0.0 112.425 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.18 155.1 7.01 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.479 0.711 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 151.25 65.5 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 122.859 0.464 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' HD11 ' A' ' 2' ' ' LEU . 22.8 Cg_endo -63.14 -40.16 34.93 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.989 1.792 . . . . 0.0 114.91 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.567 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -59.05 -45.33 91.04 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.411 0.684 . . . . 0.0 110.095 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.39 -32.02 72.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.275 -0.265 . . . . 0.0 111.47 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.1 mt -69.42 -57.68 4.96 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.261 1.024 . . . . 0.0 109.981 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.49 -40.49 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.48 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -53.37 -51.97 60.79 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.925 0.89 . . . . 0.0 110.127 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -28.26 65.03 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.6 -39.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -60.77 -39.47 88.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.84 -21.84 66.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 0.0 112.279 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -86.27 -9.41 56.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.223 0.919 . . . . 0.0 110.468 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.97 21.45 18.27 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.657 -1.079 . . . . 0.0 114.229 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.93 179.55 4.08 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.415 1.608 . . . . 0.0 108.048 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -120.57 109.48 15.31 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.24 165.64 12.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 118.902 0.774 . . . . 0.0 110.353 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -157.91 132.63 8.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.877 -0.514 . . . . 0.0 111.339 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.78 147.86 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.46 33.83 4.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.29 1.036 . . . . 0.0 110.177 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.569 2.348 . . . . 0.0 107.028 179.26 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mt . . . . . 0 C--O 1.233 0.196 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -132.26 123.66 27.38 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.448 HD21 ' HB ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -126.57 133.11 51.16 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.711 0.804 . . . . 0.0 109.436 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -88.19 121.27 30.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.28 150.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -142.48 120.49 12.08 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.77 -10.71 9.61 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.05 1.31 . . . . 0.0 115.141 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.2 mtm -74.92 111.88 10.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 120.052 1.926 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.67 11.42 9.14 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.533 0.733 . . . . 0.0 111.797 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.0 t -151.24 151.86 32.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -60.76 -27.96 68.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.902 0.481 . . . . 0.0 110.599 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -63.26 -32.5 73.93 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.844 0.747 . . . . 0.0 110.4 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -64.89 -47.74 76.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -57.17 -57.03 11.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.296 1.038 . . . . 0.0 110.057 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ptm -63.78 -36.46 83.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.95 -49.51 65.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.491 1.041 . . . . 0.0 108.582 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.46 -32.11 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.905 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -57.12 -43.74 82.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -67.52 -47.26 70.46 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.163 -0.96 . . . . 0.0 109.954 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.38 -46.66 69.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.525 0.73 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.88 -38.09 86.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.786 1.234 . . . . 0.0 109.511 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -76.77 -6.99 54.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 117.322 -1.323 . . . . 0.0 111.167 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.73 -27.66 63.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.207 1.821 . . . . 0.0 107.669 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.67 120.69 47.7 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 125.018 1.327 . . . . 0.0 107.75 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.3 101.49 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.48 2.787 . . . . 0.0 109.456 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.88 -7.4 1.91 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.858 1.694 . . . . 0.0 111.801 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.56 141.12 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 120.495 -1.591 . . . . 0.0 111.074 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.79 -59.44 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.011 1.324 . . . . 0.0 107.743 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -135.68 157.27 47.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.849 1.259 . . . . 0.0 108.711 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 t -142.33 145.43 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.37 77.02 1.45 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.611 1.964 . . . . 0.0 109.742 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.3 t -85.89 143.05 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -141.61 133.47 27.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.24 1.016 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.59 -64.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.788 1.635 . . . . 0.0 112.373 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.03 -30.2 71.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.202 2.201 . . . . 0.0 114.924 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -81.91 -15.25 54.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.775 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.82 35.77 83.9 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -139.44 166.78 23.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 122.406 1.098 . . . . 0.0 112.273 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -145.82 129.3 16.94 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.281 2.633 . . . . 0.0 105.67 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mt -121.16 154.45 36.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.3 t -129.39 152.77 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.653 1.216 . . . . 0.0 111.326 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -135.2 111.38 9.63 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 100.909 -3.737 . . . . 0.0 100.909 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.71 -177.49 37.95 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 p -94.61 -0.65 54.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 111.535 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 144.94 54.05 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 111.909 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -80.82 149.27 67.01 Favored Pre-proline 0 N--CA 1.465 0.309 0 C-N-CA 125.454 1.501 . . . . 0.0 110.218 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.57 -38.57 81.58 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.519 2.146 . . . . 0.0 116.145 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -63.35 -46.77 85.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 110.477 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.23 65.68 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.74 -56.45 6.36 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.764 0.826 . . . . 0.0 110.094 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.448 ' HB ' HD21 ' A' ' 4' ' ' LEU . 1.4 p -57.02 -45.11 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.736 0.698 . . . . 0.0 109.579 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.84 -47.79 60.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 111.288 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.18 66.49 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -88.99 -35.64 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -63.85 -33.89 76.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.45 -25.7 68.12 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.68 0.792 . . . . 0.0 111.019 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.04 -4.19 56.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.038 0.836 . . . . 0.0 110.603 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.58 19.11 35.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.806 1.185 . . . . 0.0 114.137 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -113.32 177.24 4.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.961 1.381 . . . . 0.0 108.944 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -116.01 116.46 27.94 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.23 154.49 38.7 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -153.72 138.28 16.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.587 1.155 . . . . 0.0 108.966 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.87 140.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.446 -0.784 . . . . 0.0 111.13 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -98.94 19.36 15.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.735 1.214 . . . . 0.0 110.82 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.893 2.077 . . . . 0.0 105.473 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.236 0.356 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -123.74 159.41 29.5 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 108.019 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mt -157.05 131.8 8.78 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -99.57 122.5 42.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.68 144.4 22.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -135.59 125.28 25.35 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.43 -15.95 8.05 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.298 -1.279 . . . . 0.0 114.221 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 69.6 mtm -65.2 131.97 47.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.401 2.1 . . . . 0.0 106.944 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -134.45 -21.85 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.3 m -135.45 167.62 20.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.47 1.032 . . . . 0.0 109.137 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.4 -36.66 64.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.411 1.485 . . . . 0.0 109.11 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -59.32 -44.3 92.58 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.853 1.661 . . . . 0.0 110.195 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 m -59.77 -43.98 94.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.32 -53.85 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.021 0.529 . . . . 0.0 110.101 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ptm -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.104 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.29 -59.92 4.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.967 0.803 . . . . 0.0 108.879 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.16 -38.74 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.534 0.734 . . . . 0.0 109.994 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -58.66 -52.87 63.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.076 -1.64 . . . . 0.0 109.161 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -61.6 -43.84 98.12 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 121.623 -0.673 . . . . 0.0 112.33 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.27 86.07 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.681 0.613 . . . . 0.0 110.793 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.57 -39.46 93.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 0.0 109.497 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -67.05 -11.79 58.1 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.14 -17.93 60.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.883 1.219 . . . . 0.0 110.082 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.64 133.95 95.27 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 124.575 1.15 . . . . 0.0 111.616 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.66 115.99 4.2 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.218 1.945 . . . . 0.0 107.553 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.56 26.8 Favored Glycine 0 C--N 1.318 -0.457 0 C-N-CA 126.537 2.018 . . . . 0.0 113.627 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -80.98 131.13 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 120.755 2.278 . . . . 0.0 107.428 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -104.35 -62.41 1.32 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -136.06 158.18 45.04 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.986 0.915 . . . . 0.0 108.546 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.23 154.46 20.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 126.035 1.734 . . . . 0.0 107.525 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -145.29 112.15 5.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.18 149.8 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.821 0.849 . . . . 0.0 110.349 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -126.96 135.41 50.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.104 1.362 . . . . 0.0 109.033 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 tp -84.45 -21.09 30.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.362 0.665 . . . . 0.0 110.65 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -84.3 -38.29 20.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.313 1.045 . . . . 0.0 111.967 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -98.86 -13.06 20.24 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.6 33.33 81.55 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 120.043 1.292 . . . . 0.0 111.382 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -119.31 148.84 42.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.233 1.013 . . . . 0.0 108.568 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.19 98.73 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 109.214 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.7 mm? -83.99 147.41 27.46 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.46 151.01 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 125.011 1.324 . . . . 0.0 107.456 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.75 -9.73 7.28 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.26 -168.1 41.19 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.07 0.85 . . . . 0.0 114.458 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.1 p -100.2 9.48 42.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.206 1.403 . . . . 0.0 111.203 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.5 155.5 18.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.54 0.736 . . . . 0.0 111.749 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.83 149.41 50.8 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.513 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.4 -37.46 17.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 112.291 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.79 -36.56 67.53 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.26 0.624 . . . . 0.0 111.676 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.88 26.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.115 0.966 . . . . 0.0 112.175 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 mt -63.91 -53.35 51.76 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.296 1.038 . . . . 0.0 109.77 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.38 -39.96 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.538 0.608 . . . . 0.0 110.156 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -47.35 77.74 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.174 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.19 -18.8 50.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.81 -39.57 10.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 119.809 1.186 . . . . 0.0 108.838 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -66.78 -32.39 73.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.27 -13.16 62.06 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.982 0.81 . . . . 0.0 109.838 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.66 -6.6 45.99 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.445 -1.409 . . . . 0.0 108.926 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.15 2.42 71.16 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 128.215 2.817 . . . . 0.0 114.952 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -88.39 159.95 17.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 118.92 1.36 . . . . 0.0 107.651 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -98.07 118.26 34.26 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.23 162.98 24.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.524 0.602 . . . . 0.0 110.626 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -163.35 145.93 10.07 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.167 1.387 . . . . 0.0 109.105 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.49 150.94 5.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.5 mt -110.68 9.68 22.83 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.243 1.017 . . . . 0.0 110.995 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.644 1.578 . . . . 0.0 107.247 179.476 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.9 mt . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.187 0.517 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -137.03 143.98 42.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.38 157.93 44.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.328 2.651 . . . . 0.0 108.026 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -123.87 122.45 38.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 127.499 2.32 . . . . 0.0 105.485 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.26 145.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 125.766 1.626 . . . . 0.0 108.368 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.66 130.11 33.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.55 -11.08 12.52 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.248 -1.307 . . . . 0.0 112.343 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.7 mtm -71.75 138.01 48.14 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.345 2.073 . . . . 0.0 108.269 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.8 p -135.17 -15.27 1.97 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.91 177.14 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 109.556 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -62.08 -31.58 72.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.831 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -60.18 -35.71 75.99 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.472 1.033 . . . . 0.0 109.062 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.8 m -65.61 -47.76 74.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -55.9 -54.49 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.604 0.762 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -37.94 88.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.729 1.149 . . . . 0.0 111.58 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.61 -51.15 64.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.794 0.725 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.2 t -61.22 -40.76 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.677 1.191 . . . . 0.0 108.608 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.2 m -58.01 -61.11 2.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.58 -33.4 69.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.331 0.968 . . . . 0.0 112.951 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.71 95.97 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.93 -36.74 70.03 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.91 -1.119 . . . . 0.0 108.361 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -64.75 -33.52 76.16 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.759 -1.213 . . . . 0.0 114.166 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.27 -20.37 64.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.839 1.2 . . . . 0.0 113.15 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 128.41 89.81 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.51 102.74 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.217 2.612 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.12 -10.2 4.16 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.45 1.024 . . . . 0.0 111.574 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.41 132.1 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 118.464 1.132 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -104.54 -56.48 2.18 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.877 1.671 . . . . 0.0 108.556 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -138.74 159.87 41.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.569 1.148 . . . . 0.0 108.2 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 42' ' ' VAL . 47.7 t -140.44 159.57 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -135.68 122.75 21.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.68 159.77 41.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 119.429 1.013 . . . . 0.0 109.539 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -141.24 126.93 19.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.15 1.38 . . . . 0.0 109.086 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.21 -52.41 41.42 Favored 'General case' 0 N--CA 1.46 0.061 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -60.01 -56.61 19.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.237 1.015 . . . . 0.0 112.303 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -72.44 -28.07 62.72 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.203 0.456 . . . . 0.0 111.896 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.66 80.87 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -89.55 150.99 22.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.947 1.373 . . . . 0.0 108.242 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.09 139.16 39.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.95 156.17 49.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.611 HG21 HD22 ' A' ' 51' ' ' LEU . 12.8 t -128.27 144.22 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.438 1.095 . . . . 0.0 109.3 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -110.19 -4.02 15.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.33 -172.52 47.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.426 -0.796 . . . . 0.0 112.121 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -97.57 6.16 48.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.145 1.778 . . . . 0.0 110.892 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.57 167.98 4.01 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.74 1.216 . . . . 0.0 111.165 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -99.21 153.1 37.95 Favored Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 124.28 1.032 . . . . 0.0 112.877 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.25 -48.08 15.04 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.218 2.612 . . . . 0.0 113.91 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -61.18 -44.07 97.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 -178.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -31.81 72.43 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.873 -0.517 . . . . 0.0 111.888 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 42' ' ' VAL . 40.8 mt -73.11 -50.43 22.83 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.092 0.957 . . . . 0.0 110.76 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -60.19 -41.36 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.11 -56.1 16.58 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.415 1.486 . . . . 0.0 110.367 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.59 64.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.0 t -81.08 -34.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 119.275 0.943 . . . . 0.0 110.267 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.95 -26.97 68.53 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -66.33 -15.85 63.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.167 -0.958 . . . . 0.0 111.166 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -98.26 3.16 48.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.356 1.463 . . . . 0.0 111.338 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.53 85.66 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.996 0.816 . . . . 0.0 113.889 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.59 161.52 14.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -109.4 114.46 28.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.42 154.65 33.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.282 0.563 . . . . 0.0 111.523 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.86 133.93 17.1 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.3 150.74 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.245 1.418 . . . . 0.0 109.704 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.61 61.46 1.56 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.185 1.394 . . . . 0.0 109.676 -179.035 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.235 0.3 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -108.35 146.88 32.34 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.729 0.695 . . . . 0.0 110.71 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -139.0 156.18 47.42 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.443 1.497 . . . . 0.0 107.782 178.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -120.14 136.58 54.56 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -127.11 151.61 34.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 124.744 1.218 . . . . 0.0 107.955 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -141.69 145.91 35.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.86 -21.06 41.63 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.863 1.221 . . . . 0.0 112.781 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.5 mtm -66.7 122.56 17.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -125.79 -12.68 6.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.47 165.23 28.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.286 -0.884 . . . . 0.0 110.826 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -60.46 -34.25 73.74 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -62.73 -27.71 69.46 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.229 0.612 . . . . 0.0 110.716 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.93 -48.15 22.4 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.8 t -54.1 -57.3 6.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 123.784 0.834 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.2 ptm -55.36 -32.24 62.4 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.76 -54.42 31.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -63.49 -39.53 85.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.368 0.667 . . . . 0.0 109.794 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -56.17 -46.91 79.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.892 1.224 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -66.84 -43.69 83.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.127 -0.358 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.5 81.07 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.533 0.733 . . . . 0.0 110.1 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.59 -38.1 70.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.977 -1.077 . . . . 0.0 109.048 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -67.22 -30.63 70.61 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.696 -1.253 . . . . 0.0 114.299 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -65.66 -22.94 66.69 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.997 1.271 . . . . 0.0 110.186 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.2 t -56.87 130.3 78.57 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.52 110.48 1.63 Allowed 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.221 1.947 . . . . 0.0 110.532 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.55 19.56 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.224 1.392 . . . . 0.0 113.684 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -88.28 106.94 17.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 119.661 1.73 . . . . 0.0 111.912 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -81.51 -45.0 16.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.503 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -149.29 163.27 38.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.28 138.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -122.46 79.51 1.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 t -85.71 145.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.95 1.3 . . . . 0.0 109.184 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -134.97 131.81 37.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.845 1.258 . . . . 0.0 108.699 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.8 tp -68.94 -59.93 2.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.569 1.147 . . . . 0.0 109.318 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.17 -43.32 78.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.512 1.125 . . . . 0.0 111.969 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -81.97 -18.03 44.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 117.946 -1.026 . . . . 0.0 113.575 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.81 70.32 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -135.66 154.17 51.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.341 -1.093 . . . . 0.0 109.499 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.92 149.68 47.74 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.001 1.32 . . . . 0.0 109.96 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.84 129.62 40.66 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.28 118.82 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.705 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -82.14 -16.88 48.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.833 0.853 . . . . 0.0 111.026 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.76 177.28 31.03 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.341 0.972 . . . . 0.0 112.466 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 p -95.61 0.2 52.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.949 0.9 . . . . 0.0 113.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.06 148.66 0.8 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.596 1.958 . . . . 0.0 114.642 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -71.87 137.15 82.47 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -59.36 -41.07 61.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.248 1.966 . . . . 0.0 112.554 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -59.81 -32.8 70.98 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.633 1.173 . . . . 0.0 112.198 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -34.71 41.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.084 0.553 . . . . 0.0 110.15 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.14 -56.52 16.08 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.802 0.841 . . . . 0.0 109.252 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.03 -41.62 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.635 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -58.14 -45.13 87.91 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.721 0.691 . . . . 0.0 110.265 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.66 66.2 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.8 -38.6 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.373 -1.455 . . . . 0.0 108.163 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.73 -34.31 77.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.911 0.884 . . . . 0.0 110.576 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.74 -22.5 65.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.182 0.901 . . . . 0.0 110.733 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -85.01 0.75 50.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.33 1.052 . . . . 0.0 110.049 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.29 7.82 75.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.226 1.393 . . . . 0.0 115.014 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.56 166.68 11.91 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.871 1.335 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -106.23 110.17 22.33 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.15 165.06 16.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.747 0.654 . . . . 0.0 112.327 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.424 ' O ' HD23 ' A' ' 4' ' ' LEU . 12.5 pt-20 -162.32 141.56 9.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.552 1.941 . . . . 0.0 107.572 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 81.1 t -76.82 152.72 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.3 mt -126.58 59.15 1.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.438 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 C-N-CA 124.454 1.102 . . . . 0.0 108.812 177.886 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.415 HD11 ' HD3' ' A' ' 48' ' ' PRO . 2.2 mt . . . . . 0 CA--C 1.521 -0.173 0 CA-C-O 119.179 -0.438 . . . . 0.0 111.855 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.09 151.08 21.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.374 1.469 . . . . 0.0 111.331 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.18 144.49 24.01 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.244 1.818 . . . . 0.0 107.5 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.49 125.75 52.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.47 140.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.74 125.11 42.46 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.73 -9.68 8.59 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.984 1.278 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.1 mtm -74.1 90.17 2.01 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 107.252 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -98.36 -12.46 21.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.509 1.124 . . . . 0.0 112.416 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.8 m -136.19 162.08 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.398 -0.814 . . . . 0.0 110.247 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.89 -37.17 75.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.924 0.49 . . . . 0.0 110.207 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.72 -37.52 76.33 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.29 -46.95 88.05 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.18 0.9 . . . . 0.0 109.493 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.79 -55.12 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.202 1.001 . . . . 0.0 110.065 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptm -62.31 -28.93 70.08 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.674 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.11 -53.07 13.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.6 t -52.75 -47.14 51.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.946 1.298 . . . . 0.0 107.696 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 m -53.86 -55.07 30.09 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.418 1.087 . . . . 0.0 109.032 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -62.56 -36.78 83.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 117.92 -1.038 . . . . 0.0 113.292 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.65 71.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.158 0.89 . . . . 0.0 109.343 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.03 -41.01 99.42 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -61.97 -11.64 14.44 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.324 -0.846 . . . . 0.0 113.208 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -77.29 -20.28 55.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.028 1.286 . . . . 0.0 110.576 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.06 128.79 93.46 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.28 100.24 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.759 2.306 . . . . 0.0 111.542 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.3 -7.71 4.35 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.821 1.201 . . . . 0.0 112.463 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.52 104.6 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.213 -1.169 . . . . 0.0 111.005 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.15 -56.52 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -148.07 160.61 42.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.467 1.107 . . . . 0.0 108.671 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.14 153.62 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -137.14 90.62 2.54 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.1 t -99.16 139.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.401 1.48 . . . . 0.0 107.854 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -126.4 136.94 53.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.64 -60.59 3.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 125.029 1.332 . . . . 0.0 110.615 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.23 -46.1 89.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.815 1.246 . . . . 0.0 112.303 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -74.92 -31.45 61.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.494 -0.765 . . . . 0.0 113.057 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.09 40.93 55.54 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.61 167.41 21.72 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.238 -1.154 . . . . 0.0 109.206 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.4 123.73 20.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.397 1.879 . . . . 0.0 106.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.0 mt -111.51 143.63 42.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.439 HG21 HD22 ' A' ' 51' ' ' LEU . 42.1 t -122.04 126.53 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 119.893 1.224 . . . . 0.0 110.473 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -93.45 2.64 56.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.862 2.065 . . . . 0.0 110.387 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.94 -179.34 38.81 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.86 1.695 . . . . 0.0 112.932 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.5 p -96.18 4.75 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.483 1.913 . . . . 0.0 111.706 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.83 165.87 3.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.134 0.974 . . . . 0.0 112.73 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.07 147.56 33.16 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.965 2.106 . . . . 0.0 109.41 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HD3' HD11 ' A' ' 2' ' ' LEU . 36.5 Cg_endo -66.94 -42.17 8.83 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.933 1.755 . . . . 0.0 112.757 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -59.03 -30.23 67.87 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.329 0.968 . . . . 0.0 111.741 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -23.66 32.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 111.624 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 42' ' ' VAL . 42.9 mt -82.18 -56.46 3.91 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.022 2.129 . . . . 0.0 109.489 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.1 p -50.57 -40.57 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.016 1.326 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -58.66 -43.84 89.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.604 0.362 . . . . 0.0 110.99 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.36 -14.64 57.53 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.7 t -93.75 -43.32 13.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.528 1.131 . . . . 0.0 108.01 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.32 -30.82 71.85 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.306 1.042 . . . . 0.0 111.31 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.62 -9.57 59.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.829 0.852 . . . . 0.0 111.031 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.94 41.79 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 119.181 -0.789 . . . . 0.0 113.524 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -85.93 177.8 7.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.682 1.241 . . . . 0.0 107.817 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -114.69 134.07 55.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.81 158.34 44.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.477 0.581 . . . . 0.0 112.041 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.77 136.29 11.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.611 1.565 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' ALA . 8.7 p -77.76 131.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.056 -1.028 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -101.9 22.68 12.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.438 -0.789 . . . . 0.0 110.343 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.419 1.887 . . . . 0.0 111.203 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 48' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -111.77 136.46 51.01 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.678 1.591 . . . . 0.0 110.888 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.77 159.94 40.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.413 1.085 . . . . 0.0 109.7 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HE2' ' OE1' ' A' ' 7' ' ' GLU . 3.2 ttpm? -127.82 123.18 34.53 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.97 137.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' HE2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -120.05 148.77 43.17 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.88 -12.48 65.77 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 117.783 -1.565 . . . . 0.0 113.54 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.8 mtm -66.11 146.15 55.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.729 2.264 . . . . 0.0 108.24 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.0 p -136.11 -38.04 0.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.2 m -141.68 179.83 6.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.11 1.364 . . . . 0.0 109.401 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -52.99 -36.0 59.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.258 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -52.34 -35.16 50.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.944 0.793 . . . . 0.0 111.068 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -74.57 -55.62 5.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.2 t -49.59 -51.85 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.952 1.301 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.8 ptm -65.64 -37.57 86.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.705 0.802 . . . . 0.0 112.743 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.12 -53.65 50.11 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.4 -48.54 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.58 1.952 . . . . 0.0 108.832 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.4 m -54.01 -61.76 2.09 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.565 1.146 . . . . 0.0 110.389 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.16 -26.69 68.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.99 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.03 -45.13 67.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.476 1.035 . . . . 0.0 109.092 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.87 -32.12 69.17 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HA ' HG11 ' A' ' 28' ' ' VAL . 47.1 mttm -70.12 -13.47 62.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -78.49 -7.45 57.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.898 1.226 . . . . 0.0 111.638 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 28' ' ' VAL . 94.6 t -78.74 127.49 80.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.294 1.438 . . . . 0.0 112.11 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.98 107.05 1.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.856 2.371 . . . . 0.0 111.927 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 -9.71 7.11 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 126.498 1.999 . . . . 0.0 113.342 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.8 p -78.57 146.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.46 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -124.96 -53.6 1.64 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.182 1.793 . . . . 0.0 108.122 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -132.6 147.46 52.35 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.811 0.844 . . . . 0.0 109.426 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.99 155.34 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.644 1.978 . . . . 0.0 106.05 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -145.17 138.2 26.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -135.41 140.8 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -130.77 116.81 18.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.203 1.001 . . . . 0.0 110.657 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 tp -60.2 -54.61 43.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.158 0.583 . . . . 0.0 109.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.95 -38.42 72.92 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -85.36 -17.74 35.86 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.45 25.52 67.04 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -126.86 155.05 43.56 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 118.265 1.032 . . . . 0.0 110.672 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.43 125.74 29.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.091 1.756 . . . . 0.0 106.503 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.67 138.87 49.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.83 146.75 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.82 -12.05 10.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.279 1.032 . . . . 0.0 111.453 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.36 37.48 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.0 p -98.07 8.1 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.448 1.499 . . . . 0.0 111.547 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.72 143.92 11.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.275 1.03 . . . . 0.0 111.594 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.52 149.41 95.56 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.439 ' HB3' HD21 ' A' ' 2' ' ' LEU . 20.2 Cg_endo -61.36 -51.46 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.819 1.679 . . . . 0.0 112.597 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -53.98 -34.94 61.17 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.633 1.173 . . . . 0.0 112.792 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.21 -31.46 60.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.791 0.837 . . . . 0.0 112.805 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -68.89 -50.3 50.81 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.53 -44.61 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -48.99 -49.74 39.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.819 0.848 . . . . 0.0 111.524 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.62 -27.99 69.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.041 -0.981 . . . . 0.0 113.632 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.8 t -88.71 -31.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 120.074 1.307 . . . . 0.0 110.711 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -61.52 -32.8 72.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.08 -0.99 23.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.735 2.414 . . . . 0.0 112.973 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.1 -10.44 17.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.782 1.174 . . . . 0.0 110.569 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.41 24.79 11.78 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.066 -0.852 . . . . 0.0 112.04 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -126.13 161.4 27.73 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.888 1.275 . . . . 0.0 108.019 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -98.74 106.38 18.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.38 155.48 18.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.343 0.519 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -154.15 133.3 12.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.28 1.432 . . . . 0.0 108.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 66' ' ' ALA . 97.0 t -89.46 129.95 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.2 mt -109.89 32.1 5.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.764 1.226 . . . . 0.0 110.945 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.473 ' H ' HG12 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.245 0.833 0 C-N-CA 125.087 1.355 . . . . 0.0 107.368 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -113.67 113.5 25.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.103 1.361 . . . . 0.0 109.364 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -112.79 124.22 52.08 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.281 1.032 . . . . 0.0 109.255 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -90.13 122.11 32.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.86 151.63 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.005 0.922 . . . . 0.0 110.919 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.83 144.88 47.85 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.141 1.776 . . . . 0.0 106.214 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.0 -12.99 49.49 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.793 2.14 . . . . 0.0 111.999 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.0 mtm -74.62 75.28 2.01 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.132 1.466 . . . . 0.0 111.1 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.5 p -80.63 -33.79 35.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.555 -0.716 . . . . 0.0 111.676 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.6 m -118.1 161.43 19.85 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.238 1.415 . . . . 0.0 113.154 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.271 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -64.59 -32.51 74.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.271 1.028 . . . . 0.0 108.773 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 m -72.95 -49.79 27.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -52.02 -48.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.774 1.23 . . . . 0.0 110.765 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.5 ptm -63.72 -36.63 84.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.734 0.697 . . . . 0.0 112.125 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.17 -50.82 59.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.95 -39.65 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.553 1.141 . . . . 0.0 108.761 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.1 m -60.5 -59.24 5.71 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.258 -0.901 . . . . 0.0 108.866 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.18 -35.85 78.25 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.889 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.93 95.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.424 1.09 . . . . 0.0 109.877 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.0 mt -65.13 -33.62 76.45 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.809 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -74.12 6.53 3.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -90.8 -13.02 34.68 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.277 -1.514 . . . . 0.0 108.996 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 28' ' ' VAL . 58.4 t -74.49 132.12 79.06 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.626 1.57 . . . . 0.0 112.629 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.55 109.09 1.98 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.085 1.857 . . . . 0.0 110.879 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.23 -7.64 7.58 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.786 1.66 . . . . 0.0 114.706 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 23' ' ' LYS . 13.9 p -80.17 136.0 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 1.36 . . . . 0.0 112.253 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -97.29 -61.38 1.41 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -145.72 165.82 27.66 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.058 1.343 . . . . 0.0 107.447 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.1 t -145.86 143.36 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -125.05 101.1 6.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 t -100.61 136.92 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 m -119.63 132.62 55.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.745 1.218 . . . . 0.0 109.385 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.2 -68.72 0.27 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.656 1.583 . . . . 0.0 111.431 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.21 -53.42 35.24 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.918 1.687 . . . . 0.0 112.858 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.15 -21.89 64.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.987 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.36 39.54 92.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -132.02 157.84 43.08 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.656 1.182 . . . . 0.0 109.401 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.76 129.57 40.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.262 2.225 . . . . 0.0 107.263 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.24 102.3 10.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -82.27 126.06 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -96.31 -10.24 28.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.308 1.443 . . . . 0.0 113.784 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.88 -173.17 39.32 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -99.8 14.26 30.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.958 1.303 . . . . 0.0 112.248 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 150.83 3.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.212 0.605 . . . . 0.0 110.531 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.77 140.64 58.91 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 123.283 0.633 . . . . 0.0 111.617 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.93 -41.98 56.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.467 2.111 . . . . 0.0 113.219 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -57.66 -36.03 71.35 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.833 1.253 . . . . 0.0 112.529 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.82 -30.78 22.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.788 . . . . 0.0 111.616 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.7 mt -67.79 -55.04 14.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.223 1.009 . . . . 0.0 109.252 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.86 -43.42 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -55.94 -52.61 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.369 1.067 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 -25.94 36.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.76 -40.9 16.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 119.207 0.912 . . . . 0.0 108.648 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.68 -37.15 86.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.384 0.538 . . . . 0.0 109.559 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.51 -19.83 64.0 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.015 0.526 . . . . 0.0 111.369 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -86.52 -5.21 59.21 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.509 -1.369 . . . . 0.0 110.982 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.82 13.15 51.28 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.386 0.993 . . . . 0.0 112.961 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -105.71 -177.74 3.45 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -126.52 137.55 53.38 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.4 35.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 123.684 0.615 . . . . 0.0 110.292 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.5 138.76 14.7 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.188 1.395 . . . . 0.0 108.034 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.05 119.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -81.1 23.28 0.58 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.16 1.784 . . . . 0.0 109.232 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--O 1.234 0.241 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -117.02 130.11 56.46 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.144 1.378 . . . . 0.0 111.714 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.52 164.42 26.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.433 1.493 . . . . 0.0 110.331 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.56 128.31 44.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.57 2.748 . . . . 0.0 105.527 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.77 145.03 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -137.94 109.93 7.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.33 -11.1 2.5 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.476 1.513 . . . . 0.0 115.875 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.5 mtm -72.34 127.44 32.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 121.029 2.414 . . . . 0.0 112.708 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -133.27 -5.85 3.0 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.141 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.1 m -145.63 164.89 30.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.904 1.281 . . . . 0.0 109.912 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.33 -40.9 71.74 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.956 1.303 . . . . 0.0 110.672 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 16' ' ' MET . 3.6 t60 -56.84 -38.3 72.47 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.108 0.563 . . . . 0.0 111.546 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 m -59.92 -47.44 85.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 t -57.09 -49.04 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 109.375 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.412 ' HG2' ' HA ' ' A' ' 13' ' ' HIS . 27.3 ptm -65.83 -39.53 90.91 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.536 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.33 -53.19 60.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.57 1.077 . . . . 0.0 109.283 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -49.57 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 109.382 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.9 m -55.11 -50.1 70.06 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.277 1.031 . . . . 0.0 109.583 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -60.43 -46.76 88.88 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.949 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.32 81.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 123.704 0.628 . . . . 0.0 110.133 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.28 -33.44 75.52 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.254 0.621 . . . . 0.0 110.358 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.621 ' HA ' HG11 ' A' ' 28' ' ' VAL . 59.5 mtpt -76.24 -11.81 59.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.402 -0.808 . . . . 0.0 112.221 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.5 -7.72 56.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.307 1.412 . . . . 0.0 111.488 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 28' ' ' VAL . 58.9 t -73.25 142.38 81.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 112.526 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.74 112.64 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.015 1.81 . . . . 0.0 109.875 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.69 26.92 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.374 1.464 . . . . 0.0 115.67 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.621 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.2 p -77.19 145.42 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 119.6 1.7 . . . . 0.0 109.822 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -120.14 -57.9 1.9 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.557 1.143 . . . . 0.0 109.063 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -133.32 152.59 51.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.57 144.69 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -124.31 99.61 6.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 t -107.47 117.51 53.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -80.15 174.92 11.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.5 tp -122.55 -33.96 3.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -99.2 -32.8 11.04 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.057 0.844 . . . . 0.0 111.228 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -74.36 -17.53 60.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.39 32.97 84.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.647 1.112 . . . . 0.0 112.593 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -133.65 153.31 51.78 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.799 -1.412 . . . . 0.0 107.342 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.35 148.74 50.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.9 mt -140.53 158.46 43.96 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.2 t -134.51 143.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.567 1.147 . . . . 0.0 111.565 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -100.69 -33.8 10.12 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.961 0.904 . . . . 0.0 110.022 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.46 177.28 1.87 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.851 0.738 . . . . 0.0 113.816 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 t -89.06 6.54 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.173 1.389 . . . . 0.0 110.951 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.37 151.99 3.73 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.369 0.668 . . . . 0.0 112.405 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.59 146.17 52.73 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.7 -37.96 53.19 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.409 2.073 . . . . 0.0 113.069 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.34 -48.55 80.19 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.698 0.799 . . . . 0.0 111.262 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.41 -24.89 63.91 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.874 -0.516 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.8 mt -74.21 -55.37 6.13 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.701 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 -44.43 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.708 0.685 . . . . 0.0 109.43 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.24 -51.59 61.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.196 1.798 . . . . 0.0 111.25 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.15 -35.72 71.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.81 -40.7 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 121.198 -0.939 . . . . 0.0 108.929 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -61.51 -33.59 74.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.923 0.889 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.73 -23.43 66.74 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.231 1.012 . . . . 0.0 111.72 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -86.62 3.76 43.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.399 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.54 80.94 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.669 1.604 . . . . 0.0 114.474 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.84 177.32 6.22 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.52 1.66 . . . . 0.0 107.188 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -114.14 133.31 55.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.19 167.82 19.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.079 0.943 . . . . 0.0 111.631 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.49 146.57 16.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.873 1.269 . . . . 0.0 109.787 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.57 141.66 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.07 34.94 3.45 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.521 0.728 . . . . 0.0 111.038 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.423 0 C-N-CA 127.907 2.483 . . . . 0.0 107.219 179.1 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 121.435 0.636 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -127.57 118.3 23.67 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 128.215 2.606 . . . . 0.0 109.489 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.77 152.26 36.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -119.59 122.67 42.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -107.32 150.98 9.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -135.46 160.25 39.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.43 -22.81 25.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.211 -1.327 . . . . 0.0 111.729 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 32.0 mtm -64.19 146.65 53.93 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.626 1.713 . . . . 0.0 107.262 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.2 p -136.91 -22.08 1.22 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.5 p -145.29 177.08 9.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.086 0.946 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -62.49 -31.73 72.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.402 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.49 -39.45 91.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -62.37 -49.93 73.59 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 t -54.44 -56.28 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.506 1.523 . . . . 0.0 110.651 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -34.49 69.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.957 0.799 . . . . 0.0 112.607 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.88 45.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.234 0.925 . . . . 0.0 109.715 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.434 HG21 HG13 ' A' ' 55' ' ' VAL . 2.7 p -60.92 -38.16 78.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.109 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.723 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -56.31 -48.93 75.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -65.2 -34.6 78.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.507 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.83 -41.1 75.41 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 108.454 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.37 -39.1 86.02 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.801 -1.187 . . . . 0.0 110.081 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -65.31 -14.24 60.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -69.24 -27.51 65.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.98 0.809 . . . . 0.0 110.715 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.25 134.21 93.15 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.68 1.192 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.24 108.27 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.255 2.637 . . . . 0.0 110.425 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.03 -2.51 19.32 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-O 119.204 -0.775 . . . . 0.0 113.012 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -86.99 98.23 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 119.254 1.527 . . . . 0.0 110.583 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.17 -44.16 39.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.541 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.38 158.61 41.74 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.56 143.76 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.72 87.42 2.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.993 1.317 . . . . 0.0 107.658 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.74 145.94 6.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -139.83 122.04 15.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.477 1.111 . . . . 0.0 111.239 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.83 -39.75 79.83 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -60.02 -29.5 68.53 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.383 1.473 . . . . 0.0 112.546 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -102.65 -30.5 10.89 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.55 1.14 . . . . 0.0 113.565 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.18 21.75 66.92 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.49 161.91 19.77 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -1.156 . . . . 0.0 111.772 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.97 108.52 7.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.153 2.181 . . . . 0.0 106.548 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.28 151.13 19.8 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.533 HG21 HD22 ' A' ' 51' ' ' LEU . 46.5 t -128.06 124.7 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 119.894 1.224 . . . . 0.0 108.975 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -88.07 -13.61 41.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.49 -176.95 16.13 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.626 1.584 . . . . 0.0 114.198 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.0 t -103.62 -6.67 21.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.634 1.973 . . . . 0.0 113.912 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.33 157.93 0.91 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.745 2.018 . . . . 0.0 115.556 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.26 146.39 58.06 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 123.422 0.689 . . . . 0.0 110.254 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.3 -34.31 55.97 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.75 1.633 . . . . 0.0 113.477 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -61.46 -39.72 91.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.178 1.354 . . . . 0.0 112.114 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.2 78.56 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.533 HD22 HG21 ' A' ' 42' ' ' VAL . 41.9 mt -66.6 -47.13 73.67 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 124.905 1.282 . . . . 0.0 108.842 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.07 -48.27 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -59.8 -27.73 66.83 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.45 87.5 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.073 0.852 . . . . 0.0 110.52 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.434 HG13 HG21 ' A' ' 18' ' ' VAL . 29.4 t -84.02 -44.2 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 125.254 1.422 . . . . 0.0 110.455 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -65.19 -6.57 9.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.309 1.044 . . . . 0.0 111.777 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -107.07 -13.6 15.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.807 1.185 . . . . 0.0 109.482 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -83.89 -10.77 57.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.346 1.459 . . . . 0.0 110.251 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.9 29.11 7.03 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.604 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -136.3 172.36 13.12 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.18 1.49 . . . . 0.0 109.949 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -102.74 142.74 33.39 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.11 141.24 44.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -131.13 116.7 18.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.628 1.571 . . . . 0.0 108.266 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' ALA . 2.4 p -77.09 139.54 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -120.53 45.38 2.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.252 1.216 0 C-N-CA 125.244 1.418 . . . . 0.0 107.555 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.489 0.185 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -136.55 133.62 36.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.696 1.599 . . . . 0.0 109.372 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.475 HD21 HG22 ' A' ' 52' ' ' VAL . 7.0 mt -138.26 149.61 45.89 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 126.213 1.805 . . . . 0.0 107.5 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -110.45 129.14 55.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.07 147.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -137.42 114.48 10.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.553 1.141 . . . . 0.0 108.156 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.29 -10.75 4.11 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.745 1.641 . . . . 0.0 113.887 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.4 mtm -73.42 97.09 2.47 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.689 1.744 . . . . 0.0 107.809 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -115.19 3.36 14.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.682 1.193 . . . . 0.0 111.139 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 m -146.57 152.9 39.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.433 1.493 . . . . 0.0 107.441 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -60.56 -36.19 77.88 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -59.18 -32.64 70.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.397 1.079 . . . . 0.0 110.478 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.4 m -66.46 -39.66 88.94 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -59.73 -59.26 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.2 ptm -57.49 -33.71 68.3 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.943 0.792 . . . . 0.0 112.991 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.24 -53.53 53.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.54 1.064 . . . . 0.0 109.604 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.81 -39.8 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.109 1.363 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m -59.97 -46.02 90.78 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.928 -1.108 . . . . 0.0 108.846 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -44.84 95.94 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 121.819 -0.55 . . . . 0.0 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.43 95.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.4 -33.36 74.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.588 1.085 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.597 ' HA ' HG11 ' A' ' 28' ' ' VAL . 35.6 mttm -76.33 -16.85 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.052 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -76.28 -17.28 59.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.536 1.971 . . . . 0.0 111.733 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 28' ' ' VAL . 86.5 t -62.07 140.0 95.94 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 126.805 2.042 . . . . 0.0 112.711 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.06 108.71 2.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 109.923 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.92 -6.83 9.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.171 1.843 . . . . 0.0 114.728 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.597 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.4 p -80.97 159.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.118 1.459 . . . . 0.0 108.013 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -130.71 -64.62 0.82 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -132.56 159.92 38.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 108.302 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.6 139.09 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -128.45 106.92 9.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.06 154.58 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.747 1.219 . . . . 0.0 111.501 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.6 t -129.61 129.34 44.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.303 1.841 . . . . 0.0 109.563 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.01 -43.22 88.31 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.744 0.817 . . . . 0.0 109.996 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.31 -47.9 46.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -76.98 -20.62 55.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 35.54 92.17 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -128.96 137.47 51.4 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.02 136.78 54.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.283 2.233 . . . . 0.0 108.822 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.45 155.46 38.85 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 51' ' ' LEU . 7.0 t -129.29 122.12 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -81.36 -18.67 44.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.605 1.162 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.32 -168.74 27.62 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.623 1.106 . . . . 0.0 113.189 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -105.96 5.75 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.245 1.418 . . . . 0.0 113.067 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.3 147.79 9.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.647 0.658 . . . . 0.0 110.902 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.74 146.93 83.85 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.01 -39.33 71.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.297 1.998 . . . . 0.0 114.615 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -60.12 -41.99 93.79 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.605 0.639 . . . . 0.0 109.625 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.64 76.53 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.832 -0.542 . . . . 0.0 109.849 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 42' ' ' VAL . 95.9 mt -68.91 -49.37 58.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.041 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 4' ' ' LEU . 53.6 t -55.04 -49.13 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -49.69 -54.39 19.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.466 1.106 . . . . 0.0 109.439 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.18 -34.86 47.07 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 60' ' ' TYR . 15.4 t -79.35 -42.48 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.21 -40.06 88.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.104 1.762 . . . . 0.0 109.191 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.4 -4.19 17.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.167 2.187 . . . . 0.0 111.892 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -110.64 2.21 18.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.723 1.209 . . . . 0.0 109.832 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.98 22.4 57.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.12 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 55' ' ' VAL . 64.3 m-85 -106.89 170.05 8.18 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -109.92 121.16 44.61 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.64 151.73 48.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.707 0.685 . . . . 0.0 109.92 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.91 125.91 15.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.24 153.16 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -111.34 18.83 18.86 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.061 0.945 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.465 1.106 . . . . 0.0 108.76 179.3 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.229 0.538 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -138.93 129.13 25.45 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.739 1.616 . . . . 0.0 108.581 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.522 HD22 ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -125.76 156.3 39.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 127.53 2.332 . . . . 0.0 108.211 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -113.73 136.03 53.29 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.23 137.55 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 125.581 1.553 . . . . 0.0 108.093 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -132.98 128.77 37.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.69 -14.8 7.59 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.133 -1.37 . . . . 0.0 112.377 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 67.1 mtm -73.69 133.45 43.38 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.934 1.867 . . . . 0.0 106.828 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -126.72 -22.88 3.81 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.954 0.343 . . . . 0.0 111.658 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.2 m -139.32 167.69 21.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.749 1.62 . . . . 0.0 108.598 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -57.12 -37.57 72.18 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.093 0.957 . . . . 0.0 113.253 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -58.62 -33.06 69.61 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.2 m -62.97 -35.33 79.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.476 0.58 . . . . 0.0 110.503 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.85 -51.29 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.523 1.529 . . . . 0.0 109.568 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -63.84 -31.94 73.28 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.307 -0.871 . . . . 0.0 111.315 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.97 4.84 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.625 HG21 HG13 ' A' ' 55' ' ' VAL . 5.0 p -58.06 -35.13 51.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 111.764 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 m -56.58 -43.36 79.97 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -66.96 -44.71 79.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.192 -0.942 . . . . 0.0 111.262 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.87 97.53 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.446 0.641 . . . . 0.0 110.701 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -32.68 73.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.437 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -79.86 -4.85 53.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.658 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.37 -23.3 40.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.52 1.509 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.12 126.16 72.69 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 125.475 1.51 . . . . 0.0 111.503 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 110.59 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.705 2.27 . . . . 0.0 106.433 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.04 -1.43 7.81 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.315 1.912 . . . . 0.0 112.07 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.8 t -100.49 138.38 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 119.756 1.778 . . . . 0.0 110.886 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -123.17 -52.47 1.86 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.615 1.566 . . . . 0.0 110.308 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -128.01 149.1 50.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.3 165.81 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 125.275 1.609 . . . . 0.0 108.045 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -152.96 97.44 2.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.374 0.669 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.2 156.4 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.951 -1.093 . . . . 0.0 108.853 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -144.63 135.62 25.01 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.87 0.868 . . . . 0.0 110.291 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.0 tp -66.56 -52.04 49.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.557 0.743 . . . . 0.0 109.838 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -53.99 -65.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.092 2.157 . . . . 0.0 112.187 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -69.35 -17.9 63.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.194 -0.908 . . . . 0.0 112.722 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.89 31.59 68.51 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.263 0.938 . . . . 0.0 111.097 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -122.1 156.98 32.47 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.922 0.889 . . . . 0.0 110.212 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.45 130.88 28.93 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.44 1.896 . . . . 0.0 109.64 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.04 158.05 34.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 51' ' ' LEU . 95.3 t -136.67 142.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.484 1.114 . . . . 0.0 108.866 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -104.17 -17.61 14.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.655 0.782 . . . . 0.0 111.45 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.16 -177.83 21.95 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 t -90.37 2.49 55.53 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.231 -1.158 . . . . 0.0 111.746 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 149.94 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -82.02 148.23 59.93 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 124.684 1.194 . . . . 0.0 111.318 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.27 -41.08 44.7 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.078 1.852 . . . . 0.0 113.202 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -58.46 -40.82 83.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.02 0.528 . . . . 0.0 110.821 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.77 -32.38 67.62 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.024 0.829 . . . . 0.0 110.672 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 42' ' ' VAL . 96.3 mt -67.46 -56.19 10.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.485 1.114 . . . . 0.0 110.004 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.42 ' HB ' HD21 ' A' ' 4' ' ' LEU . 7.8 p -57.35 -42.81 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.877 0.762 . . . . 0.0 109.461 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -57.99 -41.61 83.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.679 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.75 -19.0 47.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.386 0.993 . . . . 0.0 112.57 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.625 HG13 HG21 ' A' ' 18' ' ' VAL . 19.5 t -94.04 -36.88 7.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 108.566 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -67.6 -31.11 70.93 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.71 -17.73 62.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.122 1.769 . . . . 0.0 110.602 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.19 -3.98 49.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.612 1.565 . . . . 0.0 110.258 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.8 10.42 63.06 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 125.185 1.374 . . . . 0.0 114.731 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.48 ' HB2' HG12 ' A' ' 55' ' ' VAL . 91.9 m-85 -98.56 -176.76 3.47 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.498 1.649 . . . . 0.0 108.415 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -122.27 119.37 30.96 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HB1' HD22 ' A' ' 4' ' ' LEU . . . -130.51 161.26 31.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.89 0.768 . . . . 0.0 110.355 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.471 ' C ' HD23 ' A' ' 4' ' ' LEU . 14.6 tt0 -156.86 138.48 14.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.211 1.404 . . . . 0.0 109.196 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.48 133.76 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.9 mt -88.86 24.11 2.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.023 0.929 . . . . 0.0 112.804 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.757 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.011 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.235 0.312 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.25 150.04 52.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.775 0.83 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mt -144.1 155.82 44.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.215 2.206 . . . . 0.0 105.918 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -121.44 118.48 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.15 134.88 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.99 115.13 14.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.39 -6.29 4.25 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.533 2.016 . . . . 0.0 113.173 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 72.2 mtm -77.09 129.37 35.95 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.379 2.09 . . . . 0.0 107.132 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -141.04 16.08 2.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.0 0.818 . . . . 0.0 111.901 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t -156.17 156.92 35.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.616 1.566 . . . . 0.0 108.525 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.34 -35.72 74.38 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.989 0.916 . . . . 0.0 109.543 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -60.49 -36.04 77.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.45 0.7 . . . . 0.0 110.213 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 m -62.08 -47.01 86.56 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.35 -56.02 13.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.754 0.822 . . . . 0.0 110.436 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . 0.261 5.3 ppp? -62.57 -27.48 69.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.619 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.33 -51.29 15.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 108.278 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.21 -40.19 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.4 m -60.02 -45.22 93.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.981 0.913 . . . . 0.0 108.849 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -62.46 -47.0 85.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 121.009 -1.057 . . . . 0.0 111.01 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.83 84.09 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.4 mt -64.7 -39.05 93.0 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.899 -1.126 . . . . 0.0 110.055 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.682 ' HA ' HG11 ' A' ' 28' ' ' VAL . 47.0 mttm -72.82 -14.36 61.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.952 -1.092 . . . . 0.0 113.057 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -13.17 59.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.098 1.317 . . . . 0.0 110.722 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 28' ' ' VAL . 59.4 t -70.01 130.6 89.7 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.749 1.619 . . . . 0.0 111.978 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.4 106.4 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.101 2.534 . . . . 0.0 110.638 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.95 -8.09 6.4 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.316 0.96 . . . . 0.0 115.03 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.682 HG11 ' HA ' ' A' ' 23' ' ' LYS . 10.2 p -75.36 150.17 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.207 1.503 . . . . 0.0 111.242 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.2 -58.48 1.99 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.828 1.651 . . . . 0.0 107.287 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -144.63 155.4 43.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.857 1.263 . . . . 0.0 108.144 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' CG2' ' HE2' ' A' ' 23' ' ' LYS . 2.1 m -138.93 152.65 24.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.949 1.699 . . . . 0.0 109.919 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -138.28 88.97 2.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.722 2.009 . . . . 0.0 109.247 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.87 148.11 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -135.01 116.43 14.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.565 1.146 . . . . 0.0 113.056 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.46 -39.72 92.35 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.636 1.174 . . . . 0.0 110.193 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.98 -54.34 8.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.518 0.727 . . . . 0.0 110.759 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 -21.81 62.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.169 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.2 31.93 82.42 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.32 159.4 40.38 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.454 1.502 . . . . 0.0 107.147 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.63 122.66 12.83 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.57 148.08 28.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.67 123.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.658 0.783 . . . . 0.0 110.062 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 -19.92 27.29 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.58 -172.74 5.05 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.402 1.477 . . . . 0.0 114.44 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.34 8.81 18.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 158.03 15.2 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.908 0.776 . . . . 0.0 109.84 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 145.88 79.03 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 124.259 1.023 . . . . 0.0 111.97 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.23 -35.77 61.31 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.627 1.551 . . . . 0.0 112.941 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -38.5 89.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.056 0.389 . . . . 0.0 110.882 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.36 -38.08 56.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.857 0.463 . . . . 0.0 110.31 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.67 -53.44 58.04 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 125.151 1.38 . . . . 0.0 110.731 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.27 -44.63 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -54.65 -50.28 68.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.731 1.213 . . . . 0.0 113.162 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.82 68.86 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.76 -43.51 86.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.393 0.677 . . . . 0.0 109.353 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.82 -28.85 70.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.103 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -63.8 -35.29 80.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.823 0.738 . . . . 0.0 110.511 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -70.88 -17.29 62.72 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.695 -0.628 . . . . 0.0 109.862 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.34 -6.45 26.69 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 126.062 1.792 . . . . 0.0 114.692 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -77.27 166.41 23.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.943 1.872 . . . . 0.0 110.13 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -97.75 128.62 44.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.22 147.23 50.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.26 142.69 18.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.058 1.343 . . . . 0.0 107.637 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.99 149.91 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.452 1.101 . . . . 0.0 111.424 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -117.87 25.68 10.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.147 1.379 . . . . 0.0 110.213 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.761 2.024 . . . . 0.0 108.961 -179.06 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.071 0.463 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.64 151.58 25.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 mt -147.9 143.55 27.46 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.061 1.345 . . . . 0.0 107.387 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -117.89 111.6 19.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.853 1.261 . . . . 0.0 108.327 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 158.87 3.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.3 134.97 13.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.35 -12.22 36.55 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.01 -1.439 . . . . 0.0 115.312 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.9 mtm -75.64 130.64 39.08 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.64 2.22 . . . . 0.0 108.612 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.29 0.6 OUTLIER -126.31 -1.2 6.98 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -149.77 157.91 43.66 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.1 1.36 . . . . 0.0 108.631 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.93 -28.72 58.12 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -63.94 -23.15 67.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.488 1.04 . . . . 0.0 111.209 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.63 -48.48 59.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.5 t -49.67 -58.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 125.935 1.694 . . . . 0.0 109.892 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.8 ptm -58.84 -26.67 64.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.69 -51.05 20.96 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.38 -41.42 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.888 1.675 . . . . 0.0 108.528 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.0 m -57.86 -59.05 5.84 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.231 0.923 . . . . 0.0 109.366 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -56.32 -39.11 72.25 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.314 0.645 . . . . 0.0 112.588 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.2 78.47 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.096 0.958 . . . . 0.0 108.783 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.03 -26.57 68.62 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.876 -1.765 . . . . 0.0 109.188 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.767 ' HA ' HG11 ' A' ' 28' ' ' VAL . 3.7 mtpm? -82.44 -9.6 59.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.789 0.836 . . . . 0.0 112.141 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.32 -12.26 60.23 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.41 1.005 . . . . 0.0 110.386 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 28' ' ' VAL . 37.8 t -78.16 123.42 86.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 126.755 2.022 . . . . 0.0 111.819 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.31 107.41 2.26 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.677 2.251 . . . . 0.0 110.766 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.16 -18.0 3.78 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.469 1.509 . . . . 0.0 112.166 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.767 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.9 p -72.2 161.76 4.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 120.873 -1.369 . . . . 0.0 109.675 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.78 -66.13 0.73 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -125.42 158.35 34.59 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.675 0.79 . . . . 0.0 110.189 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -150.73 164.11 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.908 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 144.75 26.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 t -144.2 136.77 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -134.01 114.84 13.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 118.362 0.528 . . . . 0.0 112.255 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 tp -56.98 -63.12 1.31 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 112.049 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.47 -28.86 47.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.076 1.35 . . . . 0.0 114.53 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -82.32 -57.66 3.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.074 0.95 . . . . 0.0 109.08 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.43 26.16 7.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.944 1.735 . . . . 0.0 110.209 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -136.29 169.47 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.341 1.571 . . . . 0.0 111.49 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.61 152.58 44.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.439 1.896 . . . . 0.0 108.767 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.43 156.32 43.37 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.964 2.106 . . . . 0.0 108.853 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.1 t -137.63 147.59 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -125.0 -7.99 7.18 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.58 -155.52 23.07 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.385 0.993 . . . . 0.0 113.112 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -106.38 6.36 30.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.515 1.926 . . . . 0.0 111.773 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 148.04 23.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.929 . . . . 0.0 111.121 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.48 146.61 70.24 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.904 1.281 . . . . 0.0 109.131 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.74 -42.3 26.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.206 1.937 . . . . 0.0 112.395 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -57.5 -38.52 74.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.469 0.708 . . . . 0.0 111.341 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.04 52.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.707 0.685 . . . . 0.0 110.846 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.61 -49.13 69.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.87 0.868 . . . . 0.0 109.743 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.27 -49.97 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.151 -0.452 . . . . 0.0 109.963 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -28.28 67.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.606 0.639 . . . . 0.0 112.65 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.45 -34.42 75.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.543 -0.723 . . . . 0.0 110.232 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -78.63 -39.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.94 -31.25 71.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.97 -22.46 67.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.731 0.812 . . . . 0.0 112.222 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -86.05 -4.12 59.1 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.281 1.032 . . . . 0.0 112.574 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.94 38.44 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.781 -1.011 . . . . 0.0 113.702 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.37 166.42 12.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.662 1.231 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -103.52 138.84 39.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.14 49.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.19 137.26 19.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 66' ' ' ALA . 48.3 t -83.17 141.35 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.978 0.911 . . . . 0.0 108.726 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.41 39.87 3.02 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.567 1.147 . . . . 0.0 108.405 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.453 ' H ' HG12 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.248 0.992 0 C-N-CA 125.958 1.703 . . . . 0.0 108.897 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--O 1.235 0.322 0 CA-C-O 119.469 -0.3 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -120.77 136.94 54.75 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 mt -133.75 157.12 46.66 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.731 2.012 . . . . 0.0 109.217 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.0 122.41 44.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.645 1.578 . . . . 0.0 106.968 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -105.38 142.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -136.89 147.43 46.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.13 -19.85 47.42 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.457 1.504 . . . . 0.0 113.126 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.8 mtm -70.44 125.7 27.55 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.863 1.831 . . . . 0.0 111.2 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -129.8 6.1 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.163 0.985 . . . . 0.0 111.608 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.6 t -144.39 146.55 32.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.119 0.968 . . . . 0.0 108.862 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.93 -32.37 71.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.744 0.418 . . . . 0.0 110.727 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -58.59 -30.38 67.16 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.525 -0.734 . . . . 0.0 111.038 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 m -69.5 -40.15 77.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.41 0.684 . . . . 0.0 109.382 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.52 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.246 1.018 . . . . 0.0 108.658 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 ptm -58.84 -35.87 73.62 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.68 -55.36 20.57 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.099 0.863 . . . . 0.0 109.505 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -65.79 -27.29 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.913 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 m -62.12 -42.76 99.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -65.87 -34.54 78.38 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 120.798 -1.189 . . . . 0.0 110.169 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.45 81.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.36 -29.26 68.8 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 110.11 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 28' ' ' VAL . 35.3 mttm -74.13 -10.58 59.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.834 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -81.56 -15.52 54.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.16 1.345 . . . . 0.0 111.024 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.25 128.08 90.58 Favored Pre-proline 0 N--CA 1.44 -0.94 0 C-N-CA 125.204 1.402 . . . . 0.0 112.022 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.6 109.18 1.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.415 2.076 . . . . 0.0 111.631 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.54 15.98 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.523 1.535 . . . . 0.0 113.178 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.4 p -75.62 154.24 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 119.367 1.583 . . . . 0.0 108.471 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -130.92 -57.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -135.28 145.34 47.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.1 m -124.56 153.58 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 127.115 2.166 . . . . 0.0 107.817 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 115.89 5.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 40' ' ' ALA . 2.4 t -130.96 156.77 43.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 118.922 0.783 . . . . 0.0 109.777 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -145.04 137.89 26.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.4 -47.76 54.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.193 0.997 . . . . 0.0 110.049 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.72 -34.11 72.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.412 0.685 . . . . 0.0 112.699 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -92.56 -30.76 15.49 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.565 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.0 94.71 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 106.236 -2.746 . . . . 0.0 106.236 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.61 147.27 48.6 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.97 1.308 . . . . 0.0 108.626 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -127.89 128.65 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.01 2.124 . . . . 0.0 108.117 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.93 150.83 39.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.409 1.484 . . . . 0.0 108.684 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 44' ' ' GLY . 72.7 t -127.51 139.18 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 123.469 0.708 . . . . 0.0 109.555 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -106.42 1.49 25.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.591 1.156 . . . . 0.0 111.537 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.458 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -95.11 -151.37 28.26 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.706 1.622 . . . . 0.0 109.581 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 11.54 8.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.802 1.641 . . . . 0.0 112.578 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.28 149.99 2.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.682 1.193 . . . . 0.0 113.065 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.18 140.22 87.94 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.227 1.011 . . . . 0.0 109.659 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.59 -45.19 11.88 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.439 1.426 . . . . 0.0 110.164 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -57.05 -37.61 72.05 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.449 1.499 . . . . 0.0 112.018 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.86 31.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.386 0.539 . . . . 0.0 110.796 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.84 -51.22 50.93 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.286 -0.884 . . . . 0.0 108.75 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 p -60.08 -37.32 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.99 -50.26 71.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.134 0.974 . . . . 0.0 111.659 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.17 35.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.334 0.97 . . . . 0.0 113.423 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 90.2 t -74.14 -46.75 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.34 1.456 . . . . 0.0 108.618 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.57 -31.06 71.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.338 0.655 . . . . 0.0 110.378 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.56 -33.34 75.69 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -78.5 -17.51 56.15 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.4 -0.813 . . . . 0.0 108.866 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.89 5.95 35.15 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 117.241 -1.866 . . . . 0.0 117.074 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -96.32 160.42 14.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.067 1.933 . . . . 0.0 109.072 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -85.89 137.74 32.53 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.21 140.95 37.92 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.87 134.29 14.37 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.965 1.306 . . . . 0.0 108.608 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.42 131.29 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 127.062 2.145 . . . . 0.0 111.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt -98.82 37.6 1.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.856 1.262 . . . . 0.0 111.148 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.997 1.719 . . . . 0.0 107.957 178.769 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.24 145.8 42.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.475 1.11 . . . . 0.0 109.518 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.19 139.15 28.57 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 108.947 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -105.14 111.16 23.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -88.41 162.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -152.47 122.51 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.24 -10.59 9.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.614 1.578 . . . . 0.0 113.547 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.5 mtm -73.99 122.39 22.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.586 2.193 . . . . 0.0 109.544 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.7 p -121.12 -12.17 8.74 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 m -137.11 165.49 25.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.925 0.89 . . . . 0.0 110.674 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -60.54 -27.74 67.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.449 1.099 . . . . 0.0 109.604 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -42.27 98.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.8 -40.76 96.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.055 0.388 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.68 -53.02 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.5 ptm -64.65 -43.58 93.16 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.893 0.77 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.0 -57.62 10.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.772 0.829 . . . . 0.0 110.177 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 55' ' ' VAL . 2.4 p -60.42 -38.28 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.595 HG22 ' HE2' ' A' ' 23' ' ' LYS . 50.0 m -57.97 -42.27 84.71 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.186 -0.947 . . . . 0.0 110.271 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.54 -43.9 79.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.969 . . . . 0.0 110.593 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.91 85.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 122.807 0.443 . . . . 0.0 110.131 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -62.49 -36.08 81.4 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.242 -1.536 . . . . 0.0 108.376 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.773 ' HA ' HG11 ' A' ' 28' ' ' VAL . 49.1 mttm -69.24 -7.28 35.36 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.742 -1.224 . . . . 0.0 112.381 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -73.15 -17.78 61.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.719 1.6 . . . . 0.0 110.723 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 28' ' ' VAL . 70.4 t -76.13 133.6 71.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.42 108.09 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.871 2.38 . . . . 0.0 112.846 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.46 -17.91 6.48 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.84 1.686 . . . . 0.0 113.174 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.773 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.9 p -62.33 144.34 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.475 1.637 . . . . 0.0 110.873 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -122.77 -54.49 1.84 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.097 0.959 . . . . 0.0 108.502 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -140.41 150.49 43.93 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 t -133.25 142.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.47 96.72 4.5 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 t -108.27 152.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.977 0.911 . . . . 0.0 109.321 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -146.67 138.2 24.44 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.467 0.576 . . . . 0.0 111.013 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.63 -52.21 41.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.466 1.106 . . . . 0.0 110.403 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -58.9 -38.12 78.15 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.699 1.6 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -86.39 -26.4 24.8 Favored 'General case' 0 N--CA 1.458 -0.067 0 O-C-N 121.988 -0.445 . . . . 0.0 110.623 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.43 35.23 88.22 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.47 158.42 43.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.69 135.3 48.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.801 2.04 . . . . 0.0 107.532 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -122.23 146.76 46.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.419 HG21 HD22 ' A' ' 51' ' ' LEU . 48.1 t -132.62 136.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 118.813 0.733 . . . . 0.0 109.444 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.6 -14.54 16.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.8 1.24 . . . . 0.0 111.432 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.83 -175.07 40.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.19 -0.944 . . . . 0.0 113.47 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.0 p -91.63 12.05 22.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.0 2.12 . . . . 0.0 110.236 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.75 149.17 14.95 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.549 -0.72 . . . . 0.0 111.134 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.03 142.97 60.54 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.304 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.0 -47.98 15.97 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.474 2.783 . . . . 0.0 112.799 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -58.73 -38.83 79.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.331 0.514 . . . . 0.0 110.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.22 -29.6 68.47 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.401 -0.812 . . . . 0.0 110.643 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD22 HG21 ' A' ' 42' ' ' VAL . 89.4 mt -65.22 -55.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -58.77 -42.81 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.67 -52.73 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.688 1.195 . . . . 0.0 110.257 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -22.91 60.11 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 18' ' ' VAL . 81.4 t -87.11 -38.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 120.806 -1.184 . . . . 0.0 108.245 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.47 -31.44 68.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.48 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.22 -22.79 67.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.179 0.9 . . . . 0.0 110.559 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.89 -12.49 47.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.978 1.311 . . . . 0.0 110.235 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.44 -3.93 40.18 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.218 1.389 . . . . 0.0 116.04 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -81.73 165.2 21.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.192 1.996 . . . . 0.0 109.641 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.18 114.01 25.67 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.62 156.83 33.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.75 139.36 15.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.959 0.904 . . . . 0.0 109.118 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.7 t -78.91 140.53 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.93 50.87 0.76 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.914 0.885 . . . . 0.0 108.719 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.443 0 C-N-CA 127.168 2.187 . . . . 0.0 108.607 179.239 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptm . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mt -70.6 150.54 45.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.849 0.357 . . . . 0.0 111.262 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -116.18 131.15 57.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.713 1.605 . . . . 0.0 109.866 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -132.63 144.38 50.32 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.549 1.539 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -110.94 115.73 30.0 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.88 142.64 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.53 115.97 13.65 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.581 0.753 . . . . 0.0 109.888 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.62 -17.03 5.31 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.446 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.5 mtm -73.4 107.99 6.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.742 1.771 . . . . 0.0 107.612 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -121.23 16.9 11.51 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.908 -0.495 . . . . 0.0 111.209 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.0 t -151.94 152.46 32.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.63 1.172 . . . . 0.0 108.039 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -61.0 -30.95 70.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.002 0.521 . . . . 0.0 110.014 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.15 -39.24 81.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 110.765 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.4 m -63.68 -53.66 47.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.241 1.016 . . . . 0.0 108.968 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.92 -50.45 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 125.561 1.545 . . . . 0.0 110.839 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.9 ptm -63.49 -40.97 98.49 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.706 1.139 . . . . 0.0 112.355 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.94 79.65 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.29 -39.15 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.758 2.023 . . . . 0.0 110.471 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -55.48 -58.86 6.01 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.49 -41.07 96.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.653 -0.654 . . . . 0.0 111.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -43.13 77.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.029 0.532 . . . . 0.0 111.295 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.87 -36.12 77.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -65.68 -13.13 58.6 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.883 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -75.44 -8.01 55.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.9 1.227 . . . . 0.0 111.368 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.03 134.64 59.51 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 124.143 0.977 . . . . 0.0 111.048 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.14 112.9 2.65 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.719 2.279 . . . . 0.0 107.558 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.93 -3.98 14.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.848 1.69 . . . . 0.0 113.806 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -87.42 139.99 16.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 120.288 2.044 . . . . 0.0 109.486 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -118.75 -59.76 1.83 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.856 1.662 . . . . 0.0 108.815 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -135.76 158.99 43.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 162.75 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -144.5 107.83 4.58 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.24 122.65 68.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.795 0.838 . . . . 0.0 109.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.7 t -84.73 -177.74 6.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.22 1.008 . . . . 0.0 108.804 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.6 tp -132.44 -14.24 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.907 2.083 . . . . 0.0 109.214 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.68 -27.35 7.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.616 1.167 . . . . 0.0 112.281 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -89.97 -15.12 32.62 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 117.641 -1.171 . . . . 0.0 113.625 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.9 35.39 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 119.785 1.175 . . . . 0.0 110.557 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -122.08 154.39 37.39 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.763 1.225 . . . . 0.0 110.64 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.81 79.43 1.62 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.345 1.458 . . . . 0.0 110.255 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.68 145.83 55.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.664 0.786 . . . . 0.0 109.821 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.5 t -128.37 127.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.259 1.423 . . . . 0.0 107.67 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -93.57 -23.15 18.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.522 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.13 176.41 30.39 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.934 0.778 . . . . 0.0 111.601 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -95.5 10.39 36.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.519 1.528 . . . . 0.0 111.939 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.7 4.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.914 -0.491 . . . . 0.0 112.002 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.68 149.39 46.09 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.62 -33.23 46.09 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.202 1.935 . . . . 0.0 113.861 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -61.58 -47.97 83.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.98 69.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.061 0.545 . . . . 0.0 111.544 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.75 -59.0 2.98 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.564 0.746 . . . . 0.0 109.986 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.47 -39.98 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.091 0.957 . . . . 0.0 110.819 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -53.19 -51.33 62.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.26 1.424 . . . . 0.0 109.312 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.49 -26.18 65.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -83.73 -43.15 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 119.651 1.114 . . . . 0.0 108.604 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -60.67 -32.69 71.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.577 1.151 . . . . 0.0 108.663 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.84 -29.14 70.08 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.108 1.363 . . . . 0.0 110.841 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -79.6 -0.68 34.72 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.536 -0.727 . . . . 0.0 110.374 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 11.64 67.6 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.763 1.173 . . . . 0.0 114.563 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -102.98 -178.71 3.75 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.24 1.52 . . . . 0.0 108.104 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -116.42 130.95 57.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 118.167 -0.92 . . . . 0.0 108.627 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.18 159.05 43.03 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.822 0.737 . . . . 0.0 110.25 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.53 144.04 20.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.636 1.174 . . . . 0.0 108.631 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' ALA . 9.9 p -77.99 158.83 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -119.27 21.17 12.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 109.733 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 126.17 1.788 . . . . 0.0 106.374 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ttt . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.46 156.57 22.42 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.503 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -121.52 128.68 52.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.29 145.89 51.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.938 1.695 . . . . 0.0 108.98 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' HD21 ' A' ' 65' ' ' LEU . 24.6 ttmm -109.32 119.06 38.34 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.4 t -109.09 146.46 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -141.57 126.26 17.98 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 126.54 -23.31 5.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.958 1.266 . . . . 0.0 113.015 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.1 mtm -68.03 118.4 11.16 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.261 1.531 . . . . 0.0 108.684 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -119.58 -8.7 9.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.732 0.813 . . . . 0.0 111.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.68 158.16 43.93 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.846 1.258 . . . . 0.0 108.399 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.27 -32.31 62.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 112.204 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -60.42 -34.75 74.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.531 0.605 . . . . 0.0 110.76 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m -69.13 -48.53 62.18 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -54.59 -54.09 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 125.103 1.361 . . . . 0.0 110.526 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ptm -60.86 -29.56 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.767 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.14 48.27 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.9 t -55.42 -46.2 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.854 1.261 . . . . 0.0 108.418 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.3 m -55.38 -53.56 54.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.894 0.878 . . . . 0.0 109.719 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -64.82 -40.52 95.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.073 -1.017 . . . . 0.0 112.613 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.52 98.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.004 0.521 . . . . 0.0 111.191 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.21 -44.02 92.26 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -65.87 -9.46 29.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.404 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -74.96 -24.78 58.51 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 121.428 1.922 . . . . 0.0 110.015 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.07 128.22 91.97 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 123.508 0.723 . . . . 0.0 110.72 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.06 108.25 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.152 2.568 . . . . 0.0 108.377 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.84 -4.48 7.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 124.559 1.076 . . . . 0.0 111.829 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.2 t -91.28 100.58 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 119.601 1.701 . . . . 0.0 110.946 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.25 -56.09 5.06 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.427 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -146.28 160.23 42.29 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -150.0 175.46 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 126.966 2.106 . . . . 0.0 108.918 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -152.46 143.75 23.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.77 126.01 6.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 t -84.2 176.42 8.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.9 tp -117.76 -13.99 10.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.68 1.592 . . . . 0.0 109.903 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -125.63 -39.06 2.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 112.814 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.37 -17.56 64.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.56 42.14 97.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -141.67 129.17 21.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.212 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.13 144.98 48.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 106.185 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.57 156.19 48.91 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 51' ' ' LEU . 16.5 t -128.12 142.26 44.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.559 1.144 . . . . 0.0 108.406 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -125.01 42.34 3.3 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.296 1.838 . . . . 0.0 110.142 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.4 -167.23 12.07 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.464 1.506 . . . . 0.0 112.796 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -104.53 3.37 31.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.457 1.903 . . . . 0.0 111.993 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.94 169.06 1.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.947 -1.095 . . . . 0.0 113.518 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.33 148.73 35.56 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.834 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -58.21 -34.49 98.61 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.472 2.115 . . . . 0.0 113.78 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -69.68 -52.65 23.73 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.165 0.986 . . . . 0.0 111.429 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.05 66.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 42' ' ' VAL . 67.3 mt -67.86 -60.65 2.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.365 1.466 . . . . 0.0 111.302 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -55.52 -44.93 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -57.62 -39.9 77.97 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.552 0.741 . . . . 0.0 111.366 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.71 -28.15 68.85 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.208 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.33 -37.18 15.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 108.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.0 -33.29 75.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.58 -12.47 61.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.878 1.271 . . . . 0.0 111.816 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -90.4 -9.79 46.27 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.31 1.414 . . . . 0.0 109.031 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.96 15.09 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.728 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -114.99 -179.37 3.61 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.618 1.709 . . . . 0.0 108.683 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -118.68 127.84 53.95 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.34 157.91 45.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.746 0.703 . . . . 0.0 111.37 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.03 135.16 13.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.535 1.534 . . . . 0.0 108.592 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 66' ' ' ALA . 7.1 p -77.97 147.81 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.885 0.766 . . . . 0.0 110.759 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.414 HD21 ' HE2' ' A' ' 5' ' ' LYS . 84.8 mt -123.77 20.21 9.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.678 2.391 . . . . 0.0 111.009 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.459 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.244 0.814 0 C-N-CA 124.565 1.146 . . . . 0.0 108.283 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 119.122 -0.466 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mt -88.92 151.14 22.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.186 0.448 . . . . 0.0 110.987 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.57 ' HE3' HD21 ' A' ' 41' ' ' LEU . 25.1 mtpt -115.54 134.88 54.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.781 1.232 . . . . 0.0 108.499 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mt -128.3 132.04 48.66 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.493 1.517 . . . . 0.0 108.373 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -92.0 117.55 29.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.56 159.73 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -143.65 148.92 36.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.42 63.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.488 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.0 mtm -73.82 109.4 7.29 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.582 2.191 . . . . 0.0 106.23 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.2 p -123.31 -6.13 8.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -150.02 162.62 40.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.108 -0.995 . . . . 0.0 108.792 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.38 -37.43 67.55 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.692 1.597 . . . . 0.0 111.262 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -64.89 -38.8 92.19 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 m -60.5 -46.52 89.82 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.22 -58.57 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptm -59.16 -37.52 77.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.59 69.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.513 0.597 . . . . 0.0 109.562 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.43 -44.04 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -52.64 -58.96 5.12 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 120.954 -1.091 . . . . 0.0 109.626 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.45 -36.96 81.85 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 112.702 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.61 67.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.0 0.92 . . . . 0.0 109.881 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.26 -46.18 15.16 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -24.01 39.75 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.095 1.358 . . . . 0.0 114.434 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -64.77 -24.1 67.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.75 1.159 . . . . 0.0 111.036 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.03 127.73 88.23 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 118.944 0.793 . . . . 0.0 110.585 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.62 110.75 2.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.594 2.196 . . . . 0.0 107.764 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 -9.86 6.91 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.993 1.759 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.0 t -88.75 104.01 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 118.4 1.1 . . . . 0.0 109.823 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.76 -64.69 0.82 Allowed 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -146.62 166.96 24.98 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.15 156.51 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.71 110.96 8.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.4 t -113.28 134.02 57.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.073 0.949 . . . . 0.0 109.01 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 t -114.78 125.77 54.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.792 1.237 . . . . 0.0 109.812 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.22 -37.56 80.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.49 0.716 . . . . 0.0 110.7 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.35 -54.43 9.46 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.03 0.532 . . . . 0.0 110.251 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.87 -28.17 68.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.205 0.912 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.94 26.59 74.56 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.61 164.59 16.27 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.965 1.306 . . . . 0.0 109.68 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.12 31.03 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.999 1.72 . . . . 0.0 108.14 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.57 HD21 ' HE3' ' A' ' 3' ' ' LYS . 3.3 mm? -108.13 136.16 48.28 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 1' ' ' MET . 95.0 t -121.55 125.53 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.0 -9.6 52.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.252 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.15 -166.07 4.49 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.901 1.238 . . . . 0.0 114.154 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -124.31 8.42 8.47 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.806 1.642 . . . . 0.0 111.176 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.25 158.71 16.53 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.273 1.029 . . . . 0.0 109.768 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 148.87 90.36 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 125.557 1.543 . . . . 0.0 110.06 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.51 -30.43 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.228 1.286 . . . . 0.0 111.585 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -63.76 -56.49 15.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.818 1.247 . . . . 0.0 108.251 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.22 67.35 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.29 -55.32 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.855 1.262 . . . . 0.0 111.211 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.13 -43.94 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.399 1.0 . . . . 0.0 111.39 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -46.46 82.89 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.831 1.252 . . . . 0.0 108.264 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -23.01 60.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.241 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.06 -42.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.345 1.43 . . . . 0.0 109.71 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.59 -26.91 68.84 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.52 -15.94 63.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.428 1.891 . . . . 0.0 113.156 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -97.7 -6.09 33.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.665 1.12 . . . . 0.0 109.055 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.87 6.86 53.9 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.317 0.96 . . . . 0.0 112.624 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -95.48 -170.47 2.17 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -132.19 134.04 44.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.37 167.55 21.65 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 118.329 0.513 . . . . 0.0 111.422 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -159.57 130.86 6.05 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 124.811 1.244 . . . . 0.0 108.687 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 66' ' ' ALA . 1.8 p -74.9 130.98 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.09 16.25 18.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.082 0.953 . . . . 0.0 112.638 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.588 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.537 1.535 . . . . 0.0 110.61 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttp . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mt -103.74 -159.53 0.72 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 128.524 2.73 . . . . 0.0 110.14 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -159.13 131.58 6.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mt -138.23 160.06 40.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.15 1.38 . . . . 0.0 109.309 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -126.98 145.91 50.53 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.5 141.04 44.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 127.391 2.277 . . . . 0.0 109.5 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.84 114.2 10.24 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.116 1.366 . . . . 0.0 108.237 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.62 -6.62 5.23 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.911 1.72 . . . . 0.0 115.0 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -68.28 155.02 40.58 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.88 2.34 . . . . 0.0 109.816 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -137.15 -41.43 0.58 Allowed 'General case' 0 C--N 1.339 0.12 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 m -136.73 169.15 18.2 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 124.581 1.152 . . . . 0.0 109.699 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -49.55 -43.09 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.514 1.525 . . . . 0.0 111.698 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -58.75 -37.76 76.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.106 0.563 . . . . 0.0 111.67 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.99 -39.81 94.03 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.01 -58.81 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 109.449 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -53.33 -37.06 61.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.94 -55.15 38.65 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.911 0.862 . . . . 0.0 108.797 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.09 -40.84 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.396 1.078 . . . . 0.0 110.021 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.4 m -55.69 -46.0 77.72 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.986 1.267 . . . . 0.0 108.12 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -67.81 -36.36 80.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.206 -0.934 . . . . 0.0 111.315 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.01 73.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.774 0.715 . . . . 0.0 111.385 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mt -61.24 -39.45 90.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.657 1.117 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -67.42 -9.65 43.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.882 0.873 . . . . 0.0 112.834 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.31 -29.09 66.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.021 1.282 . . . . 0.0 109.544 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -58.89 129.52 85.57 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.231 1.413 . . . . 0.0 112.796 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.83 117.34 4.82 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 122.445 2.097 . . . . 0.0 107.66 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.82 -14.43 12.79 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 126.423 1.963 . . . . 0.0 112.613 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.3 140.89 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-N 119.335 1.567 . . . . 0.0 107.757 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -121.49 -54.88 1.96 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.248 1.019 . . . . 0.0 108.49 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -137.27 153.97 50.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -140.92 168.76 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.199 0.937 . . . . 0.0 111.033 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.92 138.66 34.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.652 2.381 . . . . 0.0 104.631 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -151.65 136.53 10.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -137.19 129.55 29.74 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.682 0.674 . . . . 0.0 110.369 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -66.47 -48.82 68.65 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.663 1.185 . . . . 0.0 109.81 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -61.3 -35.18 76.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -84.27 -29.92 26.05 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.283 0.633 . . . . 0.0 111.941 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.56 33.39 71.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.85 169.52 17.62 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.042 1.421 . . . . 0.0 112.787 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.33 140.25 33.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.931 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.8 149.6 47.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.416 1.886 . . . . 0.0 106.899 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -131.18 133.66 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.79 2.036 . . . . 0.0 108.243 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -100.22 -3.97 30.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.742 0.817 . . . . 0.0 111.669 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.19 -170.67 46.49 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.294 0.949 . . . . 0.0 113.296 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 t -101.08 3.82 41.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.957 1.703 . . . . 0.0 111.483 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.55 153.84 9.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.004 0.922 . . . . 0.0 112.849 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 150.64 61.02 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.102 0.561 . . . . 0.0 110.578 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.58 -40.85 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.483 2.122 . . . . 0.0 113.009 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -55.68 -47.22 77.14 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.625 0.77 . . . . 0.0 110.714 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.57 79.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.262 0.625 . . . . 0.0 111.623 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.6 mt -67.24 -52.52 40.02 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 123.839 0.856 . . . . 0.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 p -60.52 -40.51 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.12 -45.66 86.93 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.051 0.941 . . . . 0.0 109.929 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -85.96 -33.21 7.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.92 -32.74 74.59 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.34 -29.23 69.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.715 1.206 . . . . 0.0 109.782 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -78.33 -7.4 57.22 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.85 25.33 41.85 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.681 1.61 . . . . 0.0 113.475 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.45 177.88 4.66 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -115.22 98.33 6.71 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.717 0.807 . . . . 0.0 109.685 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.0 161.53 13.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.688 -0.632 . . . . 0.0 110.747 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -151.36 138.76 19.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.155 0.982 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.9 t -78.06 138.72 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.38 9.65 18.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.054 0.942 . . . . 0.0 111.561 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.661 1.585 . . . . 0.0 108.722 179.319 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 ttm . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.418 HD11 ' HD3' ' A' ' 48' ' ' PRO . 6.0 mt -132.33 149.69 52.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.87 130.37 56.8 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 108.713 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.06 151.68 51.62 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 125.37 1.468 . . . . 0.0 107.315 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -118.52 120.86 38.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.42 138.89 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -137.05 102.95 4.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.86 -8.56 1.76 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.801 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.5 mtm -75.38 130.35 38.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.5 t -136.15 14.33 3.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.263 0.483 . . . . 0.0 111.753 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 t -160.93 165.27 30.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.938 -1.101 . . . . 0.0 109.646 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -61.28 -33.22 73.2 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.365 1.066 . . . . 0.0 110.973 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.27 -25.57 63.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.983 0.513 . . . . 0.0 111.656 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -71.67 -47.01 57.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -55.46 -56.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.66 0.784 . . . . 0.0 109.54 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.2 ptm -58.54 -34.13 70.66 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.66 -51.1 66.6 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.37 -39.06 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.616 1.167 . . . . 0.0 109.4 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.1 m -57.05 -50.26 73.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.292 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -69.87 -37.78 76.18 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.656 -1.278 . . . . 0.0 111.468 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.37 78.83 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.439 1.095 . . . . 0.0 108.669 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.76 -41.17 60.58 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.927 -1.108 . . . . 0.0 109.276 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -64.78 -16.54 63.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -13.76 60.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.74 1.609 . . . . 0.0 110.987 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.54 130.14 89.34 Favored Pre-proline 0 N--CA 1.452 -0.351 0 C-N-CA 124.581 1.153 . . . . 0.0 110.623 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.56 111.51 2.13 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 106.073 -2.318 . . . . 0.0 106.073 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.95 -3.9 9.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.758 1.647 . . . . 0.0 112.318 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.05 138.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.587 2.193 . . . . 0.0 109.076 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.52 -51.9 1.72 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.565 1.546 . . . . 0.0 111.451 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -139.47 153.58 47.56 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 m -147.4 166.28 5.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.24 94.17 2.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.342 1.057 . . . . 0.0 109.993 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.17 134.01 38.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.639 1.176 . . . . 0.0 108.609 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -131.6 134.53 46.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.073 0.949 . . . . 0.0 109.902 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.3 tp -76.99 -42.07 40.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.81 -53.03 62.8 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.844 0.857 . . . . 0.0 110.183 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -14.92 55.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.839 -1.076 . . . . 0.0 113.395 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 55.16 29.71 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.4 170.06 18.15 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.849 -0.795 . . . . 0.0 110.577 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.9 95.26 2.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.668 1.187 . . . . 0.0 113.312 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.46 152.82 40.61 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.891 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.19 135.89 60.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.269 1.428 . . . . 0.0 108.249 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -103.65 -19.26 14.4 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.738 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.73 -172.1 28.6 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.3 p -103.53 8.78 37.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.649 1.179 . . . . 0.0 112.425 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.18 155.1 7.01 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.479 0.711 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 151.25 65.5 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 122.859 0.464 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' HD11 ' A' ' 2' ' ' LEU . 22.8 Cg_endo -63.14 -40.16 34.93 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.989 1.792 . . . . 0.0 114.91 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.567 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -59.05 -45.33 91.04 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.411 0.684 . . . . 0.0 110.095 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.39 -32.02 72.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.275 -0.265 . . . . 0.0 111.47 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.1 mt -69.42 -57.68 4.96 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.261 1.024 . . . . 0.0 109.981 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.49 -40.49 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.48 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -53.37 -51.97 60.79 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.925 0.89 . . . . 0.0 110.127 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -28.26 65.03 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.6 -39.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -60.77 -39.47 88.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.84 -21.84 66.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 0.0 112.279 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -86.27 -9.41 56.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.223 0.919 . . . . 0.0 110.468 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.97 21.45 18.27 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.657 -1.079 . . . . 0.0 114.229 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.93 179.55 4.08 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.415 1.608 . . . . 0.0 108.048 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -120.57 109.48 15.31 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.24 165.64 12.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 118.902 0.774 . . . . 0.0 110.353 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -157.91 132.63 8.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.877 -0.514 . . . . 0.0 111.339 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.78 147.86 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.46 33.83 4.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.29 1.036 . . . . 0.0 110.177 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.569 2.348 . . . . 0.0 107.028 179.26 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 2.2 tmt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mt -120.35 164.45 16.31 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.535 1.134 . . . . 0.0 109.218 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -132.26 123.66 27.38 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.448 HD21 ' HB ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -126.57 133.11 51.16 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.711 0.804 . . . . 0.0 109.436 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -88.19 121.27 30.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.28 150.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -142.48 120.49 12.08 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.77 -10.71 9.61 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.05 1.31 . . . . 0.0 115.141 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.2 mtm -74.92 111.88 10.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 120.052 1.926 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.67 11.42 9.14 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.533 0.733 . . . . 0.0 111.797 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.0 t -151.24 151.86 32.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -60.76 -27.96 68.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.902 0.481 . . . . 0.0 110.599 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -63.26 -32.5 73.93 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.844 0.747 . . . . 0.0 110.4 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -64.89 -47.74 76.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -57.17 -57.03 11.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.296 1.038 . . . . 0.0 110.057 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ptm -63.78 -36.46 83.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.95 -49.51 65.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.491 1.041 . . . . 0.0 108.582 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.46 -32.11 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.905 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -57.12 -43.74 82.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -67.52 -47.26 70.46 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.163 -0.96 . . . . 0.0 109.954 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.38 -46.66 69.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.525 0.73 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.88 -38.09 86.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.786 1.234 . . . . 0.0 109.511 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -76.77 -6.99 54.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 117.322 -1.323 . . . . 0.0 111.167 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.73 -27.66 63.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.207 1.821 . . . . 0.0 107.669 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.67 120.69 47.7 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 125.018 1.327 . . . . 0.0 107.75 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.3 101.49 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.48 2.787 . . . . 0.0 109.456 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.88 -7.4 1.91 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.858 1.694 . . . . 0.0 111.801 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.56 141.12 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 120.495 -1.591 . . . . 0.0 111.074 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.79 -59.44 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.011 1.324 . . . . 0.0 107.743 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -135.68 157.27 47.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.849 1.259 . . . . 0.0 108.711 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 t -142.33 145.43 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.37 77.02 1.45 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.611 1.964 . . . . 0.0 109.742 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.3 t -85.89 143.05 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -141.61 133.47 27.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.24 1.016 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.59 -64.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.788 1.635 . . . . 0.0 112.373 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.03 -30.2 71.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.202 2.201 . . . . 0.0 114.924 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -81.91 -15.25 54.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.775 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.82 35.77 83.9 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -139.44 166.78 23.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 122.406 1.098 . . . . 0.0 112.273 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -145.82 129.3 16.94 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.281 2.633 . . . . 0.0 105.67 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mt -121.16 154.45 36.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 1' ' ' MET . 53.3 t -129.39 152.77 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.653 1.216 . . . . 0.0 111.326 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -135.2 111.38 9.63 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 100.909 -3.737 . . . . 0.0 100.909 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.71 -177.49 37.95 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 p -94.61 -0.65 54.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 111.535 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 144.94 54.05 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 111.909 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -80.82 149.27 67.01 Favored Pre-proline 0 N--CA 1.465 0.309 0 C-N-CA 125.454 1.501 . . . . 0.0 110.218 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.57 -38.57 81.58 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.519 2.146 . . . . 0.0 116.145 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -63.35 -46.77 85.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 110.477 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.23 65.68 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.74 -56.45 6.36 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.764 0.826 . . . . 0.0 110.094 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.448 ' HB ' HD21 ' A' ' 4' ' ' LEU . 1.4 p -57.02 -45.11 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.736 0.698 . . . . 0.0 109.579 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.84 -47.79 60.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 111.288 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.18 66.49 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -88.99 -35.64 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -63.85 -33.89 76.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.45 -25.7 68.12 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.68 0.792 . . . . 0.0 111.019 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.04 -4.19 56.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.038 0.836 . . . . 0.0 110.603 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.58 19.11 35.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.806 1.185 . . . . 0.0 114.137 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -113.32 177.24 4.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.961 1.381 . . . . 0.0 108.944 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -116.01 116.46 27.94 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.23 154.49 38.7 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -153.72 138.28 16.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.587 1.155 . . . . 0.0 108.966 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.87 140.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.446 -0.784 . . . . 0.0 111.13 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -98.94 19.36 15.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.735 1.214 . . . . 0.0 110.82 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.893 2.077 . . . . 0.0 105.473 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 11.3 ttt . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.01 167.73 20.68 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.944 1.297 . . . . 0.0 108.418 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -123.74 159.41 29.5 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 108.019 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mt -157.05 131.8 8.78 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -99.57 122.5 42.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.68 144.4 22.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -135.59 125.28 25.35 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.43 -15.95 8.05 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.298 -1.279 . . . . 0.0 114.221 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 69.6 mtm -65.2 131.97 47.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.401 2.1 . . . . 0.0 106.944 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -134.45 -21.85 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.3 m -135.45 167.62 20.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.47 1.032 . . . . 0.0 109.137 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.4 -36.66 64.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.411 1.485 . . . . 0.0 109.11 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -59.32 -44.3 92.58 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.853 1.661 . . . . 0.0 110.195 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 m -59.77 -43.98 94.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.32 -53.85 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.021 0.529 . . . . 0.0 110.101 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ptm -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.104 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.29 -59.92 4.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.967 0.803 . . . . 0.0 108.879 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.16 -38.74 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.534 0.734 . . . . 0.0 109.994 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -58.66 -52.87 63.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.076 -1.64 . . . . 0.0 109.161 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -61.6 -43.84 98.12 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 121.623 -0.673 . . . . 0.0 112.33 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.27 86.07 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.681 0.613 . . . . 0.0 110.793 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.57 -39.46 93.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 0.0 109.497 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -67.05 -11.79 58.1 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.14 -17.93 60.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.883 1.219 . . . . 0.0 110.082 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.64 133.95 95.27 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 124.575 1.15 . . . . 0.0 111.616 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.66 115.99 4.2 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.218 1.945 . . . . 0.0 107.553 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.56 26.8 Favored Glycine 0 C--N 1.318 -0.457 0 C-N-CA 126.537 2.018 . . . . 0.0 113.627 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -80.98 131.13 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 120.755 2.278 . . . . 0.0 107.428 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -104.35 -62.41 1.32 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -136.06 158.18 45.04 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.986 0.915 . . . . 0.0 108.546 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.23 154.46 20.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 126.035 1.734 . . . . 0.0 107.525 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -145.29 112.15 5.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.18 149.8 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.821 0.849 . . . . 0.0 110.349 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -126.96 135.41 50.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.104 1.362 . . . . 0.0 109.033 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 tp -84.45 -21.09 30.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.362 0.665 . . . . 0.0 110.65 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -84.3 -38.29 20.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.313 1.045 . . . . 0.0 111.967 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -98.86 -13.06 20.24 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.6 33.33 81.55 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 120.043 1.292 . . . . 0.0 111.382 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -119.31 148.84 42.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.233 1.013 . . . . 0.0 108.568 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.19 98.73 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 109.214 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.7 mm? -83.99 147.41 27.46 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.5 t -122.46 151.01 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 125.011 1.324 . . . . 0.0 107.456 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.75 -9.73 7.28 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.26 -168.1 41.19 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.07 0.85 . . . . 0.0 114.458 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.1 p -100.2 9.48 42.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.206 1.403 . . . . 0.0 111.203 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.5 155.5 18.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.54 0.736 . . . . 0.0 111.749 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.83 149.41 50.8 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.513 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.4 -37.46 17.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 112.291 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.79 -36.56 67.53 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.26 0.624 . . . . 0.0 111.676 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.88 26.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.115 0.966 . . . . 0.0 112.175 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 mt -63.91 -53.35 51.76 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.296 1.038 . . . . 0.0 109.77 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.38 -39.96 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.538 0.608 . . . . 0.0 110.156 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -47.35 77.74 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.174 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.19 -18.8 50.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.81 -39.57 10.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 119.809 1.186 . . . . 0.0 108.838 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -66.78 -32.39 73.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.27 -13.16 62.06 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.982 0.81 . . . . 0.0 109.838 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.66 -6.6 45.99 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.445 -1.409 . . . . 0.0 108.926 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.15 2.42 71.16 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 128.215 2.817 . . . . 0.0 114.952 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -88.39 159.95 17.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 118.92 1.36 . . . . 0.0 107.651 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -98.07 118.26 34.26 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.23 162.98 24.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.524 0.602 . . . . 0.0 110.626 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -163.35 145.93 10.07 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.167 1.387 . . . . 0.0 109.105 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.49 150.94 5.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.5 mt -110.68 9.68 22.83 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.243 1.017 . . . . 0.0 110.995 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.644 1.578 . . . . 0.0 107.247 179.476 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.32 165.68 11.32 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.151 0.98 . . . . 0.0 110.547 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -137.03 143.98 42.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.38 157.93 44.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.328 2.651 . . . . 0.0 108.026 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -123.87 122.45 38.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 127.499 2.32 . . . . 0.0 105.485 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.26 145.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 125.766 1.626 . . . . 0.0 108.368 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.66 130.11 33.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.55 -11.08 12.52 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.248 -1.307 . . . . 0.0 112.343 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.7 mtm -71.75 138.01 48.14 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.345 2.073 . . . . 0.0 108.269 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.8 p -135.17 -15.27 1.97 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.91 177.14 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 109.556 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -62.08 -31.58 72.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.831 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -60.18 -35.71 75.99 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.472 1.033 . . . . 0.0 109.062 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.8 m -65.61 -47.76 74.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -55.9 -54.49 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.604 0.762 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -37.94 88.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.729 1.149 . . . . 0.0 111.58 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.61 -51.15 64.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.794 0.725 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.2 t -61.22 -40.76 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.677 1.191 . . . . 0.0 108.608 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.2 m -58.01 -61.11 2.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.58 -33.4 69.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.331 0.968 . . . . 0.0 112.951 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.71 95.97 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.93 -36.74 70.03 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.91 -1.119 . . . . 0.0 108.361 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -64.75 -33.52 76.16 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.759 -1.213 . . . . 0.0 114.166 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.27 -20.37 64.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.839 1.2 . . . . 0.0 113.15 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 128.41 89.81 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.51 102.74 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.217 2.612 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.12 -10.2 4.16 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.45 1.024 . . . . 0.0 111.574 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.41 132.1 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 118.464 1.132 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -104.54 -56.48 2.18 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.877 1.671 . . . . 0.0 108.556 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -138.74 159.87 41.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.569 1.148 . . . . 0.0 108.2 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 42' ' ' VAL . 47.7 t -140.44 159.57 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -135.68 122.75 21.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.68 159.77 41.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 119.429 1.013 . . . . 0.0 109.539 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -141.24 126.93 19.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.15 1.38 . . . . 0.0 109.086 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.21 -52.41 41.42 Favored 'General case' 0 N--CA 1.46 0.061 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -60.01 -56.61 19.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.237 1.015 . . . . 0.0 112.303 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -72.44 -28.07 62.72 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.203 0.456 . . . . 0.0 111.896 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.66 80.87 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -89.55 150.99 22.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.947 1.373 . . . . 0.0 108.242 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.09 139.16 39.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.95 156.17 49.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.611 HG21 HD22 ' A' ' 51' ' ' LEU . 12.8 t -128.27 144.22 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.438 1.095 . . . . 0.0 109.3 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -110.19 -4.02 15.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.33 -172.52 47.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.426 -0.796 . . . . 0.0 112.121 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -97.57 6.16 48.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.145 1.778 . . . . 0.0 110.892 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.57 167.98 4.01 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.74 1.216 . . . . 0.0 111.165 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -99.21 153.1 37.95 Favored Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 124.28 1.032 . . . . 0.0 112.877 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.25 -48.08 15.04 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.218 2.612 . . . . 0.0 113.91 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -61.18 -44.07 97.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 -178.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -31.81 72.43 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.873 -0.517 . . . . 0.0 111.888 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 42' ' ' VAL . 40.8 mt -73.11 -50.43 22.83 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.092 0.957 . . . . 0.0 110.76 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -60.19 -41.36 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.11 -56.1 16.58 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.415 1.486 . . . . 0.0 110.367 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.59 64.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.0 t -81.08 -34.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 119.275 0.943 . . . . 0.0 110.267 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.95 -26.97 68.53 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -66.33 -15.85 63.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.167 -0.958 . . . . 0.0 111.166 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -98.26 3.16 48.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.356 1.463 . . . . 0.0 111.338 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.53 85.66 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.996 0.816 . . . . 0.0 113.889 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.59 161.52 14.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -109.4 114.46 28.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.42 154.65 33.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.282 0.563 . . . . 0.0 111.523 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.86 133.93 17.1 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.3 150.74 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.245 1.418 . . . . 0.0 109.704 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.61 61.46 1.56 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.185 1.394 . . . . 0.0 109.676 -179.035 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tmm? . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt -115.13 142.22 46.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.405 1.482 . . . . 0.0 109.645 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -108.35 146.88 32.34 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.729 0.695 . . . . 0.0 110.71 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -139.0 156.18 47.42 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.443 1.497 . . . . 0.0 107.782 178.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -120.14 136.58 54.56 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -127.11 151.61 34.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 124.744 1.218 . . . . 0.0 107.955 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -141.69 145.91 35.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.86 -21.06 41.63 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.863 1.221 . . . . 0.0 112.781 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.5 mtm -66.7 122.56 17.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -125.79 -12.68 6.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.47 165.23 28.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.286 -0.884 . . . . 0.0 110.826 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -60.46 -34.25 73.74 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -62.73 -27.71 69.46 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.229 0.612 . . . . 0.0 110.716 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.93 -48.15 22.4 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.8 t -54.1 -57.3 6.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 123.784 0.834 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.2 ptm -55.36 -32.24 62.4 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.76 -54.42 31.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -63.49 -39.53 85.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.368 0.667 . . . . 0.0 109.794 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -56.17 -46.91 79.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.892 1.224 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -66.84 -43.69 83.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.127 -0.358 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.5 81.07 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.533 0.733 . . . . 0.0 110.1 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.59 -38.1 70.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.977 -1.077 . . . . 0.0 109.048 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -67.22 -30.63 70.61 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.696 -1.253 . . . . 0.0 114.299 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -65.66 -22.94 66.69 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.997 1.271 . . . . 0.0 110.186 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.2 t -56.87 130.3 78.57 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.52 110.48 1.63 Allowed 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.221 1.947 . . . . 0.0 110.532 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.55 19.56 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.224 1.392 . . . . 0.0 113.684 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -88.28 106.94 17.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 119.661 1.73 . . . . 0.0 111.912 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -81.51 -45.0 16.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.503 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -149.29 163.27 38.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.28 138.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -122.46 79.51 1.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 t -85.71 145.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.95 1.3 . . . . 0.0 109.184 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -134.97 131.81 37.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.845 1.258 . . . . 0.0 108.699 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.8 tp -68.94 -59.93 2.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.569 1.147 . . . . 0.0 109.318 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.17 -43.32 78.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.512 1.125 . . . . 0.0 111.969 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -81.97 -18.03 44.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 117.946 -1.026 . . . . 0.0 113.575 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.81 70.32 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -135.66 154.17 51.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.341 -1.093 . . . . 0.0 109.499 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.92 149.68 47.74 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.001 1.32 . . . . 0.0 109.96 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.84 129.62 40.66 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.28 118.82 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.705 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -82.14 -16.88 48.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.833 0.853 . . . . 0.0 111.026 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.76 177.28 31.03 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.341 0.972 . . . . 0.0 112.466 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 p -95.61 0.2 52.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.949 0.9 . . . . 0.0 113.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.06 148.66 0.8 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.596 1.958 . . . . 0.0 114.642 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -71.87 137.15 82.47 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -59.36 -41.07 61.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.248 1.966 . . . . 0.0 112.554 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -59.81 -32.8 70.98 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.633 1.173 . . . . 0.0 112.198 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -34.71 41.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.084 0.553 . . . . 0.0 110.15 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.14 -56.52 16.08 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.802 0.841 . . . . 0.0 109.252 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.03 -41.62 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.635 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -58.14 -45.13 87.91 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.721 0.691 . . . . 0.0 110.265 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.66 66.2 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.8 -38.6 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.373 -1.455 . . . . 0.0 108.163 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.73 -34.31 77.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.911 0.884 . . . . 0.0 110.576 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.74 -22.5 65.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.182 0.901 . . . . 0.0 110.733 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -85.01 0.75 50.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.33 1.052 . . . . 0.0 110.049 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.29 7.82 75.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.226 1.393 . . . . 0.0 115.014 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.56 166.68 11.91 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.871 1.335 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -106.23 110.17 22.33 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.15 165.06 16.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.747 0.654 . . . . 0.0 112.327 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.424 ' O ' HD23 ' A' ' 4' ' ' LEU . 12.5 pt-20 -162.32 141.56 9.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.552 1.941 . . . . 0.0 107.572 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 81.1 t -76.82 152.72 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.3 mt -126.58 59.15 1.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.438 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 C-N-CA 124.454 1.102 . . . . 0.0 108.812 177.886 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttt . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.415 HD11 ' HD3' ' A' ' 48' ' ' PRO . 2.2 mt -48.17 131.49 16.13 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 126.032 1.733 . . . . 0.0 111.855 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.09 151.08 21.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.374 1.469 . . . . 0.0 111.331 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.18 144.49 24.01 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.244 1.818 . . . . 0.0 107.5 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.49 125.75 52.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.47 140.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.74 125.11 42.46 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.73 -9.68 8.59 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.984 1.278 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.1 mtm -74.1 90.17 2.01 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 107.252 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -98.36 -12.46 21.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.509 1.124 . . . . 0.0 112.416 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.8 m -136.19 162.08 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.398 -0.814 . . . . 0.0 110.247 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.89 -37.17 75.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.924 0.49 . . . . 0.0 110.207 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.72 -37.52 76.33 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.29 -46.95 88.05 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.18 0.9 . . . . 0.0 109.493 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.79 -55.12 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.202 1.001 . . . . 0.0 110.065 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptm -62.31 -28.93 70.08 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.674 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.11 -53.07 13.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.6 t -52.75 -47.14 51.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.946 1.298 . . . . 0.0 107.696 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 m -53.86 -55.07 30.09 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.418 1.087 . . . . 0.0 109.032 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -62.56 -36.78 83.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 117.92 -1.038 . . . . 0.0 113.292 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.65 71.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.158 0.89 . . . . 0.0 109.343 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.03 -41.01 99.42 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -61.97 -11.64 14.44 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.324 -0.846 . . . . 0.0 113.208 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -77.29 -20.28 55.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.028 1.286 . . . . 0.0 110.576 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.06 128.79 93.46 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.28 100.24 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.759 2.306 . . . . 0.0 111.542 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.3 -7.71 4.35 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.821 1.201 . . . . 0.0 112.463 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.52 104.6 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.213 -1.169 . . . . 0.0 111.005 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.15 -56.52 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -148.07 160.61 42.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.467 1.107 . . . . 0.0 108.671 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.14 153.62 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -137.14 90.62 2.54 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.1 t -99.16 139.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.401 1.48 . . . . 0.0 107.854 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -126.4 136.94 53.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.64 -60.59 3.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 125.029 1.332 . . . . 0.0 110.615 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.23 -46.1 89.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.815 1.246 . . . . 0.0 112.303 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -74.92 -31.45 61.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.494 -0.765 . . . . 0.0 113.057 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.09 40.93 55.54 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.61 167.41 21.72 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.238 -1.154 . . . . 0.0 109.206 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.4 123.73 20.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.397 1.879 . . . . 0.0 106.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.0 mt -111.51 143.63 42.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.439 HG21 HD22 ' A' ' 51' ' ' LEU . 42.1 t -122.04 126.53 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 119.893 1.224 . . . . 0.0 110.473 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -93.45 2.64 56.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.862 2.065 . . . . 0.0 110.387 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.94 -179.34 38.81 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.86 1.695 . . . . 0.0 112.932 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.5 p -96.18 4.75 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.483 1.913 . . . . 0.0 111.706 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.83 165.87 3.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.134 0.974 . . . . 0.0 112.73 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.07 147.56 33.16 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.965 2.106 . . . . 0.0 109.41 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HD3' HD11 ' A' ' 2' ' ' LEU . 36.5 Cg_endo -66.94 -42.17 8.83 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.933 1.755 . . . . 0.0 112.757 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -59.03 -30.23 67.87 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.329 0.968 . . . . 0.0 111.741 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -23.66 32.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 111.624 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 42' ' ' VAL . 42.9 mt -82.18 -56.46 3.91 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.022 2.129 . . . . 0.0 109.489 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.1 p -50.57 -40.57 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.016 1.326 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -58.66 -43.84 89.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.604 0.362 . . . . 0.0 110.99 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.36 -14.64 57.53 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.7 t -93.75 -43.32 13.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.528 1.131 . . . . 0.0 108.01 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.32 -30.82 71.85 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.306 1.042 . . . . 0.0 111.31 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.62 -9.57 59.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.829 0.852 . . . . 0.0 111.031 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.94 41.79 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 119.181 -0.789 . . . . 0.0 113.524 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -85.93 177.8 7.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.682 1.241 . . . . 0.0 107.817 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -114.69 134.07 55.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.81 158.34 44.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.477 0.581 . . . . 0.0 112.041 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.77 136.29 11.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.611 1.565 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' ALA . 8.7 p -77.76 131.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.056 -1.028 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -101.9 22.68 12.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.438 -0.789 . . . . 0.0 110.343 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.419 1.887 . . . . 0.0 111.203 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 11.8 ttt . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -62.33 139.47 58.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.923 0.889 . . . . 0.0 111.654 -177.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -111.77 136.46 51.01 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.678 1.591 . . . . 0.0 110.888 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.77 159.94 40.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.413 1.085 . . . . 0.0 109.7 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HE2' ' OE1' ' A' ' 7' ' ' GLU . 3.2 ttpm? -127.82 123.18 34.53 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.97 137.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' HE2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -120.05 148.77 43.17 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.88 -12.48 65.77 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 117.783 -1.565 . . . . 0.0 113.54 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.8 mtm -66.11 146.15 55.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.729 2.264 . . . . 0.0 108.24 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.0 p -136.11 -38.04 0.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.2 m -141.68 179.83 6.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.11 1.364 . . . . 0.0 109.401 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -52.99 -36.0 59.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.258 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -52.34 -35.16 50.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.944 0.793 . . . . 0.0 111.068 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -74.57 -55.62 5.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.2 t -49.59 -51.85 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.952 1.301 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.8 ptm -65.64 -37.57 86.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.705 0.802 . . . . 0.0 112.743 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.12 -53.65 50.11 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.4 -48.54 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.58 1.952 . . . . 0.0 108.832 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.4 m -54.01 -61.76 2.09 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.565 1.146 . . . . 0.0 110.389 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.16 -26.69 68.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.99 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.03 -45.13 67.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.476 1.035 . . . . 0.0 109.092 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.87 -32.12 69.17 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HA ' HG11 ' A' ' 28' ' ' VAL . 47.1 mttm -70.12 -13.47 62.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -78.49 -7.45 57.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.898 1.226 . . . . 0.0 111.638 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 28' ' ' VAL . 94.6 t -78.74 127.49 80.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.294 1.438 . . . . 0.0 112.11 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.98 107.05 1.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.856 2.371 . . . . 0.0 111.927 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 -9.71 7.11 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 126.498 1.999 . . . . 0.0 113.342 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.8 p -78.57 146.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.46 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -124.96 -53.6 1.64 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.182 1.793 . . . . 0.0 108.122 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -132.6 147.46 52.35 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.811 0.844 . . . . 0.0 109.426 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.99 155.34 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.644 1.978 . . . . 0.0 106.05 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -145.17 138.2 26.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -135.41 140.8 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -130.77 116.81 18.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.203 1.001 . . . . 0.0 110.657 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 tp -60.2 -54.61 43.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.158 0.583 . . . . 0.0 109.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.95 -38.42 72.92 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -85.36 -17.74 35.86 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.45 25.52 67.04 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -126.86 155.05 43.56 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 118.265 1.032 . . . . 0.0 110.672 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.43 125.74 29.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.091 1.756 . . . . 0.0 106.503 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.67 138.87 49.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.8 t -118.83 146.75 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.82 -12.05 10.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.279 1.032 . . . . 0.0 111.453 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.36 37.48 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.0 p -98.07 8.1 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.448 1.499 . . . . 0.0 111.547 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.72 143.92 11.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.275 1.03 . . . . 0.0 111.594 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.52 149.41 95.56 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.439 ' HB3' HD21 ' A' ' 2' ' ' LEU . 20.2 Cg_endo -61.36 -51.46 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.819 1.679 . . . . 0.0 112.597 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -53.98 -34.94 61.17 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.633 1.173 . . . . 0.0 112.792 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.21 -31.46 60.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.791 0.837 . . . . 0.0 112.805 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -68.89 -50.3 50.81 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.53 -44.61 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -48.99 -49.74 39.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.819 0.848 . . . . 0.0 111.524 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.62 -27.99 69.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.041 -0.981 . . . . 0.0 113.632 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.8 t -88.71 -31.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 120.074 1.307 . . . . 0.0 110.711 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -61.52 -32.8 72.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.08 -0.99 23.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.735 2.414 . . . . 0.0 112.973 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.1 -10.44 17.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.782 1.174 . . . . 0.0 110.569 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.41 24.79 11.78 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.066 -0.852 . . . . 0.0 112.04 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -126.13 161.4 27.73 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.888 1.275 . . . . 0.0 108.019 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -98.74 106.38 18.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.38 155.48 18.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.343 0.519 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -154.15 133.3 12.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.28 1.432 . . . . 0.0 108.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 66' ' ' ALA . 97.0 t -89.46 129.95 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.2 mt -109.89 32.1 5.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.764 1.226 . . . . 0.0 110.945 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.473 ' H ' HG12 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.245 0.833 0 C-N-CA 125.087 1.355 . . . . 0.0 107.368 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.55 150.67 43.74 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.356 0.98 . . . . 0.0 109.424 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -113.67 113.5 25.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.103 1.361 . . . . 0.0 109.364 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -112.79 124.22 52.08 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.281 1.032 . . . . 0.0 109.255 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -90.13 122.11 32.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.86 151.63 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.005 0.922 . . . . 0.0 110.919 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.83 144.88 47.85 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.141 1.776 . . . . 0.0 106.214 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.0 -12.99 49.49 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.793 2.14 . . . . 0.0 111.999 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.0 mtm -74.62 75.28 2.01 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.132 1.466 . . . . 0.0 111.1 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.5 p -80.63 -33.79 35.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.555 -0.716 . . . . 0.0 111.676 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.6 m -118.1 161.43 19.85 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.238 1.415 . . . . 0.0 113.154 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.271 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -64.59 -32.51 74.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.271 1.028 . . . . 0.0 108.773 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 m -72.95 -49.79 27.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -52.02 -48.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.774 1.23 . . . . 0.0 110.765 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.5 ptm -63.72 -36.63 84.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.734 0.697 . . . . 0.0 112.125 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.17 -50.82 59.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.95 -39.65 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.553 1.141 . . . . 0.0 108.761 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.1 m -60.5 -59.24 5.71 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.258 -0.901 . . . . 0.0 108.866 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.18 -35.85 78.25 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.889 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.93 95.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.424 1.09 . . . . 0.0 109.877 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.0 mt -65.13 -33.62 76.45 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.809 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -74.12 6.53 3.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -90.8 -13.02 34.68 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.277 -1.514 . . . . 0.0 108.996 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 28' ' ' VAL . 58.4 t -74.49 132.12 79.06 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.626 1.57 . . . . 0.0 112.629 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.55 109.09 1.98 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.085 1.857 . . . . 0.0 110.879 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.23 -7.64 7.58 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.786 1.66 . . . . 0.0 114.706 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 23' ' ' LYS . 13.9 p -80.17 136.0 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 1.36 . . . . 0.0 112.253 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -97.29 -61.38 1.41 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -145.72 165.82 27.66 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.058 1.343 . . . . 0.0 107.447 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.1 t -145.86 143.36 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -125.05 101.1 6.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 t -100.61 136.92 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 m -119.63 132.62 55.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.745 1.218 . . . . 0.0 109.385 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.2 -68.72 0.27 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.656 1.583 . . . . 0.0 111.431 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.21 -53.42 35.24 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.918 1.687 . . . . 0.0 112.858 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.15 -21.89 64.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.987 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.36 39.54 92.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -132.02 157.84 43.08 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.656 1.182 . . . . 0.0 109.401 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.76 129.57 40.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.262 2.225 . . . . 0.0 107.263 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.24 102.3 10.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -82.27 126.06 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -96.31 -10.24 28.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.308 1.443 . . . . 0.0 113.784 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.88 -173.17 39.32 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -99.8 14.26 30.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.958 1.303 . . . . 0.0 112.248 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 150.83 3.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.212 0.605 . . . . 0.0 110.531 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.77 140.64 58.91 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 123.283 0.633 . . . . 0.0 111.617 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.93 -41.98 56.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.467 2.111 . . . . 0.0 113.219 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -57.66 -36.03 71.35 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.833 1.253 . . . . 0.0 112.529 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.82 -30.78 22.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.788 . . . . 0.0 111.616 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.7 mt -67.79 -55.04 14.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.223 1.009 . . . . 0.0 109.252 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.86 -43.42 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -55.94 -52.61 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.369 1.067 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 -25.94 36.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.76 -40.9 16.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 119.207 0.912 . . . . 0.0 108.648 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.68 -37.15 86.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.384 0.538 . . . . 0.0 109.559 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.51 -19.83 64.0 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.015 0.526 . . . . 0.0 111.369 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -86.52 -5.21 59.21 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.509 -1.369 . . . . 0.0 110.982 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.82 13.15 51.28 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.386 0.993 . . . . 0.0 112.961 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -105.71 -177.74 3.45 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -126.52 137.55 53.38 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.4 35.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 123.684 0.615 . . . . 0.0 110.292 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.5 138.76 14.7 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.188 1.395 . . . . 0.0 108.034 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.05 119.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -81.1 23.28 0.58 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.16 1.784 . . . . 0.0 109.232 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttp . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.98 144.75 54.04 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 122.875 0.47 . . . . 0.0 109.993 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -117.02 130.11 56.46 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.144 1.378 . . . . 0.0 111.714 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.52 164.42 26.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.433 1.493 . . . . 0.0 110.331 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.56 128.31 44.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.57 2.748 . . . . 0.0 105.527 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.77 145.03 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -137.94 109.93 7.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.33 -11.1 2.5 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.476 1.513 . . . . 0.0 115.875 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.5 mtm -72.34 127.44 32.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 121.029 2.414 . . . . 0.0 112.708 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -133.27 -5.85 3.0 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.141 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.1 m -145.63 164.89 30.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.904 1.281 . . . . 0.0 109.912 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.33 -40.9 71.74 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.956 1.303 . . . . 0.0 110.672 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 16' ' ' MET . 3.6 t60 -56.84 -38.3 72.47 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.108 0.563 . . . . 0.0 111.546 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 m -59.92 -47.44 85.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 t -57.09 -49.04 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 109.375 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.412 ' HG2' ' HA ' ' A' ' 13' ' ' HIS . 27.3 ptm -65.83 -39.53 90.91 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.536 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.33 -53.19 60.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.57 1.077 . . . . 0.0 109.283 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -49.57 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 109.382 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.9 m -55.11 -50.1 70.06 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.277 1.031 . . . . 0.0 109.583 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -60.43 -46.76 88.88 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.949 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.32 81.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 123.704 0.628 . . . . 0.0 110.133 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.28 -33.44 75.52 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.254 0.621 . . . . 0.0 110.358 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.621 ' HA ' HG11 ' A' ' 28' ' ' VAL . 59.5 mtpt -76.24 -11.81 59.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.402 -0.808 . . . . 0.0 112.221 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.5 -7.72 56.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.307 1.412 . . . . 0.0 111.488 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 28' ' ' VAL . 58.9 t -73.25 142.38 81.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 112.526 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.74 112.64 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.015 1.81 . . . . 0.0 109.875 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.69 26.92 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.374 1.464 . . . . 0.0 115.67 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.621 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.2 p -77.19 145.42 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 119.6 1.7 . . . . 0.0 109.822 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -120.14 -57.9 1.9 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.557 1.143 . . . . 0.0 109.063 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -133.32 152.59 51.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.57 144.69 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -124.31 99.61 6.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 t -107.47 117.51 53.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -80.15 174.92 11.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.5 tp -122.55 -33.96 3.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -99.2 -32.8 11.04 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.057 0.844 . . . . 0.0 111.228 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -74.36 -17.53 60.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.39 32.97 84.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.647 1.112 . . . . 0.0 112.593 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -133.65 153.31 51.78 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.799 -1.412 . . . . 0.0 107.342 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.35 148.74 50.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.9 mt -140.53 158.46 43.96 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.2 t -134.51 143.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.567 1.147 . . . . 0.0 111.565 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -100.69 -33.8 10.12 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.961 0.904 . . . . 0.0 110.022 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.46 177.28 1.87 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.851 0.738 . . . . 0.0 113.816 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 t -89.06 6.54 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.173 1.389 . . . . 0.0 110.951 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.37 151.99 3.73 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.369 0.668 . . . . 0.0 112.405 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.59 146.17 52.73 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.7 -37.96 53.19 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.409 2.073 . . . . 0.0 113.069 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.34 -48.55 80.19 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.698 0.799 . . . . 0.0 111.262 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.41 -24.89 63.91 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.874 -0.516 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.8 mt -74.21 -55.37 6.13 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.701 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 -44.43 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.708 0.685 . . . . 0.0 109.43 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.24 -51.59 61.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.196 1.798 . . . . 0.0 111.25 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.15 -35.72 71.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.81 -40.7 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 121.198 -0.939 . . . . 0.0 108.929 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -61.51 -33.59 74.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.923 0.889 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.73 -23.43 66.74 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.231 1.012 . . . . 0.0 111.72 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -86.62 3.76 43.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.399 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.54 80.94 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.669 1.604 . . . . 0.0 114.474 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.84 177.32 6.22 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.52 1.66 . . . . 0.0 107.188 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -114.14 133.31 55.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.19 167.82 19.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.079 0.943 . . . . 0.0 111.631 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.49 146.57 16.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.873 1.269 . . . . 0.0 109.787 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.57 141.66 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.07 34.94 3.45 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.521 0.728 . . . . 0.0 111.038 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.423 0 C-N-CA 127.907 2.483 . . . . 0.0 107.219 179.1 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 24.2 ttt . . . . . 0 C--O 1.235 0.333 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.7 mt -66.24 156.81 33.18 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.184 0.994 . . . . 0.0 112.011 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -127.57 118.3 23.67 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 128.215 2.606 . . . . 0.0 109.489 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.77 152.26 36.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -119.59 122.67 42.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -107.32 150.98 9.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -135.46 160.25 39.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.43 -22.81 25.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.211 -1.327 . . . . 0.0 111.729 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 32.0 mtm -64.19 146.65 53.93 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.626 1.713 . . . . 0.0 107.262 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.2 p -136.91 -22.08 1.22 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.5 p -145.29 177.08 9.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.086 0.946 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -62.49 -31.73 72.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.402 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.49 -39.45 91.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -62.37 -49.93 73.59 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 t -54.44 -56.28 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.506 1.523 . . . . 0.0 110.651 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -34.49 69.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.957 0.799 . . . . 0.0 112.607 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.88 45.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.234 0.925 . . . . 0.0 109.715 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.434 HG21 HG13 ' A' ' 55' ' ' VAL . 2.7 p -60.92 -38.16 78.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.109 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.723 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -56.31 -48.93 75.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -65.2 -34.6 78.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.507 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.83 -41.1 75.41 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 108.454 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.37 -39.1 86.02 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.801 -1.187 . . . . 0.0 110.081 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -65.31 -14.24 60.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -69.24 -27.51 65.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.98 0.809 . . . . 0.0 110.715 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.25 134.21 93.15 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.68 1.192 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.24 108.27 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.255 2.637 . . . . 0.0 110.425 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.03 -2.51 19.32 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-O 119.204 -0.775 . . . . 0.0 113.012 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -86.99 98.23 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 119.254 1.527 . . . . 0.0 110.583 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.17 -44.16 39.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.541 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.38 158.61 41.74 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.56 143.76 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.72 87.42 2.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.993 1.317 . . . . 0.0 107.658 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.74 145.94 6.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -139.83 122.04 15.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.477 1.111 . . . . 0.0 111.239 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.83 -39.75 79.83 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -60.02 -29.5 68.53 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.383 1.473 . . . . 0.0 112.546 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -102.65 -30.5 10.89 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.55 1.14 . . . . 0.0 113.565 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.18 21.75 66.92 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.49 161.91 19.77 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -1.156 . . . . 0.0 111.772 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.97 108.52 7.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.153 2.181 . . . . 0.0 106.548 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.28 151.13 19.8 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.533 HG21 HD22 ' A' ' 51' ' ' LEU . 46.5 t -128.06 124.7 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 119.894 1.224 . . . . 0.0 108.975 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -88.07 -13.61 41.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.49 -176.95 16.13 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.626 1.584 . . . . 0.0 114.198 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.0 t -103.62 -6.67 21.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.634 1.973 . . . . 0.0 113.912 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.33 157.93 0.91 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.745 2.018 . . . . 0.0 115.556 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.26 146.39 58.06 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 123.422 0.689 . . . . 0.0 110.254 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.3 -34.31 55.97 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.75 1.633 . . . . 0.0 113.477 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -61.46 -39.72 91.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.178 1.354 . . . . 0.0 112.114 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.2 78.56 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.533 HD22 HG21 ' A' ' 42' ' ' VAL . 41.9 mt -66.6 -47.13 73.67 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 124.905 1.282 . . . . 0.0 108.842 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.07 -48.27 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -59.8 -27.73 66.83 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.45 87.5 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.073 0.852 . . . . 0.0 110.52 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.434 HG13 HG21 ' A' ' 18' ' ' VAL . 29.4 t -84.02 -44.2 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 125.254 1.422 . . . . 0.0 110.455 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -65.19 -6.57 9.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.309 1.044 . . . . 0.0 111.777 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -107.07 -13.6 15.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.807 1.185 . . . . 0.0 109.482 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -83.89 -10.77 57.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.346 1.459 . . . . 0.0 110.251 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.9 29.11 7.03 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.604 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -136.3 172.36 13.12 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.18 1.49 . . . . 0.0 109.949 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -102.74 142.74 33.39 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.11 141.24 44.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -131.13 116.7 18.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.628 1.571 . . . . 0.0 108.266 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' ALA . 2.4 p -77.09 139.54 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -120.53 45.38 2.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.252 1.216 0 C-N-CA 125.244 1.418 . . . . 0.0 107.555 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptm . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.07 169.28 16.07 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.746 0.819 . . . . 0.0 110.525 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -136.55 133.62 36.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.696 1.599 . . . . 0.0 109.372 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.475 HD21 HG22 ' A' ' 52' ' ' VAL . 7.0 mt -138.26 149.61 45.89 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 126.213 1.805 . . . . 0.0 107.5 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -110.45 129.14 55.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.07 147.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -137.42 114.48 10.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.553 1.141 . . . . 0.0 108.156 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.29 -10.75 4.11 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.745 1.641 . . . . 0.0 113.887 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.4 mtm -73.42 97.09 2.47 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.689 1.744 . . . . 0.0 107.809 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -115.19 3.36 14.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.682 1.193 . . . . 0.0 111.139 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 m -146.57 152.9 39.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.433 1.493 . . . . 0.0 107.441 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -60.56 -36.19 77.88 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -59.18 -32.64 70.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.397 1.079 . . . . 0.0 110.478 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.4 m -66.46 -39.66 88.94 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -59.73 -59.26 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.2 ptm -57.49 -33.71 68.3 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.943 0.792 . . . . 0.0 112.991 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.24 -53.53 53.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.54 1.064 . . . . 0.0 109.604 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.81 -39.8 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.109 1.363 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m -59.97 -46.02 90.78 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.928 -1.108 . . . . 0.0 108.846 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -44.84 95.94 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 121.819 -0.55 . . . . 0.0 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.43 95.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.4 -33.36 74.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.588 1.085 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.597 ' HA ' HG11 ' A' ' 28' ' ' VAL . 35.6 mttm -76.33 -16.85 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.052 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -76.28 -17.28 59.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.536 1.971 . . . . 0.0 111.733 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 28' ' ' VAL . 86.5 t -62.07 140.0 95.94 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 126.805 2.042 . . . . 0.0 112.711 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.06 108.71 2.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 109.923 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.92 -6.83 9.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.171 1.843 . . . . 0.0 114.728 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.597 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.4 p -80.97 159.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.118 1.459 . . . . 0.0 108.013 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -130.71 -64.62 0.82 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -132.56 159.92 38.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 108.302 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.6 139.09 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -128.45 106.92 9.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.06 154.58 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.747 1.219 . . . . 0.0 111.501 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.6 t -129.61 129.34 44.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.303 1.841 . . . . 0.0 109.563 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.01 -43.22 88.31 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.744 0.817 . . . . 0.0 109.996 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.31 -47.9 46.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -76.98 -20.62 55.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 35.54 92.17 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -128.96 137.47 51.4 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.02 136.78 54.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.283 2.233 . . . . 0.0 108.822 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.45 155.46 38.85 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 51' ' ' LEU . 7.0 t -129.29 122.12 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -81.36 -18.67 44.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.605 1.162 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.32 -168.74 27.62 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.623 1.106 . . . . 0.0 113.189 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -105.96 5.75 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.245 1.418 . . . . 0.0 113.067 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.3 147.79 9.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.647 0.658 . . . . 0.0 110.902 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.74 146.93 83.85 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.01 -39.33 71.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.297 1.998 . . . . 0.0 114.615 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -60.12 -41.99 93.79 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.605 0.639 . . . . 0.0 109.625 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.64 76.53 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.832 -0.542 . . . . 0.0 109.849 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 42' ' ' VAL . 95.9 mt -68.91 -49.37 58.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.041 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 4' ' ' LEU . 53.6 t -55.04 -49.13 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -49.69 -54.39 19.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.466 1.106 . . . . 0.0 109.439 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.18 -34.86 47.07 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 60' ' ' TYR . 15.4 t -79.35 -42.48 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.21 -40.06 88.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.104 1.762 . . . . 0.0 109.191 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.4 -4.19 17.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.167 2.187 . . . . 0.0 111.892 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -110.64 2.21 18.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.723 1.209 . . . . 0.0 109.832 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.98 22.4 57.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.12 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 55' ' ' VAL . 64.3 m-85 -106.89 170.05 8.18 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -109.92 121.16 44.61 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.64 151.73 48.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.707 0.685 . . . . 0.0 109.92 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.91 125.91 15.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.24 153.16 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -111.34 18.83 18.86 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.061 0.945 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.465 1.106 . . . . 0.0 108.76 179.3 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 29.7 ttm . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mt -95.94 170.09 9.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.248 1.019 . . . . 0.0 110.241 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -138.93 129.13 25.45 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.739 1.616 . . . . 0.0 108.581 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.522 HD22 ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -125.76 156.3 39.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 127.53 2.332 . . . . 0.0 108.211 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -113.73 136.03 53.29 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.23 137.55 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 125.581 1.553 . . . . 0.0 108.093 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -132.98 128.77 37.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.69 -14.8 7.59 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.133 -1.37 . . . . 0.0 112.377 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 67.1 mtm -73.69 133.45 43.38 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.934 1.867 . . . . 0.0 106.828 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -126.72 -22.88 3.81 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.954 0.343 . . . . 0.0 111.658 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.2 m -139.32 167.69 21.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.749 1.62 . . . . 0.0 108.598 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -57.12 -37.57 72.18 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.093 0.957 . . . . 0.0 113.253 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -58.62 -33.06 69.61 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.2 m -62.97 -35.33 79.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.476 0.58 . . . . 0.0 110.503 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.85 -51.29 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.523 1.529 . . . . 0.0 109.568 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -63.84 -31.94 73.28 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.307 -0.871 . . . . 0.0 111.315 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.97 4.84 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.625 HG21 HG13 ' A' ' 55' ' ' VAL . 5.0 p -58.06 -35.13 51.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 111.764 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 m -56.58 -43.36 79.97 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -66.96 -44.71 79.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.192 -0.942 . . . . 0.0 111.262 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.87 97.53 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.446 0.641 . . . . 0.0 110.701 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -32.68 73.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.437 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -79.86 -4.85 53.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.658 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.37 -23.3 40.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.52 1.509 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.12 126.16 72.69 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 125.475 1.51 . . . . 0.0 111.503 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 110.59 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.705 2.27 . . . . 0.0 106.433 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.04 -1.43 7.81 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.315 1.912 . . . . 0.0 112.07 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.8 t -100.49 138.38 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 119.756 1.778 . . . . 0.0 110.886 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -123.17 -52.47 1.86 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.615 1.566 . . . . 0.0 110.308 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -128.01 149.1 50.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.3 165.81 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 125.275 1.609 . . . . 0.0 108.045 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -152.96 97.44 2.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.374 0.669 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.2 156.4 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.951 -1.093 . . . . 0.0 108.853 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -144.63 135.62 25.01 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.87 0.868 . . . . 0.0 110.291 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.0 tp -66.56 -52.04 49.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.557 0.743 . . . . 0.0 109.838 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -53.99 -65.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.092 2.157 . . . . 0.0 112.187 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -69.35 -17.9 63.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.194 -0.908 . . . . 0.0 112.722 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.89 31.59 68.51 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.263 0.938 . . . . 0.0 111.097 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -122.1 156.98 32.47 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.922 0.889 . . . . 0.0 110.212 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.45 130.88 28.93 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.44 1.896 . . . . 0.0 109.64 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.04 158.05 34.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 1' ' ' MET . 95.3 t -136.67 142.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.484 1.114 . . . . 0.0 108.866 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -104.17 -17.61 14.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.655 0.782 . . . . 0.0 111.45 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.16 -177.83 21.95 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 t -90.37 2.49 55.53 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.231 -1.158 . . . . 0.0 111.746 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 149.94 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -82.02 148.23 59.93 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 124.684 1.194 . . . . 0.0 111.318 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.27 -41.08 44.7 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.078 1.852 . . . . 0.0 113.202 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -58.46 -40.82 83.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.02 0.528 . . . . 0.0 110.821 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.77 -32.38 67.62 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.024 0.829 . . . . 0.0 110.672 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 42' ' ' VAL . 96.3 mt -67.46 -56.19 10.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.485 1.114 . . . . 0.0 110.004 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.42 ' HB ' HD21 ' A' ' 4' ' ' LEU . 7.8 p -57.35 -42.81 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.877 0.762 . . . . 0.0 109.461 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -57.99 -41.61 83.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.679 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.75 -19.0 47.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.386 0.993 . . . . 0.0 112.57 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.625 HG13 HG21 ' A' ' 18' ' ' VAL . 19.5 t -94.04 -36.88 7.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 108.566 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -67.6 -31.11 70.93 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.71 -17.73 62.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.122 1.769 . . . . 0.0 110.602 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.19 -3.98 49.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.612 1.565 . . . . 0.0 110.258 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.8 10.42 63.06 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 125.185 1.374 . . . . 0.0 114.731 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.48 ' HB2' HG12 ' A' ' 55' ' ' VAL . 91.9 m-85 -98.56 -176.76 3.47 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.498 1.649 . . . . 0.0 108.415 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -122.27 119.37 30.96 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HB1' HD22 ' A' ' 4' ' ' LEU . . . -130.51 161.26 31.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.89 0.768 . . . . 0.0 110.355 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.471 ' C ' HD23 ' A' ' 4' ' ' LEU . 14.6 tt0 -156.86 138.48 14.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.211 1.404 . . . . 0.0 109.196 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.48 133.76 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.9 mt -88.86 24.11 2.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.023 0.929 . . . . 0.0 112.804 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.757 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.011 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ptm . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mt -77.06 162.34 27.58 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.25 150.04 52.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.775 0.83 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mt -144.1 155.82 44.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.215 2.206 . . . . 0.0 105.918 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -121.44 118.48 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.15 134.88 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.99 115.13 14.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.39 -6.29 4.25 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.533 2.016 . . . . 0.0 113.173 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 72.2 mtm -77.09 129.37 35.95 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.379 2.09 . . . . 0.0 107.132 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -141.04 16.08 2.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.0 0.818 . . . . 0.0 111.901 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t -156.17 156.92 35.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.616 1.566 . . . . 0.0 108.525 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.34 -35.72 74.38 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.989 0.916 . . . . 0.0 109.543 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -60.49 -36.04 77.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.45 0.7 . . . . 0.0 110.213 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 m -62.08 -47.01 86.56 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.35 -56.02 13.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.754 0.822 . . . . 0.0 110.436 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . 0.261 5.3 ppp? -62.57 -27.48 69.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.619 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.33 -51.29 15.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 108.278 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.21 -40.19 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.4 m -60.02 -45.22 93.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.981 0.913 . . . . 0.0 108.849 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -62.46 -47.0 85.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 121.009 -1.057 . . . . 0.0 111.01 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.83 84.09 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.4 mt -64.7 -39.05 93.0 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.899 -1.126 . . . . 0.0 110.055 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.682 ' HA ' HG11 ' A' ' 28' ' ' VAL . 47.0 mttm -72.82 -14.36 61.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.952 -1.092 . . . . 0.0 113.057 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -13.17 59.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.098 1.317 . . . . 0.0 110.722 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 28' ' ' VAL . 59.4 t -70.01 130.6 89.7 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.749 1.619 . . . . 0.0 111.978 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.4 106.4 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.101 2.534 . . . . 0.0 110.638 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.95 -8.09 6.4 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.316 0.96 . . . . 0.0 115.03 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.682 HG11 ' HA ' ' A' ' 23' ' ' LYS . 10.2 p -75.36 150.17 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.207 1.503 . . . . 0.0 111.242 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.2 -58.48 1.99 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.828 1.651 . . . . 0.0 107.287 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -144.63 155.4 43.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.857 1.263 . . . . 0.0 108.144 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' CG2' ' HE2' ' A' ' 23' ' ' LYS . 2.1 m -138.93 152.65 24.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.949 1.699 . . . . 0.0 109.919 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -138.28 88.97 2.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.722 2.009 . . . . 0.0 109.247 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.87 148.11 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -135.01 116.43 14.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.565 1.146 . . . . 0.0 113.056 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.46 -39.72 92.35 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.636 1.174 . . . . 0.0 110.193 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.98 -54.34 8.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.518 0.727 . . . . 0.0 110.759 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 -21.81 62.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.169 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.2 31.93 82.42 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.32 159.4 40.38 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.454 1.502 . . . . 0.0 107.147 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.63 122.66 12.83 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.57 148.08 28.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.67 123.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.658 0.783 . . . . 0.0 110.062 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 -19.92 27.29 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.58 -172.74 5.05 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.402 1.477 . . . . 0.0 114.44 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.34 8.81 18.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 158.03 15.2 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.908 0.776 . . . . 0.0 109.84 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 145.88 79.03 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 124.259 1.023 . . . . 0.0 111.97 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.23 -35.77 61.31 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.627 1.551 . . . . 0.0 112.941 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -38.5 89.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.056 0.389 . . . . 0.0 110.882 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.36 -38.08 56.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.857 0.463 . . . . 0.0 110.31 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.67 -53.44 58.04 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 125.151 1.38 . . . . 0.0 110.731 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.27 -44.63 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -54.65 -50.28 68.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.731 1.213 . . . . 0.0 113.162 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.82 68.86 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.76 -43.51 86.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.393 0.677 . . . . 0.0 109.353 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.82 -28.85 70.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.103 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -63.8 -35.29 80.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.823 0.738 . . . . 0.0 110.511 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -70.88 -17.29 62.72 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.695 -0.628 . . . . 0.0 109.862 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.34 -6.45 26.69 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 126.062 1.792 . . . . 0.0 114.692 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -77.27 166.41 23.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.943 1.872 . . . . 0.0 110.13 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -97.75 128.62 44.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.22 147.23 50.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.26 142.69 18.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.058 1.343 . . . . 0.0 107.637 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.99 149.91 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.452 1.101 . . . . 0.0 111.424 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -117.87 25.68 10.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.147 1.379 . . . . 0.0 110.213 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.761 2.024 . . . . 0.0 108.961 -179.06 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mt -77.92 148.06 34.72 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.071 0.463 . . . . 0.0 111.131 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.64 151.58 25.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 mt -147.9 143.55 27.46 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.061 1.345 . . . . 0.0 107.387 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -117.89 111.6 19.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.853 1.261 . . . . 0.0 108.327 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 158.87 3.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.3 134.97 13.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.35 -12.22 36.55 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.01 -1.439 . . . . 0.0 115.312 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.9 mtm -75.64 130.64 39.08 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.64 2.22 . . . . 0.0 108.612 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.29 0.6 OUTLIER -126.31 -1.2 6.98 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -149.77 157.91 43.66 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.1 1.36 . . . . 0.0 108.631 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.93 -28.72 58.12 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -63.94 -23.15 67.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.488 1.04 . . . . 0.0 111.209 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.63 -48.48 59.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.5 t -49.67 -58.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 125.935 1.694 . . . . 0.0 109.892 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.8 ptm -58.84 -26.67 64.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.69 -51.05 20.96 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.38 -41.42 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.888 1.675 . . . . 0.0 108.528 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.0 m -57.86 -59.05 5.84 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.231 0.923 . . . . 0.0 109.366 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -56.32 -39.11 72.25 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.314 0.645 . . . . 0.0 112.588 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.2 78.47 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.096 0.958 . . . . 0.0 108.783 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.03 -26.57 68.62 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.876 -1.765 . . . . 0.0 109.188 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.767 ' HA ' HG11 ' A' ' 28' ' ' VAL . 3.7 mtpm? -82.44 -9.6 59.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.789 0.836 . . . . 0.0 112.141 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.32 -12.26 60.23 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.41 1.005 . . . . 0.0 110.386 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 28' ' ' VAL . 37.8 t -78.16 123.42 86.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 126.755 2.022 . . . . 0.0 111.819 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.31 107.41 2.26 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.677 2.251 . . . . 0.0 110.766 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.16 -18.0 3.78 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.469 1.509 . . . . 0.0 112.166 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.767 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.9 p -72.2 161.76 4.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 120.873 -1.369 . . . . 0.0 109.675 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.78 -66.13 0.73 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -125.42 158.35 34.59 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.675 0.79 . . . . 0.0 110.189 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -150.73 164.11 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.908 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 144.75 26.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 t -144.2 136.77 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -134.01 114.84 13.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 118.362 0.528 . . . . 0.0 112.255 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 tp -56.98 -63.12 1.31 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 112.049 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.47 -28.86 47.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.076 1.35 . . . . 0.0 114.53 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -82.32 -57.66 3.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.074 0.95 . . . . 0.0 109.08 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.43 26.16 7.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.944 1.735 . . . . 0.0 110.209 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -136.29 169.47 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.341 1.571 . . . . 0.0 111.49 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.61 152.58 44.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.439 1.896 . . . . 0.0 108.767 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.43 156.32 43.37 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.964 2.106 . . . . 0.0 108.853 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.1 t -137.63 147.59 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -125.0 -7.99 7.18 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.58 -155.52 23.07 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.385 0.993 . . . . 0.0 113.112 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -106.38 6.36 30.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.515 1.926 . . . . 0.0 111.773 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 148.04 23.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.929 . . . . 0.0 111.121 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.48 146.61 70.24 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.904 1.281 . . . . 0.0 109.131 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.74 -42.3 26.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.206 1.937 . . . . 0.0 112.395 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -57.5 -38.52 74.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.469 0.708 . . . . 0.0 111.341 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.04 52.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.707 0.685 . . . . 0.0 110.846 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.61 -49.13 69.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.87 0.868 . . . . 0.0 109.743 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.27 -49.97 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.151 -0.452 . . . . 0.0 109.963 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -28.28 67.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.606 0.639 . . . . 0.0 112.65 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.45 -34.42 75.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.543 -0.723 . . . . 0.0 110.232 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -78.63 -39.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.94 -31.25 71.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.97 -22.46 67.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.731 0.812 . . . . 0.0 112.222 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -86.05 -4.12 59.1 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.281 1.032 . . . . 0.0 112.574 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.94 38.44 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.781 -1.011 . . . . 0.0 113.702 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.37 166.42 12.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.662 1.231 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -103.52 138.84 39.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.14 49.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.19 137.26 19.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 66' ' ' ALA . 48.3 t -83.17 141.35 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.978 0.911 . . . . 0.0 108.726 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.41 39.87 3.02 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.567 1.147 . . . . 0.0 108.405 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.453 ' H ' HG12 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.248 0.992 0 C-N-CA 125.958 1.703 . . . . 0.0 108.897 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ttt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mt -69.96 147.7 49.85 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.77 0.428 . . . . 0.0 111.113 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -120.77 136.94 54.75 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 mt -133.75 157.12 46.66 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.731 2.012 . . . . 0.0 109.217 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.0 122.41 44.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.645 1.578 . . . . 0.0 106.968 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -105.38 142.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -136.89 147.43 46.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.13 -19.85 47.42 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.457 1.504 . . . . 0.0 113.126 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.8 mtm -70.44 125.7 27.55 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.863 1.831 . . . . 0.0 111.2 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -129.8 6.1 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.163 0.985 . . . . 0.0 111.608 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.6 t -144.39 146.55 32.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.119 0.968 . . . . 0.0 108.862 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.93 -32.37 71.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.744 0.418 . . . . 0.0 110.727 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -58.59 -30.38 67.16 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.525 -0.734 . . . . 0.0 111.038 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 m -69.5 -40.15 77.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.41 0.684 . . . . 0.0 109.382 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.52 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.246 1.018 . . . . 0.0 108.658 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 ptm -58.84 -35.87 73.62 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.68 -55.36 20.57 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.099 0.863 . . . . 0.0 109.505 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -65.79 -27.29 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.913 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 m -62.12 -42.76 99.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -65.87 -34.54 78.38 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 120.798 -1.189 . . . . 0.0 110.169 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.45 81.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.36 -29.26 68.8 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 110.11 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 28' ' ' VAL . 35.3 mttm -74.13 -10.58 59.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.834 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -81.56 -15.52 54.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.16 1.345 . . . . 0.0 111.024 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.25 128.08 90.58 Favored Pre-proline 0 N--CA 1.44 -0.94 0 C-N-CA 125.204 1.402 . . . . 0.0 112.022 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.6 109.18 1.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.415 2.076 . . . . 0.0 111.631 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.54 15.98 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.523 1.535 . . . . 0.0 113.178 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.4 p -75.62 154.24 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 119.367 1.583 . . . . 0.0 108.471 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -130.92 -57.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -135.28 145.34 47.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.1 m -124.56 153.58 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 127.115 2.166 . . . . 0.0 107.817 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 115.89 5.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 40' ' ' ALA . 2.4 t -130.96 156.77 43.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 118.922 0.783 . . . . 0.0 109.777 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -145.04 137.89 26.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.4 -47.76 54.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.193 0.997 . . . . 0.0 110.049 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.72 -34.11 72.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.412 0.685 . . . . 0.0 112.699 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -92.56 -30.76 15.49 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.565 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.0 94.71 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 106.236 -2.746 . . . . 0.0 106.236 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.61 147.27 48.6 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.97 1.308 . . . . 0.0 108.626 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -127.89 128.65 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.01 2.124 . . . . 0.0 108.117 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.93 150.83 39.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.409 1.484 . . . . 0.0 108.684 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 44' ' ' GLY . 72.7 t -127.51 139.18 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 123.469 0.708 . . . . 0.0 109.555 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -106.42 1.49 25.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.591 1.156 . . . . 0.0 111.537 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.458 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -95.11 -151.37 28.26 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.706 1.622 . . . . 0.0 109.581 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 11.54 8.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.802 1.641 . . . . 0.0 112.578 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.28 149.99 2.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.682 1.193 . . . . 0.0 113.065 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.18 140.22 87.94 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.227 1.011 . . . . 0.0 109.659 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.59 -45.19 11.88 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.439 1.426 . . . . 0.0 110.164 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -57.05 -37.61 72.05 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.449 1.499 . . . . 0.0 112.018 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.86 31.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.386 0.539 . . . . 0.0 110.796 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.84 -51.22 50.93 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.286 -0.884 . . . . 0.0 108.75 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 p -60.08 -37.32 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.99 -50.26 71.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.134 0.974 . . . . 0.0 111.659 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.17 35.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.334 0.97 . . . . 0.0 113.423 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 90.2 t -74.14 -46.75 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.34 1.456 . . . . 0.0 108.618 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.57 -31.06 71.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.338 0.655 . . . . 0.0 110.378 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.56 -33.34 75.69 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -78.5 -17.51 56.15 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.4 -0.813 . . . . 0.0 108.866 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.89 5.95 35.15 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 117.241 -1.866 . . . . 0.0 117.074 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -96.32 160.42 14.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.067 1.933 . . . . 0.0 109.072 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -85.89 137.74 32.53 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.21 140.95 37.92 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.87 134.29 14.37 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.965 1.306 . . . . 0.0 108.608 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.42 131.29 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 127.062 2.145 . . . . 0.0 111.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt -98.82 37.6 1.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.856 1.262 . . . . 0.0 111.148 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.997 1.719 . . . . 0.0 107.957 178.769 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttt . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mt -67.79 149.49 49.85 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.249 0.477 . . . . 0.0 110.38 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.24 145.8 42.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.475 1.11 . . . . 0.0 109.518 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.19 139.15 28.57 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 108.947 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -105.14 111.16 23.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -88.41 162.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -152.47 122.51 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.24 -10.59 9.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.614 1.578 . . . . 0.0 113.547 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.5 mtm -73.99 122.39 22.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.586 2.193 . . . . 0.0 109.544 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.7 p -121.12 -12.17 8.74 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 m -137.11 165.49 25.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.925 0.89 . . . . 0.0 110.674 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -60.54 -27.74 67.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.449 1.099 . . . . 0.0 109.604 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -42.27 98.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.8 -40.76 96.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.055 0.388 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.68 -53.02 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.5 ptm -64.65 -43.58 93.16 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.893 0.77 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.0 -57.62 10.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.772 0.829 . . . . 0.0 110.177 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 55' ' ' VAL . 2.4 p -60.42 -38.28 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.595 HG22 ' HE2' ' A' ' 23' ' ' LYS . 50.0 m -57.97 -42.27 84.71 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.186 -0.947 . . . . 0.0 110.271 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.54 -43.9 79.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.969 . . . . 0.0 110.593 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.91 85.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 122.807 0.443 . . . . 0.0 110.131 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -62.49 -36.08 81.4 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.242 -1.536 . . . . 0.0 108.376 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.773 ' HA ' HG11 ' A' ' 28' ' ' VAL . 49.1 mttm -69.24 -7.28 35.36 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.742 -1.224 . . . . 0.0 112.381 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -73.15 -17.78 61.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.719 1.6 . . . . 0.0 110.723 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 28' ' ' VAL . 70.4 t -76.13 133.6 71.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.42 108.09 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.871 2.38 . . . . 0.0 112.846 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.46 -17.91 6.48 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.84 1.686 . . . . 0.0 113.174 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.773 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.9 p -62.33 144.34 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.475 1.637 . . . . 0.0 110.873 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -122.77 -54.49 1.84 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.097 0.959 . . . . 0.0 108.502 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -140.41 150.49 43.93 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 t -133.25 142.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.47 96.72 4.5 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 t -108.27 152.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.977 0.911 . . . . 0.0 109.321 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -146.67 138.2 24.44 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.467 0.576 . . . . 0.0 111.013 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.63 -52.21 41.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.466 1.106 . . . . 0.0 110.403 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -58.9 -38.12 78.15 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.699 1.6 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -86.39 -26.4 24.8 Favored 'General case' 0 N--CA 1.458 -0.067 0 O-C-N 121.988 -0.445 . . . . 0.0 110.623 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.43 35.23 88.22 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.47 158.42 43.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.69 135.3 48.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.801 2.04 . . . . 0.0 107.532 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -122.23 146.76 46.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.419 HG21 HD22 ' A' ' 51' ' ' LEU . 48.1 t -132.62 136.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 118.813 0.733 . . . . 0.0 109.444 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.6 -14.54 16.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.8 1.24 . . . . 0.0 111.432 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.83 -175.07 40.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.19 -0.944 . . . . 0.0 113.47 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.0 p -91.63 12.05 22.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.0 2.12 . . . . 0.0 110.236 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.75 149.17 14.95 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.549 -0.72 . . . . 0.0 111.134 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.03 142.97 60.54 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.304 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.0 -47.98 15.97 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.474 2.783 . . . . 0.0 112.799 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -58.73 -38.83 79.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.331 0.514 . . . . 0.0 110.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.22 -29.6 68.47 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.401 -0.812 . . . . 0.0 110.643 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD22 HG21 ' A' ' 42' ' ' VAL . 89.4 mt -65.22 -55.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -58.77 -42.81 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.67 -52.73 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.688 1.195 . . . . 0.0 110.257 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -22.91 60.11 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 18' ' ' VAL . 81.4 t -87.11 -38.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 120.806 -1.184 . . . . 0.0 108.245 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.47 -31.44 68.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.48 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.22 -22.79 67.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.179 0.9 . . . . 0.0 110.559 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.89 -12.49 47.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.978 1.311 . . . . 0.0 110.235 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.44 -3.93 40.18 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.218 1.389 . . . . 0.0 116.04 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -81.73 165.2 21.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.192 1.996 . . . . 0.0 109.641 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.18 114.01 25.67 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.62 156.83 33.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.75 139.36 15.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.959 0.904 . . . . 0.0 109.118 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.7 t -78.91 140.53 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.93 50.87 0.76 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.914 0.885 . . . . 0.0 108.719 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.443 0 C-N-CA 127.168 2.187 . . . . 0.0 108.607 179.239 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.849 0.357 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -116.18 131.15 57.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.713 1.605 . . . . 0.0 109.866 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -132.63 144.38 50.32 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.549 1.539 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -110.94 115.73 30.0 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.88 142.64 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.53 115.97 13.65 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.581 0.753 . . . . 0.0 109.888 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.62 -17.03 5.31 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.446 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.5 mtm -73.4 107.99 6.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.742 1.771 . . . . 0.0 107.612 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -121.23 16.9 11.51 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.908 -0.495 . . . . 0.0 111.209 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.0 t -151.94 152.46 32.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.63 1.172 . . . . 0.0 108.039 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -61.0 -30.95 70.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.002 0.521 . . . . 0.0 110.014 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.15 -39.24 81.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 110.765 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.4 m -63.68 -53.66 47.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.241 1.016 . . . . 0.0 108.968 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.92 -50.45 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 125.561 1.545 . . . . 0.0 110.839 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.9 ptm -63.49 -40.97 98.49 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.706 1.139 . . . . 0.0 112.355 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.94 79.65 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.29 -39.15 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.758 2.023 . . . . 0.0 110.471 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -55.48 -58.86 6.01 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.49 -41.07 96.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.653 -0.654 . . . . 0.0 111.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -43.13 77.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.029 0.532 . . . . 0.0 111.295 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.87 -36.12 77.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -65.68 -13.13 58.6 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.883 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -75.44 -8.01 55.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.9 1.227 . . . . 0.0 111.368 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.03 134.64 59.51 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 124.143 0.977 . . . . 0.0 111.048 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.14 112.9 2.65 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.719 2.279 . . . . 0.0 107.558 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.93 -3.98 14.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.848 1.69 . . . . 0.0 113.806 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -87.42 139.99 16.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 120.288 2.044 . . . . 0.0 109.486 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -118.75 -59.76 1.83 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.856 1.662 . . . . 0.0 108.815 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -135.76 158.99 43.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 162.75 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -144.5 107.83 4.58 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.24 122.65 68.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.795 0.838 . . . . 0.0 109.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.7 t -84.73 -177.74 6.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.22 1.008 . . . . 0.0 108.804 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.6 tp -132.44 -14.24 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.907 2.083 . . . . 0.0 109.214 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.68 -27.35 7.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.616 1.167 . . . . 0.0 112.281 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -89.97 -15.12 32.62 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 117.641 -1.171 . . . . 0.0 113.625 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.9 35.39 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 119.785 1.175 . . . . 0.0 110.557 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -122.08 154.39 37.39 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.763 1.225 . . . . 0.0 110.64 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.81 79.43 1.62 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.345 1.458 . . . . 0.0 110.255 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.68 145.83 55.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.664 0.786 . . . . 0.0 109.821 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.5 t -128.37 127.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.259 1.423 . . . . 0.0 107.67 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -93.57 -23.15 18.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.522 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.13 176.41 30.39 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.934 0.778 . . . . 0.0 111.601 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -95.5 10.39 36.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.519 1.528 . . . . 0.0 111.939 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.7 4.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.914 -0.491 . . . . 0.0 112.002 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.68 149.39 46.09 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.62 -33.23 46.09 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.202 1.935 . . . . 0.0 113.861 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -61.58 -47.97 83.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.98 69.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.061 0.545 . . . . 0.0 111.544 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.75 -59.0 2.98 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.564 0.746 . . . . 0.0 109.986 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.47 -39.98 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.091 0.957 . . . . 0.0 110.819 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -53.19 -51.33 62.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.26 1.424 . . . . 0.0 109.312 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.49 -26.18 65.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -83.73 -43.15 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 119.651 1.114 . . . . 0.0 108.604 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -60.67 -32.69 71.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.577 1.151 . . . . 0.0 108.663 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.84 -29.14 70.08 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.108 1.363 . . . . 0.0 110.841 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -79.6 -0.68 34.72 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.536 -0.727 . . . . 0.0 110.374 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 11.64 67.6 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.763 1.173 . . . . 0.0 114.563 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -102.98 -178.71 3.75 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.24 1.52 . . . . 0.0 108.104 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -116.42 130.95 57.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 118.167 -0.92 . . . . 0.0 108.627 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.18 159.05 43.03 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.822 0.737 . . . . 0.0 110.25 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.53 144.04 20.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.636 1.174 . . . . 0.0 108.631 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' ALA . 9.9 p -77.99 158.83 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -119.27 21.17 12.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 109.733 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 126.17 1.788 . . . . 0.0 106.374 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.476 0.655 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -121.52 128.68 52.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.29 145.89 51.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.938 1.695 . . . . 0.0 108.98 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' HD21 ' A' ' 65' ' ' LEU . 24.6 ttmm -109.32 119.06 38.34 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.4 t -109.09 146.46 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -141.57 126.26 17.98 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 126.54 -23.31 5.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.958 1.266 . . . . 0.0 113.015 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.1 mtm -68.03 118.4 11.16 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.261 1.531 . . . . 0.0 108.684 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -119.58 -8.7 9.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.732 0.813 . . . . 0.0 111.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.68 158.16 43.93 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.846 1.258 . . . . 0.0 108.399 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.27 -32.31 62.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 112.204 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -60.42 -34.75 74.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.531 0.605 . . . . 0.0 110.76 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m -69.13 -48.53 62.18 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -54.59 -54.09 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 125.103 1.361 . . . . 0.0 110.526 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ptm -60.86 -29.56 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.767 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.14 48.27 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.9 t -55.42 -46.2 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.854 1.261 . . . . 0.0 108.418 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.3 m -55.38 -53.56 54.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.894 0.878 . . . . 0.0 109.719 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -64.82 -40.52 95.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.073 -1.017 . . . . 0.0 112.613 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.52 98.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.004 0.521 . . . . 0.0 111.191 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.21 -44.02 92.26 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -65.87 -9.46 29.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.404 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -74.96 -24.78 58.51 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 121.428 1.922 . . . . 0.0 110.015 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.07 128.22 91.97 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 123.508 0.723 . . . . 0.0 110.72 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.06 108.25 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.152 2.568 . . . . 0.0 108.377 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.84 -4.48 7.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 124.559 1.076 . . . . 0.0 111.829 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.2 t -91.28 100.58 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 119.601 1.701 . . . . 0.0 110.946 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.25 -56.09 5.06 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.427 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -146.28 160.23 42.29 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -150.0 175.46 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 126.966 2.106 . . . . 0.0 108.918 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -152.46 143.75 23.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.77 126.01 6.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 t -84.2 176.42 8.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.9 tp -117.76 -13.99 10.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.68 1.592 . . . . 0.0 109.903 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -125.63 -39.06 2.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 112.814 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.37 -17.56 64.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.56 42.14 97.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -141.67 129.17 21.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.212 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.13 144.98 48.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 106.185 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.57 156.19 48.91 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 51' ' ' LEU . 16.5 t -128.12 142.26 44.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.559 1.144 . . . . 0.0 108.406 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -125.01 42.34 3.3 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.296 1.838 . . . . 0.0 110.142 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.4 -167.23 12.07 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.464 1.506 . . . . 0.0 112.796 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -104.53 3.37 31.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.457 1.903 . . . . 0.0 111.993 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.94 169.06 1.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.947 -1.095 . . . . 0.0 113.518 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.33 148.73 35.56 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.834 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -58.21 -34.49 98.61 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.472 2.115 . . . . 0.0 113.78 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -69.68 -52.65 23.73 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.165 0.986 . . . . 0.0 111.429 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.05 66.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 42' ' ' VAL . 67.3 mt -67.86 -60.65 2.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.365 1.466 . . . . 0.0 111.302 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -55.52 -44.93 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -57.62 -39.9 77.97 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.552 0.741 . . . . 0.0 111.366 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.71 -28.15 68.85 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.208 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.33 -37.18 15.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 108.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.0 -33.29 75.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.58 -12.47 61.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.878 1.271 . . . . 0.0 111.816 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -90.4 -9.79 46.27 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.31 1.414 . . . . 0.0 109.031 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.96 15.09 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.728 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -114.99 -179.37 3.61 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.618 1.709 . . . . 0.0 108.683 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -118.68 127.84 53.95 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.34 157.91 45.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.746 0.703 . . . . 0.0 111.37 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.03 135.16 13.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.535 1.534 . . . . 0.0 108.592 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 66' ' ' ALA . 7.1 p -77.97 147.81 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.885 0.766 . . . . 0.0 110.759 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.414 HD21 ' HE2' ' A' ' 5' ' ' LYS . 84.8 mt -123.77 20.21 9.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.678 2.391 . . . . 0.0 111.009 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.459 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.244 0.814 0 C-N-CA 124.565 1.146 . . . . 0.0 108.283 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.234 0.278 0 CA-C-O 119.51 -0.281 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.57 ' HE3' HD21 ' A' ' 41' ' ' LEU . 25.1 mtpt -115.54 134.88 54.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.781 1.232 . . . . 0.0 108.499 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mt -128.3 132.04 48.66 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.493 1.517 . . . . 0.0 108.373 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -92.0 117.55 29.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.56 159.73 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -143.65 148.92 36.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.42 63.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.488 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.0 mtm -73.82 109.4 7.29 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.582 2.191 . . . . 0.0 106.23 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.2 p -123.31 -6.13 8.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -150.02 162.62 40.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.108 -0.995 . . . . 0.0 108.792 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.38 -37.43 67.55 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.692 1.597 . . . . 0.0 111.262 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -64.89 -38.8 92.19 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 m -60.5 -46.52 89.82 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.22 -58.57 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptm -59.16 -37.52 77.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.59 69.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.513 0.597 . . . . 0.0 109.562 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.43 -44.04 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -52.64 -58.96 5.12 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 120.954 -1.091 . . . . 0.0 109.626 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.45 -36.96 81.85 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 112.702 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.61 67.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.0 0.92 . . . . 0.0 109.881 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.26 -46.18 15.16 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -24.01 39.75 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.095 1.358 . . . . 0.0 114.434 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -64.77 -24.1 67.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.75 1.159 . . . . 0.0 111.036 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.03 127.73 88.23 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 118.944 0.793 . . . . 0.0 110.585 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.62 110.75 2.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.594 2.196 . . . . 0.0 107.764 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 -9.86 6.91 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.993 1.759 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.0 t -88.75 104.01 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 118.4 1.1 . . . . 0.0 109.823 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.76 -64.69 0.82 Allowed 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -146.62 166.96 24.98 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.15 156.51 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.71 110.96 8.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.4 t -113.28 134.02 57.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.073 0.949 . . . . 0.0 109.01 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 t -114.78 125.77 54.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.792 1.237 . . . . 0.0 109.812 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.22 -37.56 80.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.49 0.716 . . . . 0.0 110.7 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.35 -54.43 9.46 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.03 0.532 . . . . 0.0 110.251 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.87 -28.17 68.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.205 0.912 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.94 26.59 74.56 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.61 164.59 16.27 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.965 1.306 . . . . 0.0 109.68 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.12 31.03 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.999 1.72 . . . . 0.0 108.14 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.57 HD21 ' HE3' ' A' ' 3' ' ' LYS . 3.3 mm? -108.13 136.16 48.28 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -121.55 125.53 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.0 -9.6 52.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.252 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.15 -166.07 4.49 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.901 1.238 . . . . 0.0 114.154 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -124.31 8.42 8.47 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.806 1.642 . . . . 0.0 111.176 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.25 158.71 16.53 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.273 1.029 . . . . 0.0 109.768 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 148.87 90.36 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 125.557 1.543 . . . . 0.0 110.06 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.51 -30.43 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.228 1.286 . . . . 0.0 111.585 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -63.76 -56.49 15.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.818 1.247 . . . . 0.0 108.251 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.22 67.35 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.29 -55.32 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.855 1.262 . . . . 0.0 111.211 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.13 -43.94 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.399 1.0 . . . . 0.0 111.39 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -46.46 82.89 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.831 1.252 . . . . 0.0 108.264 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -23.01 60.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.241 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.06 -42.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.345 1.43 . . . . 0.0 109.71 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.59 -26.91 68.84 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.52 -15.94 63.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.428 1.891 . . . . 0.0 113.156 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -97.7 -6.09 33.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.665 1.12 . . . . 0.0 109.055 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.87 6.86 53.9 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.317 0.96 . . . . 0.0 112.624 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -95.48 -170.47 2.17 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -132.19 134.04 44.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.37 167.55 21.65 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 118.329 0.513 . . . . 0.0 111.422 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -159.57 130.86 6.05 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 124.811 1.244 . . . . 0.0 108.687 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 66' ' ' ALA . 1.8 p -74.9 130.98 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.09 16.25 18.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.082 0.953 . . . . 0.0 112.638 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.588 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.537 1.535 . . . . 0.0 110.61 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 C--O 1.236 0.368 0 CA-C-O 122.558 1.171 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -159.13 131.58 6.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mt -138.23 160.06 40.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.15 1.38 . . . . 0.0 109.309 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -126.98 145.91 50.53 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.5 141.04 44.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 127.391 2.277 . . . . 0.0 109.5 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.84 114.2 10.24 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.116 1.366 . . . . 0.0 108.237 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.62 -6.62 5.23 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.911 1.72 . . . . 0.0 115.0 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -68.28 155.02 40.58 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.88 2.34 . . . . 0.0 109.816 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -137.15 -41.43 0.58 Allowed 'General case' 0 C--N 1.339 0.12 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 m -136.73 169.15 18.2 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 124.581 1.152 . . . . 0.0 109.699 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -49.55 -43.09 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.514 1.525 . . . . 0.0 111.698 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -58.75 -37.76 76.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.106 0.563 . . . . 0.0 111.67 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.99 -39.81 94.03 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.01 -58.81 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 109.449 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -53.33 -37.06 61.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.94 -55.15 38.65 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.911 0.862 . . . . 0.0 108.797 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.09 -40.84 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.396 1.078 . . . . 0.0 110.021 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.4 m -55.69 -46.0 77.72 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.986 1.267 . . . . 0.0 108.12 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -67.81 -36.36 80.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.206 -0.934 . . . . 0.0 111.315 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.01 73.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.774 0.715 . . . . 0.0 111.385 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mt -61.24 -39.45 90.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.657 1.117 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -67.42 -9.65 43.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.882 0.873 . . . . 0.0 112.834 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.31 -29.09 66.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.021 1.282 . . . . 0.0 109.544 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -58.89 129.52 85.57 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.231 1.413 . . . . 0.0 112.796 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.83 117.34 4.82 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 122.445 2.097 . . . . 0.0 107.66 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.82 -14.43 12.79 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 126.423 1.963 . . . . 0.0 112.613 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.3 140.89 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-N 119.335 1.567 . . . . 0.0 107.757 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -121.49 -54.88 1.96 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.248 1.019 . . . . 0.0 108.49 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -137.27 153.97 50.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -140.92 168.76 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.199 0.937 . . . . 0.0 111.033 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.92 138.66 34.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.652 2.381 . . . . 0.0 104.631 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -151.65 136.53 10.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -137.19 129.55 29.74 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.682 0.674 . . . . 0.0 110.369 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -66.47 -48.82 68.65 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.663 1.185 . . . . 0.0 109.81 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -61.3 -35.18 76.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -84.27 -29.92 26.05 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.283 0.633 . . . . 0.0 111.941 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.56 33.39 71.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.85 169.52 17.62 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.042 1.421 . . . . 0.0 112.787 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.33 140.25 33.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.931 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.8 149.6 47.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.416 1.886 . . . . 0.0 106.899 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -131.18 133.66 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.79 2.036 . . . . 0.0 108.243 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -100.22 -3.97 30.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.742 0.817 . . . . 0.0 111.669 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.19 -170.67 46.49 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.294 0.949 . . . . 0.0 113.296 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 t -101.08 3.82 41.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.957 1.703 . . . . 0.0 111.483 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.55 153.84 9.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.004 0.922 . . . . 0.0 112.849 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 150.64 61.02 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.102 0.561 . . . . 0.0 110.578 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.58 -40.85 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.483 2.122 . . . . 0.0 113.009 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -55.68 -47.22 77.14 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.625 0.77 . . . . 0.0 110.714 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.57 79.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.262 0.625 . . . . 0.0 111.623 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.6 mt -67.24 -52.52 40.02 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 123.839 0.856 . . . . 0.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 p -60.52 -40.51 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.12 -45.66 86.93 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.051 0.941 . . . . 0.0 109.929 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -85.96 -33.21 7.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.92 -32.74 74.59 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.34 -29.23 69.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.715 1.206 . . . . 0.0 109.782 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -78.33 -7.4 57.22 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.85 25.33 41.85 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.681 1.61 . . . . 0.0 113.475 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.45 177.88 4.66 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -115.22 98.33 6.71 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.717 0.807 . . . . 0.0 109.685 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.0 161.53 13.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.688 -0.632 . . . . 0.0 110.747 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -151.36 138.76 19.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.155 0.982 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.9 t -78.06 138.72 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.38 9.65 18.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.054 0.942 . . . . 0.0 111.561 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.661 1.585 . . . . 0.0 108.722 179.319 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.418 HD11 ' HD3' ' A' ' 48' ' ' PRO . 6.0 mt . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.87 130.37 56.8 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 108.713 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.06 151.68 51.62 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 125.37 1.468 . . . . 0.0 107.315 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -118.52 120.86 38.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.42 138.89 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -137.05 102.95 4.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.86 -8.56 1.76 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.801 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.5 mtm -75.38 130.35 38.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.5 t -136.15 14.33 3.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.263 0.483 . . . . 0.0 111.753 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 t -160.93 165.27 30.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.938 -1.101 . . . . 0.0 109.646 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -61.28 -33.22 73.2 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.365 1.066 . . . . 0.0 110.973 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.27 -25.57 63.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.983 0.513 . . . . 0.0 111.656 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -71.67 -47.01 57.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -55.46 -56.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.66 0.784 . . . . 0.0 109.54 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.2 ptm -58.54 -34.13 70.66 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.66 -51.1 66.6 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.37 -39.06 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.616 1.167 . . . . 0.0 109.4 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.1 m -57.05 -50.26 73.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.292 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -69.87 -37.78 76.18 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.656 -1.278 . . . . 0.0 111.468 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.37 78.83 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.439 1.095 . . . . 0.0 108.669 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.76 -41.17 60.58 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.927 -1.108 . . . . 0.0 109.276 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -64.78 -16.54 63.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -13.76 60.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.74 1.609 . . . . 0.0 110.987 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.54 130.14 89.34 Favored Pre-proline 0 N--CA 1.452 -0.351 0 C-N-CA 124.581 1.153 . . . . 0.0 110.623 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.56 111.51 2.13 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 106.073 -2.318 . . . . 0.0 106.073 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.95 -3.9 9.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.758 1.647 . . . . 0.0 112.318 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.05 138.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.587 2.193 . . . . 0.0 109.076 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.52 -51.9 1.72 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.565 1.546 . . . . 0.0 111.451 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -139.47 153.58 47.56 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 m -147.4 166.28 5.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.24 94.17 2.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.342 1.057 . . . . 0.0 109.993 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.17 134.01 38.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.639 1.176 . . . . 0.0 108.609 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -131.6 134.53 46.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.073 0.949 . . . . 0.0 109.902 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.3 tp -76.99 -42.07 40.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.81 -53.03 62.8 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.844 0.857 . . . . 0.0 110.183 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -14.92 55.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.839 -1.076 . . . . 0.0 113.395 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 55.16 29.71 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.4 170.06 18.15 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.849 -0.795 . . . . 0.0 110.577 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.9 95.26 2.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.668 1.187 . . . . 0.0 113.312 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.46 152.82 40.61 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.891 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.19 135.89 60.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.269 1.428 . . . . 0.0 108.249 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -103.65 -19.26 14.4 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.738 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.73 -172.1 28.6 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.3 p -103.53 8.78 37.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.649 1.179 . . . . 0.0 112.425 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.18 155.1 7.01 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.479 0.711 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 151.25 65.5 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 122.859 0.464 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' HD11 ' A' ' 2' ' ' LEU . 22.8 Cg_endo -63.14 -40.16 34.93 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.989 1.792 . . . . 0.0 114.91 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.567 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -59.05 -45.33 91.04 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.411 0.684 . . . . 0.0 110.095 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.39 -32.02 72.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.275 -0.265 . . . . 0.0 111.47 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.1 mt -69.42 -57.68 4.96 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.261 1.024 . . . . 0.0 109.981 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.49 -40.49 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.48 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -53.37 -51.97 60.79 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.925 0.89 . . . . 0.0 110.127 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -28.26 65.03 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.6 -39.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -60.77 -39.47 88.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.84 -21.84 66.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 0.0 112.279 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -86.27 -9.41 56.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.223 0.919 . . . . 0.0 110.468 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.97 21.45 18.27 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.657 -1.079 . . . . 0.0 114.229 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.93 179.55 4.08 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.415 1.608 . . . . 0.0 108.048 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -120.57 109.48 15.31 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.24 165.64 12.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 118.902 0.774 . . . . 0.0 110.353 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -157.91 132.63 8.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.877 -0.514 . . . . 0.0 111.339 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.78 147.86 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.46 33.83 4.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.29 1.036 . . . . 0.0 110.177 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.569 2.348 . . . . 0.0 107.028 179.26 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mt . . . . . 0 C--O 1.233 0.196 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -132.26 123.66 27.38 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.448 HD21 ' HB ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -126.57 133.11 51.16 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.711 0.804 . . . . 0.0 109.436 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -88.19 121.27 30.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.28 150.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -142.48 120.49 12.08 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.77 -10.71 9.61 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.05 1.31 . . . . 0.0 115.141 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.2 mtm -74.92 111.88 10.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 120.052 1.926 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.67 11.42 9.14 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.533 0.733 . . . . 0.0 111.797 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.0 t -151.24 151.86 32.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -60.76 -27.96 68.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.902 0.481 . . . . 0.0 110.599 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -63.26 -32.5 73.93 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.844 0.747 . . . . 0.0 110.4 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -64.89 -47.74 76.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -57.17 -57.03 11.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.296 1.038 . . . . 0.0 110.057 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ptm -63.78 -36.46 83.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.95 -49.51 65.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.491 1.041 . . . . 0.0 108.582 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.46 -32.11 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.905 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -57.12 -43.74 82.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -67.52 -47.26 70.46 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.163 -0.96 . . . . 0.0 109.954 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.38 -46.66 69.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.525 0.73 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.88 -38.09 86.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.786 1.234 . . . . 0.0 109.511 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -76.77 -6.99 54.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 117.322 -1.323 . . . . 0.0 111.167 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.73 -27.66 63.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.207 1.821 . . . . 0.0 107.669 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.67 120.69 47.7 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 125.018 1.327 . . . . 0.0 107.75 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.3 101.49 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.48 2.787 . . . . 0.0 109.456 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.88 -7.4 1.91 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.858 1.694 . . . . 0.0 111.801 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.56 141.12 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 120.495 -1.591 . . . . 0.0 111.074 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.79 -59.44 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.011 1.324 . . . . 0.0 107.743 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -135.68 157.27 47.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.849 1.259 . . . . 0.0 108.711 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 t -142.33 145.43 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.37 77.02 1.45 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.611 1.964 . . . . 0.0 109.742 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.3 t -85.89 143.05 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -141.61 133.47 27.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.24 1.016 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.59 -64.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.788 1.635 . . . . 0.0 112.373 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.03 -30.2 71.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.202 2.201 . . . . 0.0 114.924 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -81.91 -15.25 54.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.775 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.82 35.77 83.9 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -139.44 166.78 23.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 122.406 1.098 . . . . 0.0 112.273 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -145.82 129.3 16.94 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.281 2.633 . . . . 0.0 105.67 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mt -121.16 154.45 36.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.3 t -129.39 152.77 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.653 1.216 . . . . 0.0 111.326 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -135.2 111.38 9.63 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 100.909 -3.737 . . . . 0.0 100.909 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.71 -177.49 37.95 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 p -94.61 -0.65 54.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 111.535 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 144.94 54.05 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 111.909 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -80.82 149.27 67.01 Favored Pre-proline 0 N--CA 1.465 0.309 0 C-N-CA 125.454 1.501 . . . . 0.0 110.218 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.57 -38.57 81.58 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.519 2.146 . . . . 0.0 116.145 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -63.35 -46.77 85.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 110.477 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.23 65.68 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.74 -56.45 6.36 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.764 0.826 . . . . 0.0 110.094 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.448 ' HB ' HD21 ' A' ' 4' ' ' LEU . 1.4 p -57.02 -45.11 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.736 0.698 . . . . 0.0 109.579 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.84 -47.79 60.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 111.288 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.18 66.49 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -88.99 -35.64 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -63.85 -33.89 76.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.45 -25.7 68.12 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.68 0.792 . . . . 0.0 111.019 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.04 -4.19 56.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.038 0.836 . . . . 0.0 110.603 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.58 19.11 35.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.806 1.185 . . . . 0.0 114.137 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -113.32 177.24 4.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.961 1.381 . . . . 0.0 108.944 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -116.01 116.46 27.94 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.23 154.49 38.7 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -153.72 138.28 16.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.587 1.155 . . . . 0.0 108.966 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.87 140.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.446 -0.784 . . . . 0.0 111.13 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -98.94 19.36 15.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.735 1.214 . . . . 0.0 110.82 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.893 2.077 . . . . 0.0 105.473 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.236 0.356 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -123.74 159.41 29.5 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 108.019 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mt -157.05 131.8 8.78 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -99.57 122.5 42.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.68 144.4 22.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -135.59 125.28 25.35 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.43 -15.95 8.05 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.298 -1.279 . . . . 0.0 114.221 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 69.6 mtm -65.2 131.97 47.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.401 2.1 . . . . 0.0 106.944 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -134.45 -21.85 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.3 m -135.45 167.62 20.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.47 1.032 . . . . 0.0 109.137 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.4 -36.66 64.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.411 1.485 . . . . 0.0 109.11 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -59.32 -44.3 92.58 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.853 1.661 . . . . 0.0 110.195 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 m -59.77 -43.98 94.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.32 -53.85 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.021 0.529 . . . . 0.0 110.101 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ptm -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.104 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.29 -59.92 4.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.967 0.803 . . . . 0.0 108.879 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.16 -38.74 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.534 0.734 . . . . 0.0 109.994 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -58.66 -52.87 63.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.076 -1.64 . . . . 0.0 109.161 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -61.6 -43.84 98.12 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 121.623 -0.673 . . . . 0.0 112.33 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.27 86.07 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.681 0.613 . . . . 0.0 110.793 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.57 -39.46 93.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 0.0 109.497 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -67.05 -11.79 58.1 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.14 -17.93 60.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.883 1.219 . . . . 0.0 110.082 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.64 133.95 95.27 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 124.575 1.15 . . . . 0.0 111.616 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.66 115.99 4.2 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.218 1.945 . . . . 0.0 107.553 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.56 26.8 Favored Glycine 0 C--N 1.318 -0.457 0 C-N-CA 126.537 2.018 . . . . 0.0 113.627 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -80.98 131.13 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 120.755 2.278 . . . . 0.0 107.428 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -104.35 -62.41 1.32 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -136.06 158.18 45.04 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.986 0.915 . . . . 0.0 108.546 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.23 154.46 20.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 126.035 1.734 . . . . 0.0 107.525 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -145.29 112.15 5.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.18 149.8 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.821 0.849 . . . . 0.0 110.349 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -126.96 135.41 50.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.104 1.362 . . . . 0.0 109.033 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 tp -84.45 -21.09 30.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.362 0.665 . . . . 0.0 110.65 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -84.3 -38.29 20.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.313 1.045 . . . . 0.0 111.967 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -98.86 -13.06 20.24 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.6 33.33 81.55 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 120.043 1.292 . . . . 0.0 111.382 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -119.31 148.84 42.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.233 1.013 . . . . 0.0 108.568 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.19 98.73 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 109.214 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.7 mm? -83.99 147.41 27.46 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.46 151.01 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 125.011 1.324 . . . . 0.0 107.456 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.75 -9.73 7.28 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.26 -168.1 41.19 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.07 0.85 . . . . 0.0 114.458 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.1 p -100.2 9.48 42.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.206 1.403 . . . . 0.0 111.203 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.5 155.5 18.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.54 0.736 . . . . 0.0 111.749 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.83 149.41 50.8 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.513 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.4 -37.46 17.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 112.291 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.79 -36.56 67.53 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.26 0.624 . . . . 0.0 111.676 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.88 26.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.115 0.966 . . . . 0.0 112.175 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 mt -63.91 -53.35 51.76 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.296 1.038 . . . . 0.0 109.77 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.38 -39.96 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.538 0.608 . . . . 0.0 110.156 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -47.35 77.74 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.174 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.19 -18.8 50.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.81 -39.57 10.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 119.809 1.186 . . . . 0.0 108.838 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -66.78 -32.39 73.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.27 -13.16 62.06 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.982 0.81 . . . . 0.0 109.838 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.66 -6.6 45.99 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.445 -1.409 . . . . 0.0 108.926 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.15 2.42 71.16 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 128.215 2.817 . . . . 0.0 114.952 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -88.39 159.95 17.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 118.92 1.36 . . . . 0.0 107.651 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -98.07 118.26 34.26 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.23 162.98 24.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.524 0.602 . . . . 0.0 110.626 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -163.35 145.93 10.07 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.167 1.387 . . . . 0.0 109.105 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.49 150.94 5.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.5 mt -110.68 9.68 22.83 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.243 1.017 . . . . 0.0 110.995 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.644 1.578 . . . . 0.0 107.247 179.476 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.9 mt . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.187 0.517 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -137.03 143.98 42.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.38 157.93 44.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.328 2.651 . . . . 0.0 108.026 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -123.87 122.45 38.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 127.499 2.32 . . . . 0.0 105.485 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.26 145.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 125.766 1.626 . . . . 0.0 108.368 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.66 130.11 33.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.55 -11.08 12.52 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.248 -1.307 . . . . 0.0 112.343 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.7 mtm -71.75 138.01 48.14 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.345 2.073 . . . . 0.0 108.269 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.8 p -135.17 -15.27 1.97 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.91 177.14 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 109.556 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -62.08 -31.58 72.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.831 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -60.18 -35.71 75.99 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.472 1.033 . . . . 0.0 109.062 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.8 m -65.61 -47.76 74.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -55.9 -54.49 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.604 0.762 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -37.94 88.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.729 1.149 . . . . 0.0 111.58 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.61 -51.15 64.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.794 0.725 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.2 t -61.22 -40.76 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.677 1.191 . . . . 0.0 108.608 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.2 m -58.01 -61.11 2.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.58 -33.4 69.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.331 0.968 . . . . 0.0 112.951 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.71 95.97 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.93 -36.74 70.03 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.91 -1.119 . . . . 0.0 108.361 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -64.75 -33.52 76.16 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.759 -1.213 . . . . 0.0 114.166 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.27 -20.37 64.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.839 1.2 . . . . 0.0 113.15 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 128.41 89.81 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.51 102.74 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.217 2.612 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.12 -10.2 4.16 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.45 1.024 . . . . 0.0 111.574 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.41 132.1 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 118.464 1.132 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -104.54 -56.48 2.18 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.877 1.671 . . . . 0.0 108.556 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -138.74 159.87 41.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.569 1.148 . . . . 0.0 108.2 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 42' ' ' VAL . 47.7 t -140.44 159.57 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -135.68 122.75 21.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.68 159.77 41.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 119.429 1.013 . . . . 0.0 109.539 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -141.24 126.93 19.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.15 1.38 . . . . 0.0 109.086 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.21 -52.41 41.42 Favored 'General case' 0 N--CA 1.46 0.061 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -60.01 -56.61 19.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.237 1.015 . . . . 0.0 112.303 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -72.44 -28.07 62.72 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.203 0.456 . . . . 0.0 111.896 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.66 80.87 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -89.55 150.99 22.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.947 1.373 . . . . 0.0 108.242 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.09 139.16 39.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.95 156.17 49.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.611 HG21 HD22 ' A' ' 51' ' ' LEU . 12.8 t -128.27 144.22 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.438 1.095 . . . . 0.0 109.3 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -110.19 -4.02 15.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.33 -172.52 47.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.426 -0.796 . . . . 0.0 112.121 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -97.57 6.16 48.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.145 1.778 . . . . 0.0 110.892 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.57 167.98 4.01 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.74 1.216 . . . . 0.0 111.165 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -99.21 153.1 37.95 Favored Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 124.28 1.032 . . . . 0.0 112.877 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.25 -48.08 15.04 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.218 2.612 . . . . 0.0 113.91 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -61.18 -44.07 97.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 -178.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -31.81 72.43 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.873 -0.517 . . . . 0.0 111.888 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 42' ' ' VAL . 40.8 mt -73.11 -50.43 22.83 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.092 0.957 . . . . 0.0 110.76 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -60.19 -41.36 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.11 -56.1 16.58 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.415 1.486 . . . . 0.0 110.367 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.59 64.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.0 t -81.08 -34.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 119.275 0.943 . . . . 0.0 110.267 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.95 -26.97 68.53 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -66.33 -15.85 63.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.167 -0.958 . . . . 0.0 111.166 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -98.26 3.16 48.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.356 1.463 . . . . 0.0 111.338 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.53 85.66 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.996 0.816 . . . . 0.0 113.889 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.59 161.52 14.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -109.4 114.46 28.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.42 154.65 33.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.282 0.563 . . . . 0.0 111.523 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.86 133.93 17.1 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.3 150.74 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.245 1.418 . . . . 0.0 109.704 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.61 61.46 1.56 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.185 1.394 . . . . 0.0 109.676 -179.035 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.235 0.3 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -108.35 146.88 32.34 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.729 0.695 . . . . 0.0 110.71 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -139.0 156.18 47.42 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.443 1.497 . . . . 0.0 107.782 178.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -120.14 136.58 54.56 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -127.11 151.61 34.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 124.744 1.218 . . . . 0.0 107.955 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -141.69 145.91 35.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.86 -21.06 41.63 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.863 1.221 . . . . 0.0 112.781 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.5 mtm -66.7 122.56 17.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -125.79 -12.68 6.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.47 165.23 28.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.286 -0.884 . . . . 0.0 110.826 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -60.46 -34.25 73.74 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -62.73 -27.71 69.46 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.229 0.612 . . . . 0.0 110.716 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.93 -48.15 22.4 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.8 t -54.1 -57.3 6.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 123.784 0.834 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.2 ptm -55.36 -32.24 62.4 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.76 -54.42 31.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -63.49 -39.53 85.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.368 0.667 . . . . 0.0 109.794 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -56.17 -46.91 79.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.892 1.224 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -66.84 -43.69 83.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.127 -0.358 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.5 81.07 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.533 0.733 . . . . 0.0 110.1 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.59 -38.1 70.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.977 -1.077 . . . . 0.0 109.048 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -67.22 -30.63 70.61 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.696 -1.253 . . . . 0.0 114.299 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -65.66 -22.94 66.69 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.997 1.271 . . . . 0.0 110.186 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.2 t -56.87 130.3 78.57 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.52 110.48 1.63 Allowed 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.221 1.947 . . . . 0.0 110.532 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.55 19.56 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.224 1.392 . . . . 0.0 113.684 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -88.28 106.94 17.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 119.661 1.73 . . . . 0.0 111.912 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -81.51 -45.0 16.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.503 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -149.29 163.27 38.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.28 138.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -122.46 79.51 1.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 t -85.71 145.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.95 1.3 . . . . 0.0 109.184 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -134.97 131.81 37.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.845 1.258 . . . . 0.0 108.699 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.8 tp -68.94 -59.93 2.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.569 1.147 . . . . 0.0 109.318 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.17 -43.32 78.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.512 1.125 . . . . 0.0 111.969 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -81.97 -18.03 44.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 117.946 -1.026 . . . . 0.0 113.575 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.81 70.32 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -135.66 154.17 51.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.341 -1.093 . . . . 0.0 109.499 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.92 149.68 47.74 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.001 1.32 . . . . 0.0 109.96 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.84 129.62 40.66 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.28 118.82 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.705 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -82.14 -16.88 48.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.833 0.853 . . . . 0.0 111.026 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.76 177.28 31.03 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.341 0.972 . . . . 0.0 112.466 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 p -95.61 0.2 52.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.949 0.9 . . . . 0.0 113.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.06 148.66 0.8 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.596 1.958 . . . . 0.0 114.642 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -71.87 137.15 82.47 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -59.36 -41.07 61.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.248 1.966 . . . . 0.0 112.554 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -59.81 -32.8 70.98 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.633 1.173 . . . . 0.0 112.198 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -34.71 41.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.084 0.553 . . . . 0.0 110.15 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.14 -56.52 16.08 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.802 0.841 . . . . 0.0 109.252 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.03 -41.62 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.635 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -58.14 -45.13 87.91 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.721 0.691 . . . . 0.0 110.265 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.66 66.2 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.8 -38.6 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.373 -1.455 . . . . 0.0 108.163 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.73 -34.31 77.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.911 0.884 . . . . 0.0 110.576 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.74 -22.5 65.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.182 0.901 . . . . 0.0 110.733 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -85.01 0.75 50.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.33 1.052 . . . . 0.0 110.049 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.29 7.82 75.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.226 1.393 . . . . 0.0 115.014 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.56 166.68 11.91 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.871 1.335 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -106.23 110.17 22.33 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.15 165.06 16.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.747 0.654 . . . . 0.0 112.327 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.424 ' O ' HD23 ' A' ' 4' ' ' LEU . 12.5 pt-20 -162.32 141.56 9.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.552 1.941 . . . . 0.0 107.572 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 81.1 t -76.82 152.72 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.3 mt -126.58 59.15 1.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.438 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 C-N-CA 124.454 1.102 . . . . 0.0 108.812 177.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.415 HD11 ' HD3' ' A' ' 48' ' ' PRO . 2.2 mt . . . . . 0 CA--C 1.521 -0.173 0 CA-C-O 119.179 -0.438 . . . . 0.0 111.855 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.09 151.08 21.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.374 1.469 . . . . 0.0 111.331 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.18 144.49 24.01 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.244 1.818 . . . . 0.0 107.5 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.49 125.75 52.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.47 140.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.74 125.11 42.46 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.73 -9.68 8.59 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.984 1.278 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.1 mtm -74.1 90.17 2.01 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 107.252 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -98.36 -12.46 21.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.509 1.124 . . . . 0.0 112.416 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.8 m -136.19 162.08 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.398 -0.814 . . . . 0.0 110.247 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.89 -37.17 75.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.924 0.49 . . . . 0.0 110.207 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.72 -37.52 76.33 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.29 -46.95 88.05 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.18 0.9 . . . . 0.0 109.493 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.79 -55.12 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.202 1.001 . . . . 0.0 110.065 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptm -62.31 -28.93 70.08 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.674 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.11 -53.07 13.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.6 t -52.75 -47.14 51.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.946 1.298 . . . . 0.0 107.696 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 m -53.86 -55.07 30.09 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.418 1.087 . . . . 0.0 109.032 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -62.56 -36.78 83.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 117.92 -1.038 . . . . 0.0 113.292 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.65 71.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.158 0.89 . . . . 0.0 109.343 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.03 -41.01 99.42 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -61.97 -11.64 14.44 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.324 -0.846 . . . . 0.0 113.208 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -77.29 -20.28 55.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.028 1.286 . . . . 0.0 110.576 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.06 128.79 93.46 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.28 100.24 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.759 2.306 . . . . 0.0 111.542 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.3 -7.71 4.35 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.821 1.201 . . . . 0.0 112.463 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.52 104.6 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.213 -1.169 . . . . 0.0 111.005 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.15 -56.52 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -148.07 160.61 42.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.467 1.107 . . . . 0.0 108.671 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.14 153.62 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -137.14 90.62 2.54 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.1 t -99.16 139.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.401 1.48 . . . . 0.0 107.854 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -126.4 136.94 53.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.64 -60.59 3.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 125.029 1.332 . . . . 0.0 110.615 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.23 -46.1 89.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.815 1.246 . . . . 0.0 112.303 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -74.92 -31.45 61.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.494 -0.765 . . . . 0.0 113.057 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.09 40.93 55.54 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.61 167.41 21.72 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.238 -1.154 . . . . 0.0 109.206 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.4 123.73 20.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.397 1.879 . . . . 0.0 106.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.0 mt -111.51 143.63 42.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.439 HG21 HD22 ' A' ' 51' ' ' LEU . 42.1 t -122.04 126.53 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 119.893 1.224 . . . . 0.0 110.473 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -93.45 2.64 56.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.862 2.065 . . . . 0.0 110.387 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.94 -179.34 38.81 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.86 1.695 . . . . 0.0 112.932 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.5 p -96.18 4.75 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.483 1.913 . . . . 0.0 111.706 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.83 165.87 3.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.134 0.974 . . . . 0.0 112.73 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.07 147.56 33.16 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.965 2.106 . . . . 0.0 109.41 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HD3' HD11 ' A' ' 2' ' ' LEU . 36.5 Cg_endo -66.94 -42.17 8.83 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.933 1.755 . . . . 0.0 112.757 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -59.03 -30.23 67.87 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.329 0.968 . . . . 0.0 111.741 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -23.66 32.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 111.624 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 42' ' ' VAL . 42.9 mt -82.18 -56.46 3.91 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.022 2.129 . . . . 0.0 109.489 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.1 p -50.57 -40.57 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.016 1.326 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -58.66 -43.84 89.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.604 0.362 . . . . 0.0 110.99 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.36 -14.64 57.53 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.7 t -93.75 -43.32 13.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.528 1.131 . . . . 0.0 108.01 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.32 -30.82 71.85 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.306 1.042 . . . . 0.0 111.31 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.62 -9.57 59.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.829 0.852 . . . . 0.0 111.031 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.94 41.79 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 119.181 -0.789 . . . . 0.0 113.524 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -85.93 177.8 7.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.682 1.241 . . . . 0.0 107.817 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -114.69 134.07 55.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.81 158.34 44.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.477 0.581 . . . . 0.0 112.041 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.77 136.29 11.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.611 1.565 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' ALA . 8.7 p -77.76 131.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.056 -1.028 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -101.9 22.68 12.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.438 -0.789 . . . . 0.0 110.343 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.419 1.887 . . . . 0.0 111.203 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 48' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -111.77 136.46 51.01 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.678 1.591 . . . . 0.0 110.888 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.77 159.94 40.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.413 1.085 . . . . 0.0 109.7 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HE2' ' OE1' ' A' ' 7' ' ' GLU . 3.2 ttpm? -127.82 123.18 34.53 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.97 137.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' HE2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -120.05 148.77 43.17 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.88 -12.48 65.77 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 117.783 -1.565 . . . . 0.0 113.54 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.8 mtm -66.11 146.15 55.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.729 2.264 . . . . 0.0 108.24 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.0 p -136.11 -38.04 0.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.2 m -141.68 179.83 6.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.11 1.364 . . . . 0.0 109.401 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -52.99 -36.0 59.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.258 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -52.34 -35.16 50.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.944 0.793 . . . . 0.0 111.068 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -74.57 -55.62 5.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.2 t -49.59 -51.85 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.952 1.301 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.8 ptm -65.64 -37.57 86.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.705 0.802 . . . . 0.0 112.743 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.12 -53.65 50.11 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.4 -48.54 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.58 1.952 . . . . 0.0 108.832 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.4 m -54.01 -61.76 2.09 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.565 1.146 . . . . 0.0 110.389 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.16 -26.69 68.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.99 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.03 -45.13 67.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.476 1.035 . . . . 0.0 109.092 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.87 -32.12 69.17 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HA ' HG11 ' A' ' 28' ' ' VAL . 47.1 mttm -70.12 -13.47 62.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -78.49 -7.45 57.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.898 1.226 . . . . 0.0 111.638 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 28' ' ' VAL . 94.6 t -78.74 127.49 80.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.294 1.438 . . . . 0.0 112.11 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.98 107.05 1.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.856 2.371 . . . . 0.0 111.927 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 -9.71 7.11 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 126.498 1.999 . . . . 0.0 113.342 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.8 p -78.57 146.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.46 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -124.96 -53.6 1.64 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.182 1.793 . . . . 0.0 108.122 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -132.6 147.46 52.35 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.811 0.844 . . . . 0.0 109.426 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.99 155.34 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.644 1.978 . . . . 0.0 106.05 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -145.17 138.2 26.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -135.41 140.8 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -130.77 116.81 18.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.203 1.001 . . . . 0.0 110.657 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 tp -60.2 -54.61 43.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.158 0.583 . . . . 0.0 109.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.95 -38.42 72.92 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -85.36 -17.74 35.86 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.45 25.52 67.04 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -126.86 155.05 43.56 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 118.265 1.032 . . . . 0.0 110.672 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.43 125.74 29.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.091 1.756 . . . . 0.0 106.503 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.67 138.87 49.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.83 146.75 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.82 -12.05 10.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.279 1.032 . . . . 0.0 111.453 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.36 37.48 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.0 p -98.07 8.1 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.448 1.499 . . . . 0.0 111.547 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.72 143.92 11.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.275 1.03 . . . . 0.0 111.594 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.52 149.41 95.56 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.439 ' HB3' HD21 ' A' ' 2' ' ' LEU . 20.2 Cg_endo -61.36 -51.46 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.819 1.679 . . . . 0.0 112.597 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -53.98 -34.94 61.17 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.633 1.173 . . . . 0.0 112.792 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.21 -31.46 60.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.791 0.837 . . . . 0.0 112.805 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -68.89 -50.3 50.81 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.53 -44.61 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -48.99 -49.74 39.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.819 0.848 . . . . 0.0 111.524 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.62 -27.99 69.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.041 -0.981 . . . . 0.0 113.632 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.8 t -88.71 -31.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 120.074 1.307 . . . . 0.0 110.711 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -61.52 -32.8 72.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.08 -0.99 23.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.735 2.414 . . . . 0.0 112.973 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.1 -10.44 17.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.782 1.174 . . . . 0.0 110.569 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.41 24.79 11.78 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.066 -0.852 . . . . 0.0 112.04 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -126.13 161.4 27.73 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.888 1.275 . . . . 0.0 108.019 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -98.74 106.38 18.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.38 155.48 18.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.343 0.519 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -154.15 133.3 12.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.28 1.432 . . . . 0.0 108.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 66' ' ' ALA . 97.0 t -89.46 129.95 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.2 mt -109.89 32.1 5.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.764 1.226 . . . . 0.0 110.945 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.473 ' H ' HG12 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.245 0.833 0 C-N-CA 125.087 1.355 . . . . 0.0 107.368 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -113.67 113.5 25.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.103 1.361 . . . . 0.0 109.364 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -112.79 124.22 52.08 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.281 1.032 . . . . 0.0 109.255 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -90.13 122.11 32.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.86 151.63 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.005 0.922 . . . . 0.0 110.919 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.83 144.88 47.85 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.141 1.776 . . . . 0.0 106.214 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.0 -12.99 49.49 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.793 2.14 . . . . 0.0 111.999 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.0 mtm -74.62 75.28 2.01 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.132 1.466 . . . . 0.0 111.1 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.5 p -80.63 -33.79 35.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.555 -0.716 . . . . 0.0 111.676 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.6 m -118.1 161.43 19.85 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.238 1.415 . . . . 0.0 113.154 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.271 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -64.59 -32.51 74.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.271 1.028 . . . . 0.0 108.773 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 m -72.95 -49.79 27.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -52.02 -48.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.774 1.23 . . . . 0.0 110.765 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.5 ptm -63.72 -36.63 84.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.734 0.697 . . . . 0.0 112.125 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.17 -50.82 59.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.95 -39.65 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.553 1.141 . . . . 0.0 108.761 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.1 m -60.5 -59.24 5.71 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.258 -0.901 . . . . 0.0 108.866 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.18 -35.85 78.25 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.889 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.93 95.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.424 1.09 . . . . 0.0 109.877 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.0 mt -65.13 -33.62 76.45 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.809 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -74.12 6.53 3.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -90.8 -13.02 34.68 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.277 -1.514 . . . . 0.0 108.996 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 28' ' ' VAL . 58.4 t -74.49 132.12 79.06 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.626 1.57 . . . . 0.0 112.629 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.55 109.09 1.98 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.085 1.857 . . . . 0.0 110.879 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.23 -7.64 7.58 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.786 1.66 . . . . 0.0 114.706 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 23' ' ' LYS . 13.9 p -80.17 136.0 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 1.36 . . . . 0.0 112.253 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -97.29 -61.38 1.41 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -145.72 165.82 27.66 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.058 1.343 . . . . 0.0 107.447 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.1 t -145.86 143.36 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -125.05 101.1 6.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 t -100.61 136.92 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 m -119.63 132.62 55.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.745 1.218 . . . . 0.0 109.385 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.2 -68.72 0.27 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.656 1.583 . . . . 0.0 111.431 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.21 -53.42 35.24 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.918 1.687 . . . . 0.0 112.858 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.15 -21.89 64.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.987 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.36 39.54 92.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -132.02 157.84 43.08 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.656 1.182 . . . . 0.0 109.401 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.76 129.57 40.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.262 2.225 . . . . 0.0 107.263 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.24 102.3 10.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -82.27 126.06 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -96.31 -10.24 28.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.308 1.443 . . . . 0.0 113.784 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.88 -173.17 39.32 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -99.8 14.26 30.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.958 1.303 . . . . 0.0 112.248 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 150.83 3.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.212 0.605 . . . . 0.0 110.531 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.77 140.64 58.91 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 123.283 0.633 . . . . 0.0 111.617 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.93 -41.98 56.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.467 2.111 . . . . 0.0 113.219 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -57.66 -36.03 71.35 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.833 1.253 . . . . 0.0 112.529 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.82 -30.78 22.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.788 . . . . 0.0 111.616 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.7 mt -67.79 -55.04 14.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.223 1.009 . . . . 0.0 109.252 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.86 -43.42 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -55.94 -52.61 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.369 1.067 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 -25.94 36.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.76 -40.9 16.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 119.207 0.912 . . . . 0.0 108.648 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.68 -37.15 86.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.384 0.538 . . . . 0.0 109.559 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.51 -19.83 64.0 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.015 0.526 . . . . 0.0 111.369 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -86.52 -5.21 59.21 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.509 -1.369 . . . . 0.0 110.982 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.82 13.15 51.28 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.386 0.993 . . . . 0.0 112.961 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -105.71 -177.74 3.45 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -126.52 137.55 53.38 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.4 35.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 123.684 0.615 . . . . 0.0 110.292 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.5 138.76 14.7 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.188 1.395 . . . . 0.0 108.034 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.05 119.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -81.1 23.28 0.58 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.16 1.784 . . . . 0.0 109.232 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--O 1.234 0.241 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -117.02 130.11 56.46 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.144 1.378 . . . . 0.0 111.714 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.52 164.42 26.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.433 1.493 . . . . 0.0 110.331 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.56 128.31 44.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.57 2.748 . . . . 0.0 105.527 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.77 145.03 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -137.94 109.93 7.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.33 -11.1 2.5 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.476 1.513 . . . . 0.0 115.875 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.5 mtm -72.34 127.44 32.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 121.029 2.414 . . . . 0.0 112.708 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -133.27 -5.85 3.0 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.141 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.1 m -145.63 164.89 30.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.904 1.281 . . . . 0.0 109.912 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.33 -40.9 71.74 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.956 1.303 . . . . 0.0 110.672 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 16' ' ' MET . 3.6 t60 -56.84 -38.3 72.47 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.108 0.563 . . . . 0.0 111.546 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 m -59.92 -47.44 85.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 t -57.09 -49.04 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 109.375 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.412 ' HG2' ' HA ' ' A' ' 13' ' ' HIS . 27.3 ptm -65.83 -39.53 90.91 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.536 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.33 -53.19 60.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.57 1.077 . . . . 0.0 109.283 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -49.57 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 109.382 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.9 m -55.11 -50.1 70.06 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.277 1.031 . . . . 0.0 109.583 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -60.43 -46.76 88.88 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.949 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.32 81.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 123.704 0.628 . . . . 0.0 110.133 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.28 -33.44 75.52 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.254 0.621 . . . . 0.0 110.358 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.621 ' HA ' HG11 ' A' ' 28' ' ' VAL . 59.5 mtpt -76.24 -11.81 59.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.402 -0.808 . . . . 0.0 112.221 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.5 -7.72 56.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.307 1.412 . . . . 0.0 111.488 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 28' ' ' VAL . 58.9 t -73.25 142.38 81.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 112.526 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.74 112.64 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.015 1.81 . . . . 0.0 109.875 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.69 26.92 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.374 1.464 . . . . 0.0 115.67 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.621 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.2 p -77.19 145.42 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 119.6 1.7 . . . . 0.0 109.822 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -120.14 -57.9 1.9 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.557 1.143 . . . . 0.0 109.063 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -133.32 152.59 51.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.57 144.69 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -124.31 99.61 6.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 t -107.47 117.51 53.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -80.15 174.92 11.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.5 tp -122.55 -33.96 3.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -99.2 -32.8 11.04 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.057 0.844 . . . . 0.0 111.228 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -74.36 -17.53 60.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.39 32.97 84.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.647 1.112 . . . . 0.0 112.593 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -133.65 153.31 51.78 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.799 -1.412 . . . . 0.0 107.342 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.35 148.74 50.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.9 mt -140.53 158.46 43.96 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.2 t -134.51 143.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.567 1.147 . . . . 0.0 111.565 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -100.69 -33.8 10.12 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.961 0.904 . . . . 0.0 110.022 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.46 177.28 1.87 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.851 0.738 . . . . 0.0 113.816 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 t -89.06 6.54 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.173 1.389 . . . . 0.0 110.951 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.37 151.99 3.73 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.369 0.668 . . . . 0.0 112.405 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.59 146.17 52.73 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.7 -37.96 53.19 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.409 2.073 . . . . 0.0 113.069 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.34 -48.55 80.19 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.698 0.799 . . . . 0.0 111.262 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.41 -24.89 63.91 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.874 -0.516 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.8 mt -74.21 -55.37 6.13 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.701 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 -44.43 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.708 0.685 . . . . 0.0 109.43 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.24 -51.59 61.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.196 1.798 . . . . 0.0 111.25 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.15 -35.72 71.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.81 -40.7 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 121.198 -0.939 . . . . 0.0 108.929 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -61.51 -33.59 74.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.923 0.889 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.73 -23.43 66.74 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.231 1.012 . . . . 0.0 111.72 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -86.62 3.76 43.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.399 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.54 80.94 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.669 1.604 . . . . 0.0 114.474 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.84 177.32 6.22 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.52 1.66 . . . . 0.0 107.188 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -114.14 133.31 55.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.19 167.82 19.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.079 0.943 . . . . 0.0 111.631 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.49 146.57 16.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.873 1.269 . . . . 0.0 109.787 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.57 141.66 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.07 34.94 3.45 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.521 0.728 . . . . 0.0 111.038 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.423 0 C-N-CA 127.907 2.483 . . . . 0.0 107.219 179.1 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 121.435 0.636 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -127.57 118.3 23.67 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 128.215 2.606 . . . . 0.0 109.489 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.77 152.26 36.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -119.59 122.67 42.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -107.32 150.98 9.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -135.46 160.25 39.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.43 -22.81 25.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.211 -1.327 . . . . 0.0 111.729 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 32.0 mtm -64.19 146.65 53.93 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.626 1.713 . . . . 0.0 107.262 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.2 p -136.91 -22.08 1.22 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.5 p -145.29 177.08 9.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.086 0.946 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -62.49 -31.73 72.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.402 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.49 -39.45 91.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -62.37 -49.93 73.59 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 t -54.44 -56.28 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.506 1.523 . . . . 0.0 110.651 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -34.49 69.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.957 0.799 . . . . 0.0 112.607 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.88 45.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.234 0.925 . . . . 0.0 109.715 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.434 HG21 HG13 ' A' ' 55' ' ' VAL . 2.7 p -60.92 -38.16 78.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.109 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.723 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -56.31 -48.93 75.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -65.2 -34.6 78.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.507 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.83 -41.1 75.41 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 108.454 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.37 -39.1 86.02 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.801 -1.187 . . . . 0.0 110.081 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -65.31 -14.24 60.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -69.24 -27.51 65.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.98 0.809 . . . . 0.0 110.715 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.25 134.21 93.15 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.68 1.192 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.24 108.27 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.255 2.637 . . . . 0.0 110.425 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.03 -2.51 19.32 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-O 119.204 -0.775 . . . . 0.0 113.012 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -86.99 98.23 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 119.254 1.527 . . . . 0.0 110.583 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.17 -44.16 39.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.541 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.38 158.61 41.74 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.56 143.76 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.72 87.42 2.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.993 1.317 . . . . 0.0 107.658 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.74 145.94 6.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -139.83 122.04 15.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.477 1.111 . . . . 0.0 111.239 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.83 -39.75 79.83 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -60.02 -29.5 68.53 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.383 1.473 . . . . 0.0 112.546 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -102.65 -30.5 10.89 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.55 1.14 . . . . 0.0 113.565 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.18 21.75 66.92 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.49 161.91 19.77 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -1.156 . . . . 0.0 111.772 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.97 108.52 7.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.153 2.181 . . . . 0.0 106.548 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.28 151.13 19.8 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.533 HG21 HD22 ' A' ' 51' ' ' LEU . 46.5 t -128.06 124.7 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 119.894 1.224 . . . . 0.0 108.975 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -88.07 -13.61 41.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.49 -176.95 16.13 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.626 1.584 . . . . 0.0 114.198 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.0 t -103.62 -6.67 21.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.634 1.973 . . . . 0.0 113.912 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.33 157.93 0.91 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.745 2.018 . . . . 0.0 115.556 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.26 146.39 58.06 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 123.422 0.689 . . . . 0.0 110.254 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.3 -34.31 55.97 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.75 1.633 . . . . 0.0 113.477 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -61.46 -39.72 91.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.178 1.354 . . . . 0.0 112.114 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.2 78.56 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.533 HD22 HG21 ' A' ' 42' ' ' VAL . 41.9 mt -66.6 -47.13 73.67 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 124.905 1.282 . . . . 0.0 108.842 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.07 -48.27 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -59.8 -27.73 66.83 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.45 87.5 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.073 0.852 . . . . 0.0 110.52 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.434 HG13 HG21 ' A' ' 18' ' ' VAL . 29.4 t -84.02 -44.2 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 125.254 1.422 . . . . 0.0 110.455 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -65.19 -6.57 9.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.309 1.044 . . . . 0.0 111.777 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -107.07 -13.6 15.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.807 1.185 . . . . 0.0 109.482 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -83.89 -10.77 57.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.346 1.459 . . . . 0.0 110.251 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.9 29.11 7.03 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.604 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -136.3 172.36 13.12 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.18 1.49 . . . . 0.0 109.949 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -102.74 142.74 33.39 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.11 141.24 44.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -131.13 116.7 18.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.628 1.571 . . . . 0.0 108.266 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' ALA . 2.4 p -77.09 139.54 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -120.53 45.38 2.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.252 1.216 0 C-N-CA 125.244 1.418 . . . . 0.0 107.555 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.489 0.185 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -136.55 133.62 36.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.696 1.599 . . . . 0.0 109.372 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.475 HD21 HG22 ' A' ' 52' ' ' VAL . 7.0 mt -138.26 149.61 45.89 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 126.213 1.805 . . . . 0.0 107.5 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -110.45 129.14 55.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.07 147.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -137.42 114.48 10.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.553 1.141 . . . . 0.0 108.156 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.29 -10.75 4.11 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.745 1.641 . . . . 0.0 113.887 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.4 mtm -73.42 97.09 2.47 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.689 1.744 . . . . 0.0 107.809 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -115.19 3.36 14.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.682 1.193 . . . . 0.0 111.139 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 m -146.57 152.9 39.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.433 1.493 . . . . 0.0 107.441 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -60.56 -36.19 77.88 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -59.18 -32.64 70.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.397 1.079 . . . . 0.0 110.478 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.4 m -66.46 -39.66 88.94 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -59.73 -59.26 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.2 ptm -57.49 -33.71 68.3 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.943 0.792 . . . . 0.0 112.991 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.24 -53.53 53.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.54 1.064 . . . . 0.0 109.604 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.81 -39.8 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.109 1.363 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m -59.97 -46.02 90.78 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.928 -1.108 . . . . 0.0 108.846 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -44.84 95.94 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 121.819 -0.55 . . . . 0.0 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.43 95.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.4 -33.36 74.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.588 1.085 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.597 ' HA ' HG11 ' A' ' 28' ' ' VAL . 35.6 mttm -76.33 -16.85 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.052 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -76.28 -17.28 59.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.536 1.971 . . . . 0.0 111.733 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 28' ' ' VAL . 86.5 t -62.07 140.0 95.94 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 126.805 2.042 . . . . 0.0 112.711 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.06 108.71 2.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 109.923 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.92 -6.83 9.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.171 1.843 . . . . 0.0 114.728 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.597 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.4 p -80.97 159.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.118 1.459 . . . . 0.0 108.013 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -130.71 -64.62 0.82 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -132.56 159.92 38.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 108.302 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.6 139.09 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -128.45 106.92 9.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.06 154.58 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.747 1.219 . . . . 0.0 111.501 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.6 t -129.61 129.34 44.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.303 1.841 . . . . 0.0 109.563 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.01 -43.22 88.31 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.744 0.817 . . . . 0.0 109.996 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.31 -47.9 46.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -76.98 -20.62 55.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 35.54 92.17 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -128.96 137.47 51.4 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.02 136.78 54.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.283 2.233 . . . . 0.0 108.822 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.45 155.46 38.85 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 51' ' ' LEU . 7.0 t -129.29 122.12 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -81.36 -18.67 44.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.605 1.162 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.32 -168.74 27.62 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.623 1.106 . . . . 0.0 113.189 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -105.96 5.75 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.245 1.418 . . . . 0.0 113.067 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.3 147.79 9.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.647 0.658 . . . . 0.0 110.902 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.74 146.93 83.85 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.01 -39.33 71.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.297 1.998 . . . . 0.0 114.615 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -60.12 -41.99 93.79 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.605 0.639 . . . . 0.0 109.625 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.64 76.53 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.832 -0.542 . . . . 0.0 109.849 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 42' ' ' VAL . 95.9 mt -68.91 -49.37 58.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.041 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 4' ' ' LEU . 53.6 t -55.04 -49.13 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -49.69 -54.39 19.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.466 1.106 . . . . 0.0 109.439 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.18 -34.86 47.07 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 60' ' ' TYR . 15.4 t -79.35 -42.48 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.21 -40.06 88.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.104 1.762 . . . . 0.0 109.191 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.4 -4.19 17.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.167 2.187 . . . . 0.0 111.892 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -110.64 2.21 18.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.723 1.209 . . . . 0.0 109.832 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.98 22.4 57.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.12 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 55' ' ' VAL . 64.3 m-85 -106.89 170.05 8.18 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -109.92 121.16 44.61 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.64 151.73 48.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.707 0.685 . . . . 0.0 109.92 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.91 125.91 15.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.24 153.16 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -111.34 18.83 18.86 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.061 0.945 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.465 1.106 . . . . 0.0 108.76 179.3 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.229 0.538 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -138.93 129.13 25.45 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.739 1.616 . . . . 0.0 108.581 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.522 HD22 ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -125.76 156.3 39.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 127.53 2.332 . . . . 0.0 108.211 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -113.73 136.03 53.29 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.23 137.55 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 125.581 1.553 . . . . 0.0 108.093 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -132.98 128.77 37.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.69 -14.8 7.59 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.133 -1.37 . . . . 0.0 112.377 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 67.1 mtm -73.69 133.45 43.38 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.934 1.867 . . . . 0.0 106.828 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -126.72 -22.88 3.81 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.954 0.343 . . . . 0.0 111.658 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.2 m -139.32 167.69 21.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.749 1.62 . . . . 0.0 108.598 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -57.12 -37.57 72.18 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.093 0.957 . . . . 0.0 113.253 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -58.62 -33.06 69.61 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.2 m -62.97 -35.33 79.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.476 0.58 . . . . 0.0 110.503 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.85 -51.29 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.523 1.529 . . . . 0.0 109.568 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -63.84 -31.94 73.28 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.307 -0.871 . . . . 0.0 111.315 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.97 4.84 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.625 HG21 HG13 ' A' ' 55' ' ' VAL . 5.0 p -58.06 -35.13 51.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 111.764 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 m -56.58 -43.36 79.97 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -66.96 -44.71 79.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.192 -0.942 . . . . 0.0 111.262 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.87 97.53 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.446 0.641 . . . . 0.0 110.701 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -32.68 73.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.437 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -79.86 -4.85 53.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.658 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.37 -23.3 40.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.52 1.509 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.12 126.16 72.69 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 125.475 1.51 . . . . 0.0 111.503 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 110.59 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.705 2.27 . . . . 0.0 106.433 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.04 -1.43 7.81 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.315 1.912 . . . . 0.0 112.07 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.8 t -100.49 138.38 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 119.756 1.778 . . . . 0.0 110.886 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -123.17 -52.47 1.86 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.615 1.566 . . . . 0.0 110.308 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -128.01 149.1 50.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.3 165.81 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 125.275 1.609 . . . . 0.0 108.045 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -152.96 97.44 2.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.374 0.669 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.2 156.4 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.951 -1.093 . . . . 0.0 108.853 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -144.63 135.62 25.01 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.87 0.868 . . . . 0.0 110.291 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.0 tp -66.56 -52.04 49.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.557 0.743 . . . . 0.0 109.838 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -53.99 -65.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.092 2.157 . . . . 0.0 112.187 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -69.35 -17.9 63.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.194 -0.908 . . . . 0.0 112.722 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.89 31.59 68.51 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.263 0.938 . . . . 0.0 111.097 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -122.1 156.98 32.47 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.922 0.889 . . . . 0.0 110.212 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.45 130.88 28.93 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.44 1.896 . . . . 0.0 109.64 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.04 158.05 34.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 51' ' ' LEU . 95.3 t -136.67 142.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.484 1.114 . . . . 0.0 108.866 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -104.17 -17.61 14.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.655 0.782 . . . . 0.0 111.45 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.16 -177.83 21.95 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 t -90.37 2.49 55.53 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.231 -1.158 . . . . 0.0 111.746 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 149.94 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -82.02 148.23 59.93 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 124.684 1.194 . . . . 0.0 111.318 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.27 -41.08 44.7 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.078 1.852 . . . . 0.0 113.202 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -58.46 -40.82 83.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.02 0.528 . . . . 0.0 110.821 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.77 -32.38 67.62 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.024 0.829 . . . . 0.0 110.672 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 42' ' ' VAL . 96.3 mt -67.46 -56.19 10.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.485 1.114 . . . . 0.0 110.004 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.42 ' HB ' HD21 ' A' ' 4' ' ' LEU . 7.8 p -57.35 -42.81 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.877 0.762 . . . . 0.0 109.461 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -57.99 -41.61 83.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.679 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.75 -19.0 47.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.386 0.993 . . . . 0.0 112.57 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.625 HG13 HG21 ' A' ' 18' ' ' VAL . 19.5 t -94.04 -36.88 7.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 108.566 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -67.6 -31.11 70.93 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.71 -17.73 62.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.122 1.769 . . . . 0.0 110.602 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.19 -3.98 49.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.612 1.565 . . . . 0.0 110.258 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.8 10.42 63.06 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 125.185 1.374 . . . . 0.0 114.731 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.48 ' HB2' HG12 ' A' ' 55' ' ' VAL . 91.9 m-85 -98.56 -176.76 3.47 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.498 1.649 . . . . 0.0 108.415 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -122.27 119.37 30.96 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HB1' HD22 ' A' ' 4' ' ' LEU . . . -130.51 161.26 31.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.89 0.768 . . . . 0.0 110.355 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.471 ' C ' HD23 ' A' ' 4' ' ' LEU . 14.6 tt0 -156.86 138.48 14.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.211 1.404 . . . . 0.0 109.196 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.48 133.76 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.9 mt -88.86 24.11 2.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.023 0.929 . . . . 0.0 112.804 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.757 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.011 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.235 0.312 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.25 150.04 52.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.775 0.83 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mt -144.1 155.82 44.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.215 2.206 . . . . 0.0 105.918 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -121.44 118.48 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.15 134.88 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.99 115.13 14.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.39 -6.29 4.25 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.533 2.016 . . . . 0.0 113.173 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 72.2 mtm -77.09 129.37 35.95 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.379 2.09 . . . . 0.0 107.132 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -141.04 16.08 2.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.0 0.818 . . . . 0.0 111.901 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t -156.17 156.92 35.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.616 1.566 . . . . 0.0 108.525 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.34 -35.72 74.38 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.989 0.916 . . . . 0.0 109.543 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -60.49 -36.04 77.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.45 0.7 . . . . 0.0 110.213 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 m -62.08 -47.01 86.56 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.35 -56.02 13.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.754 0.822 . . . . 0.0 110.436 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . 0.261 5.3 ppp? -62.57 -27.48 69.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.619 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.33 -51.29 15.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 108.278 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.21 -40.19 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.4 m -60.02 -45.22 93.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.981 0.913 . . . . 0.0 108.849 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -62.46 -47.0 85.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 121.009 -1.057 . . . . 0.0 111.01 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.83 84.09 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.4 mt -64.7 -39.05 93.0 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.899 -1.126 . . . . 0.0 110.055 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.682 ' HA ' HG11 ' A' ' 28' ' ' VAL . 47.0 mttm -72.82 -14.36 61.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.952 -1.092 . . . . 0.0 113.057 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -13.17 59.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.098 1.317 . . . . 0.0 110.722 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 28' ' ' VAL . 59.4 t -70.01 130.6 89.7 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.749 1.619 . . . . 0.0 111.978 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.4 106.4 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.101 2.534 . . . . 0.0 110.638 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.95 -8.09 6.4 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.316 0.96 . . . . 0.0 115.03 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.682 HG11 ' HA ' ' A' ' 23' ' ' LYS . 10.2 p -75.36 150.17 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.207 1.503 . . . . 0.0 111.242 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.2 -58.48 1.99 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.828 1.651 . . . . 0.0 107.287 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -144.63 155.4 43.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.857 1.263 . . . . 0.0 108.144 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' CG2' ' HE2' ' A' ' 23' ' ' LYS . 2.1 m -138.93 152.65 24.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.949 1.699 . . . . 0.0 109.919 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -138.28 88.97 2.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.722 2.009 . . . . 0.0 109.247 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.87 148.11 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -135.01 116.43 14.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.565 1.146 . . . . 0.0 113.056 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.46 -39.72 92.35 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.636 1.174 . . . . 0.0 110.193 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.98 -54.34 8.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.518 0.727 . . . . 0.0 110.759 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 -21.81 62.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.169 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.2 31.93 82.42 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.32 159.4 40.38 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.454 1.502 . . . . 0.0 107.147 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.63 122.66 12.83 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.57 148.08 28.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.67 123.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.658 0.783 . . . . 0.0 110.062 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 -19.92 27.29 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.58 -172.74 5.05 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.402 1.477 . . . . 0.0 114.44 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.34 8.81 18.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 158.03 15.2 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.908 0.776 . . . . 0.0 109.84 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 145.88 79.03 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 124.259 1.023 . . . . 0.0 111.97 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.23 -35.77 61.31 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.627 1.551 . . . . 0.0 112.941 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -38.5 89.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.056 0.389 . . . . 0.0 110.882 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.36 -38.08 56.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.857 0.463 . . . . 0.0 110.31 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.67 -53.44 58.04 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 125.151 1.38 . . . . 0.0 110.731 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.27 -44.63 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -54.65 -50.28 68.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.731 1.213 . . . . 0.0 113.162 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.82 68.86 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.76 -43.51 86.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.393 0.677 . . . . 0.0 109.353 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.82 -28.85 70.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.103 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -63.8 -35.29 80.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.823 0.738 . . . . 0.0 110.511 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -70.88 -17.29 62.72 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.695 -0.628 . . . . 0.0 109.862 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.34 -6.45 26.69 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 126.062 1.792 . . . . 0.0 114.692 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -77.27 166.41 23.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.943 1.872 . . . . 0.0 110.13 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -97.75 128.62 44.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.22 147.23 50.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.26 142.69 18.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.058 1.343 . . . . 0.0 107.637 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.99 149.91 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.452 1.101 . . . . 0.0 111.424 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -117.87 25.68 10.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.147 1.379 . . . . 0.0 110.213 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.761 2.024 . . . . 0.0 108.961 -179.06 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.071 0.463 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.64 151.58 25.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 mt -147.9 143.55 27.46 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.061 1.345 . . . . 0.0 107.387 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -117.89 111.6 19.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.853 1.261 . . . . 0.0 108.327 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 158.87 3.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.3 134.97 13.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.35 -12.22 36.55 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.01 -1.439 . . . . 0.0 115.312 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.9 mtm -75.64 130.64 39.08 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.64 2.22 . . . . 0.0 108.612 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.29 0.6 OUTLIER -126.31 -1.2 6.98 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -149.77 157.91 43.66 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.1 1.36 . . . . 0.0 108.631 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.93 -28.72 58.12 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -63.94 -23.15 67.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.488 1.04 . . . . 0.0 111.209 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.63 -48.48 59.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.5 t -49.67 -58.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 125.935 1.694 . . . . 0.0 109.892 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.8 ptm -58.84 -26.67 64.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.69 -51.05 20.96 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.38 -41.42 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.888 1.675 . . . . 0.0 108.528 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.0 m -57.86 -59.05 5.84 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.231 0.923 . . . . 0.0 109.366 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -56.32 -39.11 72.25 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.314 0.645 . . . . 0.0 112.588 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.2 78.47 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.096 0.958 . . . . 0.0 108.783 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.03 -26.57 68.62 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.876 -1.765 . . . . 0.0 109.188 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.767 ' HA ' HG11 ' A' ' 28' ' ' VAL . 3.7 mtpm? -82.44 -9.6 59.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.789 0.836 . . . . 0.0 112.141 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.32 -12.26 60.23 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.41 1.005 . . . . 0.0 110.386 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 28' ' ' VAL . 37.8 t -78.16 123.42 86.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 126.755 2.022 . . . . 0.0 111.819 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.31 107.41 2.26 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.677 2.251 . . . . 0.0 110.766 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.16 -18.0 3.78 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.469 1.509 . . . . 0.0 112.166 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.767 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.9 p -72.2 161.76 4.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 120.873 -1.369 . . . . 0.0 109.675 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.78 -66.13 0.73 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -125.42 158.35 34.59 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.675 0.79 . . . . 0.0 110.189 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -150.73 164.11 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.908 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 144.75 26.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 t -144.2 136.77 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -134.01 114.84 13.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 118.362 0.528 . . . . 0.0 112.255 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 tp -56.98 -63.12 1.31 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 112.049 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.47 -28.86 47.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.076 1.35 . . . . 0.0 114.53 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -82.32 -57.66 3.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.074 0.95 . . . . 0.0 109.08 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.43 26.16 7.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.944 1.735 . . . . 0.0 110.209 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -136.29 169.47 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.341 1.571 . . . . 0.0 111.49 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.61 152.58 44.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.439 1.896 . . . . 0.0 108.767 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.43 156.32 43.37 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.964 2.106 . . . . 0.0 108.853 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.1 t -137.63 147.59 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -125.0 -7.99 7.18 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.58 -155.52 23.07 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.385 0.993 . . . . 0.0 113.112 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -106.38 6.36 30.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.515 1.926 . . . . 0.0 111.773 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 148.04 23.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.929 . . . . 0.0 111.121 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.48 146.61 70.24 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.904 1.281 . . . . 0.0 109.131 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.74 -42.3 26.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.206 1.937 . . . . 0.0 112.395 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -57.5 -38.52 74.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.469 0.708 . . . . 0.0 111.341 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.04 52.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.707 0.685 . . . . 0.0 110.846 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.61 -49.13 69.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.87 0.868 . . . . 0.0 109.743 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.27 -49.97 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.151 -0.452 . . . . 0.0 109.963 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -28.28 67.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.606 0.639 . . . . 0.0 112.65 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.45 -34.42 75.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.543 -0.723 . . . . 0.0 110.232 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -78.63 -39.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.94 -31.25 71.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.97 -22.46 67.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.731 0.812 . . . . 0.0 112.222 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -86.05 -4.12 59.1 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.281 1.032 . . . . 0.0 112.574 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.94 38.44 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.781 -1.011 . . . . 0.0 113.702 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.37 166.42 12.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.662 1.231 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -103.52 138.84 39.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.14 49.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.19 137.26 19.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 66' ' ' ALA . 48.3 t -83.17 141.35 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.978 0.911 . . . . 0.0 108.726 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.41 39.87 3.02 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.567 1.147 . . . . 0.0 108.405 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.453 ' H ' HG12 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.248 0.992 0 C-N-CA 125.958 1.703 . . . . 0.0 108.897 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--O 1.235 0.322 0 CA-C-O 119.469 -0.3 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -120.77 136.94 54.75 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 mt -133.75 157.12 46.66 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.731 2.012 . . . . 0.0 109.217 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.0 122.41 44.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.645 1.578 . . . . 0.0 106.968 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -105.38 142.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -136.89 147.43 46.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.13 -19.85 47.42 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.457 1.504 . . . . 0.0 113.126 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.8 mtm -70.44 125.7 27.55 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.863 1.831 . . . . 0.0 111.2 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -129.8 6.1 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.163 0.985 . . . . 0.0 111.608 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.6 t -144.39 146.55 32.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.119 0.968 . . . . 0.0 108.862 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.93 -32.37 71.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.744 0.418 . . . . 0.0 110.727 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -58.59 -30.38 67.16 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.525 -0.734 . . . . 0.0 111.038 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 m -69.5 -40.15 77.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.41 0.684 . . . . 0.0 109.382 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.52 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.246 1.018 . . . . 0.0 108.658 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 ptm -58.84 -35.87 73.62 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.68 -55.36 20.57 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.099 0.863 . . . . 0.0 109.505 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -65.79 -27.29 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.913 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 m -62.12 -42.76 99.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -65.87 -34.54 78.38 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 120.798 -1.189 . . . . 0.0 110.169 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.45 81.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.36 -29.26 68.8 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 110.11 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 28' ' ' VAL . 35.3 mttm -74.13 -10.58 59.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.834 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -81.56 -15.52 54.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.16 1.345 . . . . 0.0 111.024 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.25 128.08 90.58 Favored Pre-proline 0 N--CA 1.44 -0.94 0 C-N-CA 125.204 1.402 . . . . 0.0 112.022 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.6 109.18 1.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.415 2.076 . . . . 0.0 111.631 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.54 15.98 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.523 1.535 . . . . 0.0 113.178 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.4 p -75.62 154.24 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 119.367 1.583 . . . . 0.0 108.471 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -130.92 -57.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -135.28 145.34 47.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.1 m -124.56 153.58 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 127.115 2.166 . . . . 0.0 107.817 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 115.89 5.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 40' ' ' ALA . 2.4 t -130.96 156.77 43.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 118.922 0.783 . . . . 0.0 109.777 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -145.04 137.89 26.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.4 -47.76 54.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.193 0.997 . . . . 0.0 110.049 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.72 -34.11 72.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.412 0.685 . . . . 0.0 112.699 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -92.56 -30.76 15.49 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.565 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.0 94.71 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 106.236 -2.746 . . . . 0.0 106.236 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.61 147.27 48.6 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.97 1.308 . . . . 0.0 108.626 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -127.89 128.65 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.01 2.124 . . . . 0.0 108.117 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.93 150.83 39.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.409 1.484 . . . . 0.0 108.684 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 44' ' ' GLY . 72.7 t -127.51 139.18 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 123.469 0.708 . . . . 0.0 109.555 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -106.42 1.49 25.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.591 1.156 . . . . 0.0 111.537 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.458 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -95.11 -151.37 28.26 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.706 1.622 . . . . 0.0 109.581 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 11.54 8.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.802 1.641 . . . . 0.0 112.578 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.28 149.99 2.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.682 1.193 . . . . 0.0 113.065 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.18 140.22 87.94 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.227 1.011 . . . . 0.0 109.659 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.59 -45.19 11.88 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.439 1.426 . . . . 0.0 110.164 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -57.05 -37.61 72.05 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.449 1.499 . . . . 0.0 112.018 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.86 31.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.386 0.539 . . . . 0.0 110.796 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.84 -51.22 50.93 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.286 -0.884 . . . . 0.0 108.75 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 p -60.08 -37.32 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.99 -50.26 71.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.134 0.974 . . . . 0.0 111.659 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.17 35.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.334 0.97 . . . . 0.0 113.423 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 90.2 t -74.14 -46.75 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.34 1.456 . . . . 0.0 108.618 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.57 -31.06 71.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.338 0.655 . . . . 0.0 110.378 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.56 -33.34 75.69 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -78.5 -17.51 56.15 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.4 -0.813 . . . . 0.0 108.866 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.89 5.95 35.15 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 117.241 -1.866 . . . . 0.0 117.074 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -96.32 160.42 14.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.067 1.933 . . . . 0.0 109.072 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -85.89 137.74 32.53 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.21 140.95 37.92 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.87 134.29 14.37 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.965 1.306 . . . . 0.0 108.608 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.42 131.29 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 127.062 2.145 . . . . 0.0 111.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt -98.82 37.6 1.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.856 1.262 . . . . 0.0 111.148 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.997 1.719 . . . . 0.0 107.957 178.769 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.24 145.8 42.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.475 1.11 . . . . 0.0 109.518 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.19 139.15 28.57 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 108.947 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -105.14 111.16 23.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -88.41 162.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -152.47 122.51 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.24 -10.59 9.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.614 1.578 . . . . 0.0 113.547 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.5 mtm -73.99 122.39 22.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.586 2.193 . . . . 0.0 109.544 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.7 p -121.12 -12.17 8.74 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 m -137.11 165.49 25.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.925 0.89 . . . . 0.0 110.674 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -60.54 -27.74 67.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.449 1.099 . . . . 0.0 109.604 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -42.27 98.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.8 -40.76 96.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.055 0.388 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.68 -53.02 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.5 ptm -64.65 -43.58 93.16 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.893 0.77 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.0 -57.62 10.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.772 0.829 . . . . 0.0 110.177 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 55' ' ' VAL . 2.4 p -60.42 -38.28 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.595 HG22 ' HE2' ' A' ' 23' ' ' LYS . 50.0 m -57.97 -42.27 84.71 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.186 -0.947 . . . . 0.0 110.271 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.54 -43.9 79.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.969 . . . . 0.0 110.593 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.91 85.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 122.807 0.443 . . . . 0.0 110.131 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -62.49 -36.08 81.4 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.242 -1.536 . . . . 0.0 108.376 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.773 ' HA ' HG11 ' A' ' 28' ' ' VAL . 49.1 mttm -69.24 -7.28 35.36 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.742 -1.224 . . . . 0.0 112.381 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -73.15 -17.78 61.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.719 1.6 . . . . 0.0 110.723 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 28' ' ' VAL . 70.4 t -76.13 133.6 71.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.42 108.09 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.871 2.38 . . . . 0.0 112.846 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.46 -17.91 6.48 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.84 1.686 . . . . 0.0 113.174 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.773 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.9 p -62.33 144.34 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.475 1.637 . . . . 0.0 110.873 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -122.77 -54.49 1.84 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.097 0.959 . . . . 0.0 108.502 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -140.41 150.49 43.93 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 t -133.25 142.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.47 96.72 4.5 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 t -108.27 152.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.977 0.911 . . . . 0.0 109.321 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -146.67 138.2 24.44 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.467 0.576 . . . . 0.0 111.013 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.63 -52.21 41.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.466 1.106 . . . . 0.0 110.403 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -58.9 -38.12 78.15 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.699 1.6 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -86.39 -26.4 24.8 Favored 'General case' 0 N--CA 1.458 -0.067 0 O-C-N 121.988 -0.445 . . . . 0.0 110.623 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.43 35.23 88.22 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.47 158.42 43.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.69 135.3 48.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.801 2.04 . . . . 0.0 107.532 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -122.23 146.76 46.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.419 HG21 HD22 ' A' ' 51' ' ' LEU . 48.1 t -132.62 136.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 118.813 0.733 . . . . 0.0 109.444 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.6 -14.54 16.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.8 1.24 . . . . 0.0 111.432 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.83 -175.07 40.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.19 -0.944 . . . . 0.0 113.47 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.0 p -91.63 12.05 22.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.0 2.12 . . . . 0.0 110.236 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.75 149.17 14.95 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.549 -0.72 . . . . 0.0 111.134 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.03 142.97 60.54 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.304 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.0 -47.98 15.97 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.474 2.783 . . . . 0.0 112.799 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -58.73 -38.83 79.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.331 0.514 . . . . 0.0 110.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.22 -29.6 68.47 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.401 -0.812 . . . . 0.0 110.643 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD22 HG21 ' A' ' 42' ' ' VAL . 89.4 mt -65.22 -55.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -58.77 -42.81 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.67 -52.73 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.688 1.195 . . . . 0.0 110.257 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -22.91 60.11 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 18' ' ' VAL . 81.4 t -87.11 -38.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 120.806 -1.184 . . . . 0.0 108.245 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.47 -31.44 68.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.48 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.22 -22.79 67.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.179 0.9 . . . . 0.0 110.559 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.89 -12.49 47.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.978 1.311 . . . . 0.0 110.235 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.44 -3.93 40.18 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.218 1.389 . . . . 0.0 116.04 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -81.73 165.2 21.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.192 1.996 . . . . 0.0 109.641 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.18 114.01 25.67 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.62 156.83 33.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.75 139.36 15.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.959 0.904 . . . . 0.0 109.118 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.7 t -78.91 140.53 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.93 50.87 0.76 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.914 0.885 . . . . 0.0 108.719 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.443 0 C-N-CA 127.168 2.187 . . . . 0.0 108.607 179.239 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptm . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mt -70.6 150.54 45.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.849 0.357 . . . . 0.0 111.262 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -116.18 131.15 57.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.713 1.605 . . . . 0.0 109.866 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -132.63 144.38 50.32 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.549 1.539 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -110.94 115.73 30.0 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.88 142.64 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.53 115.97 13.65 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.581 0.753 . . . . 0.0 109.888 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.62 -17.03 5.31 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.446 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.5 mtm -73.4 107.99 6.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.742 1.771 . . . . 0.0 107.612 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -121.23 16.9 11.51 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.908 -0.495 . . . . 0.0 111.209 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.0 t -151.94 152.46 32.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.63 1.172 . . . . 0.0 108.039 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -61.0 -30.95 70.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.002 0.521 . . . . 0.0 110.014 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.15 -39.24 81.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 110.765 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.4 m -63.68 -53.66 47.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.241 1.016 . . . . 0.0 108.968 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.92 -50.45 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 125.561 1.545 . . . . 0.0 110.839 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.9 ptm -63.49 -40.97 98.49 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.706 1.139 . . . . 0.0 112.355 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.94 79.65 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.29 -39.15 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.758 2.023 . . . . 0.0 110.471 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -55.48 -58.86 6.01 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.49 -41.07 96.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.653 -0.654 . . . . 0.0 111.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -43.13 77.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.029 0.532 . . . . 0.0 111.295 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.87 -36.12 77.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -65.68 -13.13 58.6 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.883 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -75.44 -8.01 55.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.9 1.227 . . . . 0.0 111.368 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.8 t -79.03 134.64 59.51 Favored Pre-proline 0 N--CA 1.45 -0.443 0 C-N-CA 124.143 0.977 . . . . 0.0 111.048 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.14 112.9 2.65 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.719 2.279 . . . . 0.0 107.558 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.93 -3.98 14.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.848 1.69 . . . . 0.0 113.806 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -87.42 139.99 16.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 120.288 2.044 . . . . 0.0 109.486 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -118.75 -59.76 1.83 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.856 1.662 . . . . 0.0 108.815 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -135.76 158.99 43.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.73 162.75 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -144.5 107.83 4.58 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.24 122.65 68.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.795 0.838 . . . . 0.0 109.796 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.7 t -84.73 -177.74 6.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.22 1.008 . . . . 0.0 108.804 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.6 tp -132.44 -14.24 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.907 2.083 . . . . 0.0 109.214 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.68 -27.35 7.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.616 1.167 . . . . 0.0 112.281 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -89.97 -15.12 32.62 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 117.641 -1.171 . . . . 0.0 113.625 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.9 35.39 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 119.785 1.175 . . . . 0.0 110.557 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -122.08 154.39 37.39 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.763 1.225 . . . . 0.0 110.64 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.81 79.43 1.62 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.345 1.458 . . . . 0.0 110.255 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.68 145.83 55.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.664 0.786 . . . . 0.0 109.821 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.5 t -128.37 127.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.259 1.423 . . . . 0.0 107.67 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -93.57 -23.15 18.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.795 0.838 . . . . 0.0 110.522 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.13 176.41 30.39 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.934 0.778 . . . . 0.0 111.601 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -95.5 10.39 36.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.519 1.528 . . . . 0.0 111.939 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.7 4.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.914 -0.491 . . . . 0.0 112.002 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.68 149.39 46.09 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.62 -33.23 46.09 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.202 1.935 . . . . 0.0 113.861 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -61.58 -47.97 83.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.98 69.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.061 0.545 . . . . 0.0 111.544 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.75 -59.0 2.98 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.564 0.746 . . . . 0.0 109.986 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.47 -39.98 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.091 0.957 . . . . 0.0 110.819 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -53.19 -51.33 62.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.26 1.424 . . . . 0.0 109.312 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.49 -26.18 65.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -83.73 -43.15 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 119.651 1.114 . . . . 0.0 108.604 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -60.67 -32.69 71.88 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.577 1.151 . . . . 0.0 108.663 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.84 -29.14 70.08 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.108 1.363 . . . . 0.0 110.841 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -79.6 -0.68 34.72 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.536 -0.727 . . . . 0.0 110.374 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.86 11.64 67.6 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.763 1.173 . . . . 0.0 114.563 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -102.98 -178.71 3.75 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.24 1.52 . . . . 0.0 108.104 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -116.42 130.95 57.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 118.167 -0.92 . . . . 0.0 108.627 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.18 159.05 43.03 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.822 0.737 . . . . 0.0 110.25 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.53 144.04 20.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.636 1.174 . . . . 0.0 108.631 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' ALA . 9.9 p -77.99 158.83 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -119.27 21.17 12.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 109.733 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 126.17 1.788 . . . . 0.0 106.374 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ttt . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.46 156.57 22.42 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.503 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -121.52 128.68 52.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.29 145.89 51.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.938 1.695 . . . . 0.0 108.98 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' HD21 ' A' ' 65' ' ' LEU . 24.6 ttmm -109.32 119.06 38.34 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.4 t -109.09 146.46 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -141.57 126.26 17.98 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 126.54 -23.31 5.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.958 1.266 . . . . 0.0 113.015 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.1 mtm -68.03 118.4 11.16 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.261 1.531 . . . . 0.0 108.684 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -119.58 -8.7 9.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.732 0.813 . . . . 0.0 111.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.68 158.16 43.93 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.846 1.258 . . . . 0.0 108.399 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.27 -32.31 62.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 112.204 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -60.42 -34.75 74.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.531 0.605 . . . . 0.0 110.76 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m -69.13 -48.53 62.18 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -54.59 -54.09 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 125.103 1.361 . . . . 0.0 110.526 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ptm -60.86 -29.56 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.767 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.14 48.27 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.9 t -55.42 -46.2 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.854 1.261 . . . . 0.0 108.418 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.3 m -55.38 -53.56 54.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.894 0.878 . . . . 0.0 109.719 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -64.82 -40.52 95.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.073 -1.017 . . . . 0.0 112.613 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.52 98.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.004 0.521 . . . . 0.0 111.191 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.21 -44.02 92.26 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -65.87 -9.46 29.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.404 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -74.96 -24.78 58.51 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 121.428 1.922 . . . . 0.0 110.015 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.07 128.22 91.97 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 123.508 0.723 . . . . 0.0 110.72 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.06 108.25 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.152 2.568 . . . . 0.0 108.377 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.84 -4.48 7.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 124.559 1.076 . . . . 0.0 111.829 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.2 t -91.28 100.58 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 119.601 1.701 . . . . 0.0 110.946 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.25 -56.09 5.06 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.427 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -146.28 160.23 42.29 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.4 m -150.0 175.46 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 126.966 2.106 . . . . 0.0 108.918 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -152.46 143.75 23.26 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.77 126.01 6.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 t -84.2 176.42 8.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.9 tp -117.76 -13.99 10.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.68 1.592 . . . . 0.0 109.903 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -125.63 -39.06 2.18 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 112.814 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.37 -17.56 64.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.56 42.14 97.58 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -141.67 129.17 21.35 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.212 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.13 144.98 48.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 106.185 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.57 156.19 48.91 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 51' ' ' LEU . 16.5 t -128.12 142.26 44.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.559 1.144 . . . . 0.0 108.406 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -125.01 42.34 3.3 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.296 1.838 . . . . 0.0 110.142 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.4 -167.23 12.07 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.464 1.506 . . . . 0.0 112.796 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -104.53 3.37 31.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.457 1.903 . . . . 0.0 111.993 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.94 169.06 1.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.947 -1.095 . . . . 0.0 113.518 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.33 148.73 35.56 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.834 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -58.21 -34.49 98.61 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.472 2.115 . . . . 0.0 113.78 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -69.68 -52.65 23.73 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.165 0.986 . . . . 0.0 111.429 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.05 66.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 42' ' ' VAL . 67.3 mt -67.86 -60.65 2.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.365 1.466 . . . . 0.0 111.302 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -55.52 -44.93 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -57.62 -39.9 77.97 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.552 0.741 . . . . 0.0 111.366 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.71 -28.15 68.85 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.208 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.33 -37.18 15.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 108.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.0 -33.29 75.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.58 -12.47 61.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.878 1.271 . . . . 0.0 111.816 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -90.4 -9.79 46.27 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.31 1.414 . . . . 0.0 109.031 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.82 20.96 15.09 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.728 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -114.99 -179.37 3.61 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.618 1.709 . . . . 0.0 108.683 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -118.68 127.84 53.95 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.34 157.91 45.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.746 0.703 . . . . 0.0 111.37 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.03 135.16 13.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.535 1.534 . . . . 0.0 108.592 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 66' ' ' ALA . 7.1 p -77.97 147.81 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.885 0.766 . . . . 0.0 110.759 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.414 HD21 ' HE2' ' A' ' 5' ' ' LYS . 84.8 mt -123.77 20.21 9.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.678 2.391 . . . . 0.0 111.009 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.459 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.244 0.814 0 C-N-CA 124.565 1.146 . . . . 0.0 108.283 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 119.122 -0.466 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mt -88.92 151.14 22.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.186 0.448 . . . . 0.0 110.987 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.57 ' HE3' HD21 ' A' ' 41' ' ' LEU . 25.1 mtpt -115.54 134.88 54.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.781 1.232 . . . . 0.0 108.499 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mt -128.3 132.04 48.66 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.493 1.517 . . . . 0.0 108.373 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -92.0 117.55 29.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.56 159.73 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -143.65 148.92 36.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.42 63.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.488 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.0 mtm -73.82 109.4 7.29 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.582 2.191 . . . . 0.0 106.23 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.2 p -123.31 -6.13 8.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -150.02 162.62 40.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.108 -0.995 . . . . 0.0 108.792 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.38 -37.43 67.55 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.692 1.597 . . . . 0.0 111.262 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -64.89 -38.8 92.19 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 m -60.5 -46.52 89.82 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.22 -58.57 3.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ptm -59.16 -37.52 77.54 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.59 69.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.513 0.597 . . . . 0.0 109.562 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.43 -44.04 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.1 m -52.64 -58.96 5.12 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 120.954 -1.091 . . . . 0.0 109.626 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.45 -36.96 81.85 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 112.702 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.61 67.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.0 0.92 . . . . 0.0 109.881 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.26 -46.18 15.16 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -24.01 39.75 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.095 1.358 . . . . 0.0 114.434 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -64.77 -24.1 67.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.75 1.159 . . . . 0.0 111.036 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.03 127.73 88.23 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 118.944 0.793 . . . . 0.0 110.585 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.62 110.75 2.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.594 2.196 . . . . 0.0 107.764 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 -9.86 6.91 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.993 1.759 . . . . 0.0 111.045 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.0 t -88.75 104.01 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 118.4 1.1 . . . . 0.0 109.823 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.76 -64.69 0.82 Allowed 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -146.62 166.96 24.98 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.15 156.51 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.71 110.96 8.4 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 36.4 t -113.28 134.02 57.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.073 0.949 . . . . 0.0 109.01 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 t -114.78 125.77 54.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.792 1.237 . . . . 0.0 109.812 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.22 -37.56 80.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.49 0.716 . . . . 0.0 110.7 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.35 -54.43 9.46 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.03 0.532 . . . . 0.0 110.251 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.87 -28.17 68.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.205 0.912 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.94 26.59 74.56 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.61 164.59 16.27 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.965 1.306 . . . . 0.0 109.68 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.12 31.03 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.999 1.72 . . . . 0.0 108.14 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.57 HD21 ' HE3' ' A' ' 3' ' ' LYS . 3.3 mm? -108.13 136.16 48.28 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 1' ' ' MET . 95.0 t -121.55 125.53 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.0 -9.6 52.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.252 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.15 -166.07 4.49 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.901 1.238 . . . . 0.0 114.154 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -124.31 8.42 8.47 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.806 1.642 . . . . 0.0 111.176 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.25 158.71 16.53 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.273 1.029 . . . . 0.0 109.768 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 148.87 90.36 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 125.557 1.543 . . . . 0.0 110.06 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.51 -30.43 35.73 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.228 1.286 . . . . 0.0 111.585 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -63.76 -56.49 15.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.818 1.247 . . . . 0.0 108.251 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.22 67.35 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.29 -55.32 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.855 1.262 . . . . 0.0 111.211 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.13 -43.94 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.399 1.0 . . . . 0.0 111.39 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -46.46 82.89 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.831 1.252 . . . . 0.0 108.264 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -23.01 60.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.241 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.06 -42.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.345 1.43 . . . . 0.0 109.71 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.59 -26.91 68.84 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.52 -15.94 63.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.428 1.891 . . . . 0.0 113.156 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -97.7 -6.09 33.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.665 1.12 . . . . 0.0 109.055 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.87 6.86 53.9 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.317 0.96 . . . . 0.0 112.624 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -95.48 -170.47 2.17 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -132.19 134.04 44.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.37 167.55 21.65 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 118.329 0.513 . . . . 0.0 111.422 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -159.57 130.86 6.05 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 124.811 1.244 . . . . 0.0 108.687 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 66' ' ' ALA . 1.8 p -74.9 130.98 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.09 16.25 18.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.082 0.953 . . . . 0.0 112.638 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.588 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.537 1.535 . . . . 0.0 110.61 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttp . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mt -103.74 -159.53 0.72 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 128.524 2.73 . . . . 0.0 110.14 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -159.13 131.58 6.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.453 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mt -138.23 160.06 40.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.15 1.38 . . . . 0.0 109.309 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -126.98 145.91 50.53 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.5 141.04 44.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 127.391 2.277 . . . . 0.0 109.5 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.84 114.2 10.24 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.116 1.366 . . . . 0.0 108.237 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.62 -6.62 5.23 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.911 1.72 . . . . 0.0 115.0 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.7 mtm -68.28 155.02 40.58 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.88 2.34 . . . . 0.0 109.816 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -137.15 -41.43 0.58 Allowed 'General case' 0 C--N 1.339 0.12 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.2 m -136.73 169.15 18.2 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 124.581 1.152 . . . . 0.0 109.699 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -49.55 -43.09 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.514 1.525 . . . . 0.0 111.698 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -58.75 -37.76 76.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.106 0.563 . . . . 0.0 111.67 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.99 -39.81 94.03 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.01 -58.81 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 123.572 0.749 . . . . 0.0 109.449 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -53.33 -37.06 61.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.94 -55.15 38.65 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.911 0.862 . . . . 0.0 108.797 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.09 -40.84 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.396 1.078 . . . . 0.0 110.021 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.4 m -55.69 -46.0 77.72 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.986 1.267 . . . . 0.0 108.12 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -67.81 -36.36 80.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.206 -0.934 . . . . 0.0 111.315 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.01 73.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.774 0.715 . . . . 0.0 111.385 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mt -61.24 -39.45 90.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.657 1.117 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -67.42 -9.65 43.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.882 0.873 . . . . 0.0 112.834 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -69.31 -29.09 66.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.021 1.282 . . . . 0.0 109.544 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -58.89 129.52 85.57 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.231 1.413 . . . . 0.0 112.796 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.83 117.34 4.82 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 122.445 2.097 . . . . 0.0 107.66 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.82 -14.43 12.79 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 126.423 1.963 . . . . 0.0 112.613 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.3 140.89 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-N 119.335 1.567 . . . . 0.0 107.757 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -121.49 -54.88 1.96 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.248 1.019 . . . . 0.0 108.49 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -137.27 153.97 50.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -140.92 168.76 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 O-C-N 124.199 0.937 . . . . 0.0 111.033 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.92 138.66 34.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.652 2.381 . . . . 0.0 104.631 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -151.65 136.53 10.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 t -137.19 129.55 29.74 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.682 0.674 . . . . 0.0 110.369 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.1 tp -66.47 -48.82 68.65 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.663 1.185 . . . . 0.0 109.81 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -61.3 -35.18 76.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -84.27 -29.92 26.05 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.283 0.633 . . . . 0.0 111.941 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.56 33.39 71.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.85 169.52 17.62 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.042 1.421 . . . . 0.0 112.787 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.33 140.25 33.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.931 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.8 149.6 47.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.416 1.886 . . . . 0.0 106.899 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -131.18 133.66 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.79 2.036 . . . . 0.0 108.243 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -100.22 -3.97 30.43 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.742 0.817 . . . . 0.0 111.669 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.19 -170.67 46.49 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.294 0.949 . . . . 0.0 113.296 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 t -101.08 3.82 41.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.957 1.703 . . . . 0.0 111.483 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.55 153.84 9.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.004 0.922 . . . . 0.0 112.849 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 150.64 61.02 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.102 0.561 . . . . 0.0 110.578 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.58 -40.85 21.62 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.483 2.122 . . . . 0.0 113.009 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -55.68 -47.22 77.14 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.625 0.77 . . . . 0.0 110.714 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.57 79.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.262 0.625 . . . . 0.0 111.623 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.6 mt -67.24 -52.52 40.02 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 123.839 0.856 . . . . 0.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 p -60.52 -40.51 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -58.12 -45.66 86.93 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.051 0.941 . . . . 0.0 109.929 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -85.96 -33.21 7.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.92 -32.74 74.59 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.34 -29.23 69.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.715 1.206 . . . . 0.0 109.782 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -78.33 -7.4 57.22 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.85 25.33 41.85 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.681 1.61 . . . . 0.0 113.475 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.45 177.88 4.66 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -115.22 98.33 6.71 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.717 0.807 . . . . 0.0 109.685 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.0 161.53 13.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.688 -0.632 . . . . 0.0 110.747 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -151.36 138.76 19.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.155 0.982 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.9 t -78.06 138.72 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -113.38 9.65 18.22 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.054 0.942 . . . . 0.0 111.561 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.661 1.585 . . . . 0.0 108.722 179.319 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 ttm . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.418 HD11 ' HD3' ' A' ' 48' ' ' PRO . 6.0 mt -132.33 149.69 52.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.87 130.37 56.8 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 108.713 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.06 151.68 51.62 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 125.37 1.468 . . . . 0.0 107.315 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -118.52 120.86 38.76 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.42 138.89 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -137.05 102.95 4.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.86 -8.56 1.76 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.801 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.5 mtm -75.38 130.35 38.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.5 t -136.15 14.33 3.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.263 0.483 . . . . 0.0 111.753 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 t -160.93 165.27 30.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.938 -1.101 . . . . 0.0 109.646 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -61.28 -33.22 73.2 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.365 1.066 . . . . 0.0 110.973 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.27 -25.57 63.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.983 0.513 . . . . 0.0 111.656 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -71.67 -47.01 57.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -55.46 -56.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.66 0.784 . . . . 0.0 109.54 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.2 ptm -58.54 -34.13 70.66 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.66 -51.1 66.6 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.37 -39.06 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.616 1.167 . . . . 0.0 109.4 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.1 m -57.05 -50.26 73.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.292 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -69.87 -37.78 76.18 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.656 -1.278 . . . . 0.0 111.468 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.37 78.83 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.439 1.095 . . . . 0.0 108.669 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.76 -41.17 60.58 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.927 -1.108 . . . . 0.0 109.276 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -64.78 -16.54 63.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -13.76 60.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.74 1.609 . . . . 0.0 110.987 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.54 130.14 89.34 Favored Pre-proline 0 N--CA 1.452 -0.351 0 C-N-CA 124.581 1.153 . . . . 0.0 110.623 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.56 111.51 2.13 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 106.073 -2.318 . . . . 0.0 106.073 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.95 -3.9 9.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.758 1.647 . . . . 0.0 112.318 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.05 138.8 20.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.587 2.193 . . . . 0.0 109.076 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.52 -51.9 1.72 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.565 1.546 . . . . 0.0 111.451 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -139.47 153.58 47.56 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 m -147.4 166.28 5.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.24 94.17 2.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.342 1.057 . . . . 0.0 109.993 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.17 134.01 38.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.639 1.176 . . . . 0.0 108.609 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -131.6 134.53 46.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.073 0.949 . . . . 0.0 109.902 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.3 tp -76.99 -42.07 40.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.81 -53.03 62.8 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.844 0.857 . . . . 0.0 110.183 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -14.92 55.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.839 -1.076 . . . . 0.0 113.395 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 55.16 29.71 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.4 170.06 18.15 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.849 -0.795 . . . . 0.0 110.577 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.9 95.26 2.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.668 1.187 . . . . 0.0 113.312 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.46 152.82 40.61 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.891 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.19 135.89 60.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.269 1.428 . . . . 0.0 108.249 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -103.65 -19.26 14.4 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.738 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.73 -172.1 28.6 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.3 p -103.53 8.78 37.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.649 1.179 . . . . 0.0 112.425 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.18 155.1 7.01 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.479 0.711 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 151.25 65.5 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 122.859 0.464 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' HD11 ' A' ' 2' ' ' LEU . 22.8 Cg_endo -63.14 -40.16 34.93 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.989 1.792 . . . . 0.0 114.91 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.567 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -59.05 -45.33 91.04 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.411 0.684 . . . . 0.0 110.095 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.39 -32.02 72.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.275 -0.265 . . . . 0.0 111.47 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 20.1 mt -69.42 -57.68 4.96 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.261 1.024 . . . . 0.0 109.981 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.49 -40.49 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.48 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -53.37 -51.97 60.79 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.925 0.89 . . . . 0.0 110.127 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -28.26 65.03 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.2 t -81.6 -39.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -60.77 -39.47 88.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.84 -21.84 66.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 0.0 112.279 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -86.27 -9.41 56.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.223 0.919 . . . . 0.0 110.468 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.97 21.45 18.27 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.657 -1.079 . . . . 0.0 114.229 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.93 179.55 4.08 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.415 1.608 . . . . 0.0 108.048 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -120.57 109.48 15.31 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.24 165.64 12.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 118.902 0.774 . . . . 0.0 110.353 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -157.91 132.63 8.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.877 -0.514 . . . . 0.0 111.339 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.78 147.86 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.46 33.83 4.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.29 1.036 . . . . 0.0 110.177 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.569 2.348 . . . . 0.0 107.028 179.26 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 2.2 tmt? . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mt -120.35 164.45 16.31 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.535 1.134 . . . . 0.0 109.218 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -132.26 123.66 27.38 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.448 HD21 ' HB ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -126.57 133.11 51.16 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.711 0.804 . . . . 0.0 109.436 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -88.19 121.27 30.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.28 150.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -142.48 120.49 12.08 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.77 -10.71 9.61 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.05 1.31 . . . . 0.0 115.141 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.2 mtm -74.92 111.88 10.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 120.052 1.926 . . . . 0.0 110.007 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.67 11.42 9.14 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.533 0.733 . . . . 0.0 111.797 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.0 t -151.24 151.86 32.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -60.76 -27.96 68.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.902 0.481 . . . . 0.0 110.599 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -63.26 -32.5 73.93 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.844 0.747 . . . . 0.0 110.4 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -64.89 -47.74 76.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -57.17 -57.03 11.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.296 1.038 . . . . 0.0 110.057 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 ptm -63.78 -36.46 83.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.95 -49.51 65.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.491 1.041 . . . . 0.0 108.582 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.46 -32.11 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.905 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -57.12 -43.74 82.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -67.52 -47.26 70.46 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.163 -0.96 . . . . 0.0 109.954 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.38 -46.66 69.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.525 0.73 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.88 -38.09 86.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.786 1.234 . . . . 0.0 109.511 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -76.77 -6.99 54.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 117.322 -1.323 . . . . 0.0 111.167 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.73 -27.66 63.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.207 1.821 . . . . 0.0 107.669 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.67 120.69 47.7 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 125.018 1.327 . . . . 0.0 107.75 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.3 101.49 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.48 2.787 . . . . 0.0 109.456 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 143.88 -7.4 1.91 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.858 1.694 . . . . 0.0 111.801 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.56 141.12 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 120.495 -1.591 . . . . 0.0 111.074 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.79 -59.44 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.011 1.324 . . . . 0.0 107.743 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -135.68 157.27 47.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.849 1.259 . . . . 0.0 108.711 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 t -142.33 145.43 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.37 77.02 1.45 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.611 1.964 . . . . 0.0 109.742 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.3 t -85.89 143.05 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -141.61 133.47 27.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.24 1.016 . . . . 0.0 110.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.59 -64.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.788 1.635 . . . . 0.0 112.373 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.03 -30.2 71.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.202 2.201 . . . . 0.0 114.924 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -81.91 -15.25 54.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.775 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.82 35.77 83.9 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -139.44 166.78 23.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 122.406 1.098 . . . . 0.0 112.273 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -145.82 129.3 16.94 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.281 2.633 . . . . 0.0 105.67 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mt -121.16 154.45 36.2 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 1' ' ' MET . 53.3 t -129.39 152.77 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.653 1.216 . . . . 0.0 111.326 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -135.2 111.38 9.63 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 100.909 -3.737 . . . . 0.0 100.909 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.71 -177.49 37.95 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 p -94.61 -0.65 54.31 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 111.535 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 144.94 54.05 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 111.909 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -80.82 149.27 67.01 Favored Pre-proline 0 N--CA 1.465 0.309 0 C-N-CA 125.454 1.501 . . . . 0.0 110.218 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.57 -38.57 81.58 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.519 2.146 . . . . 0.0 116.145 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -63.35 -46.77 85.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 110.477 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.23 65.68 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.74 -56.45 6.36 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.764 0.826 . . . . 0.0 110.094 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.448 ' HB ' HD21 ' A' ' 4' ' ' LEU . 1.4 p -57.02 -45.11 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.736 0.698 . . . . 0.0 109.579 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.84 -47.79 60.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 111.288 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.18 66.49 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -88.99 -35.64 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -63.85 -33.89 76.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.45 -25.7 68.12 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.68 0.792 . . . . 0.0 111.019 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.04 -4.19 56.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.038 0.836 . . . . 0.0 110.603 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.58 19.11 35.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.806 1.185 . . . . 0.0 114.137 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -113.32 177.24 4.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.961 1.381 . . . . 0.0 108.944 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -116.01 116.46 27.94 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.23 154.49 38.7 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -153.72 138.28 16.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.587 1.155 . . . . 0.0 108.966 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.87 140.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.446 -0.784 . . . . 0.0 111.13 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -98.94 19.36 15.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.735 1.214 . . . . 0.0 110.82 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.893 2.077 . . . . 0.0 105.473 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 11.3 ttt . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.01 167.73 20.68 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.944 1.297 . . . . 0.0 108.418 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -123.74 159.41 29.5 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 108.019 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mt -157.05 131.8 8.78 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -99.57 122.5 42.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.68 144.4 22.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -135.59 125.28 25.35 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.43 -15.95 8.05 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.298 -1.279 . . . . 0.0 114.221 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 69.6 mtm -65.2 131.97 47.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.401 2.1 . . . . 0.0 106.944 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -134.45 -21.85 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.3 m -135.45 167.62 20.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.47 1.032 . . . . 0.0 109.137 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.4 -36.66 64.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.411 1.485 . . . . 0.0 109.11 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -59.32 -44.3 92.58 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.853 1.661 . . . . 0.0 110.195 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 m -59.77 -43.98 94.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.32 -53.85 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.021 0.529 . . . . 0.0 110.101 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ptm -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.104 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.29 -59.92 4.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.967 0.803 . . . . 0.0 108.879 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.16 -38.74 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.534 0.734 . . . . 0.0 109.994 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -58.66 -52.87 63.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.076 -1.64 . . . . 0.0 109.161 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -61.6 -43.84 98.12 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 121.623 -0.673 . . . . 0.0 112.33 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.27 86.07 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 123.681 0.613 . . . . 0.0 110.793 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.57 -39.46 93.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 0.0 109.497 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -67.05 -11.79 58.1 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.14 -17.93 60.32 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.883 1.219 . . . . 0.0 110.082 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.64 133.95 95.27 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 124.575 1.15 . . . . 0.0 111.616 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.66 115.99 4.2 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.218 1.945 . . . . 0.0 107.553 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.56 26.8 Favored Glycine 0 C--N 1.318 -0.457 0 C-N-CA 126.537 2.018 . . . . 0.0 113.627 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -80.98 131.13 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 120.755 2.278 . . . . 0.0 107.428 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -104.35 -62.41 1.32 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -136.06 158.18 45.04 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.986 0.915 . . . . 0.0 108.546 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.23 154.46 20.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 126.035 1.734 . . . . 0.0 107.525 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -145.29 112.15 5.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.18 149.8 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.821 0.849 . . . . 0.0 110.349 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -126.96 135.41 50.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.104 1.362 . . . . 0.0 109.033 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 tp -84.45 -21.09 30.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.362 0.665 . . . . 0.0 110.65 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -84.3 -38.29 20.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.313 1.045 . . . . 0.0 111.967 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -98.86 -13.06 20.24 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.6 33.33 81.55 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 120.043 1.292 . . . . 0.0 111.382 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -119.31 148.84 42.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.233 1.013 . . . . 0.0 108.568 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.19 98.73 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 109.214 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.7 mm? -83.99 147.41 27.46 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.5 t -122.46 151.01 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 125.011 1.324 . . . . 0.0 107.456 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.75 -9.73 7.28 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.26 -168.1 41.19 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.07 0.85 . . . . 0.0 114.458 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.1 p -100.2 9.48 42.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.206 1.403 . . . . 0.0 111.203 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.5 155.5 18.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.54 0.736 . . . . 0.0 111.749 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.83 149.41 50.8 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.513 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.4 -37.46 17.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 112.291 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.79 -36.56 67.53 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.26 0.624 . . . . 0.0 111.676 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.34 -31.88 26.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.115 0.966 . . . . 0.0 112.175 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 mt -63.91 -53.35 51.76 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 124.296 1.038 . . . . 0.0 109.77 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.38 -39.96 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.538 0.608 . . . . 0.0 110.156 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -47.35 77.74 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.174 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.19 -18.8 50.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.81 -39.57 10.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 119.809 1.186 . . . . 0.0 108.838 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -66.78 -32.39 73.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.27 -13.16 62.06 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.982 0.81 . . . . 0.0 109.838 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.66 -6.6 45.99 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.445 -1.409 . . . . 0.0 108.926 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.15 2.42 71.16 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 128.215 2.817 . . . . 0.0 114.952 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -88.39 159.95 17.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 118.92 1.36 . . . . 0.0 107.651 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -98.07 118.26 34.26 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.23 162.98 24.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.524 0.602 . . . . 0.0 110.626 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -163.35 145.93 10.07 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.167 1.387 . . . . 0.0 109.105 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.49 150.94 5.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.5 mt -110.68 9.68 22.83 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.243 1.017 . . . . 0.0 110.995 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.644 1.578 . . . . 0.0 107.247 179.476 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.32 165.68 11.32 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.151 0.98 . . . . 0.0 110.547 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -137.03 143.98 42.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.38 157.93 44.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.328 2.651 . . . . 0.0 108.026 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -123.87 122.45 38.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 127.499 2.32 . . . . 0.0 105.485 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.26 145.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 125.766 1.626 . . . . 0.0 108.368 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -135.66 130.11 33.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.55 -11.08 12.52 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.248 -1.307 . . . . 0.0 112.343 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.7 mtm -71.75 138.01 48.14 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.345 2.073 . . . . 0.0 108.269 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.8 p -135.17 -15.27 1.97 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.91 177.14 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 109.556 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -62.08 -31.58 72.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.831 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -60.18 -35.71 75.99 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.472 1.033 . . . . 0.0 109.062 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.8 m -65.61 -47.76 74.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -55.9 -54.49 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.604 0.762 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -37.94 88.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.729 1.149 . . . . 0.0 111.58 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.61 -51.15 64.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.794 0.725 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.2 t -61.22 -40.76 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.677 1.191 . . . . 0.0 108.608 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.2 m -58.01 -61.11 2.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.58 -33.4 69.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.331 0.968 . . . . 0.0 112.951 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.71 95.97 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.4 mt -71.93 -36.74 70.03 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.91 -1.119 . . . . 0.0 108.361 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -64.75 -33.52 76.16 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.759 -1.213 . . . . 0.0 114.166 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.27 -20.37 64.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.839 1.2 . . . . 0.0 113.15 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 128.41 89.81 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.51 102.74 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.217 2.612 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.12 -10.2 4.16 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.45 1.024 . . . . 0.0 111.574 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.41 132.1 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 118.464 1.132 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -104.54 -56.48 2.18 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.877 1.671 . . . . 0.0 108.556 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -138.74 159.87 41.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.569 1.148 . . . . 0.0 108.2 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 42' ' ' VAL . 47.7 t -140.44 159.57 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -135.68 122.75 21.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 t -129.68 159.77 41.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 119.429 1.013 . . . . 0.0 109.539 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -141.24 126.93 19.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.15 1.38 . . . . 0.0 109.086 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.21 -52.41 41.42 Favored 'General case' 0 N--CA 1.46 0.061 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -60.01 -56.61 19.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.237 1.015 . . . . 0.0 112.303 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -72.44 -28.07 62.72 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.203 0.456 . . . . 0.0 111.896 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.66 80.87 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -89.55 150.99 22.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.947 1.373 . . . . 0.0 108.242 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.09 139.16 39.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.95 156.17 49.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.611 HG21 HD22 ' A' ' 51' ' ' LEU . 12.8 t -128.27 144.22 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.438 1.095 . . . . 0.0 109.3 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -110.19 -4.02 15.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.33 -172.52 47.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.426 -0.796 . . . . 0.0 112.121 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -97.57 6.16 48.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.145 1.778 . . . . 0.0 110.892 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.57 167.98 4.01 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.74 1.216 . . . . 0.0 111.165 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -99.21 153.1 37.95 Favored Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 124.28 1.032 . . . . 0.0 112.877 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.25 -48.08 15.04 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.218 2.612 . . . . 0.0 113.91 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -61.18 -44.07 97.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 -178.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -31.81 72.43 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.873 -0.517 . . . . 0.0 111.888 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 42' ' ' VAL . 40.8 mt -73.11 -50.43 22.83 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.092 0.957 . . . . 0.0 110.76 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -60.19 -41.36 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.11 -56.1 16.58 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.415 1.486 . . . . 0.0 110.367 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.59 64.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.0 t -81.08 -34.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 119.275 0.943 . . . . 0.0 110.267 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.95 -26.97 68.53 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -66.33 -15.85 63.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.167 -0.958 . . . . 0.0 111.166 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -98.26 3.16 48.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.356 1.463 . . . . 0.0 111.338 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.53 85.66 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.996 0.816 . . . . 0.0 113.889 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.59 161.52 14.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -109.4 114.46 28.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.42 154.65 33.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.282 0.563 . . . . 0.0 111.523 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.86 133.93 17.1 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.3 150.74 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.245 1.418 . . . . 0.0 109.704 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.61 61.46 1.56 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.185 1.394 . . . . 0.0 109.676 -179.035 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tmm? . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 mt -115.13 142.22 46.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.405 1.482 . . . . 0.0 109.645 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -108.35 146.88 32.34 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.729 0.695 . . . . 0.0 110.71 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -139.0 156.18 47.42 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 125.443 1.497 . . . . 0.0 107.782 178.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -120.14 136.58 54.56 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -127.11 151.61 34.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 124.744 1.218 . . . . 0.0 107.955 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -141.69 145.91 35.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.86 -21.06 41.63 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.863 1.221 . . . . 0.0 112.781 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.5 mtm -66.7 122.56 17.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -125.79 -12.68 6.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.47 165.23 28.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.286 -0.884 . . . . 0.0 110.826 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -60.46 -34.25 73.74 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -62.73 -27.71 69.46 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.229 0.612 . . . . 0.0 110.716 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -75.93 -48.15 22.4 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.8 t -54.1 -57.3 6.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 123.784 0.834 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.2 ptm -55.36 -32.24 62.4 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.76 -54.42 31.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -63.49 -39.53 85.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.368 0.667 . . . . 0.0 109.794 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -56.17 -46.91 79.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.892 1.224 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -66.84 -43.69 83.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.127 -0.358 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.5 81.07 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.533 0.733 . . . . 0.0 110.1 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.59 -38.1 70.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.977 -1.077 . . . . 0.0 109.048 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -67.22 -30.63 70.61 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.696 -1.253 . . . . 0.0 114.299 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -65.66 -22.94 66.69 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.997 1.271 . . . . 0.0 110.186 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.2 t -56.87 130.3 78.57 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.52 110.48 1.63 Allowed 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.221 1.947 . . . . 0.0 110.532 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.55 19.56 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.224 1.392 . . . . 0.0 113.684 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -88.28 106.94 17.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 119.661 1.73 . . . . 0.0 111.912 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -81.51 -45.0 16.58 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.503 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -149.29 163.27 38.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.28 138.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -122.46 79.51 1.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 t -85.71 145.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.95 1.3 . . . . 0.0 109.184 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 t -134.97 131.81 37.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.845 1.258 . . . . 0.0 108.699 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.8 tp -68.94 -59.93 2.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.569 1.147 . . . . 0.0 109.318 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.17 -43.32 78.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.512 1.125 . . . . 0.0 111.969 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -81.97 -18.03 44.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 117.946 -1.026 . . . . 0.0 113.575 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.81 70.32 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -135.66 154.17 51.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.341 -1.093 . . . . 0.0 109.499 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.92 149.68 47.74 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.001 1.32 . . . . 0.0 109.96 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.84 129.62 40.66 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.28 118.82 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.705 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -82.14 -16.88 48.33 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.833 0.853 . . . . 0.0 111.026 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.76 177.28 31.03 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.341 0.972 . . . . 0.0 112.466 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 p -95.61 0.2 52.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.949 0.9 . . . . 0.0 113.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.06 148.66 0.8 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.596 1.958 . . . . 0.0 114.642 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -71.87 137.15 82.47 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -59.36 -41.07 61.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.248 1.966 . . . . 0.0 112.554 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -59.81 -32.8 70.98 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.633 1.173 . . . . 0.0 112.198 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -34.71 41.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.084 0.553 . . . . 0.0 110.15 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.14 -56.52 16.08 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.802 0.841 . . . . 0.0 109.252 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.03 -41.62 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.635 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -58.14 -45.13 87.91 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.721 0.691 . . . . 0.0 110.265 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.66 66.2 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.8 -38.6 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.373 -1.455 . . . . 0.0 108.163 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.73 -34.31 77.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.911 0.884 . . . . 0.0 110.576 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.74 -22.5 65.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.182 0.901 . . . . 0.0 110.733 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -85.01 0.75 50.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.33 1.052 . . . . 0.0 110.049 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.29 7.82 75.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.226 1.393 . . . . 0.0 115.014 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -94.56 166.68 11.91 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.871 1.335 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -106.23 110.17 22.33 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.15 165.06 16.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 123.747 0.654 . . . . 0.0 112.327 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.424 ' O ' HD23 ' A' ' 4' ' ' LEU . 12.5 pt-20 -162.32 141.56 9.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.552 1.941 . . . . 0.0 107.572 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 81.1 t -76.82 152.72 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.3 mt -126.58 59.15 1.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.438 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 C-N-CA 124.454 1.102 . . . . 0.0 108.812 177.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttt . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.415 HD11 ' HD3' ' A' ' 48' ' ' PRO . 2.2 mt -48.17 131.49 16.13 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 126.032 1.733 . . . . 0.0 111.855 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.09 151.08 21.81 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.374 1.469 . . . . 0.0 111.331 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.18 144.49 24.01 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.244 1.818 . . . . 0.0 107.5 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.49 125.75 52.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.8 t -115.47 140.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.74 125.11 42.46 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.73 -9.68 8.59 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.984 1.278 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.1 mtm -74.1 90.17 2.01 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 107.252 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -98.36 -12.46 21.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.509 1.124 . . . . 0.0 112.416 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.8 m -136.19 162.08 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.398 -0.814 . . . . 0.0 110.247 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.89 -37.17 75.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.924 0.49 . . . . 0.0 110.207 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.72 -37.52 76.33 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.29 -46.95 88.05 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.18 0.9 . . . . 0.0 109.493 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.79 -55.12 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.202 1.001 . . . . 0.0 110.065 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptm -62.31 -28.93 70.08 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.674 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.11 -53.07 13.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.6 t -52.75 -47.14 51.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.946 1.298 . . . . 0.0 107.696 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 m -53.86 -55.07 30.09 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.418 1.087 . . . . 0.0 109.032 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -62.56 -36.78 83.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 117.92 -1.038 . . . . 0.0 113.292 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.65 71.52 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.158 0.89 . . . . 0.0 109.343 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.03 -41.01 99.42 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -61.97 -11.64 14.44 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.324 -0.846 . . . . 0.0 113.208 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -77.29 -20.28 55.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.028 1.286 . . . . 0.0 110.576 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.06 128.79 93.46 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.28 100.24 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.759 2.306 . . . . 0.0 111.542 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.3 -7.71 4.35 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.821 1.201 . . . . 0.0 112.463 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -81.52 104.6 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.213 -1.169 . . . . 0.0 111.005 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.15 -56.52 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -148.07 160.61 42.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.467 1.107 . . . . 0.0 108.671 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.14 153.62 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -137.14 90.62 2.54 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.1 t -99.16 139.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.401 1.48 . . . . 0.0 107.854 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -126.4 136.94 53.31 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.64 -60.59 3.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 125.029 1.332 . . . . 0.0 110.615 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.23 -46.1 89.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.815 1.246 . . . . 0.0 112.303 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -74.92 -31.45 61.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.494 -0.765 . . . . 0.0 113.057 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.09 40.93 55.54 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.61 167.41 21.72 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.238 -1.154 . . . . 0.0 109.206 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.4 123.73 20.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.397 1.879 . . . . 0.0 106.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.0 mt -111.51 143.63 42.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.439 HG21 HD22 ' A' ' 51' ' ' LEU . 42.1 t -122.04 126.53 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 119.893 1.224 . . . . 0.0 110.473 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -93.45 2.64 56.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.862 2.065 . . . . 0.0 110.387 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.94 -179.34 38.81 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.86 1.695 . . . . 0.0 112.932 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.5 p -96.18 4.75 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.483 1.913 . . . . 0.0 111.706 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.83 165.87 3.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.134 0.974 . . . . 0.0 112.73 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.07 147.56 33.16 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.965 2.106 . . . . 0.0 109.41 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HD3' HD11 ' A' ' 2' ' ' LEU . 36.5 Cg_endo -66.94 -42.17 8.83 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.933 1.755 . . . . 0.0 112.757 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -59.03 -30.23 67.87 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.329 0.968 . . . . 0.0 111.741 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -23.66 32.57 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 111.624 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 42' ' ' VAL . 42.9 mt -82.18 -56.46 3.91 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.022 2.129 . . . . 0.0 109.489 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.1 p -50.57 -40.57 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.016 1.326 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -58.66 -43.84 89.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.604 0.362 . . . . 0.0 110.99 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.36 -14.64 57.53 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.7 t -93.75 -43.32 13.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.528 1.131 . . . . 0.0 108.01 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.32 -30.82 71.85 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.306 1.042 . . . . 0.0 111.31 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.62 -9.57 59.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.829 0.852 . . . . 0.0 111.031 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.94 41.79 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 119.181 -0.789 . . . . 0.0 113.524 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -85.93 177.8 7.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.682 1.241 . . . . 0.0 107.817 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -114.69 134.07 55.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.81 158.34 44.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.477 0.581 . . . . 0.0 112.041 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.77 136.29 11.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.611 1.565 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' ALA . 8.7 p -77.76 131.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.056 -1.028 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -101.9 22.68 12.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.438 -0.789 . . . . 0.0 110.343 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.419 1.887 . . . . 0.0 111.203 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 11.8 ttt . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -62.33 139.47 58.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.923 0.889 . . . . 0.0 111.654 -177.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -111.77 136.46 51.01 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.678 1.591 . . . . 0.0 110.888 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.77 159.94 40.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.413 1.085 . . . . 0.0 109.7 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HE2' ' OE1' ' A' ' 7' ' ' GLU . 3.2 ttpm? -127.82 123.18 34.53 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.97 137.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' HE2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -120.05 148.77 43.17 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.88 -12.48 65.77 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 117.783 -1.565 . . . . 0.0 113.54 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.8 mtm -66.11 146.15 55.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 120.729 2.264 . . . . 0.0 108.24 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.0 p -136.11 -38.04 0.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.2 m -141.68 179.83 6.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.11 1.364 . . . . 0.0 109.401 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -52.99 -36.0 59.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.258 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -52.34 -35.16 50.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.944 0.793 . . . . 0.0 111.068 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -74.57 -55.62 5.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.2 t -49.59 -51.85 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.952 1.301 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.8 ptm -65.64 -37.57 86.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.705 0.802 . . . . 0.0 112.743 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.12 -53.65 50.11 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.4 -48.54 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.58 1.952 . . . . 0.0 108.832 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.4 m -54.01 -61.76 2.09 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.565 1.146 . . . . 0.0 110.389 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.16 -26.69 68.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.99 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.03 -45.13 67.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 119.476 1.035 . . . . 0.0 109.092 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.87 -32.12 69.17 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HA ' HG11 ' A' ' 28' ' ' VAL . 47.1 mttm -70.12 -13.47 62.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -78.49 -7.45 57.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.898 1.226 . . . . 0.0 111.638 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 28' ' ' VAL . 94.6 t -78.74 127.49 80.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.294 1.438 . . . . 0.0 112.11 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.98 107.05 1.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.856 2.371 . . . . 0.0 111.927 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 -9.71 7.11 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 126.498 1.999 . . . . 0.0 113.342 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.8 p -78.57 146.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.46 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -124.96 -53.6 1.64 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.182 1.793 . . . . 0.0 108.122 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -132.6 147.46 52.35 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.811 0.844 . . . . 0.0 109.426 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.99 155.34 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.644 1.978 . . . . 0.0 106.05 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -145.17 138.2 26.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -135.41 140.8 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -130.77 116.81 18.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.203 1.001 . . . . 0.0 110.657 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.7 tp -60.2 -54.61 43.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.158 0.583 . . . . 0.0 109.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.95 -38.42 72.92 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -85.36 -17.74 35.86 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.45 25.52 67.04 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -126.86 155.05 43.56 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 118.265 1.032 . . . . 0.0 110.672 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.43 125.74 29.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.091 1.756 . . . . 0.0 106.503 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.67 138.87 49.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.8 t -118.83 146.75 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.82 -12.05 10.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.279 1.032 . . . . 0.0 111.453 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.73 -173.36 37.48 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.0 p -98.07 8.1 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.448 1.499 . . . . 0.0 111.547 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.72 143.92 11.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.275 1.03 . . . . 0.0 111.594 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.52 149.41 95.56 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.439 ' HB3' HD21 ' A' ' 2' ' ' LEU . 20.2 Cg_endo -61.36 -51.46 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.819 1.679 . . . . 0.0 112.597 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -53.98 -34.94 61.17 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.633 1.173 . . . . 0.0 112.792 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.21 -31.46 60.9 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.791 0.837 . . . . 0.0 112.805 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -68.89 -50.3 50.81 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.53 -44.61 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -48.99 -49.74 39.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.819 0.848 . . . . 0.0 111.524 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.62 -27.99 69.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.041 -0.981 . . . . 0.0 113.632 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.8 t -88.71 -31.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 120.074 1.307 . . . . 0.0 110.711 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -61.52 -32.8 72.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.08 -0.99 23.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.735 2.414 . . . . 0.0 112.973 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.1 -10.44 17.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.782 1.174 . . . . 0.0 110.569 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.41 24.79 11.78 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.066 -0.852 . . . . 0.0 112.04 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -126.13 161.4 27.73 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.888 1.275 . . . . 0.0 108.019 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -98.74 106.38 18.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.38 155.48 18.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.343 0.519 . . . . 0.0 110.064 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -154.15 133.3 12.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.28 1.432 . . . . 0.0 108.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 66' ' ' ALA . 97.0 t -89.46 129.95 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.2 mt -109.89 32.1 5.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.764 1.226 . . . . 0.0 110.945 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.473 ' H ' HG12 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.245 0.833 0 C-N-CA 125.087 1.355 . . . . 0.0 107.368 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.55 150.67 43.74 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.356 0.98 . . . . 0.0 109.424 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -113.67 113.5 25.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.103 1.361 . . . . 0.0 109.364 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mt -112.79 124.22 52.08 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.281 1.032 . . . . 0.0 109.255 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -90.13 122.11 32.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.86 151.63 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.005 0.922 . . . . 0.0 110.919 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.83 144.88 47.85 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.141 1.776 . . . . 0.0 106.214 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.0 -12.99 49.49 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.793 2.14 . . . . 0.0 111.999 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 39.0 mtm -74.62 75.28 2.01 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.132 1.466 . . . . 0.0 111.1 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.5 p -80.63 -33.79 35.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.555 -0.716 . . . . 0.0 111.676 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.6 m -118.1 161.43 19.85 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.238 1.415 . . . . 0.0 113.154 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.271 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -64.59 -32.51 74.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.271 1.028 . . . . 0.0 108.773 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 m -72.95 -49.79 27.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -52.02 -48.95 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.774 1.23 . . . . 0.0 110.765 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.5 ptm -63.72 -36.63 84.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.734 0.697 . . . . 0.0 112.125 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.17 -50.82 59.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.95 -39.65 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.553 1.141 . . . . 0.0 108.761 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.1 m -60.5 -59.24 5.71 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.258 -0.901 . . . . 0.0 108.866 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.18 -35.85 78.25 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.889 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.93 95.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.424 1.09 . . . . 0.0 109.877 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.0 mt -65.13 -33.62 76.45 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.809 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -74.12 6.53 3.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -90.8 -13.02 34.68 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 120.277 -1.514 . . . . 0.0 108.996 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 28' ' ' VAL . 58.4 t -74.49 132.12 79.06 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.626 1.57 . . . . 0.0 112.629 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.55 109.09 1.98 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.085 1.857 . . . . 0.0 110.879 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.23 -7.64 7.58 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.786 1.66 . . . . 0.0 114.706 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 23' ' ' LYS . 13.9 p -80.17 136.0 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.919 1.36 . . . . 0.0 112.253 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -97.29 -61.38 1.41 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -145.72 165.82 27.66 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.058 1.343 . . . . 0.0 107.447 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.1 t -145.86 143.36 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -125.05 101.1 6.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 t -100.61 136.92 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 m -119.63 132.62 55.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.745 1.218 . . . . 0.0 109.385 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.2 -68.72 0.27 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.656 1.583 . . . . 0.0 111.431 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.21 -53.42 35.24 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.918 1.687 . . . . 0.0 112.858 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.15 -21.89 64.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.987 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.36 39.54 92.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -132.02 157.84 43.08 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.656 1.182 . . . . 0.0 109.401 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.76 129.57 40.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.262 2.225 . . . . 0.0 107.263 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.24 102.3 10.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -82.27 126.06 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -96.31 -10.24 28.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.308 1.443 . . . . 0.0 113.784 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.88 -173.17 39.32 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -99.8 14.26 30.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.958 1.303 . . . . 0.0 112.248 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 150.83 3.75 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.212 0.605 . . . . 0.0 110.531 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.77 140.64 58.91 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 123.283 0.633 . . . . 0.0 111.617 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.93 -41.98 56.73 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.467 2.111 . . . . 0.0 113.219 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -57.66 -36.03 71.35 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.833 1.253 . . . . 0.0 112.529 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.82 -30.78 22.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.788 . . . . 0.0 111.616 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.7 mt -67.79 -55.04 14.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.223 1.009 . . . . 0.0 109.252 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.6 p -57.86 -43.42 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -55.94 -52.61 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.369 1.067 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 -25.94 36.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.76 -40.9 16.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 119.207 0.912 . . . . 0.0 108.648 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.68 -37.15 86.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.384 0.538 . . . . 0.0 109.559 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.51 -19.83 64.0 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.015 0.526 . . . . 0.0 111.369 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -86.52 -5.21 59.21 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.509 -1.369 . . . . 0.0 110.982 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.82 13.15 51.28 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.386 0.993 . . . . 0.0 112.961 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -105.71 -177.74 3.45 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -126.52 137.55 53.38 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.4 35.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 123.684 0.615 . . . . 0.0 110.292 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.5 138.76 14.7 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.188 1.395 . . . . 0.0 108.034 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.05 119.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -81.1 23.28 0.58 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.16 1.784 . . . . 0.0 109.232 179.887 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttp . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.98 144.75 54.04 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 122.875 0.47 . . . . 0.0 109.993 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -117.02 130.11 56.46 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.144 1.378 . . . . 0.0 111.714 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.52 164.42 26.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.433 1.493 . . . . 0.0 110.331 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.56 128.31 44.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.57 2.748 . . . . 0.0 105.527 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.77 145.03 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -137.94 109.93 7.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.33 -11.1 2.5 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.476 1.513 . . . . 0.0 115.875 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.5 mtm -72.34 127.44 32.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 121.029 2.414 . . . . 0.0 112.708 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -133.27 -5.85 3.0 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.141 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.1 m -145.63 164.89 30.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.904 1.281 . . . . 0.0 109.912 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.33 -40.9 71.74 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.956 1.303 . . . . 0.0 110.672 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 16' ' ' MET . 3.6 t60 -56.84 -38.3 72.47 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.108 0.563 . . . . 0.0 111.546 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 m -59.92 -47.44 85.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 t -57.09 -49.04 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 109.375 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.412 ' HG2' ' HA ' ' A' ' 13' ' ' HIS . 27.3 ptm -65.83 -39.53 90.91 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.536 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.33 -53.19 60.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.57 1.077 . . . . 0.0 109.283 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -49.57 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 109.382 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.9 m -55.11 -50.1 70.06 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.277 1.031 . . . . 0.0 109.583 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -60.43 -46.76 88.88 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.949 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.32 81.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 123.704 0.628 . . . . 0.0 110.133 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.28 -33.44 75.52 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.254 0.621 . . . . 0.0 110.358 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.621 ' HA ' HG11 ' A' ' 28' ' ' VAL . 59.5 mtpt -76.24 -11.81 59.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.402 -0.808 . . . . 0.0 112.221 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.5 -7.72 56.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.307 1.412 . . . . 0.0 111.488 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 28' ' ' VAL . 58.9 t -73.25 142.38 81.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 112.526 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.74 112.64 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.015 1.81 . . . . 0.0 109.875 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.18 -4.69 26.92 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.374 1.464 . . . . 0.0 115.67 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.621 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.2 p -77.19 145.42 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 119.6 1.7 . . . . 0.0 109.822 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -120.14 -57.9 1.9 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.557 1.143 . . . . 0.0 109.063 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -133.32 152.59 51.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.57 144.69 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -124.31 99.61 6.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 t -107.47 117.51 53.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -80.15 174.92 11.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.5 tp -122.55 -33.96 3.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -99.2 -32.8 11.04 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.057 0.844 . . . . 0.0 111.228 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -74.36 -17.53 60.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.39 32.97 84.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.647 1.112 . . . . 0.0 112.593 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -133.65 153.31 51.78 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.799 -1.412 . . . . 0.0 107.342 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.35 148.74 50.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.9 mt -140.53 158.46 43.96 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.2 t -134.51 143.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.567 1.147 . . . . 0.0 111.565 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -100.69 -33.8 10.12 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.961 0.904 . . . . 0.0 110.022 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.46 177.28 1.87 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.851 0.738 . . . . 0.0 113.816 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 t -89.06 6.54 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.173 1.389 . . . . 0.0 110.951 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.37 151.99 3.73 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.369 0.668 . . . . 0.0 112.405 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.59 146.17 52.73 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.7 -37.96 53.19 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.409 2.073 . . . . 0.0 113.069 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.34 -48.55 80.19 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.698 0.799 . . . . 0.0 111.262 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.41 -24.89 63.91 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.874 -0.516 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.8 mt -74.21 -55.37 6.13 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.701 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 -44.43 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.708 0.685 . . . . 0.0 109.43 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.24 -51.59 61.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.196 1.798 . . . . 0.0 111.25 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.15 -35.72 71.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.81 -40.7 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 121.198 -0.939 . . . . 0.0 108.929 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -61.51 -33.59 74.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.923 0.889 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.73 -23.43 66.74 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.231 1.012 . . . . 0.0 111.72 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -86.62 3.76 43.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.399 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.54 80.94 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.669 1.604 . . . . 0.0 114.474 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.84 177.32 6.22 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.52 1.66 . . . . 0.0 107.188 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -114.14 133.31 55.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.19 167.82 19.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.079 0.943 . . . . 0.0 111.631 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.49 146.57 16.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.873 1.269 . . . . 0.0 109.787 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.57 141.66 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.07 34.94 3.45 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.521 0.728 . . . . 0.0 111.038 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.423 0 C-N-CA 127.907 2.483 . . . . 0.0 107.219 179.1 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 24.2 ttt . . . . . 0 C--O 1.235 0.333 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.7 mt -66.24 156.81 33.18 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.184 0.994 . . . . 0.0 112.011 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -127.57 118.3 23.67 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 128.215 2.606 . . . . 0.0 109.489 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.77 152.26 36.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -119.59 122.67 42.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -107.32 150.98 9.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -135.46 160.25 39.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.43 -22.81 25.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.211 -1.327 . . . . 0.0 111.729 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 32.0 mtm -64.19 146.65 53.93 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.626 1.713 . . . . 0.0 107.262 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.2 p -136.91 -22.08 1.22 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.5 p -145.29 177.08 9.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.086 0.946 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -62.49 -31.73 72.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.402 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.49 -39.45 91.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -62.37 -49.93 73.59 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 t -54.44 -56.28 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.506 1.523 . . . . 0.0 110.651 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.61 -34.49 69.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.957 0.799 . . . . 0.0 112.607 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.88 45.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.234 0.925 . . . . 0.0 109.715 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.434 HG21 HG13 ' A' ' 55' ' ' VAL . 2.7 p -60.92 -38.16 78.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.109 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.723 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -56.31 -48.93 75.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -65.2 -34.6 78.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.507 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.83 -41.1 75.41 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.328 0.967 . . . . 0.0 108.454 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.37 -39.1 86.02 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.801 -1.187 . . . . 0.0 110.081 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -65.31 -14.24 60.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -69.24 -27.51 65.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.98 0.809 . . . . 0.0 110.715 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.25 134.21 93.15 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.68 1.192 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.24 108.27 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.255 2.637 . . . . 0.0 110.425 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.03 -2.51 19.32 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-O 119.204 -0.775 . . . . 0.0 113.012 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -86.99 98.23 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 119.254 1.527 . . . . 0.0 110.583 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.17 -44.16 39.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.541 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.38 158.61 41.74 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.56 143.76 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.72 87.42 2.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.993 1.317 . . . . 0.0 107.658 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.74 145.94 6.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.2 m -139.83 122.04 15.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.477 1.111 . . . . 0.0 111.239 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.83 -39.75 79.83 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -60.02 -29.5 68.53 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.383 1.473 . . . . 0.0 112.546 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -102.65 -30.5 10.89 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.55 1.14 . . . . 0.0 113.565 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.18 21.75 66.92 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.49 161.91 19.77 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -1.156 . . . . 0.0 111.772 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.97 108.52 7.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.153 2.181 . . . . 0.0 106.548 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.28 151.13 19.8 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.533 HG21 HD22 ' A' ' 51' ' ' LEU . 46.5 t -128.06 124.7 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 119.894 1.224 . . . . 0.0 108.975 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -88.07 -13.61 41.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.49 -176.95 16.13 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.626 1.584 . . . . 0.0 114.198 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.0 t -103.62 -6.67 21.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.634 1.973 . . . . 0.0 113.912 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.33 157.93 0.91 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.745 2.018 . . . . 0.0 115.556 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.26 146.39 58.06 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 123.422 0.689 . . . . 0.0 110.254 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.3 -34.31 55.97 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.75 1.633 . . . . 0.0 113.477 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -61.46 -39.72 91.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.178 1.354 . . . . 0.0 112.114 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.2 78.56 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.533 HD22 HG21 ' A' ' 42' ' ' VAL . 41.9 mt -66.6 -47.13 73.67 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 124.905 1.282 . . . . 0.0 108.842 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.07 -48.27 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -59.8 -27.73 66.83 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.45 87.5 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.073 0.852 . . . . 0.0 110.52 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.434 HG13 HG21 ' A' ' 18' ' ' VAL . 29.4 t -84.02 -44.2 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 125.254 1.422 . . . . 0.0 110.455 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -65.19 -6.57 9.71 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.309 1.044 . . . . 0.0 111.777 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -107.07 -13.6 15.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.807 1.185 . . . . 0.0 109.482 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -83.89 -10.77 57.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.346 1.459 . . . . 0.0 110.251 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.9 29.11 7.03 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.604 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -136.3 172.36 13.12 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.18 1.49 . . . . 0.0 109.949 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -102.74 142.74 33.39 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.11 141.24 44.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -131.13 116.7 18.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.628 1.571 . . . . 0.0 108.266 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' ALA . 2.4 p -77.09 139.54 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -120.53 45.38 2.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' H ' HG22 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.252 1.216 0 C-N-CA 125.244 1.418 . . . . 0.0 107.555 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptm . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.07 169.28 16.07 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.746 0.819 . . . . 0.0 110.525 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -136.55 133.62 36.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.696 1.599 . . . . 0.0 109.372 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.475 HD21 HG22 ' A' ' 52' ' ' VAL . 7.0 mt -138.26 149.61 45.89 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 126.213 1.805 . . . . 0.0 107.5 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -110.45 129.14 55.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.07 147.31 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -137.42 114.48 10.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.553 1.141 . . . . 0.0 108.156 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.29 -10.75 4.11 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.745 1.641 . . . . 0.0 113.887 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.4 mtm -73.42 97.09 2.47 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.689 1.744 . . . . 0.0 107.809 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -115.19 3.36 14.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.682 1.193 . . . . 0.0 111.139 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 m -146.57 152.9 39.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.433 1.493 . . . . 0.0 107.441 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -60.56 -36.19 77.88 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -59.18 -32.64 70.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.397 1.079 . . . . 0.0 110.478 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.4 m -66.46 -39.66 88.94 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -59.73 -59.26 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 24.2 ptm -57.49 -33.71 68.3 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.943 0.792 . . . . 0.0 112.991 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.24 -53.53 53.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.54 1.064 . . . . 0.0 109.604 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.81 -39.8 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.109 1.363 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m -59.97 -46.02 90.78 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.928 -1.108 . . . . 0.0 108.846 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -44.84 95.94 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 121.819 -0.55 . . . . 0.0 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.43 95.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.4 -33.36 74.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.588 1.085 . . . . 0.0 109.108 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.597 ' HA ' HG11 ' A' ' 28' ' ' VAL . 35.6 mttm -76.33 -16.85 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.052 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -76.28 -17.28 59.53 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.536 1.971 . . . . 0.0 111.733 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 28' ' ' VAL . 86.5 t -62.07 140.0 95.94 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 126.805 2.042 . . . . 0.0 112.711 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.06 108.71 2.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 109.923 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.92 -6.83 9.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.171 1.843 . . . . 0.0 114.728 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.597 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.4 p -80.97 159.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.118 1.459 . . . . 0.0 108.013 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -130.71 -64.62 0.82 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -132.56 159.92 38.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 108.302 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.6 139.09 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -128.45 106.92 9.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.06 154.58 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.747 1.219 . . . . 0.0 111.501 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.6 t -129.61 129.34 44.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.303 1.841 . . . . 0.0 109.563 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.01 -43.22 88.31 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.744 0.817 . . . . 0.0 109.996 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.31 -47.9 46.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -76.98 -20.62 55.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 35.54 92.17 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -128.96 137.47 51.4 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.02 136.78 54.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.283 2.233 . . . . 0.0 108.822 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.45 155.46 38.85 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 51' ' ' LEU . 7.0 t -129.29 122.12 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -81.36 -18.67 44.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.605 1.162 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.32 -168.74 27.62 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.623 1.106 . . . . 0.0 113.189 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -105.96 5.75 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.245 1.418 . . . . 0.0 113.067 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.3 147.79 9.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.647 0.658 . . . . 0.0 110.902 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.74 146.93 83.85 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.01 -39.33 71.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.297 1.998 . . . . 0.0 114.615 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -60.12 -41.99 93.79 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.605 0.639 . . . . 0.0 109.625 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.64 76.53 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.832 -0.542 . . . . 0.0 109.849 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 42' ' ' VAL . 95.9 mt -68.91 -49.37 58.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.041 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 4' ' ' LEU . 53.6 t -55.04 -49.13 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -49.69 -54.39 19.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.466 1.106 . . . . 0.0 109.439 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.18 -34.86 47.07 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 60' ' ' TYR . 15.4 t -79.35 -42.48 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.21 -40.06 88.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.104 1.762 . . . . 0.0 109.191 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.4 -4.19 17.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.167 2.187 . . . . 0.0 111.892 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -110.64 2.21 18.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.723 1.209 . . . . 0.0 109.832 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.98 22.4 57.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.12 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 55' ' ' VAL . 64.3 m-85 -106.89 170.05 8.18 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -109.92 121.16 44.61 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.64 151.73 48.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.707 0.685 . . . . 0.0 109.92 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.91 125.91 15.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.24 153.16 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -111.34 18.83 18.86 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.061 0.945 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.465 1.106 . . . . 0.0 108.76 179.3 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 29.7 ttm . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mt -95.94 170.09 9.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.248 1.019 . . . . 0.0 110.241 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -138.93 129.13 25.45 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.739 1.616 . . . . 0.0 108.581 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.522 HD22 ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -125.76 156.3 39.66 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 127.53 2.332 . . . . 0.0 108.211 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -113.73 136.03 53.29 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.23 137.55 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 125.581 1.553 . . . . 0.0 108.093 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -132.98 128.77 37.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.69 -14.8 7.59 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.133 -1.37 . . . . 0.0 112.377 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 67.1 mtm -73.69 133.45 43.38 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.934 1.867 . . . . 0.0 106.828 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -126.72 -22.88 3.81 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.954 0.343 . . . . 0.0 111.658 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.2 m -139.32 167.69 21.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.749 1.62 . . . . 0.0 108.598 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -57.12 -37.57 72.18 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.093 0.957 . . . . 0.0 113.253 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -58.62 -33.06 69.61 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.2 m -62.97 -35.33 79.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.476 0.58 . . . . 0.0 110.503 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.85 -51.29 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.523 1.529 . . . . 0.0 109.568 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -63.84 -31.94 73.28 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.307 -0.871 . . . . 0.0 111.315 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.97 4.84 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.625 HG21 HG13 ' A' ' 55' ' ' VAL . 5.0 p -58.06 -35.13 51.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 111.764 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 m -56.58 -43.36 79.97 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -66.96 -44.71 79.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.192 -0.942 . . . . 0.0 111.262 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.87 97.53 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.446 0.641 . . . . 0.0 110.701 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -32.68 73.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.437 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -79.86 -4.85 53.99 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.658 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.37 -23.3 40.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.52 1.509 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.12 126.16 72.69 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 125.475 1.51 . . . . 0.0 111.503 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 110.59 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.705 2.27 . . . . 0.0 106.433 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.04 -1.43 7.81 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.315 1.912 . . . . 0.0 112.07 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.8 t -100.49 138.38 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 119.756 1.778 . . . . 0.0 110.886 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -123.17 -52.47 1.86 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.615 1.566 . . . . 0.0 110.308 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -128.01 149.1 50.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.3 165.81 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 125.275 1.609 . . . . 0.0 108.045 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -152.96 97.44 2.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.374 0.669 . . . . 0.0 110.678 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.2 156.4 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.951 -1.093 . . . . 0.0 108.853 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -144.63 135.62 25.01 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.87 0.868 . . . . 0.0 110.291 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.0 tp -66.56 -52.04 49.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.557 0.743 . . . . 0.0 109.838 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -53.99 -65.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.092 2.157 . . . . 0.0 112.187 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -69.35 -17.9 63.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.194 -0.908 . . . . 0.0 112.722 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.89 31.59 68.51 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.263 0.938 . . . . 0.0 111.097 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -122.1 156.98 32.47 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.922 0.889 . . . . 0.0 110.212 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.45 130.88 28.93 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.44 1.896 . . . . 0.0 109.64 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.04 158.05 34.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 1' ' ' MET . 95.3 t -136.67 142.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.484 1.114 . . . . 0.0 108.866 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -104.17 -17.61 14.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.655 0.782 . . . . 0.0 111.45 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.16 -177.83 21.95 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 t -90.37 2.49 55.53 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.231 -1.158 . . . . 0.0 111.746 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 149.94 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -82.02 148.23 59.93 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 124.684 1.194 . . . . 0.0 111.318 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.27 -41.08 44.7 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.078 1.852 . . . . 0.0 113.202 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -58.46 -40.82 83.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.02 0.528 . . . . 0.0 110.821 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.77 -32.38 67.62 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.024 0.829 . . . . 0.0 110.672 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 42' ' ' VAL . 96.3 mt -67.46 -56.19 10.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.485 1.114 . . . . 0.0 110.004 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.42 ' HB ' HD21 ' A' ' 4' ' ' LEU . 7.8 p -57.35 -42.81 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.877 0.762 . . . . 0.0 109.461 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -57.99 -41.61 83.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.679 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.75 -19.0 47.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.386 0.993 . . . . 0.0 112.57 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.625 HG13 HG21 ' A' ' 18' ' ' VAL . 19.5 t -94.04 -36.88 7.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 108.566 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -67.6 -31.11 70.93 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.71 -17.73 62.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.122 1.769 . . . . 0.0 110.602 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.19 -3.98 49.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.612 1.565 . . . . 0.0 110.258 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.8 10.42 63.06 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 125.185 1.374 . . . . 0.0 114.731 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.48 ' HB2' HG12 ' A' ' 55' ' ' VAL . 91.9 m-85 -98.56 -176.76 3.47 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.498 1.649 . . . . 0.0 108.415 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -122.27 119.37 30.96 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HB1' HD22 ' A' ' 4' ' ' LEU . . . -130.51 161.26 31.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.89 0.768 . . . . 0.0 110.355 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.471 ' C ' HD23 ' A' ' 4' ' ' LEU . 14.6 tt0 -156.86 138.48 14.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.211 1.404 . . . . 0.0 109.196 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.48 133.76 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.9 mt -88.86 24.11 2.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.023 0.929 . . . . 0.0 112.804 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.757 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.011 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ptm . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mt -77.06 162.34 27.58 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.25 150.04 52.32 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.775 0.83 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mt -144.1 155.82 44.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.215 2.206 . . . . 0.0 105.918 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -121.44 118.48 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.15 134.88 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.99 115.13 14.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.39 -6.29 4.25 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.533 2.016 . . . . 0.0 113.173 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 72.2 mtm -77.09 129.37 35.95 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.379 2.09 . . . . 0.0 107.132 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -141.04 16.08 2.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.0 0.818 . . . . 0.0 111.901 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t -156.17 156.92 35.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.616 1.566 . . . . 0.0 108.525 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.34 -35.72 74.38 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.989 0.916 . . . . 0.0 109.543 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -60.49 -36.04 77.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.45 0.7 . . . . 0.0 110.213 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.2 m -62.08 -47.01 86.56 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.35 -56.02 13.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.754 0.822 . . . . 0.0 110.436 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . 0.261 5.3 ppp? -62.57 -27.48 69.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.619 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.33 -51.29 15.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 108.278 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -56.21 -40.19 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.4 m -60.02 -45.22 93.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.981 0.913 . . . . 0.0 108.849 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -62.46 -47.0 85.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 121.009 -1.057 . . . . 0.0 111.01 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.83 84.09 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.4 mt -64.7 -39.05 93.0 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.899 -1.126 . . . . 0.0 110.055 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.682 ' HA ' HG11 ' A' ' 28' ' ' VAL . 47.0 mttm -72.82 -14.36 61.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.952 -1.092 . . . . 0.0 113.057 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -13.17 59.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.098 1.317 . . . . 0.0 110.722 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 28' ' ' VAL . 59.4 t -70.01 130.6 89.7 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.749 1.619 . . . . 0.0 111.978 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.4 106.4 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.101 2.534 . . . . 0.0 110.638 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.95 -8.09 6.4 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.316 0.96 . . . . 0.0 115.03 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.682 HG11 ' HA ' ' A' ' 23' ' ' LYS . 10.2 p -75.36 150.17 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.207 1.503 . . . . 0.0 111.242 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.2 -58.48 1.99 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.828 1.651 . . . . 0.0 107.287 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -144.63 155.4 43.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.857 1.263 . . . . 0.0 108.144 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' CG2' ' HE2' ' A' ' 23' ' ' LYS . 2.1 m -138.93 152.65 24.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.949 1.699 . . . . 0.0 109.919 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -138.28 88.97 2.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.722 2.009 . . . . 0.0 109.247 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.87 148.11 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -135.01 116.43 14.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.565 1.146 . . . . 0.0 113.056 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.46 -39.72 92.35 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.636 1.174 . . . . 0.0 110.193 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.98 -54.34 8.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.518 0.727 . . . . 0.0 110.759 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 -21.81 62.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.169 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.2 31.93 82.42 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.32 159.4 40.38 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.454 1.502 . . . . 0.0 107.147 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.63 122.66 12.83 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.57 148.08 28.69 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.67 123.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.658 0.783 . . . . 0.0 110.062 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 -19.92 27.29 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.58 -172.74 5.05 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.402 1.477 . . . . 0.0 114.44 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -113.34 8.81 18.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 158.03 15.2 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.908 0.776 . . . . 0.0 109.84 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 145.88 79.03 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 124.259 1.023 . . . . 0.0 111.97 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.23 -35.77 61.31 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.627 1.551 . . . . 0.0 112.941 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -38.5 89.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.056 0.389 . . . . 0.0 110.882 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.36 -38.08 56.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.857 0.463 . . . . 0.0 110.31 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.67 -53.44 58.04 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 125.151 1.38 . . . . 0.0 110.731 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.27 -44.63 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -54.65 -50.28 68.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.731 1.213 . . . . 0.0 113.162 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.82 68.86 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.76 -43.51 86.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.393 0.677 . . . . 0.0 109.353 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.82 -28.85 70.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.103 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -63.8 -35.29 80.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.823 0.738 . . . . 0.0 110.511 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -70.88 -17.29 62.72 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.695 -0.628 . . . . 0.0 109.862 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.34 -6.45 26.69 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 126.062 1.792 . . . . 0.0 114.692 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -77.27 166.41 23.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.943 1.872 . . . . 0.0 110.13 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -97.75 128.62 44.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.22 147.23 50.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.26 142.69 18.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.058 1.343 . . . . 0.0 107.637 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.99 149.91 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.452 1.101 . . . . 0.0 111.424 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -117.87 25.68 10.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.147 1.379 . . . . 0.0 110.213 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.761 2.024 . . . . 0.0 108.961 -179.06 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mt -77.92 148.06 34.72 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.071 0.463 . . . . 0.0 111.131 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.64 151.58 25.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 mt -147.9 143.55 27.46 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.061 1.345 . . . . 0.0 107.387 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -117.89 111.6 19.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.853 1.261 . . . . 0.0 108.327 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 158.87 3.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.3 134.97 13.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.35 -12.22 36.55 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.01 -1.439 . . . . 0.0 115.312 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.9 mtm -75.64 130.64 39.08 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.64 2.22 . . . . 0.0 108.612 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.29 0.6 OUTLIER -126.31 -1.2 6.98 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -149.77 157.91 43.66 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.1 1.36 . . . . 0.0 108.631 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.93 -28.72 58.12 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -63.94 -23.15 67.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.488 1.04 . . . . 0.0 111.209 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.63 -48.48 59.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.5 t -49.67 -58.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 125.935 1.694 . . . . 0.0 109.892 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.8 ptm -58.84 -26.67 64.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.69 -51.05 20.96 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.38 -41.42 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.888 1.675 . . . . 0.0 108.528 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.0 m -57.86 -59.05 5.84 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.231 0.923 . . . . 0.0 109.366 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -56.32 -39.11 72.25 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.314 0.645 . . . . 0.0 112.588 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.2 78.47 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.096 0.958 . . . . 0.0 108.783 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.03 -26.57 68.62 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.876 -1.765 . . . . 0.0 109.188 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.767 ' HA ' HG11 ' A' ' 28' ' ' VAL . 3.7 mtpm? -82.44 -9.6 59.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.789 0.836 . . . . 0.0 112.141 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.32 -12.26 60.23 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.41 1.005 . . . . 0.0 110.386 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 28' ' ' VAL . 37.8 t -78.16 123.42 86.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 126.755 2.022 . . . . 0.0 111.819 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.31 107.41 2.26 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.677 2.251 . . . . 0.0 110.766 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.16 -18.0 3.78 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.469 1.509 . . . . 0.0 112.166 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.767 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.9 p -72.2 161.76 4.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 120.873 -1.369 . . . . 0.0 109.675 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.78 -66.13 0.73 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -125.42 158.35 34.59 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 123.675 0.79 . . . . 0.0 110.189 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -150.73 164.11 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.908 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 144.75 26.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 t -144.2 136.77 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -134.01 114.84 13.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 118.362 0.528 . . . . 0.0 112.255 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 tp -56.98 -63.12 1.31 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.118 1.367 . . . . 0.0 112.049 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.47 -28.86 47.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.076 1.35 . . . . 0.0 114.53 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -82.32 -57.66 3.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.074 0.95 . . . . 0.0 109.08 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.43 26.16 7.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.944 1.735 . . . . 0.0 110.209 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -136.29 169.47 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.341 1.571 . . . . 0.0 111.49 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.61 152.58 44.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.439 1.896 . . . . 0.0 108.767 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.43 156.32 43.37 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.964 2.106 . . . . 0.0 108.853 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.1 t -137.63 147.59 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -125.0 -7.99 7.18 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.58 -155.52 23.07 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.385 0.993 . . . . 0.0 113.112 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -106.38 6.36 30.36 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.515 1.926 . . . . 0.0 111.773 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.13 148.04 23.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.929 . . . . 0.0 111.121 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.48 146.61 70.24 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.904 1.281 . . . . 0.0 109.131 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.74 -42.3 26.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.206 1.937 . . . . 0.0 112.395 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -57.5 -38.52 74.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.469 0.708 . . . . 0.0 111.341 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.04 52.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.707 0.685 . . . . 0.0 110.846 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.61 -49.13 69.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.87 0.868 . . . . 0.0 109.743 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.27 -49.97 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.151 -0.452 . . . . 0.0 109.963 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -28.28 67.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.606 0.639 . . . . 0.0 112.65 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.45 -34.42 75.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.543 -0.723 . . . . 0.0 110.232 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -78.63 -39.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.94 -31.25 71.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.97 -22.46 67.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.731 0.812 . . . . 0.0 112.222 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -86.05 -4.12 59.1 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.281 1.032 . . . . 0.0 112.574 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.94 38.44 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.781 -1.011 . . . . 0.0 113.702 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.37 166.42 12.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.662 1.231 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -103.52 138.84 39.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.14 49.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.19 137.26 19.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 66' ' ' ALA . 48.3 t -83.17 141.35 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.978 0.911 . . . . 0.0 108.726 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.41 39.87 3.02 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.567 1.147 . . . . 0.0 108.405 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.453 ' H ' HG12 ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.248 0.992 0 C-N-CA 125.958 1.703 . . . . 0.0 108.897 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ttt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mt -69.96 147.7 49.85 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.77 0.428 . . . . 0.0 111.113 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -120.77 136.94 54.75 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 mt -133.75 157.12 46.66 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.731 2.012 . . . . 0.0 109.217 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.0 122.41 44.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.645 1.578 . . . . 0.0 106.968 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -105.38 142.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -136.89 147.43 46.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.13 -19.85 47.42 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.457 1.504 . . . . 0.0 113.126 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.8 mtm -70.44 125.7 27.55 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.863 1.831 . . . . 0.0 111.2 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -129.8 6.1 5.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.163 0.985 . . . . 0.0 111.608 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.6 t -144.39 146.55 32.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.119 0.968 . . . . 0.0 108.862 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.93 -32.37 71.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.744 0.418 . . . . 0.0 110.727 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -58.59 -30.38 67.16 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.525 -0.734 . . . . 0.0 111.038 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 m -69.5 -40.15 77.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.41 0.684 . . . . 0.0 109.382 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.52 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.246 1.018 . . . . 0.0 108.658 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 ptm -58.84 -35.87 73.62 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.68 -55.36 20.57 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.099 0.863 . . . . 0.0 109.505 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -65.79 -27.29 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.913 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 m -62.12 -42.76 99.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -65.87 -34.54 78.38 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 120.798 -1.189 . . . . 0.0 110.169 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.45 81.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.36 -29.26 68.8 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.769 0.828 . . . . 0.0 110.11 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 28' ' ' VAL . 35.3 mttm -74.13 -10.58 59.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 117.877 -1.059 . . . . 0.0 112.834 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -81.56 -15.52 54.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.16 1.345 . . . . 0.0 111.024 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.25 128.08 90.58 Favored Pre-proline 0 N--CA 1.44 -0.94 0 C-N-CA 125.204 1.402 . . . . 0.0 112.022 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.6 109.18 1.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.415 2.076 . . . . 0.0 111.631 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.54 15.98 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.523 1.535 . . . . 0.0 113.178 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 23' ' ' LYS . 9.4 p -75.62 154.24 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 119.367 1.583 . . . . 0.0 108.471 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -130.92 -57.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -135.28 145.34 47.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.1 m -124.56 153.58 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 127.115 2.166 . . . . 0.0 107.817 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.42 115.89 5.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 40' ' ' ALA . 2.4 t -130.96 156.77 43.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 118.922 0.783 . . . . 0.0 109.777 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -145.04 137.89 26.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.4 -47.76 54.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.193 0.997 . . . . 0.0 110.049 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.72 -34.11 72.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.412 0.685 . . . . 0.0 112.699 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -92.56 -30.76 15.49 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.565 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.0 94.71 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 106.236 -2.746 . . . . 0.0 106.236 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.61 147.27 48.6 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.97 1.308 . . . . 0.0 108.626 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -127.89 128.65 45.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.01 2.124 . . . . 0.0 108.117 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.93 150.83 39.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.409 1.484 . . . . 0.0 108.684 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 44' ' ' GLY . 72.7 t -127.51 139.18 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 123.469 0.708 . . . . 0.0 109.555 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -106.42 1.49 25.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.591 1.156 . . . . 0.0 111.537 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.458 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -95.11 -151.37 28.26 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.706 1.622 . . . . 0.0 109.581 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 11.54 8.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.802 1.641 . . . . 0.0 112.578 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.28 149.99 2.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.682 1.193 . . . . 0.0 113.065 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.18 140.22 87.94 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.227 1.011 . . . . 0.0 109.659 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.59 -45.19 11.88 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.439 1.426 . . . . 0.0 110.164 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -57.05 -37.61 72.05 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.449 1.499 . . . . 0.0 112.018 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.86 31.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.386 0.539 . . . . 0.0 110.796 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.84 -51.22 50.93 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.286 -0.884 . . . . 0.0 108.75 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 p -60.08 -37.32 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.99 -50.26 71.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.134 0.974 . . . . 0.0 111.659 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.17 35.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.334 0.97 . . . . 0.0 113.423 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 90.2 t -74.14 -46.75 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.34 1.456 . . . . 0.0 108.618 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.57 -31.06 71.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.338 0.655 . . . . 0.0 110.378 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.56 -33.34 75.69 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -78.5 -17.51 56.15 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.4 -0.813 . . . . 0.0 108.866 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.89 5.95 35.15 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 117.241 -1.866 . . . . 0.0 117.074 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -96.32 160.42 14.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.067 1.933 . . . . 0.0 109.072 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -85.89 137.74 32.53 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.21 140.95 37.92 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.87 134.29 14.37 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.965 1.306 . . . . 0.0 108.608 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.42 131.29 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 127.062 2.145 . . . . 0.0 111.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt -98.82 37.6 1.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.856 1.262 . . . . 0.0 111.148 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.997 1.719 . . . . 0.0 107.957 178.769 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttt . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mt -67.79 149.49 49.85 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.249 0.477 . . . . 0.0 110.38 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -116.24 145.8 42.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.475 1.11 . . . . 0.0 109.518 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.19 139.15 28.57 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 108.947 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -105.14 111.16 23.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -88.41 162.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -152.47 122.51 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.24 -10.59 9.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.614 1.578 . . . . 0.0 113.547 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.5 mtm -73.99 122.39 22.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.586 2.193 . . . . 0.0 109.544 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.7 p -121.12 -12.17 8.74 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 m -137.11 165.49 25.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.925 0.89 . . . . 0.0 110.674 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -60.54 -27.74 67.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.449 1.099 . . . . 0.0 109.604 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -42.27 98.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -61.8 -40.76 96.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.055 0.388 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.68 -53.02 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.5 ptm -64.65 -43.58 93.16 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.893 0.77 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.0 -57.62 10.94 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.772 0.829 . . . . 0.0 110.177 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 55' ' ' VAL . 2.4 p -60.42 -38.28 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.595 HG22 ' HE2' ' A' ' 23' ' ' LYS . 50.0 m -57.97 -42.27 84.71 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.186 -0.947 . . . . 0.0 110.271 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.54 -43.9 79.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.969 . . . . 0.0 110.593 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.91 85.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 122.807 0.443 . . . . 0.0 110.131 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -62.49 -36.08 81.4 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.242 -1.536 . . . . 0.0 108.376 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.773 ' HA ' HG11 ' A' ' 28' ' ' VAL . 49.1 mttm -69.24 -7.28 35.36 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.742 -1.224 . . . . 0.0 112.381 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -73.15 -17.78 61.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.719 1.6 . . . . 0.0 110.723 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 28' ' ' VAL . 70.4 t -76.13 133.6 71.91 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.42 108.09 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.871 2.38 . . . . 0.0 112.846 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.46 -17.91 6.48 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.84 1.686 . . . . 0.0 113.174 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.773 HG11 ' HA ' ' A' ' 23' ' ' LYS . 12.9 p -62.33 144.34 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.475 1.637 . . . . 0.0 110.873 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -122.77 -54.49 1.84 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.097 0.959 . . . . 0.0 108.502 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -140.41 150.49 43.93 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 t -133.25 142.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.47 96.72 4.5 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 t -108.27 152.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 123.977 0.911 . . . . 0.0 109.321 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -146.67 138.2 24.44 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.467 0.576 . . . . 0.0 111.013 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.63 -52.21 41.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.466 1.106 . . . . 0.0 110.403 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -58.9 -38.12 78.15 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.699 1.6 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -86.39 -26.4 24.8 Favored 'General case' 0 N--CA 1.458 -0.067 0 O-C-N 121.988 -0.445 . . . . 0.0 110.623 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.43 35.23 88.22 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.47 158.42 43.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.69 135.3 48.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.801 2.04 . . . . 0.0 107.532 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -122.23 146.76 46.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.419 HG21 HD22 ' A' ' 51' ' ' LEU . 48.1 t -132.62 136.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 118.813 0.733 . . . . 0.0 109.444 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.6 -14.54 16.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.8 1.24 . . . . 0.0 111.432 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.83 -175.07 40.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.19 -0.944 . . . . 0.0 113.47 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.0 p -91.63 12.05 22.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.0 2.12 . . . . 0.0 110.236 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.75 149.17 14.95 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.549 -0.72 . . . . 0.0 111.134 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.03 142.97 60.54 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.304 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.0 -47.98 15.97 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.474 2.783 . . . . 0.0 112.799 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -58.73 -38.83 79.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.331 0.514 . . . . 0.0 110.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.22 -29.6 68.47 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.401 -0.812 . . . . 0.0 110.643 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD22 HG21 ' A' ' 42' ' ' VAL . 89.4 mt -65.22 -55.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -58.77 -42.81 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.67 -52.73 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.688 1.195 . . . . 0.0 110.257 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -22.91 60.11 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 18' ' ' VAL . 81.4 t -87.11 -38.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 120.806 -1.184 . . . . 0.0 108.245 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.47 -31.44 68.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.48 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.22 -22.79 67.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.179 0.9 . . . . 0.0 110.559 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.89 -12.49 47.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.978 1.311 . . . . 0.0 110.235 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.44 -3.93 40.18 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.218 1.389 . . . . 0.0 116.04 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -81.73 165.2 21.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.192 1.996 . . . . 0.0 109.641 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.18 114.01 25.67 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.62 156.83 33.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.75 139.36 15.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.959 0.904 . . . . 0.0 109.118 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.7 t -78.91 140.53 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.93 50.87 0.76 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.914 0.885 . . . . 0.0 108.719 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.443 0 C-N-CA 127.168 2.187 . . . . 0.0 108.607 179.239 . . . . . . . . 0 0 . 1 stop_ save_